data_1r21_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1r21 _Structure_validation_residue.Date_analyzed 2017-03-24 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.2 mtp . . . . . 0 N--CA 1.496 1.828 0 N-CA-C 108.554 -0.906 . . . . 8.53 108.554 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.738 ' CD1' ' N ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -119.46 77.68 19.44 Favored Pre-proline 0 N--CA 1.446 -0.642 0 CA-C-N 115.225 -0.898 . . . . 7.41 110.768 -178.828 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -62.86 -24.5 74.35 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.742 1.628 . . . . 6.03 109.18 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 37.62 93.22 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 113.761 -1.563 . . . . 3.01 112.359 178.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.584 ' NH2' ' O ' ' A' ' 55' ' ' GLU . 87.0 mtt180 -105.48 99.57 9.17 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 105.592 -2.003 . . . . 2.65 105.592 176.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -99.12 145.05 27.57 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 113.812 1.041 . . . . 3.5 113.812 -175.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.401 ' HA ' ' O ' ' A' ' 96' ' ' ARG . 48.3 mt -110.96 106.1 15.1 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 107.502 -1.296 . . . . 2.0 107.502 175.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 76.1 t -96.22 130.11 45.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.795 -0.446 . . . . 1.21 109.795 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.477 ' OG1' ' CE2' ' A' ' 95' ' ' PHE . 89.9 m -101.51 113.05 25.82 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.673 -0.694 . . . . 1.25 109.93 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 92.5 mt -66.92 120.68 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 108.171 -1.048 . . . . 1.48 108.171 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -58.41 -59.43 5.37 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.157 0.503 . . . . 3.5 109.958 -178.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 12' ' ' ARG . 6.9 ttp180 -143.74 179.85 6.9 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.333 -0.849 . . . . 6.06 109.039 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.23 101.36 0.71 Allowed 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 112.11 0.411 . . . . 4.19 112.11 -178.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 128.51 -25.56 4.76 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 120.125 -1.036 . . . . 3.27 115.267 177.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.67 156.34 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 118.938 1.369 . . . . 3.42 113.683 -177.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -80.27 141.75 35.23 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 114.486 -1.233 . . . . 2.09 109.987 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -111.14 -165.4 18.52 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.729 -0.948 . . . . 1.08 110.729 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.45 144.97 99.26 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.821 2.347 . . . . 1.45 111.688 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.424 ' CD2' ' N ' ' A' ' 19' ' ' HIS . 18.0 m170 -90.67 166.92 12.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.261 -0.427 . . . . 1.55 110.736 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.503 ' CZ ' ' O ' ' A' ' 36' ' ' ASP . 63.2 t80 -138.02 91.86 12.91 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.6 111.443 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.39 143.99 99.5 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 122.47 2.113 . . . . 1.33 111.443 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.419 ' CD2' ' SG ' ' A' ' 27' ' ' CYS . 83.0 mt -93.46 111.94 23.72 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.165 -0.614 . . . . 1.95 111.232 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.4 m -101.33 -22.82 14.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.817 -0.629 . . . . 1.7 109.341 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 89.4 mt -113.42 144.84 42.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.393 -0.822 . . . . 2.22 110.475 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.0 p -67.04 -16.8 64.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.004 -0.544 . . . . 1.03 110.784 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.5 p -118.28 122.58 43.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.473 -0.33 . . . . 1.11 111.352 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.419 ' SG ' ' CD2' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -105.29 127.59 53.03 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.136 -0.484 . . . . 1.29 110.515 179.306 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.421 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 53.0 tp -118.78 141.47 48.6 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.153 -0.476 . . . . 1.32 110.993 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.552 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 14.7 m-85 -111.03 144.65 39.81 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.804 -0.634 . . . . 0.52 111.199 -178.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 46' ' ' LYS . . . 144.03 168.89 12.62 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.169 -1.015 . . . . 0.34 113.142 178.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -64.16 -40.53 96.32 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.681 -0.759 . . . . 3.53 111.386 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -48.45 139.08 12.23 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.117 -0.793 . . . . 0.6 111.117 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.6 tt -64.78 -26.48 40.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.206 0.527 . . . . 1.76 109.72 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.1 -16.68 54.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.506 -0.77 . . . . 1.68 110.579 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 15.9 m -78.66 130.72 36.18 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.82 0.343 . . . . 0.48 110.761 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.503 ' O ' ' CZ ' ' A' ' 20' ' ' PHE . 25.7 m-20 -62.58 -36.56 83.07 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 109.061 -0.718 . . . . 1.4 109.061 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.463 ' CG2' ' CE2' ' A' ' 95' ' ' PHE . 3.3 mm -106.34 83.49 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.146 -0.934 . . . . 1.19 109.029 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -66.4 130.11 42.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.016 -0.993 . . . . 2.71 111.412 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 97.3 mt -125.28 127.54 72.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.968 -0.56 . . . . 1.12 110.513 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -97.5 81.17 2.93 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.364 -0.534 . . . . 3.2 110.972 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -156.36 116.3 2.14 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.733 -0.667 . . . . 1.96 109.574 178.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -50.96 -36.78 54.69 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 122.559 2.173 . . . . 1.11 113.225 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.9 m -62.89 -39.54 85.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.832 -0.347 . . . . 1.11 111.565 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.1 t -68.57 140.91 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 110.158 -0.312 . . . . 1.1 110.158 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.503 ' H ' ' HD1' ' A' ' 48' ' ' HIS . 5.8 m -82.37 163.95 21.37 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.271 0.471 . . . . 1.78 112.271 -178.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.461 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 98.7 mttt -62.56 -40.8 98.01 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.374 0.607 . . . . 2.52 109.965 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -124.14 56.49 1.25 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.802 -1.184 . . . . 1.92 107.802 178.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.513 ' CD2' HG23 ' A' ' 90' ' ' ILE . 16.9 t60 -60.31 -51.3 70.11 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.576 -1.193 . . . . 0.29 112.256 -177.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.552 ' SG ' ' CD1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -149.55 160.32 43.58 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.597 -0.441 . . . . 1.48 110.887 -179.245 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.608 ' O ' ' N ' ' A' ' 61' ' ' HIS . 70.0 tttt -143.37 131.83 22.26 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.969 -0.559 . . . . 1.98 112.063 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 90.8 mt -105.65 112.89 40.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.893 -0.594 . . . . 1.5 109.609 178.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -95.15 115.1 26.99 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.592 -0.521 . . . . 1.47 109.592 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -78.88 132.67 31.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.593 -0.731 . . . . 2.04 111.683 -178.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' A' ' 57' ' ' GLU . 13.2 m-70 -114.05 173.91 6.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.368 -0.833 . . . . 2.6 110.247 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.584 ' O ' ' NH2' ' A' ' 5' ' ' ARG . 80.3 mm-40 -37.75 -42.3 0.57 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.514 -0.766 . . . . 2.29 111.176 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.427 ' HA ' ' NH2' ' A' ' 5' ' ' ARG . 99.3 mt-30 -145.97 13.27 1.29 Allowed 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.757 -0.377 . . . . 3.23 111.886 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.507 ' O ' ' N ' ' A' ' 54' ' ' HIS . 80.3 mm-40 -140.86 151.07 44.03 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 119.918 -0.713 . . . . 2.33 112.866 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -106.45 128.68 54.25 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 108.027 -1.101 . . . . 1.08 108.027 177.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.437 HD13 HG21 ' A' ' 59' ' ' ILE . 41.6 mm -118.4 126.31 74.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.568 -0.453 . . . . 1.43 111.951 -177.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.426 ' HG ' ' N ' ' A' ' 61' ' ' HIS . 4.6 tp -78.73 145.73 34.31 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.996 -0.547 . . . . 1.57 110.887 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.608 ' N ' ' O ' ' A' ' 50' ' ' LYS . 33.7 m-70 -137.74 78.64 1.7 Allowed 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.35 0.595 . . . . 0.59 109.577 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.727 ' ND2' ' H ' ' A' ' 69' ' ' THR . 25.4 t-20 -71.46 133.33 45.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.097 -0.956 . . . . 1.15 112.195 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.534 ' CE1' ' O ' ' A' ' 61' ' ' HIS . 14.5 m-85 -108.87 -29.6 8.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.504 -0.771 . . . . 0.5 110.732 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.6 t -64.92 136.82 57.28 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.203 -0.453 . . . . 1.86 111.749 -178.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.9 p -104.08 -54.69 2.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.918 -0.583 . . . . 1.88 110.96 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.29 -46.89 86.74 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.86 0.362 . . . . 1.9 110.532 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.565 ' OD1' ' N ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -118.29 80.59 16.07 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.36 -0.607 . . . . 1.16 109.36 179.298 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -73.5 149.93 45.13 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.463 2.109 . . . . 0.35 112.902 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.727 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 92.6 m -65.76 162.59 18.39 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.073 -1.084 . . . . 0.95 108.073 178.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.427 ' N ' ' O ' ' A' ' 89' ' ' THR . 98.3 mt-30 -130.24 147.19 51.94 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.428 -0.509 . . . . 1.15 112.151 -177.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.407 ' O ' ' N ' ' A' ' 74' ' ' SER . 41.9 t -128.8 131.77 68.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.541 -0.754 . . . . 1.52 110.453 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 46.52 29.67 0.95 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.062 -0.517 . . . . 1.24 110.71 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.56 20.16 69.51 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.457 -0.657 . . . . 0.62 111.457 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 71' ' ' VAL . 29.3 t -118.22 130.96 56.38 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.091 -0.337 . . . . 1.87 110.091 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.401 HG13 ' N ' ' A' ' 76' ' ' ILE . 49.4 t -66.38 143.93 15.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.425 0.631 . . . . 1.38 110.734 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.401 ' N ' HG13 ' A' ' 75' ' ' VAL . 70.4 mt -107.59 110.06 30.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 114.871 -1.059 . . . . 1.56 111.361 -178.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -76.51 -43.24 40.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.037 0.446 . . . . 1.9 110.675 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -142.63 175.29 3.01 Favored Pre-proline 0 C--N 1.332 -0.16 0 CA-C-N 115.618 -0.719 . . . . 1.83 109.489 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -51.98 137.89 52.71 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 121.861 1.707 . . . . 0.32 110.99 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.7 m -134.71 162.78 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 121.293 0.568 . . . . 1.12 112.102 -178.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 6.4 ttt180 -84.98 141.72 30.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.393 -0.821 . . . . 2.95 110.345 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 13.0 mt -112.64 148.02 35.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.367 0.603 . . . . 1.75 112.428 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.505 ' N ' ' OD2' ' A' ' 86' ' ' ASP . 98.0 mttt -107.46 158.98 16.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.978 -1.01 . . . . 3.24 108.789 177.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.714 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 28.2 t60 -64.52 130.11 42.44 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.343 -0.543 . . . . 1.0 110.378 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 94.02 0.19 66.22 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.403 -0.679 . . . . 0.45 111.403 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.505 ' OD2' ' N ' ' A' ' 83' ' ' LYS . 82.4 m-20 -67.73 147.01 53.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.743 0.306 . . . . 1.85 110.591 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.4 t -111.97 130.1 66.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.159 -0.473 . . . . 1.85 110.711 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 68.5 mt -108.59 132.46 56.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.245 -0.65 . . . . 1.28 109.245 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.427 ' O ' ' N ' ' A' ' 70' ' ' GLN . 56.0 m -129.23 130.49 46.34 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.114 0.483 . . . . 1.21 111.379 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.776 ' CG2' ' H ' ' A' ' 91' ' ' ILE . 89.9 mt -97.56 -146.55 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 108.292 -1.003 . . . . 1.53 108.292 178.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.776 ' H ' ' CG2' ' A' ' 90' ' ' ILE . 89.5 mt -64.93 -44.16 96.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 118.63 0.65 . . . . 1.26 112.433 -178.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.528 ' OD1' ' O ' ' A' ' 91' ' ' ILE . 82.1 m-20 -142.65 10.17 1.81 Allowed 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.738 0.644 . . . . 1.94 112.738 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 17.3 mtp180 -129.11 158.2 39.61 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.208 -0.597 . . . . 2.42 110.816 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 69.3 m -129.06 145.05 51.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.787 -0.642 . . . . 1.8 111.514 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.477 ' CE2' ' OG1' ' A' ' 9' ' ' THR . 57.3 m-85 -129.27 146.95 51.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.354 -0.839 . . . . 0.45 109.856 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 7' ' ' LEU . 78.2 mtp180 -115.8 136.23 53.25 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.21 -0.45 . . . . 2.57 109.877 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.497 ' C ' ' CD1' ' A' ' 97' ' ' TYR . 0.4 OUTLIER -110.21 106.36 15.76 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.483 -0.562 . . . . 0.94 109.483 179.53 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -117.24 123.83 47.57 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.912 -0.585 . . . . 1.93 112.507 -178.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.714 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 63.0 t-20 -110.42 102.15 10.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.296 -0.865 . . . . 1.86 109.487 178.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 . . . . . 0 C--N 1.327 -0.384 0 CA-C-O 121.034 0.445 . . . . 2.71 111.196 -179.384 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.1 mtp . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -154.93 70.49 5.77 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.957 0.408 . . . . 0.0 110.549 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.85 142.9 99.48 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.749 2.3 . . . . 0.0 112.239 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.689 ' HG1' ' N ' ' A' ' 5' ' ' ARG . 2.4 t -145.69 161.22 40.37 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.294 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.689 ' N ' ' HG1' ' A' ' 4' ' ' THR . 99.5 mtt180 -68.27 138.53 55.58 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -137.34 149.83 47.3 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.051 -0.66 . . . . 0.0 111.365 -178.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 67.9 mt -113.31 130.25 56.31 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.033 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.6 t -113.7 133.49 59.5 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.357 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.0 m -98.35 109.57 22.31 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.705 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.55 ' CD1' ' NE ' ' A' ' 96' ' ' ARG . 96.4 mt -70.32 128.27 33.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -120.16 152.66 37.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.169 0.509 . . . . 0.0 111.424 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 96.6 mtt-85 50.05 25.72 1.8 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.146 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 35.19 36.28 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.345 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -138.54 -100.82 0.52 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.1 t -72.77 141.25 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-O 120.877 0.37 . . . . 0.0 110.055 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -63.74 138.49 58.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.041 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -101.17 -163.87 27.59 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.49 146.52 94.8 Favored 'Trans proline' 0 C--N 1.302 -1.897 0 C-N-CA 123.282 2.655 . . . . 0.0 111.968 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.413 ' CD2' ' N ' ' A' ' 19' ' ' HIS . 7.5 m170 -96.69 174.36 6.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.002 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -134.13 120.65 15.16 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.562 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -73.99 151.89 45.47 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 122.123 1.882 . . . . 0.0 112.487 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.522 ' CD1' ' SG ' ' A' ' 27' ' ' CYS . 47.5 tp -109.48 122.09 46.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.37 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.1 p -130.4 -43.0 1.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.008 0.432 . . . . 0.0 110.458 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.545 ' N ' ' CD2' ' A' ' 24' ' ' LEU . 3.9 mm? -80.14 140.74 36.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.395 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 77.5 p -66.56 -20.35 66.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.283 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.484 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 7.3 p -120.6 115.05 22.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.724 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.522 ' SG ' ' CD1' ' A' ' 22' ' ' LEU . 1.7 m -98.63 123.32 42.76 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.908 0.385 . . . . 0.0 110.105 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.405 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 58.9 tp -114.78 140.36 48.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.742 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -110.24 147.65 33.39 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.774 -177.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 138.4 168.94 11.44 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.752 178.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 77.0 mtp85 -63.85 -40.27 96.18 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.149 -0.526 . . . . 0.0 111.568 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.566 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -46.72 148.81 2.49 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.431 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 20.1 tt -66.4 -39.33 83.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.431 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 14.1 pt-20 -54.94 -10.14 0.45 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.903 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.566 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 3.5 m -81.09 120.34 24.7 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.484 ' OD2' ' O ' ' A' ' 26' ' ' THR . 98.7 m-20 -62.09 -34.61 76.63 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.4 mm -108.42 83.89 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.596 178.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -66.86 130.6 43.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.372 -177.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.457 HG22 HH11 ' A' ' 93' ' ' ARG . 96.9 mt -122.36 127.23 75.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.081 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -97.99 81.51 2.86 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.632 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -154.91 118.55 2.51 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.953 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -52.14 -33.63 54.76 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.725 1.617 . . . . 0.0 112.121 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.2 m -64.14 -37.61 80.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.809 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 64.7 t -74.24 142.04 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.153 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.609 ' H ' ' HD1' ' A' ' 48' ' ' HIS . 11.2 m -82.8 166.44 19.01 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.854 0.359 . . . . 0.0 111.54 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -62.13 -39.23 91.87 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.426 0.632 . . . . 0.0 109.364 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -125.36 58.28 1.29 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.609 ' HD1' ' H ' ' A' ' 45' ' ' SER . 13.2 t60 -59.74 -50.62 73.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.828 -177.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.653 ' SG ' ' N ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -152.96 165.23 36.19 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.151 -179.625 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.653 ' N ' ' SG ' ' A' ' 49' ' ' CYS . 70.4 tttt -141.59 129.8 22.23 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.836 -179.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.443 ' N ' ' CD1' ' A' ' 51' ' ' ILE . 1.3 mp -103.68 103.56 15.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.422 178.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 59' ' ' ILE . 78.9 tt0 -86.33 135.56 33.48 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.483 ' CG2' ' O ' ' A' ' 53' ' ' ILE . 4.1 tp -91.82 124.76 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.353 -178.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.417 ' N ' ' O ' ' A' ' 57' ' ' GLU . 14.5 m-70 -113.48 144.02 43.54 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.247 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -36.64 -52.52 0.88 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.081 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 64.1 tp60 -79.83 -38.13 33.57 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' A' ' 54' ' ' HIS . 93.6 mt-10 -153.26 -171.16 3.83 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.077 0.465 . . . . 0.0 111.675 -179.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.479 ' CB ' ' CZ ' ' A' ' 97' ' ' TYR . . . -107.84 144.78 34.55 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.51 ' O ' ' N ' ' A' ' 52' ' ' GLU . 2.0 mp -124.74 134.73 66.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -178.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.6 tt -82.07 152.29 26.66 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.979 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.544 ' N ' ' O ' ' A' ' 50' ' ' LYS . 23.8 m-70 -144.4 78.72 1.59 Allowed 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 121.372 0.606 . . . . 0.0 110.378 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.725 ' ND2' ' H ' ' A' ' 69' ' ' THR . 23.7 t-20 -70.62 133.24 46.52 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.032 -0.986 . . . . 0.0 112.728 -179.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.471 ' CE2' ' O ' ' A' ' 61' ' ' HIS . 20.3 m-85 -112.28 -14.26 13.36 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.572 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.607 ' HG ' HD22 ' A' ' 62' ' ' ASN . 25.3 p -74.04 148.97 41.48 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.814 0.34 . . . . 0.0 111.041 -178.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.4 m -115.11 -59.34 2.03 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.069 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.501 ' OG1' ' OD1' ' A' ' 67' ' ' ASN . 62.1 p -64.67 -33.42 75.9 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.457 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.501 ' OD1' ' OG1' ' A' ' 66' ' ' THR . 0.0 OUTLIER -127.02 82.1 68.71 Favored Pre-proline 0 C--N 1.332 -0.168 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.356 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -74.81 147.43 34.78 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 121.882 1.721 . . . . 0.0 112.678 -178.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.725 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 59.6 m -67.38 162.58 22.64 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 89' ' ' THR . 84.7 mt-30 -131.83 147.07 52.46 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.079 -0.648 . . . . 0.0 111.706 -178.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.515 ' O ' ' OG ' ' A' ' 74' ' ' SER . 22.8 t -127.17 131.91 70.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.122 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 9.9 m120 49.51 26.0 1.56 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.237 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.4 -7.69 81.04 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.276 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.515 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 24.2 p -84.71 174.29 10.03 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 54.2 t -108.53 139.86 29.34 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-O 121.552 0.691 . . . . 0.0 109.823 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 73.3 mt -105.5 116.62 49.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.236 -178.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 21.0 p-10 -110.37 2.31 18.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.25 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.32 169.66 3.06 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.274 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.47 138.78 81.21 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 121.511 1.474 . . . . 0.0 111.283 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.3 m -137.74 157.85 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.136 0.493 . . . . 0.0 112.017 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -81.3 135.91 35.74 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.412 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 75.9 mt -109.03 127.6 54.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.164 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.608 ' N ' ' OD2' ' A' ' 86' ' ' ASP . 98.4 mttt -84.67 159.99 20.45 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.42 178.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.815 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 71.0 t60 -64.86 131.15 45.94 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.568 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.0 8.08 76.39 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.369 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.608 ' OD2' ' N ' ' A' ' 83' ' ' LYS . 91.9 m-20 -72.71 164.44 26.53 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 117.007 0.403 . . . . 0.0 110.455 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.2 p -123.78 133.84 68.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-O 121.108 0.48 . . . . 0.0 111.025 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 88.0 mt -107.72 132.88 54.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.853 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.408 ' O ' ' N ' ' A' ' 70' ' ' GLN . 73.7 m -128.78 127.49 42.1 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.262 0.553 . . . . 0.0 111.59 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.742 ' CG2' ' H ' ' A' ' 91' ' ' ILE . 78.3 mt -97.79 -150.46 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.742 ' H ' ' CG2' ' A' ' 90' ' ' ILE . 86.9 mt -62.71 -44.66 99.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 119.293 0.952 . . . . 0.0 112.987 -178.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -143.47 18.2 1.87 Allowed 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 119.694 -0.802 . . . . 0.0 112.502 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.457 HH11 HG22 ' A' ' 39' ' ' ILE . 78.4 mtp180 -136.74 162.31 33.54 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.476 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 57.7 m -132.83 145.72 51.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.774 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -130.8 145.69 52.04 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.852 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.55 ' NE ' ' CD1' ' A' ' 10' ' ' ILE . 89.5 mtt180 -108.56 137.29 46.76 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.302 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.517 ' OH ' ' ND2' ' A' ' 99' ' ' ASN . 3.2 t80 -117.93 105.73 12.22 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -134.74 140.39 45.9 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 120.397 -0.521 . . . . 0.0 111.362 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.815 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 83.0 m-20 -117.23 124.3 48.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.706 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 C--N 1.33 -0.277 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.115 179.073 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.6 mtp . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.64 ' CD2' ' N ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER 52.17 53.16 12.32 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.305 0.574 . . . . 0.0 111.051 179.885 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 2' ' ' TRP . 44.8 Cg_endo -67.96 -26.6 37.42 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.937 2.425 . . . . 0.0 112.502 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.8 p -132.99 172.51 12.53 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.814 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.651 HH21 ' CG2' ' A' ' 53' ' ' ILE . 86.0 mtm-85 -67.59 147.24 53.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.153 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 63.1 ttm-85 -135.75 142.3 44.95 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.994 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 16.4 tp -112.05 132.04 55.06 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.526 ' CG1' ' HE ' ' A' ' 96' ' ' ARG . 48.6 t -119.22 133.63 65.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.944 0.402 . . . . 0.0 110.885 -178.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.492 ' OG1' ' CE2' ' A' ' 95' ' ' PHE . 98.1 m -104.41 116.44 32.13 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.492 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 92.5 mt -79.42 124.41 37.62 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 CA-C-O 121.077 0.465 . . . . 0.0 110.266 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -65.24 -48.84 71.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.881 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -154.55 154.59 33.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.66 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.7 p 44.39 -127.52 0.99 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.954 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -119.3 67.29 0.39 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.9 m -129.24 163.62 33.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.831 0.348 . . . . 0.0 110.537 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.427 ' C ' ' OD1' ' A' ' 16' ' ' ASP . 60.9 t0 -81.8 115.54 21.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.241 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -108.01 -152.49 16.88 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -60.89 144.59 99.6 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 122.747 2.298 . . . . 0.0 112.305 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 8.3 m170 -103.18 169.77 8.36 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.962 0.41 . . . . 0.0 110.747 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.596 ' CZ ' ' O ' ' A' ' 36' ' ' ASP . 31.5 t80 -149.69 92.97 4.08 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.367 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -58.3 140.63 95.12 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 121.546 1.497 . . . . 0.0 110.299 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 94.5 mt -91.48 88.1 6.66 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.947 0.403 . . . . 0.0 111.485 -178.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 70.7 m -90.14 -18.9 24.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.548 178.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.7 mt -113.4 139.88 48.53 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.769 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.463 ' O ' ' N ' ' A' ' 53' ' ' ILE . 86.1 p -68.22 -17.86 64.42 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.489 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.448 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 39.6 p -116.61 109.14 16.82 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.993 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.448 ' O ' ' N ' ' A' ' 51' ' ' ILE . 3.4 t -99.59 119.03 37.41 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.147 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.427 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 4.2 tt -116.82 149.86 39.31 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.126 0.489 . . . . 0.0 112.308 -178.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -113.23 138.54 49.84 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.929 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 158.68 167.22 19.15 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 119.432 -1.366 . . . . 0.0 113.155 178.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -65.21 -36.53 84.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.661 -0.769 . . . . 0.0 111.11 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.467 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -59.55 145.21 45.3 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.581 ' C ' ' H ' ' A' ' 35' ' ' CYS . 18.7 tt -66.38 -38.8 82.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.901 0.381 . . . . 0.0 110.13 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -48.0 -11.01 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.967 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.581 ' H ' ' C ' ' A' ' 33' ' ' ILE . 25.4 m -82.4 131.71 35.22 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.051 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.596 ' O ' ' CZ ' ' A' ' 20' ' ' PHE . 56.4 m-20 -62.38 -38.04 88.08 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.9 mm -110.53 87.42 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.704 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -71.43 129.96 40.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.08 -179.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.41 HG21 HD11 ' A' ' 39' ' ' ILE . 96.7 mt -118.3 121.82 68.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.739 179.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -97.19 81.41 3.03 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.559 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.408 ' CD2' ' OD2' ' A' ' 92' ' ' ASP . 1.1 tp -154.83 129.87 5.08 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.065 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -65.27 -21.74 61.4 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 121.745 1.63 . . . . 0.0 112.525 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.491 ' O ' ' CD1' ' A' ' 91' ' ' ILE . 33.9 m -71.73 -29.41 34.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.031 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.419 ' CG1' ' N ' ' A' ' 45' ' ' SER . 95.6 t -85.14 160.64 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 120.924 -0.311 . . . . 0.0 110.203 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.419 ' N ' ' CG1' ' A' ' 44' ' ' VAL . 7.9 t -98.17 160.89 14.0 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.891 -179.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -62.39 -39.77 94.3 Favored 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -122.71 74.69 1.21 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 178.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 24.5 t60 -76.16 -66.92 0.74 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.778 -177.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 21.1 p -155.36 173.06 17.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.423 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -155.84 139.56 16.09 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 119.073 -1.051 . . . . 0.0 112.765 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.448 ' N ' ' O ' ' A' ' 27' ' ' CYS . 88.7 mt -100.02 109.53 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.519 177.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -86.3 120.79 28.03 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.651 ' CG2' HH21 ' A' ' 5' ' ' ARG . 1.5 mp -88.18 125.82 41.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.829 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.413 ' N ' ' O ' ' A' ' 57' ' ' GLU . 52.9 m-70 -110.43 177.3 4.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.202 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -40.19 -45.22 2.0 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.3 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -146.07 21.73 1.4 Allowed 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.631 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.596 ' OE2' ' NH2' ' A' ' 81' ' ' ARG . 90.9 mt-10 -143.26 148.37 36.29 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.517 0.675 . . . . 0.0 112.407 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.44 126.8 55.69 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 177.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.41 HG21 HD11 ' A' ' 59' ' ' ILE . 50.3 mm -120.01 130.31 74.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.928 0.394 . . . . 0.0 111.158 -177.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 31.2 tp -90.99 140.28 29.98 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.996 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -135.32 78.4 1.73 Allowed 'General case' 0 C--O 1.231 0.103 0 CA-C-O 121.393 0.616 . . . . 0.0 109.512 178.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.699 ' ND2' ' H ' ' A' ' 69' ' ' THR . 23.9 t-20 -62.7 135.93 57.62 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.82 -179.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -105.88 -33.56 7.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.074 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.9 m -66.18 140.72 58.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.492 -177.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.753 ' HG ' ' H ' ' A' ' 66' ' ' THR . 52.9 p -109.06 -53.5 2.64 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.979 178.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.753 ' H ' ' HG ' ' A' ' 65' ' ' SER . 28.0 m -62.99 -45.69 91.22 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.205 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.486 ' OD1' ' N ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -119.62 78.88 21.84 Favored Pre-proline 0 C--N 1.331 -0.23 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.598 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -75.14 147.21 33.11 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.251 1.967 . . . . 0.0 113.7 -178.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.699 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 85.3 m -63.29 160.8 15.07 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -130.1 148.9 52.0 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.755 -177.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.4 t -126.31 127.74 70.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.159 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.411 ' ND2' ' OD1' ' A' ' 86' ' ' ASP . 73.5 m-20 46.68 31.33 1.36 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.225 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 84.04 15.39 69.89 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 121.111 -0.566 . . . . 0.0 111.812 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.2 t -115.41 134.69 54.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.964 0.411 . . . . 0.0 110.63 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 74.8 t -66.77 145.68 13.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.511 0.672 . . . . 0.0 111.007 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 95.5 mt -110.25 114.1 46.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.205 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -94.87 -27.03 15.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.107 0.48 . . . . 0.0 110.342 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -147.87 171.79 5.92 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.452 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.9 139.46 84.34 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 121.596 1.531 . . . . 0.0 111.169 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 31.5 m -134.7 161.28 40.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.969 0.414 . . . . 0.0 111.35 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.596 ' NH2' ' OE2' ' A' ' 57' ' ' GLU . 72.9 ttt180 -87.82 138.58 31.33 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.412 HD13 ' N ' ' A' ' 82' ' ' LEU . 5.4 mp -104.08 136.8 43.04 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.042 0.449 . . . . 0.0 111.05 -178.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -96.57 169.97 9.53 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.863 ' HD1' ' H ' ' A' ' 99' ' ' ASN . 84.8 t60 -68.41 131.85 46.02 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 119.949 -0.701 . . . . 0.0 109.995 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.81 18.21 66.11 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.411 ' OD1' ' ND2' ' A' ' 72' ' ' ASN . 28.8 t70 -74.24 149.48 40.78 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.83 0.348 . . . . 0.0 110.771 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 39.6 t -115.6 131.61 67.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.335 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.402 ' N ' ' O ' ' A' ' 95' ' ' PHE . 83.0 mt -118.52 133.88 63.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.977 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 96.5 m -129.83 129.01 43.46 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.774 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.757 ' CG2' ' H ' ' A' ' 91' ' ' ILE . 39.4 mt -94.34 -145.48 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 178.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.757 ' H ' ' CG2' ' A' ' 90' ' ' ILE . 90.2 mt -62.98 -44.55 99.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 118.693 0.678 . . . . 0.0 112.097 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.408 ' OD2' ' CD2' ' A' ' 41' ' ' LEU . 45.4 p-10 -148.16 17.91 1.08 Allowed 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.246 -0.581 . . . . 0.0 111.624 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 96.6 mtt-85 -123.67 154.46 39.36 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.581 -0.447 . . . . 0.0 110.57 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.5 p -125.24 131.9 53.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.122 0.487 . . . . 0.0 111.475 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.492 ' CE2' ' OG1' ' A' ' 9' ' ' THR . 88.4 m-85 -130.05 145.49 51.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.286 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.526 ' HE ' ' CG1' ' A' ' 8' ' ' VAL . 20.6 ptt85 -134.54 130.83 37.17 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.476 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -99.32 127.26 45.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.402 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -142.83 135.85 28.17 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.352 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.863 ' H ' ' HD1' ' A' ' 84' ' ' HIS . 47.9 t30 -119.5 105.45 11.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.107 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.544 ' OE1' ' CD1' ' A' ' 2' ' ' TRP . 98.2 mt-10 . . . . . 0 C--N 1.328 -0.352 0 CA-C-O 120.935 0.398 . . . . 0.0 110.843 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.459 ' O ' ' CG ' ' A' ' 2' ' ' TRP . 98.6 mtp . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.459 ' CG ' ' O ' ' A' ' 1' ' ' MET . 30.5 m95 -167.97 66.47 0.75 Allowed Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -71.09 145.36 49.35 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.79 2.327 . . . . 0.0 112.957 -178.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 65.2 p -120.12 19.66 12.2 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.236 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 -97.74 134.4 40.96 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.637 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -137.43 143.69 41.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.879 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 9.9 tp -109.62 129.87 55.55 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 51.0 t -117.47 139.33 44.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.138 0.494 . . . . 0.0 111.452 -177.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.487 ' OG1' ' CE2' ' A' ' 95' ' ' PHE . 93.7 m -108.65 119.15 38.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.106 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 86.1 mt -81.06 124.74 39.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.854 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.429 ' O ' ' C ' ' A' ' 12' ' ' ARG . 88.1 tttt -75.02 140.48 43.61 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.875 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.429 ' C ' ' O ' ' A' ' 11' ' ' LYS . 80.6 ttt180 37.21 -98.91 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.064 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.406 ' N ' ' O ' ' A' ' 11' ' ' LYS . 13.9 t -163.79 121.88 1.87 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.263 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.72 -18.04 55.6 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.954 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.7 m -122.07 131.15 73.78 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-O 121.262 0.553 . . . . 0.0 111.063 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -68.87 138.2 54.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.243 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -101.52 -163.83 27.25 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -60.33 146.08 97.31 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 C-N-CA 122.959 2.439 . . . . 0.0 112.262 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -95.02 165.86 12.22 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -140.1 89.76 10.93 Favored Pre-proline 0 C--N 1.329 -0.29 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.247 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -57.95 144.73 93.7 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.055 1.837 . . . . 0.0 110.685 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 92.1 mt -93.65 121.64 35.29 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.501 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 74.9 p -133.92 -12.97 2.53 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.187 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.1 mp -104.94 142.17 35.25 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.963 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 57.9 p -65.28 -19.73 66.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.196 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 22.3 p -132.25 129.65 39.9 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.282 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.3 m -103.89 130.56 51.5 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.836 0.35 . . . . 0.0 110.154 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.428 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 44.3 tp -123.83 134.84 53.53 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.314 0.578 . . . . 0.0 111.312 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.507 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 9.0 m-85 -106.41 151.34 25.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.533 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 147.77 159.66 8.52 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 120.052 -1.071 . . . . 0.0 112.805 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -66.91 -40.03 87.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.446 -0.877 . . . . 0.0 111.066 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.536 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -54.86 151.86 14.47 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.2 tt -65.17 -26.81 40.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.873 0.368 . . . . 0.0 111.219 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -59.1 -27.53 65.65 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.503 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.536 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 0.5 OUTLIER -69.35 130.99 44.09 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.77 0.319 . . . . 0.0 111.467 -179.345 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.428 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 45.1 m-20 -64.53 -35.51 81.2 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 178.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.0 mm -106.89 80.73 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.221 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -65.84 132.02 47.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.133 0.492 . . . . 0.0 110.729 -178.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.441 HD12 HG23 ' A' ' 39' ' ' ILE . 98.1 mt -117.56 125.28 73.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.088 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.403 ' H ' HH12 ' A' ' 93' ' ' ARG . 83.4 mt-30 -90.58 81.72 5.88 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 119.819 -0.752 . . . . 0.0 111.253 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.88 110.3 2.14 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.423 178.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -50.12 -36.56 45.86 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 121.886 1.724 . . . . 0.0 112.933 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.52 ' O ' ' CD1' ' A' ' 91' ' ' ILE . 18.9 m -72.32 9.77 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.488 ' CG1' ' N ' ' A' ' 45' ' ' SER . 38.4 t -105.25 161.37 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.488 ' N ' ' CG1' ' A' ' 44' ' ' VAL . 9.7 t -103.33 153.23 20.66 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.955 -179.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.14 -37.69 80.87 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.599 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.508 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 18.6 mp0 -116.3 49.52 1.13 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.458 ' HD1' ' H ' ' A' ' 45' ' ' SER . 10.5 t60 -59.83 -57.25 13.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.019 -177.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.507 ' SG ' ' CD1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -141.46 155.45 45.85 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.568 179.618 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.568 ' O ' ' N ' ' A' ' 61' ' ' HIS . 81.5 tttt -141.16 124.25 16.39 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.318 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 92.8 mt -106.88 110.99 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.756 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -84.36 137.26 33.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.848 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.8 mm -107.87 130.82 59.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.3 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.757 ' HD1' ' N ' ' A' ' 55' ' ' GLU . 1.7 p80 -132.52 -167.72 1.94 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.521 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.757 ' N ' ' HD1' ' A' ' 54' ' ' HIS . 94.9 mt-10 -21.09 -68.27 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -176.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -146.17 28.05 1.13 Allowed 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 119.517 -0.873 . . . . 0.0 112.338 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.497 ' OE2' ' O ' ' A' ' 82' ' ' LEU . 79.2 tt0 -154.5 147.86 25.0 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 119.265 -0.974 . . . . 0.0 112.567 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -92.0 140.75 29.34 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.118 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 29.8 mm -125.98 128.97 72.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.39 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 46.1 tp -77.75 146.1 36.09 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 -178.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.621 ' O ' ' CE1' ' A' ' 63' ' ' PHE . 22.1 m-70 -142.12 78.18 1.61 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.819 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.677 ' ND2' ' H ' ' A' ' 69' ' ' THR . 23.6 t-20 -76.88 139.12 40.14 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.357 -178.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.621 ' CE1' ' O ' ' A' ' 61' ' ' HIS . 5.3 m-85 -109.27 -38.43 5.51 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.925 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.3 t -57.63 136.25 56.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.228 0.537 . . . . 0.0 111.885 -178.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.3 p -100.12 -56.97 2.23 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.911 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.6 p -65.11 -43.14 92.99 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.008 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.614 ' OD1' ' N ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -119.48 79.78 21.62 Favored Pre-proline 0 N--CA 1.463 0.211 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -78.3 151.02 26.03 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 122.65 2.233 . . . . 0.0 113.209 -178.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.677 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 5.6 m -65.95 160.35 23.7 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -124.05 141.72 51.8 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -177.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.4 t -128.58 131.73 68.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.498 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.8 m120 51.57 28.3 4.55 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.33 -2.2 85.47 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.8 m -91.39 154.15 19.38 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 88.2 t -84.21 143.71 11.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.516 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.467 HG23 HD12 ' A' ' 76' ' ' ILE . 50.2 mm -102.32 108.52 24.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.729 -179.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 41.7 p-10 -101.28 2.62 40.0 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.788 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -179.0 166.21 0.96 Allowed Pre-proline 0 C--N 1.33 -0.26 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.13 137.65 70.34 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.658 1.572 . . . . 0.0 111.427 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 32.2 m -137.7 161.27 33.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.158 0.504 . . . . 0.0 110.983 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.405 ' HE ' ' CD ' ' A' ' 57' ' ' GLU . 72.0 ttt180 -82.26 134.93 35.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.817 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.497 ' O ' ' OE2' ' A' ' 57' ' ' GLU . 11.7 mt -108.04 126.46 52.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.87 0.366 . . . . 0.0 110.991 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.406 ' N ' ' OD2' ' A' ' 86' ' ' ASP . 65.3 mttm -92.58 150.31 20.81 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.697 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 6.2 t60 -57.71 136.13 56.84 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.821 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.24 -3.93 66.88 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.406 ' OD2' ' N ' ' A' ' 83' ' ' LYS . 92.9 m-20 -76.95 152.95 35.07 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.9 t -116.49 132.84 64.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.874 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.512 ' O ' ' N ' ' A' ' 95' ' ' PHE . 59.3 mt -108.38 130.32 61.23 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.4 m -128.67 129.99 46.58 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.091 -178.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.537 ' CG2' ' H ' ' A' ' 91' ' ' ILE . 9.7 mm -84.56 -147.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.537 ' H ' ' CG2' ' A' ' 90' ' ' ILE . 86.4 mt -63.91 -44.45 98.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 37.7 p30 -142.73 14.46 1.94 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 120.061 -0.656 . . . . 0.0 112.52 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.403 ' NH1' HG21 ' A' ' 39' ' ' ILE . 95.3 mtt180 -125.58 148.14 49.04 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.837 0.351 . . . . 0.0 111.121 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.7 t -112.51 126.97 55.9 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.366 0.603 . . . . 0.0 112.111 -178.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.512 ' N ' ' O ' ' A' ' 88' ' ' ILE . 39.6 m-85 -117.23 131.72 56.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.01 178.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -117.75 126.12 51.87 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.252 0.549 . . . . 0.0 111.234 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.553 ' C ' ' CD1' ' A' ' 97' ' ' TYR . 0.2 OUTLIER -101.35 110.38 22.38 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.223 -179.138 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -121.99 136.56 54.93 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.128 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.697 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 56.4 t-20 -123.35 98.29 5.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.573 178.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.242 -179.563 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.2 ttp . . . . . 0 N--CA 1.494 1.76 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -95.53 132.99 26.42 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.844 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.97 154.88 48.09 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.886 2.391 . . . . 0.0 112.685 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.5 p -101.41 4.72 41.65 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.58 0.705 . . . . 0.0 109.597 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.562 HH22 ' C ' ' A' ' 56' ' ' GLN . 99.7 mtt180 -133.37 135.07 44.48 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.359 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.595 ' NE ' ' OE2' ' A' ' 100' ' ' GLU . 87.8 mtm180 -144.2 151.94 40.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.202 0.525 . . . . 0.0 111.28 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.0 mt -112.21 136.64 51.37 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.563 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 54.1 t -120.82 134.82 63.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 57.5 m -106.15 118.69 37.28 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.172 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 73.3 mt -71.77 128.32 34.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.318 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.605 ' O ' ' N ' ' A' ' 13' ' ' SER . 88.0 tttt -86.69 134.24 33.61 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.851 0.358 . . . . 0.0 111.536 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 33.62 25.04 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.015 178.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.605 ' N ' ' O ' ' A' ' 11' ' ' LYS . 0.9 OUTLIER 58.55 9.36 1.08 Allowed 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.945 179.737 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -93.95 -56.76 1.37 Allowed Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.42 ' CG2' ' N ' ' A' ' 16' ' ' ASP . 2.1 p -133.71 157.77 42.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.496 ' O ' ' OD1' ' A' ' 16' ' ' ASP . 50.2 p-10 -61.82 119.41 8.72 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.049 -0.66 . . . . 0.0 109.612 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.88 -164.55 20.54 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.531 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -59.24 144.59 99.33 Favored 'Trans proline' 0 C--N 1.302 -1.911 0 C-N-CA 123.316 2.677 . . . . 0.0 111.807 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 37.5 m170 -88.24 172.89 9.12 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.43 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.635 ' CZ ' ' O ' ' A' ' 36' ' ' ASP . 82.9 t80 -143.23 90.58 7.28 Favored Pre-proline 0 N--CA 1.45 -0.456 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.745 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -59.55 143.35 99.7 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.185 1.923 . . . . 0.0 111.038 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.6 mt -92.85 121.18 33.96 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.425 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.8 m -112.71 -15.7 12.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.906 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.7 mt -122.15 141.19 51.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.033 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 62.5 p -64.04 -19.39 65.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.757 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.9 p -115.49 119.93 37.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.129 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.1 t -109.76 126.23 53.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.0 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.9 tp -114.27 139.48 49.38 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.839 -179.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -109.52 144.75 37.37 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.077 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 144.49 171.12 14.19 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.504 178.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -63.69 -38.16 90.06 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.191 -0.504 . . . . 0.0 110.483 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -45.75 136.58 7.81 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.406 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 20.5 tt -65.25 -36.91 78.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.094 0.473 . . . . 0.0 109.931 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.406 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 15.6 pt-20 -57.33 -13.24 3.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.107 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.1 m -74.76 130.55 39.67 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 120.803 0.335 . . . . 0.0 110.481 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.635 ' O ' ' CZ ' ' A' ' 20' ' ' PHE . 56.4 m-20 -61.73 -39.64 92.28 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.539 ' CG2' ' CE2' ' A' ' 95' ' ' PHE . 3.8 mm -107.97 86.56 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.36 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -70.91 134.79 47.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.047 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 98.2 mt -118.99 128.07 75.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.331 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -99.6 79.04 2.22 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.303 0.573 . . . . 0.0 110.681 -179.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -157.55 127.69 3.39 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.565 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -63.39 -27.08 70.92 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.338 1.359 . . . . 0.0 112.772 -179.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.5 m -66.49 -31.14 52.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.572 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 99.4 t -75.19 156.61 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.768 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 75.2 m -95.12 170.42 9.41 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.295 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -61.54 -42.55 98.99 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.402 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -130.46 68.17 1.47 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.401 ' CD2' HG22 ' A' ' 90' ' ' ILE . 13.4 t60 -66.02 -49.9 66.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.497 -176.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.529 ' SG ' ' N ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -148.12 158.22 43.94 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.674 -0.411 . . . . 0.0 111.017 -179.427 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.589 ' O ' ' N ' ' A' ' 61' ' ' HIS . 69.1 tttt -140.8 129.51 22.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.266 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 91.4 mt -105.95 113.38 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.992 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -89.98 112.81 24.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.045 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.1 mp -82.43 127.39 39.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.381 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.508 ' O ' ' NH1' ' A' ' 5' ' ' ARG . 66.8 m-70 -117.65 144.53 45.12 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.192 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -42.18 -19.09 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.587 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.562 ' C ' HH22 ' A' ' 5' ' ' ARG . 64.5 tp60 -111.83 -37.91 5.0 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.196 -0.602 . . . . 0.0 112.327 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.431 ' N ' HH22 ' A' ' 5' ' ' ARG . 71.0 mm-40 -152.2 -174.04 4.75 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.707 0.765 . . . . 0.0 112.49 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -116.15 135.81 53.58 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 114.33 -1.304 . . . . 0.0 109.488 178.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.8 mp -126.22 129.85 72.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.267 0.556 . . . . 0.0 112.462 -178.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.0 tt -79.38 145.66 33.26 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.41 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.589 ' N ' ' O ' ' A' ' 50' ' ' LYS . 55.5 m-70 -136.35 79.2 1.75 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.24 0.543 . . . . 0.0 110.044 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.657 HD22 ' CB ' ' A' ' 69' ' ' THR . 0.8 OUTLIER -64.36 138.46 58.44 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.428 -179.253 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -112.93 -27.19 8.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.219 178.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.3 p -67.86 157.61 34.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.858 -178.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.3 p -129.76 -53.94 1.15 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.67 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.8 m -63.82 -48.06 78.32 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.63 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.603 ' OD1' ' N ' ' A' ' 67' ' ' ASN . 0.1 OUTLIER -117.89 80.51 14.57 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.729 179.383 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.59 147.49 40.66 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.159 1.906 . . . . 0.0 113.196 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.657 ' CB ' HD22 ' A' ' 62' ' ' ASN . 88.0 m -65.8 170.33 5.46 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 177.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.407 ' N ' ' CG2' ' A' ' 69' ' ' THR . 86.5 mt-30 -135.94 152.62 51.17 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.711 -178.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.433 ' O ' ' N ' ' A' ' 74' ' ' SER . 20.1 t -127.69 129.65 70.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.395 178.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 47.85 30.37 1.9 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.986 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.52 1.19 87.86 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 71' ' ' VAL . 8.7 p -87.92 173.27 9.02 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 122.688 -0.301 . . . . 0.0 110.801 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.4 t -110.16 136.1 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-O 121.506 0.67 . . . . 0.0 109.645 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 68.6 mt -104.22 116.49 48.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 114.579 -1.191 . . . . 0.0 111.238 -177.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -98.47 -11.5 22.25 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.954 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -165.49 170.91 5.62 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.43 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.49 138.39 74.19 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.377 1.384 . . . . 0.0 110.625 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.2 m -138.97 160.98 29.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.466 -0.493 . . . . 0.0 110.77 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -76.32 143.84 40.56 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.362 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 67.0 mt -113.86 131.06 56.4 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.31 0.576 . . . . 0.0 112.011 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.631 ' N ' ' OD2' ' A' ' 86' ' ' ASP . 43.5 tttp -89.72 158.95 17.32 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.339 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.728 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 28.7 t60 -71.46 133.98 46.26 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.938 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.88 -7.49 65.03 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.631 ' OD2' ' N ' ' A' ' 83' ' ' LYS . 97.0 m-20 -64.83 154.6 36.63 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.042 0.449 . . . . 0.0 111.261 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 8.4 p -123.04 134.23 66.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.728 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 82.4 mt -109.2 133.42 54.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.175 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 63.5 m -127.44 127.74 44.61 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.332 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.573 ' CG2' ' H ' ' A' ' 91' ' ' ILE . 21.0 mm -87.83 -147.46 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.573 ' H ' ' CG2' ' A' ' 90' ' ' ILE . 95.9 mt -64.15 -43.98 97.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.862 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.506 ' OD1' ' O ' ' A' ' 91' ' ' ILE . 91.0 m-20 -147.8 19.92 1.15 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 121.266 -0.174 . . . . 0.0 110.969 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -126.05 145.81 50.17 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.517 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.4 m -120.48 135.73 54.98 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 121.141 0.496 . . . . 0.0 112.199 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.539 ' CE2' ' CG2' ' A' ' 37' ' ' ILE . 57.3 m-85 -129.34 151.9 49.48 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.254 178.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -121.19 143.56 49.06 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.537 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.512 ' C ' ' CD1' ' A' ' 97' ' ' TYR . 0.4 OUTLIER -115.87 102.91 10.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.623 179.611 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -115.3 128.41 56.09 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.145 0.498 . . . . 0.0 111.979 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.728 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 54.5 t-20 -102.23 104.76 15.34 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.725 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.595 ' OE2' ' NE ' ' A' ' 6' ' ' ARG . 99.1 mt-10 . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.053 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mtt . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.564 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 0.4 OUTLIER -105.23 -44.56 0.15 Allowed Pre-proline 0 N--CA 1.463 0.181 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.379 -179.231 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 2' ' ' TRP . 32.6 Cg_exo -58.59 142.39 98.25 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.484 2.122 . . . . 0.0 111.909 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 93.2 m -134.5 132.43 39.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.856 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 92.3 mtm-85 -105.51 132.23 51.93 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.768 0.318 . . . . 0.0 110.32 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -141.13 149.74 41.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.92 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.6 mt -110.44 136.57 49.38 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.375 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 50.3 t -118.95 133.74 64.81 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.432 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.507 ' OG1' ' CE2' ' A' ' 95' ' ' PHE . 22.4 m -101.66 112.56 25.17 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.271 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.606 ' CG1' ' HE ' ' A' ' 96' ' ' ARG . 98.5 mt -69.83 127.64 32.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.947 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 15' ' ' VAL . 65.3 tttm -89.96 129.78 36.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.182 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.551 ' O ' ' C ' ' A' ' 13' ' ' SER . 84.5 mtp180 34.18 91.26 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.551 ' C ' ' O ' ' A' ' 12' ' ' ARG . 2.0 t -7.11 105.48 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.982 0.801 . . . . 0.0 111.515 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 131.27 -59.64 0.69 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.514 ' O ' ' N ' ' A' ' 11' ' ' LYS . 14.5 t -83.52 139.94 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-O 120.97 0.414 . . . . 0.0 111.056 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -94.87 106.74 18.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.584 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.3 -166.06 14.06 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.039 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -59.42 150.77 73.13 Favored 'Trans proline' 0 C--N 1.3 -1.974 0 C-N-CA 123.964 3.11 . . . . 0.0 113.55 -178.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -89.7 163.39 15.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.969 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.502 ' CE2' ' CD1' ' A' ' 37' ' ' ILE . 81.7 t80 -127.62 94.6 37.33 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.593 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -60.2 147.9 91.75 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 122.005 1.803 . . . . 0.0 111.194 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 91.3 mt -97.23 122.81 40.68 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.405 0.621 . . . . 0.0 111.875 -178.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.2 p -117.35 -31.59 5.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.216 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.0 tp -107.15 134.53 50.12 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.548 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.0 p -61.36 -38.15 85.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.511 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.456 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 12.5 p -92.01 108.66 20.1 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.994 -0.282 . . . . 0.0 110.463 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.534 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 1.1 t -90.43 124.99 35.41 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.413 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 52.7 tp -119.19 139.78 51.28 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.186 0.517 . . . . 0.0 111.735 -178.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.534 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 46.6 m-85 -110.24 145.09 37.94 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.466 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 153.51 171.24 20.5 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 119.474 -1.346 . . . . 0.0 112.81 178.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -69.62 -37.71 76.95 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.682 -0.759 . . . . 0.0 111.716 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.52 150.4 34.47 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 121.318 -0.467 . . . . 0.0 112.746 -178.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.6 tp -64.22 -27.76 43.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -58.94 -24.47 62.52 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.683 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.438 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 75.9 m -72.59 130.67 41.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.85 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.456 ' OD2' ' O ' ' A' ' 26' ' ' THR . 88.1 m-20 -61.97 -36.15 80.62 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.538 ' CG2' ' CE2' ' A' ' 95' ' ' PHE . 9.7 mm -109.5 91.57 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 114.178 -1.374 . . . . 0.0 108.695 179.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -71.12 140.93 50.77 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.28 -178.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.5 mt -130.78 124.19 56.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.913 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -97.66 78.38 2.62 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 119.868 -0.733 . . . . 0.0 110.612 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.6 mt -155.53 114.83 2.26 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.547 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -52.44 -31.55 48.57 Favored 'Trans proline' 0 N--CA 1.506 2.24 0 C-N-CA 122.334 2.023 . . . . 0.0 114.233 -179.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.9 m -64.6 -25.02 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 39.2 t -81.43 161.49 3.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.49 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.45 ' H ' ' HD1' ' A' ' 48' ' ' HIS . 59.8 m -105.7 156.29 18.42 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.699 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.438 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 98.9 mttt -60.31 -37.83 81.79 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.103 0.478 . . . . 0.0 110.393 -179.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -114.32 49.46 1.01 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.45 ' HD1' ' H ' ' A' ' 45' ' ' SER . 18.8 t60 -57.8 -54.72 43.66 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.094 -177.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.633 ' HG ' ' N ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -152.75 165.31 35.74 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 120.636 -0.425 . . . . 0.0 111.308 -179.284 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.633 ' N ' ' HG ' ' A' ' 49' ' ' CYS . 67.1 tttt -146.74 130.35 16.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.339 -178.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 82.7 mt -105.03 103.93 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' A' ' 59' ' ' ILE . 81.5 tt0 -79.87 135.46 36.45 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.4 mm -105.0 133.58 48.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.75 0.786 . . . . 0.0 111.78 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.476 ' O ' ' C ' ' A' ' 55' ' ' GLU . 87.8 m-70 -122.31 -177.97 3.76 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.312 -1.313 . . . . 0.0 109.973 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.476 ' C ' ' O ' ' A' ' 54' ' ' HIS . 80.3 mm-40 -29.21 -61.04 0.14 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.956 -178.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -145.09 27.0 1.31 Allowed 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.687 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -138.75 144.84 39.63 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 119.979 -0.688 . . . . 0.0 112.139 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -106.09 130.02 54.07 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.542 ' O ' ' N ' ' A' ' 52' ' ' GLU . 34.5 mm -120.11 126.77 75.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.734 0.302 . . . . 0.0 111.07 -178.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.434 ' H ' ' CD1' ' A' ' 82' ' ' LEU . 9.8 tt -78.74 149.31 32.72 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.194 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.597 ' N ' ' O ' ' A' ' 50' ' ' LYS . 22.2 m-70 -141.75 80.29 1.72 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.366 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.714 ' ND2' ' H ' ' A' ' 69' ' ' THR . 28.0 t-20 -72.86 131.98 42.94 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.852 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.41 ' CE1' ' O ' ' A' ' 61' ' ' HIS . 13.7 m-85 -108.11 -27.53 10.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.969 178.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.526 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 30.3 t -58.71 145.36 40.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.709 -179.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.2 m -115.34 -55.86 2.41 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.047 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.402 ' OG1' ' OD1' ' A' ' 67' ' ' ASN . 40.9 p -62.99 -38.95 93.22 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.428 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.53 ' OD1' ' N ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -126.65 83.46 64.93 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.046 179.401 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -74.35 146.29 35.34 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 121.445 1.43 . . . . 0.0 113.35 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.714 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 61.6 m -62.67 160.05 14.93 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 177.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -123.82 150.31 44.68 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.624 0.25 . . . . 0.0 110.946 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.424 ' O ' ' N ' ' A' ' 74' ' ' SER . 4.9 p -135.91 134.13 50.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.343 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.513 HD22 ' CG ' ' A' ' 86' ' ' ASP . 74.3 m-20 50.68 18.83 0.52 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.079 0.466 . . . . 0.0 110.382 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 89.07 16.18 58.1 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.424 ' N ' ' O ' ' A' ' 71' ' ' VAL . 41.6 t -117.02 137.33 52.3 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.195 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 79.6 t -69.84 141.1 17.59 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 CA-C-O 121.18 0.514 . . . . 0.0 110.759 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 79.5 mt -106.52 118.48 54.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.714 -178.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -96.2 -28.37 14.58 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.373 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -151.39 175.4 2.9 Favored Pre-proline 0 N--CA 1.465 0.314 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -56.04 138.63 83.16 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 121.598 1.532 . . . . 0.0 111.691 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.7 m -141.11 160.13 22.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.856 0.36 . . . . 0.0 110.863 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 69.6 ttp85 -84.38 142.74 29.93 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.443 HD12 ' N ' ' A' ' 82' ' ' LEU . 5.7 mp -116.34 141.26 48.4 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.407 -178.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -90.87 158.79 16.59 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.728 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 36.2 t60 -60.25 133.46 56.12 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.983 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.18 16.25 65.18 Favored Glycine 0 CA--C 1.533 1.156 0 N-CA-C 111.581 -0.607 . . . . 0.0 111.581 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.513 ' CG ' HD22 ' A' ' 72' ' ' ASN . 45.2 t0 -82.95 120.69 26.02 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.795 0.331 . . . . 0.0 111.024 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 53.4 t -86.57 132.61 31.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 121.267 0.556 . . . . 0.0 111.445 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.7 mt -117.05 137.13 51.95 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 56.9 m -128.42 133.94 48.68 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.25 0.547 . . . . 0.0 112.25 -177.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.641 ' CG2' ' H ' ' A' ' 91' ' ' ILE . 12.6 mm -91.67 -144.66 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.641 ' H ' ' CG2' ' A' ' 90' ' ' ILE . 36.2 mm -62.38 -45.31 99.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.972 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.491 ' OD1' ' O ' ' A' ' 91' ' ' ILE . 78.4 m-20 -147.58 14.19 1.08 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 97.0 mtt-85 -122.22 145.71 47.95 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.747 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.6 m -114.53 124.05 50.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.252 0.549 . . . . 0.0 112.088 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.538 ' CE2' ' CG2' ' A' ' 37' ' ' ILE . 56.8 m-85 -113.28 139.64 48.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.636 178.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.606 ' HE ' ' CG1' ' A' ' 10' ' ' ILE . 45.4 mtt-85 -107.13 139.08 42.11 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.104 -178.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.537 ' C ' ' CD1' ' A' ' 97' ' ' TYR . 0.7 OUTLIER -109.39 107.5 17.7 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 178.795 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -119.65 138.36 53.31 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.728 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 52.6 t-20 -116.04 97.8 6.28 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.506 178.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.7 tp10 . . . . . 0 C--N 1.33 -0.264 0 CA-C-O 120.869 0.366 . . . . 0.0 110.732 179.682 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.1 mtt . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.593 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -58.66 -43.76 98.25 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.639 -179.882 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 2' ' ' TRP . 37.3 Cg_exo -59.51 141.91 98.1 Favored 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 122.907 2.405 . . . . 0.0 112.408 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.408 HG21 ' H ' ' A' ' 5' ' ' ARG . 54.3 m -147.93 158.22 43.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.287 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.445 ' CB ' ' OD1' ' A' ' 99' ' ' ASN . 34.1 ptt180 -125.26 133.02 52.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.929 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 80.2 mtt85 -143.48 156.44 44.63 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.499 -0.481 . . . . 0.0 110.749 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 90.1 mt -109.03 136.4 48.61 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.885 -0.784 . . . . 0.0 108.885 178.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.4 t -115.45 128.9 72.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.046 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.458 ' OG1' ' CE2' ' A' ' 95' ' ' PHE . 87.7 m -110.24 120.04 41.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.1 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.44 HD12 HG23 ' A' ' 10' ' ' ILE . 14.2 mm -71.1 125.6 29.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.827 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.34 -46.0 90.65 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.176 0.512 . . . . 0.0 110.349 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 49.1 ptt85 -143.58 -139.65 0.11 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.24 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.9 t -117.91 100.77 7.79 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.449 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.04 -20.68 4.0 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.229 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.408 ' CG2' ' N ' ' A' ' 16' ' ' ASP . 3.1 p -133.96 153.04 35.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.264 -0.574 . . . . 0.0 111.698 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.437 ' C ' ' OD1' ' A' ' 16' ' ' ASP . 57.8 t0 -87.24 121.38 29.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.843 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.24 -167.5 42.6 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -61.81 145.65 97.05 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 123.261 2.641 . . . . 0.0 112.28 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 28.2 m170 -87.87 171.15 10.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.222 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.442 ' CD2' ' CD1' ' A' ' 37' ' ' ILE . 87.1 t80 -134.44 97.01 14.86 Favored Pre-proline 0 C--N 1.33 -0.273 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.162 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -59.34 147.85 89.17 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 122.149 1.9 . . . . 0.0 110.732 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.408 ' CD2' ' SG ' ' A' ' 27' ' ' CYS . 97.9 mt -104.0 126.88 51.46 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.99 0.424 . . . . 0.0 111.931 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 92.4 p -112.01 -23.22 10.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.459 178.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 97.8 mt -116.17 144.72 43.81 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.219 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 93.5 p -67.81 -19.18 65.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.562 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.9 p -111.12 114.81 28.34 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.482 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.408 ' SG ' ' CD2' ' A' ' 22' ' ' LEU . 1.1 m -99.44 131.51 45.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.964 0.411 . . . . 0.0 110.82 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 62.5 tp -120.91 135.61 55.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.463 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.565 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 23.9 m-85 -109.49 146.75 34.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.428 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.99 169.95 18.06 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 120.222 -0.99 . . . . 0.0 112.349 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -66.57 -37.14 84.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.164 -0.518 . . . . 0.0 111.845 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.417 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -57.22 149.01 32.17 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.801 -178.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 13.5 tt -70.37 -32.36 49.99 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -53.42 -15.05 0.9 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.672 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.417 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 2.9 m -81.57 134.35 35.49 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.402 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -61.86 -36.47 81.33 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.442 ' CD1' ' CD2' ' A' ' 20' ' ' PHE . 3.5 mm -108.54 88.75 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 114.942 -1.026 . . . . 0.0 108.967 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -68.63 134.01 49.31 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.503 -178.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 97.0 mt -121.99 116.88 50.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.747 178.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.415 ' H ' HH12 ' A' ' 93' ' ' ARG . 61.1 tt0 -93.54 81.01 4.32 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.622 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.13 120.0 2.56 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -179.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -60.9 -25.48 81.43 Favored 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 121.218 1.279 . . . . 0.0 114.082 -178.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.9 m -68.3 -37.15 77.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.814 -0.354 . . . . 0.0 111.396 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.43 ' CG1' ' N ' ' A' ' 45' ' ' SER . 88.1 t -67.02 159.89 4.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.666 0.269 . . . . 0.0 110.476 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.492 ' H ' ' HD1' ' A' ' 48' ' ' HIS . 44.2 m -104.92 163.38 12.57 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.544 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -60.46 -41.63 94.53 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.038 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -117.16 58.81 0.77 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.492 ' HD1' ' H ' ' A' ' 45' ' ' SER . 13.1 t60 -65.08 -56.29 13.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.324 -177.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.565 ' SG ' ' CD1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -150.72 157.8 43.38 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.354 -179.347 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.551 ' O ' ' N ' ' A' ' 61' ' ' HIS . 29.4 tttp -140.18 127.15 20.79 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.18 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 95.6 mt -105.8 105.28 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.224 178.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 59' ' ' ILE . 83.3 tt0 -85.37 121.18 27.72 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 178.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 67.4 mt -105.22 132.55 51.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.43 ' O ' ' C ' ' A' ' 55' ' ' GLU . 50.8 m-70 -100.03 -172.67 2.27 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.042 178.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 54' ' ' HIS . 98.8 mt-10 -37.09 -49.83 0.89 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.693 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -146.21 22.83 1.35 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.574 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -131.24 140.76 49.9 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 120.35 -0.54 . . . . 0.0 112.228 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -102.04 124.76 48.2 Favored 'General case' 0 CA--C 1.526 0.051 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.09 178.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.512 ' O ' ' N ' ' A' ' 52' ' ' GLU . 41.2 mm -117.98 121.05 66.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.663 -178.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 61.2 tp -77.48 148.39 35.38 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.499 0.666 . . . . 0.0 112.146 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.551 ' N ' ' O ' ' A' ' 50' ' ' LYS . 32.8 m-70 -142.39 77.91 1.6 Allowed 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.704 -1.134 . . . . 0.0 109.214 178.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.66 ' ND2' ' H ' ' A' ' 69' ' ' THR . 19.1 t-20 -75.3 127.42 33.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.124 -178.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -98.67 -34.94 10.35 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.722 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.495 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 44.3 t -58.87 142.52 50.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.482 -177.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.9 m -111.7 -55.47 2.5 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.193 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.7 p -64.28 -42.28 96.49 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.916 0.388 . . . . 0.0 110.362 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.584 ' OD1' ' N ' ' A' ' 67' ' ' ASN . 0.3 OUTLIER -121.05 78.79 33.23 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.964 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.15 152.23 39.81 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.102 1.868 . . . . 0.0 112.507 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.66 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 17.2 m -68.32 162.91 24.18 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -127.42 143.43 51.21 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -177.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.427 ' O ' ' N ' ' A' ' 74' ' ' SER . 45.8 t -128.95 131.54 68.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.011 179.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.58 ' ND2' ' OD1' ' A' ' 86' ' ' ASP . 91.0 m-20 45.6 29.07 0.59 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.206 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 87.15 1.58 84.22 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 71' ' ' VAL . 6.3 t -101.95 139.84 37.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.914 0.388 . . . . 0.0 110.533 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.6 t -71.76 150.88 8.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.115 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.416 HD12 HG22 ' A' ' 76' ' ' ILE . 40.3 mm -108.62 121.9 62.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.483 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.471 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 27.9 p-10 -114.26 7.3 16.45 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.811 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 176.41 169.1 0.4 Allowed Pre-proline 0 CA--C 1.531 0.248 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -56.39 137.04 78.76 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.762 1.641 . . . . 0.0 111.705 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.7 m -139.82 161.04 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.431 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -87.33 133.37 33.71 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.408 HD11 ' N ' ' A' ' 82' ' ' LEU . 6.1 mp -103.66 126.74 50.99 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.162 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 84' ' ' HIS . 88.7 tttt -82.15 139.5 34.31 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.77 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 41.3 t60 -40.71 132.06 2.27 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.716 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.83 1.49 73.42 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.428 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.58 ' OD1' ' ND2' ' A' ' 72' ' ' ASN . 23.6 t70 -61.96 148.82 42.51 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.077 0.465 . . . . 0.0 110.617 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 40.8 t -111.36 130.07 65.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.088 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.466 ' O ' ' N ' ' A' ' 95' ' ' PHE . 70.9 mt -114.7 132.42 63.91 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 93.3 m -130.25 120.68 24.83 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.501 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.644 ' CG2' ' H ' ' A' ' 91' ' ' ILE . 9.9 mm -77.57 -146.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.644 ' H ' ' CG2' ' A' ' 90' ' ' ILE . 95.5 mt -64.96 -44.8 96.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 120.786 -0.365 . . . . 0.0 111.418 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 21.7 p30 -142.8 13.56 1.9 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.415 HH12 ' H ' ' A' ' 40' ' ' GLN . 98.6 mtt180 -125.98 147.79 49.43 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 120.531 -0.467 . . . . 0.0 111.021 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.16 118.57 35.7 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 121.315 0.579 . . . . 0.0 112.377 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.466 ' N ' ' O ' ' A' ' 88' ' ' ILE . 51.6 m-85 -111.78 140.0 46.79 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.672 178.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 72.0 mtp85 -122.01 140.88 51.94 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.312 -178.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.436 ' C ' ' CD1' ' A' ' 97' ' ' TYR . 0.5 OUTLIER -114.66 113.1 23.89 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.251 -179.925 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -142.69 139.14 31.04 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 119.916 -0.713 . . . . 0.0 111.928 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.77 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 94.7 m-20 -112.06 146.02 38.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.169 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 . . . . . 0 C--N 1.329 -0.291 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 179.485 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.56 ' O ' ' CE3' ' A' ' 2' ' ' TRP . 64.7 mtt . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.56 ' CE3' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER 56.79 148.54 0.05 OUTLIER Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.151 179.617 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.01 145.3 61.04 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 123.045 2.497 . . . . 0.0 112.59 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.3 m -129.3 92.8 3.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.736 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.444 ' HE ' ' CG1' ' A' ' 53' ' ' ILE . 92.2 mtm-85 -127.99 145.26 51.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.931 0.396 . . . . 0.0 111.407 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.545 ' NH1' ' CG2' ' A' ' 8' ' ' VAL . 67.9 ttp85 -140.3 132.36 27.89 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.168 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 31.2 mt -104.51 135.19 46.4 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.545 ' CG2' ' NH1' ' A' ' 6' ' ' ARG . 48.8 t -122.23 134.47 65.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.76 0.314 . . . . 0.0 110.209 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.598 ' OG1' ' CE2' ' A' ' 95' ' ' PHE . 92.3 m -113.31 112.94 24.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.97 0.414 . . . . 0.0 111.649 -178.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.576 ' CD1' ' H ' ' A' ' 10' ' ' ILE . 2.7 mp -79.59 129.98 36.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.498 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.01 -41.08 99.47 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.973 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -143.93 -87.93 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.638 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.8 t -161.56 129.69 4.25 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.452 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.76 4.78 89.52 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.089 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.7 m -124.7 130.84 73.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 117.038 0.419 . . . . 0.0 110.562 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -75.59 138.49 41.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.507 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -121.54 -174.16 14.71 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.834 -0.907 . . . . 0.0 110.834 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.14 147.86 88.51 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 123.059 2.506 . . . . 0.0 111.962 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.455 ' CG ' ' NH1' ' A' ' 6' ' ' ARG . 5.3 m170 -101.17 153.7 19.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.919 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -118.35 90.87 39.65 Favored Pre-proline 0 N--CA 1.454 -0.229 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.571 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.54 144.65 99.37 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.473 2.116 . . . . 0.0 110.953 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.534 ' CD2' ' SG ' ' A' ' 27' ' ' CYS . 96.5 mt -96.38 126.38 41.54 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.481 -0.487 . . . . 0.0 111.276 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.6 m -122.4 -9.93 8.49 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.048 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.9 mt -126.92 148.43 50.04 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.314 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.6 p -70.87 -16.14 62.68 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.129 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 65.1 p -118.65 114.22 22.41 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.488 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.534 ' SG ' ' CD2' ' A' ' 22' ' ' LEU . 0.8 OUTLIER -98.51 131.97 44.32 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.257 178.666 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.412 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 59.8 tp -120.12 135.65 54.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.25 0.548 . . . . 0.0 111.583 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -103.7 144.66 31.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.989 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 150.4 151.62 5.59 Favored Glycine 0 C--O 1.224 -0.491 0 C-N-CA 120.429 -0.891 . . . . 0.0 110.956 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -70.81 -18.45 62.74 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.731 -178.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.51 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -69.99 153.34 52.03 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.7 tp -64.58 -30.28 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -54.57 -20.47 7.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.977 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.51 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 1.7 m -84.49 126.75 33.57 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.269 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.412 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 56.5 m-20 -63.25 -40.11 96.49 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -101.55 84.56 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-N 115.085 -0.961 . . . . 0.0 108.679 177.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -67.98 134.76 51.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.609 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 92.2 mt -121.74 126.0 74.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.256 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.586 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 52.6 tt0 -86.97 82.18 7.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.012 0.434 . . . . 0.0 111.753 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.1 tp -155.2 127.48 3.96 Favored Pre-proline 0 CA--C 1.531 0.235 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.62 -11.42 29.68 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 121.73 1.62 . . . . 0.0 112.741 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.4 m -95.78 3.18 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 120.746 0.308 . . . . 0.0 111.307 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 16.4 t -100.45 136.76 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.339 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.461 ' H ' ' HD1' ' A' ' 48' ' ' HIS . 4.7 m -77.89 159.7 28.74 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.97 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.485 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 98.4 mttt -62.15 -35.75 79.74 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.075 0.464 . . . . 0.0 109.915 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -124.82 57.09 1.28 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 178.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.461 ' HD1' ' H ' ' A' ' 45' ' ' SER . 17.7 t60 -60.91 -50.67 72.47 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.969 -177.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -152.49 169.52 22.42 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.816 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 61' ' ' HIS . 27.0 tttp -147.54 134.29 20.02 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.401 -0.52 . . . . 0.0 112.359 -178.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 89.7 mt -105.59 106.6 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 59' ' ' ILE . 86.8 tt0 -87.58 117.01 26.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.626 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.444 ' CG1' ' HE ' ' A' ' 5' ' ' ARG . 1.0 OUTLIER -86.36 129.8 37.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.153 -179.644 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.429 ' O ' ' C ' ' A' ' 55' ' ' GLU . 34.9 m-70 -115.15 179.09 4.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.755 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 54' ' ' HIS . 78.3 mm-40 -33.62 -59.63 0.39 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.887 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -139.26 27.92 2.3 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.81 -178.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.7 tp10 -152.6 151.67 30.92 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.429 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.98 135.87 50.15 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.249 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.521 ' O ' ' N ' ' A' ' 52' ' ' GLU . 1.9 mp -123.99 133.57 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 120.848 0.356 . . . . 0.0 111.665 -178.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.4 tt -87.32 151.48 23.07 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.033 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.526 ' N ' ' O ' ' A' ' 50' ' ' LYS . 47.9 m-70 -143.03 78.54 1.61 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.76 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.71 ' ND2' ' H ' ' A' ' 69' ' ' THR . 18.2 t-20 -66.65 133.25 49.87 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.514 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -109.81 -29.52 8.27 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.549 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.9 t -65.84 135.72 55.22 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.98 0.419 . . . . 0.0 111.703 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.0 p -101.89 -54.07 2.8 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.742 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.5 ' OG1' ' OD1' ' A' ' 67' ' ' ASN . 32.8 p -62.39 -44.15 97.14 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.555 ' OD1' ' N ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -121.78 81.47 41.43 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.547 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -74.8 148.87 36.84 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.221 1.948 . . . . 0.0 113.3 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.71 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 51.3 m -64.12 158.34 23.11 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -125.08 156.17 38.67 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.249 0.547 . . . . 0.0 111.234 -177.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.519 ' C ' ' H ' ' A' ' 73' ' ' GLY . 9.8 p -135.58 137.75 49.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.231 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 46.14 14.96 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.16 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.519 ' H ' ' C ' ' A' ' 71' ' ' VAL . . . 101.74 -12.61 57.92 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.797 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.473 ' N ' ' O ' ' A' ' 71' ' ' VAL . 13.4 p -83.04 170.52 14.76 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 74.0 t -99.77 137.32 27.61 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 CA-C-O 121.426 0.631 . . . . 0.0 110.13 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 69.7 mt -103.62 116.59 47.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.792 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -90.24 -40.77 11.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.994 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.83 172.07 7.16 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.138 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.15 140.77 80.92 Favored 'Trans proline' 0 N--CA 1.501 1.931 0 C-N-CA 122.539 2.159 . . . . 0.0 112.436 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 18.8 m -146.0 157.57 12.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.24 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -83.28 136.27 34.44 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.127 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 6.4 mp -110.77 139.42 46.08 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.488 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -89.85 153.31 20.75 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.725 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 22.7 t60 -55.9 132.83 50.69 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.905 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 99.99 -7.97 59.14 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -72.27 143.98 48.56 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.4 m -116.33 133.22 63.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.253 0.549 . . . . 0.0 111.605 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.517 ' O ' ' N ' ' A' ' 95' ' ' PHE . 53.6 mt -103.02 131.83 50.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 69.4 m -128.24 128.87 45.5 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.381 -178.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.667 ' CG2' ' H ' ' A' ' 91' ' ' ILE . 8.0 mm -80.86 -147.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 177.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.667 ' H ' ' CG2' ' A' ' 90' ' ' ILE . 91.5 mt -64.75 -44.21 96.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.624 178.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -141.65 20.5 2.18 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -178.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.586 ' NH2' ' O ' ' A' ' 40' ' ' GLN . 96.4 mtt180 -136.0 146.23 46.95 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 120.218 -0.593 . . . . 0.0 111.274 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -109.19 135.84 49.65 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 121.178 0.513 . . . . 0.0 112.316 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.598 ' CE2' ' OG1' ' A' ' 9' ' ' THR . 16.2 m-85 -123.44 136.25 54.51 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.355 -0.838 . . . . 0.0 108.958 177.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 70.7 mtp85 -110.09 130.05 55.6 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.935 0.398 . . . . 0.0 111.602 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.539 ' C ' ' CD1' ' A' ' 97' ' ' TYR . 0.4 OUTLIER -103.73 108.2 19.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.36 179.096 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.434 ' HA ' ' HD1' ' A' ' 84' ' ' HIS . 96.0 mt-10 -115.6 126.74 54.58 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.604 -178.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.725 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 42.7 t-20 -113.24 95.96 5.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.944 178.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 . . . . . 0 C--N 1.327 -0.385 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.797 -179.478 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.8 mtm . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -42.56 136.04 2.55 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.268 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.02 149.18 64.85 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.055 1.837 . . . . 0.0 112.301 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 95.7 m -125.62 124.89 42.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.483 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 89.3 mtm-85 -128.92 139.25 52.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.637 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -137.9 150.35 47.01 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.666 -0.413 . . . . 0.0 111.038 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.3 mt -112.71 134.72 54.09 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 54.2 t -120.16 133.44 66.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.963 0.411 . . . . 0.0 110.432 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.2 m -99.04 119.12 37.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.825 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.2 mt -71.23 135.09 28.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.408 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 15' ' ' VAL . 86.7 tttt -66.35 143.64 57.04 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.436 ' O ' ' C ' ' A' ' 13' ' ' SER . 42.7 ttm180 -45.65 119.14 2.04 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.376 -0.529 . . . . 0.0 110.29 -178.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 12' ' ' ARG . 70.0 m 35.28 35.78 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.005 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 12' ' ' ARG . . . -128.9 -126.86 2.9 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.415 ' O ' ' N ' ' A' ' 11' ' ' LYS . 33.2 m -120.1 -168.6 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.771 0.32 . . . . 0.0 110.613 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -64.34 137.97 58.18 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.01 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -113.58 -152.88 11.0 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.6 143.52 94.62 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.277 1.984 . . . . 0.0 111.418 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 18.7 m170 -94.24 173.35 7.69 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.043 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -140.21 108.95 6.87 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.827 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.81 152.7 52.93 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.972 1.781 . . . . 0.0 111.861 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.1 mt -100.17 123.28 44.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.41 0.624 . . . . 0.0 110.807 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.3 m -113.76 -59.1 2.06 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.386 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.0 mt -74.37 150.3 40.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.68 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 81.1 p -66.09 -16.98 64.41 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.091 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.4 p -120.68 144.01 48.42 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.827 -179.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -119.83 123.06 42.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.523 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.421 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 53.5 tp -114.03 138.62 50.13 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.301 0.572 . . . . 0.0 111.222 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -108.19 142.59 38.2 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.35 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 157.92 165.43 15.43 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 119.518 -1.325 . . . . 0.0 112.506 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.428 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 91.2 mtm180 -66.24 -38.73 88.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.934 -0.633 . . . . 0.0 111.675 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.96 153.17 42.05 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 121.34 -0.457 . . . . 0.0 112.59 -178.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.9 tp -67.15 -31.52 53.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.239 -0.48 . . . . 0.0 110.368 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -56.39 -14.6 3.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.643 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.1 m -84.99 135.05 34.19 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.512 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.421 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 95.3 m-20 -62.77 -34.34 77.03 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.486 ' CG2' ' CE2' ' A' ' 95' ' ' PHE . 3.5 mm -107.82 84.42 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.522 HH12 ' NE2' ' A' ' 40' ' ' GLN . 77.6 ttt-85 -67.99 125.8 27.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.601 -178.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.433 HD11 HG23 ' A' ' 39' ' ' ILE . 82.8 mt -113.6 123.91 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.381 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.522 ' NE2' HH12 ' A' ' 38' ' ' ARG . 84.7 mt-30 -94.0 77.83 4.11 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.368 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.412 ' CD2' ' O ' ' A' ' 40' ' ' GLN . 0.2 OUTLIER -157.19 111.71 1.9 Allowed Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.129 179.194 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -51.47 -31.45 39.07 Favored 'Trans proline' 0 N--CA 1.503 2.051 0 C-N-CA 122.29 1.993 . . . . 0.0 113.939 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.412 HG21 ' H ' ' A' ' 44' ' ' VAL . 23.4 m -62.71 -38.94 82.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.669 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.428 ' O ' ' NE ' ' A' ' 31' ' ' ARG . 86.7 t -62.54 149.32 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.497 ' H ' ' HD1' ' A' ' 48' ' ' HIS . 23.4 m -82.48 172.77 12.65 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.615 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -62.01 -39.84 93.63 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.095 0.474 . . . . 0.0 110.002 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -134.78 69.75 1.45 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 178.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.497 ' HD1' ' H ' ' A' ' 45' ' ' SER . 16.3 t60 -60.28 -51.51 69.25 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.638 -1.164 . . . . 0.0 112.783 -176.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.608 ' SG ' ' N ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -151.97 167.0 29.79 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.744 -179.419 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.608 ' N ' ' SG ' ' A' ' 49' ' ' CYS . 67.8 tttt -145.88 127.48 15.14 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.934 -178.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 93.1 mt -100.17 109.12 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 120.422 -0.511 . . . . 0.0 109.866 178.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 59' ' ' ILE . 84.4 tt0 -90.14 129.04 36.47 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.494 ' CG2' ' O ' ' A' ' 53' ' ' ILE . 2.3 tp -87.88 122.07 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 CA-C-O 121.336 0.589 . . . . 0.0 111.554 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.461 ' N ' ' O ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -95.03 166.32 11.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.903 179.354 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.42 ' OE1' ' N ' ' A' ' 55' ' ' GLU . 58.7 mp0 -40.13 -38.31 0.73 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.233 -0.439 . . . . 0.0 112.061 -179.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -141.19 7.67 2.01 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 120.127 -0.629 . . . . 0.0 112.354 -178.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.461 ' O ' ' N ' ' A' ' 54' ' ' HIS . 78.6 mm-40 -146.62 164.99 30.89 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 120.199 -0.6 . . . . 0.0 111.78 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -105.35 143.25 33.77 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.405 ' O ' ' N ' ' A' ' 52' ' ' GLU . 32.1 mm -129.95 128.43 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.792 -178.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.4 tp -79.53 149.8 31.34 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.101 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' A' ' 50' ' ' LYS . 29.5 m-70 -142.2 78.15 1.61 Allowed 'General case' 0 C--N 1.34 0.162 0 CA-C-O 121.285 0.564 . . . . 0.0 110.075 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.663 ' ND2' ' H ' ' A' ' 69' ' ' THR . 18.7 t-20 -67.94 137.17 54.98 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.237 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.412 ' CE1' ' O ' ' A' ' 61' ' ' HIS . 35.7 m-85 -112.27 -21.82 11.23 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.141 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.456 ' HB2' HD22 ' A' ' 62' ' ' ASN . 16.3 m -65.87 145.97 55.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.645 -178.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.1 t -117.1 -49.37 2.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.991 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.464 ' OG1' ' OD1' ' A' ' 67' ' ' ASN . 25.4 p -71.98 -38.66 69.67 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.901 0.381 . . . . 0.0 110.425 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.48 ' OD1' ' N ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -121.85 79.06 40.66 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.467 179.223 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.87 146.17 71.0 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 121.587 1.525 . . . . 0.0 112.656 -179.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.663 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 44.6 m -62.35 145.33 54.17 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.562 -0.745 . . . . 0.0 108.998 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.474 ' O ' ' N ' ' A' ' 89' ' ' THR . 87.7 mt-30 -112.8 130.42 56.09 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.377 0.608 . . . . 0.0 112.577 -177.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.7 t -129.98 133.59 64.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.33 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 12.2 m120 57.45 14.79 2.39 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.92 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.39 -20.31 50.33 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.556 178.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.1 m -84.22 153.83 23.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.128 0.464 . . . . 0.0 110.674 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -84.5 153.54 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.81 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.3 mt -119.71 106.12 18.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.935 -178.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -78.35 -38.86 41.04 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.394 178.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -132.33 173.92 5.31 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.57 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.55 142.8 80.75 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.399 2.066 . . . . 0.0 111.766 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.1 m -138.32 160.24 31.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.701 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 59.0 ttt85 -80.16 141.6 35.54 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 120.943 0.401 . . . . 0.0 110.806 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 85.1 mt -109.82 139.28 45.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.305 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -109.88 159.78 16.94 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.187 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.793 ' HD1' ' H ' ' A' ' 99' ' ' ASN . 44.7 t60 -64.82 128.89 37.67 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.131 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.74 -2.82 62.47 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.595 ' OD1' ' N ' ' A' ' 87' ' ' VAL . 59.3 t0 -69.38 143.31 53.72 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.595 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 53.9 t -115.45 134.77 57.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.848 0.356 . . . . 0.0 110.823 -178.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 65.1 mt -108.26 131.17 59.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.474 ' N ' ' O ' ' A' ' 70' ' ' GLN . 87.2 m -129.04 127.19 41.06 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.245 0.545 . . . . 0.0 111.113 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.735 ' CG2' ' H ' ' A' ' 91' ' ' ILE . 86.6 mt -97.18 -155.93 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.735 ' H ' ' CG2' ' A' ' 90' ' ' ILE . 96.3 mt -62.29 -43.98 98.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 118.453 0.569 . . . . 0.0 112.308 -178.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.477 ' OD1' ' O ' ' A' ' 91' ' ' ILE . 88.6 m-20 -139.79 2.57 1.98 Allowed 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 119.73 -0.788 . . . . 0.0 113.098 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 62.4 ttm-85 -128.68 146.89 50.75 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.128 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.6 m -122.88 148.2 45.7 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.429 0.633 . . . . 0.0 112.101 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.486 ' CE2' ' CG2' ' A' ' 37' ' ' ILE . 56.8 m-85 -130.36 149.25 52.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.286 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -118.01 138.69 52.03 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.427 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.43 ' CD1' ' C ' ' A' ' 97' ' ' TYR . 0.8 OUTLIER -114.47 105.72 13.43 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.456 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -114.8 118.37 33.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.736 -178.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.793 ' H ' ' HD1' ' A' ' 84' ' ' HIS . 63.7 t-20 -101.9 101.72 12.19 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.451 ' OE1' ' N ' ' A' ' 100' ' ' GLU . 52.2 mp0 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.528 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.457 ' O ' ' C ' ' A' ' 2' ' ' TRP . 5.2 ptt? . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.457 ' C ' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -32.33 97.73 0.11 Allowed Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.021 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.32 143.66 97.07 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 122.134 1.889 . . . . 0.0 111.706 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.9 t -147.06 159.9 43.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.578 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.63 HH21 ' NE2' ' A' ' 56' ' ' GLN . 85.4 mtt85 -126.65 150.46 48.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.352 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -133.63 145.49 50.04 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.807 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.2 mt -106.51 130.69 54.25 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.1 t -112.79 133.2 59.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.5 m -108.69 125.48 51.94 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.449 -178.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 82.9 mt -76.17 130.24 36.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.316 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -61.2 -45.41 94.69 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.31 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.604 ' O ' ' N ' ' A' ' 14' ' ' GLY . 77.4 ttt-85 -173.86 82.39 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.174 179.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.548 ' O ' ' OG ' ' A' ' 13' ' ' SER . 0.0 OUTLIER 36.21 24.59 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.033 0.444 . . . . 0.0 110.844 178.703 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.604 ' N ' ' O ' ' A' ' 12' ' ' ARG . . . -106.41 -116.94 4.21 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.473 ' O ' ' C ' ' A' ' 16' ' ' ASP . 26.3 m -115.95 131.46 68.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.87 0.367 . . . . 0.0 110.407 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.473 ' C ' ' O ' ' A' ' 15' ' ' VAL . 53.2 m-20 31.74 -148.3 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.501 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 152.89 -158.45 27.9 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.444 -1.063 . . . . 0.0 110.444 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.09 144.75 99.46 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.436 2.09 . . . . 0.0 111.539 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -111.36 164.87 12.47 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.825 0.345 . . . . 0.0 111.145 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -154.08 110.99 2.48 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.049 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.2 151.7 44.13 Favored 'Trans proline' 0 N--CA 1.489 1.21 0 C-N-CA 121.973 1.782 . . . . 0.0 111.457 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 14.0 tp -88.73 75.12 8.25 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.79 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.4 t -72.52 -37.07 68.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.639 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.425 ' HG ' ' H ' ' A' ' 26' ' ' THR . 41.6 tp -106.56 134.65 49.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.631 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.3 p -56.21 -34.54 66.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.708 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.425 ' H ' ' HG ' ' A' ' 24' ' ' LEU . 64.4 p -102.57 131.0 49.6 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.47 179.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.3 m -113.7 130.05 56.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.002 0.429 . . . . 0.0 110.714 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.426 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 55.8 tp -117.26 140.36 49.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.819 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.423 ' N ' ' CD1' ' A' ' 29' ' ' PHE . 8.6 m-85 -113.39 145.17 41.55 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.858 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 150.61 171.27 18.68 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 119.624 -1.274 . . . . 0.0 113.141 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 91.7 mtm180 -67.25 -42.05 84.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.54 -0.83 . . . . 0.0 112.878 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.33 154.81 44.42 Favored Glycine 0 CA--C 1.523 0.535 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.53 -178.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.41 ' C ' ' N ' ' A' ' 35' ' ' CYS . 19.8 tt -68.16 -29.83 45.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.193 0.521 . . . . 0.0 109.871 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -49.27 -19.33 0.47 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.715 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.41 ' N ' ' C ' ' A' ' 33' ' ' ILE . 34.9 m -81.5 131.88 35.29 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.599 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.426 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 93.3 m-20 -62.16 -36.78 82.9 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.478 ' CG2' ' CE2' ' A' ' 95' ' ' PHE . 4.8 mm -106.45 89.33 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.735 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -67.77 133.98 50.19 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.812 -178.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 97.5 mt -120.88 124.74 72.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.852 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 65.5 tp60 -96.99 79.85 2.92 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.231 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.9 mt -156.07 110.93 2.11 Favored Pre-proline 0 CA--C 1.536 0.422 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.691 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -50.66 -34.07 42.1 Favored 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 122.293 1.995 . . . . 0.0 112.729 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.0 m -63.56 -33.81 63.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.185 -178.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.406 ' CG1' ' N ' ' A' ' 45' ' ' SER . 81.1 t -71.11 158.48 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.593 ' H ' ' HD1' ' A' ' 48' ' ' HIS . 13.5 m -93.54 162.7 13.86 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.675 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -58.45 -39.69 80.57 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.023 0.44 . . . . 0.0 110.095 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -128.44 63.84 1.43 Allowed 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.593 ' HD1' ' H ' ' A' ' 45' ' ' SER . 15.1 t60 -59.65 -50.01 75.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 113.926 -1.488 . . . . 0.0 112.728 -177.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.668 ' SG ' ' N ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -156.62 164.14 38.52 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.133 -179.42 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.668 ' N ' ' SG ' ' A' ' 49' ' ' CYS . 71.0 tttt -144.3 133.17 22.56 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.454 -179.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.432 ' N ' HD13 ' A' ' 51' ' ' ILE . 1.6 mp -108.62 107.45 22.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.23 0.538 . . . . 0.0 110.137 178.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -90.28 129.17 36.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.405 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.8 tp -94.64 133.71 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 CA-C-O 121.164 0.507 . . . . 0.0 111.317 -178.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.439 ' O ' ' C ' ' A' ' 55' ' ' GLU . 19.6 m-70 -112.3 -179.44 3.68 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.272 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 54' ' ' HIS . 95.3 mt-10 -35.87 -53.7 0.74 Allowed 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 120.974 -0.291 . . . . 0.0 111.423 -178.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.63 ' NE2' HH21 ' A' ' 5' ' ' ARG . 45.2 tp60 -145.93 28.95 1.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.199 -0.6 . . . . 0.0 111.303 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -150.34 143.65 25.01 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.996 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -98.71 141.82 31.04 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.437 ' N ' HD13 ' A' ' 59' ' ' ILE . 2.1 mp -127.05 129.24 71.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.364 -178.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.2 tt -82.7 151.76 26.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.103 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.583 ' N ' ' O ' ' A' ' 50' ' ' LYS . 19.8 m-70 -140.61 77.64 1.61 Allowed 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 121.512 0.672 . . . . 0.0 109.416 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.62 ' ND2' ' H ' ' A' ' 69' ' ' THR . 22.4 t-20 -70.14 136.16 49.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.687 -1.142 . . . . 0.0 112.039 -179.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.515 ' CE1' ' O ' ' A' ' 61' ' ' HIS . 16.7 m-85 -117.14 -21.45 8.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.77 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.0 m -70.46 141.1 52.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.169 0.509 . . . . 0.0 112.286 -178.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.718 ' HG ' ' N ' ' A' ' 66' ' ' THR . 13.8 p -105.75 -59.0 1.83 Allowed 'General case' 0 CA--C 1.526 0.057 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.744 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.718 ' N ' ' HG ' ' A' ' 65' ' ' SER . 65.6 p -66.08 -34.32 77.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.767 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -122.34 77.85 44.54 Favored Pre-proline 0 C--N 1.33 -0.251 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -70.16 146.94 59.13 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.039 1.826 . . . . 0.0 113.043 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.62 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 46.1 m -73.63 163.44 28.0 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -128.14 146.5 50.69 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.535 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.42 ' C ' ' N ' ' A' ' 73' ' ' GLY . 7.1 p -134.64 137.89 50.42 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 CA-C-O 121.132 0.492 . . . . 0.0 111.316 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 46.13 21.46 0.11 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.301 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.42 ' N ' ' C ' ' A' ' 71' ' ' VAL . . . 89.33 13.46 61.67 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 120.89 -0.672 . . . . 0.0 111.862 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 71' ' ' VAL . 42.0 t -115.77 138.3 51.26 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.322 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.9 t -68.44 142.44 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.352 0.596 . . . . 0.0 110.454 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 85.0 mt -108.89 113.52 44.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.308 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -98.85 -12.35 20.88 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.938 0.399 . . . . 0.0 110.799 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -159.77 170.64 8.41 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.836 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -56.01 137.92 80.74 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 121.812 1.674 . . . . 0.0 111.343 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.3 m -143.43 161.68 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.137 0.494 . . . . 0.0 111.775 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 71.4 ttp85 -78.27 145.58 35.34 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.154 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.3 mt -118.5 149.05 41.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.608 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.516 ' N ' ' OD2' ' A' ' 86' ' ' ASP . 50.1 mtpt -107.86 153.81 22.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.61 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.746 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 69.6 t60 -56.89 131.08 48.51 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.474 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.57 4.27 80.13 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.215 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.516 ' OD2' ' N ' ' A' ' 83' ' ' LYS . 74.5 m-20 -67.58 145.96 54.36 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 117.324 0.562 . . . . 0.0 110.704 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 56.1 t -112.89 130.76 66.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.654 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 84.5 mt -109.75 136.38 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.547 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 68.9 m -126.8 125.89 42.46 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.221 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.762 ' CG2' ' H ' ' A' ' 91' ' ' ILE . 92.1 mt -97.22 -148.49 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.762 ' H ' ' CG2' ' A' ' 90' ' ' ILE . 84.8 mt -63.75 -44.75 98.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 119.156 0.889 . . . . 0.0 113.312 -178.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.495 ' OD1' ' O ' ' A' ' 91' ' ' ILE . 90.9 m-20 -143.59 2.91 1.26 Allowed 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.682 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -130.26 154.56 47.46 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.242 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 59.4 m -133.27 150.24 51.92 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.206 -0.598 . . . . 0.0 111.993 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.478 ' CE2' ' CG2' ' A' ' 37' ' ' ILE . 41.2 m-85 -129.13 150.41 50.53 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.806 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.7 mtp180 -120.38 138.93 53.48 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.393 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.596 ' C ' ' CD1' ' A' ' 97' ' ' TYR . 0.1 OUTLIER -108.41 115.95 31.07 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.376 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.62 133.94 26.21 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.413 0.625 . . . . 0.0 111.371 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.746 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 46.9 p30 -99.13 174.0 6.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.928 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 . . . . . 0 C--N 1.324 -0.534 0 CA-C-O 121.073 0.463 . . . . 0.0 111.284 -179.384 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.3 mtp . . . . . 0 N--CA 1.493 1.684 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.605 ' CG ' ' O ' ' A' ' 2' ' ' TRP . 1.8 t90 175.16 91.28 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.251 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.978 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -61.14 144.64 99.2 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.968 1.779 . . . . 0.0 111.625 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.5 t -148.23 165.7 30.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.689 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.62 ' NE ' ' ND2' ' A' ' 99' ' ' ASN . 84.1 mtt85 -72.0 142.63 49.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.904 0.383 . . . . 0.0 110.721 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.661 ' NH2' ' CG ' ' A' ' 19' ' ' HIS . 16.9 ptm180 -143.49 151.04 39.82 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.095 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.0 mt -111.33 132.77 54.15 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.1 t -120.76 132.91 69.07 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-O 121.456 0.646 . . . . 0.0 110.313 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.58 ' OG1' ' CE2' ' A' ' 95' ' ' PHE . 91.4 m -106.2 118.6 37.04 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.514 -179.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 62.1 mt -85.04 113.0 22.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.1 mttm -65.53 -42.56 91.86 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 120.096 -0.642 . . . . 0.0 109.641 179.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -139.21 136.16 34.71 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.203 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.9 t -57.26 132.86 54.29 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.489 -0.485 . . . . 0.0 109.924 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.22 -21.37 39.86 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.264 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.5 m -126.93 129.98 71.35 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 CA-C-O 121.546 0.689 . . . . 0.0 111.553 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 52.1 p-10 -65.56 147.75 52.88 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.408 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -123.2 -162.49 11.51 Favored Glycine 0 CA--C 1.531 1.031 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.3 150.66 47.43 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 122.634 2.222 . . . . 0.0 111.971 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.661 ' CG ' ' NH2' ' A' ' 6' ' ' ARG . 3.1 m170 -97.04 167.6 10.97 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.085 0.469 . . . . 0.0 111.539 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.527 ' CZ ' ' O ' ' A' ' 36' ' ' ASP . 82.1 t80 -137.94 89.51 14.81 Favored Pre-proline 0 N--CA 1.455 -0.188 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.761 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -58.17 145.28 93.28 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.505 2.137 . . . . 0.0 110.928 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.9 mt -85.22 136.34 33.56 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.234 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.17 -38.81 2.87 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.9 mt -107.08 143.08 35.73 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.604 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 74.4 p -61.8 -22.84 65.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.575 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.45 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 4.7 p -114.85 124.85 52.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.202 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.7 m -109.91 137.86 47.1 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.69 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 64.5 tp -120.63 141.12 50.64 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.806 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -111.38 131.11 55.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.785 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 161.68 172.68 29.37 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.048 -1.073 . . . . 0.0 112.382 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.692 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 83.6 mtm-85 -66.02 -34.54 78.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.698 -0.751 . . . . 0.0 110.837 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -51.7 142.22 21.29 Favored Glycine 0 CA--C 1.521 0.468 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.676 -178.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.1 tt -69.08 -38.63 78.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.231 0.538 . . . . 0.0 109.698 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -55.54 -14.7 2.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.02 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 86.3 m -73.16 136.07 44.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.967 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.527 ' O ' ' CZ ' ' A' ' 20' ' ' PHE . 91.8 m-20 -63.87 -38.55 91.5 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.447 ' CD1' ' CD2' ' A' ' 20' ' ' PHE . 7.1 mm -111.73 91.22 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-N 114.913 -1.039 . . . . 0.0 109.213 179.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 90.7 mtm180 -74.5 136.75 42.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.746 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.3 mt -125.65 120.11 56.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.714 179.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.553 ' H ' HH12 ' A' ' 93' ' ' ARG . 98.4 mt-30 -93.31 79.67 4.44 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 119.499 -0.88 . . . . 0.0 110.527 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.6 mt -156.71 116.41 2.08 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.818 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -50.9 -34.31 45.17 Favored 'Trans proline' 0 N--CA 1.498 1.794 0 C-N-CA 122.128 1.885 . . . . 0.0 112.942 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.518 ' O ' ' CD1' ' A' ' 91' ' ' ILE . 19.4 m -64.9 -28.92 45.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.694 -0.403 . . . . 0.0 112.073 -178.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.692 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 99.6 t -78.45 166.96 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 C-N-CA 119.801 -0.76 . . . . 0.0 109.14 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.508 ' N ' ' CG1' ' A' ' 44' ' ' VAL . 7.3 t -111.48 152.1 27.84 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.612 -179.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -59.07 -42.33 90.11 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 -111.5 60.11 0.62 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 177.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.458 ' NE2' HG22 ' A' ' 90' ' ' ILE . 17.1 t60 -70.94 -67.97 0.47 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.698 -176.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.7 p -142.09 162.61 35.04 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.6 ' O ' ' N ' ' A' ' 61' ' ' HIS . 37.0 tttm -141.42 131.07 24.06 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.244 -0.583 . . . . 0.0 112.284 -178.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 95.7 mt -104.18 115.85 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-O 121.525 0.679 . . . . 0.0 110.001 177.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.401 ' HB2' ' NZ ' ' A' ' 50' ' ' LYS . 85.4 tt0 -97.31 137.82 35.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.332 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.411 ' O ' ' CG2' ' A' ' 53' ' ' ILE . 1.4 tp -103.42 130.68 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-O 121.326 0.584 . . . . 0.0 111.036 -178.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.469 ' O ' ' C ' ' A' ' 55' ' ' GLU . 41.1 m-70 -108.6 176.73 5.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.455 179.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.469 ' C ' ' O ' ' A' ' 54' ' ' HIS . 52.0 tp10 -35.2 -51.86 0.57 Allowed 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.342 -178.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -145.54 36.3 1.08 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.743 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -152.3 149.33 28.55 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.021 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.39 133.96 52.42 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 42.4 mm -123.69 130.59 73.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.973 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.74 138.74 31.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.369 0.604 . . . . 0.0 111.022 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.6 ' N ' ' O ' ' A' ' 50' ' ' LYS . 41.5 m-70 -126.12 79.61 1.85 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.011 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.619 ' ND2' ' H ' ' A' ' 69' ' ' THR . 28.5 t-20 -71.3 123.34 22.06 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.816 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -98.66 -29.87 12.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.368 0.604 . . . . 0.0 110.154 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.594 ' OG ' ' ND2' ' A' ' 62' ' ' ASN . 20.5 p -61.27 149.2 38.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.607 -178.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.2 t -117.01 -58.43 2.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.823 179.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.3 m -62.47 -48.92 77.51 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.446 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.599 ' OD1' ' N ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -112.83 81.77 4.67 Favored Pre-proline 0 C--N 1.329 -0.3 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.015 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -76.79 147.85 27.92 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 122.252 1.968 . . . . 0.0 112.406 -178.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.619 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 7.0 m -66.26 155.09 38.14 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -125.34 153.24 43.62 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.307 0.575 . . . . 0.0 111.877 -177.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.467 ' O ' ' N ' ' A' ' 74' ' ' SER . 24.6 t -129.94 126.13 61.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.055 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 48.5 32.19 3.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.728 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.59 4.48 82.95 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.467 ' N ' ' O ' ' A' ' 71' ' ' VAL . 5.9 p -90.66 174.11 7.67 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.621 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.5 t -113.84 140.56 33.7 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 76.1 mt -112.03 90.12 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.242 -177.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.508 ' O ' ' OE1' ' A' ' 78' ' ' GLU . 74.1 m-20 -65.73 -44.71 85.16 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.112 0.482 . . . . 0.0 110.535 178.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.508 ' OE1' ' O ' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -132.64 174.11 5.09 Favored Pre-proline 0 CA--C 1.529 0.168 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.66 -179.856 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -55.49 141.16 83.11 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.237 1.958 . . . . 0.0 111.359 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.3 m -139.43 164.37 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.126 0.489 . . . . 0.0 111.885 -178.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -89.21 145.48 25.38 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.995 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 5.4 mp -117.91 149.89 40.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.059 0.457 . . . . 0.0 110.764 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -109.08 156.57 19.64 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.758 ' HD1' ' N ' ' A' ' 85' ' ' GLY . 5.0 t-80 -50.6 142.24 11.24 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.261 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.758 ' N ' ' HD1' ' A' ' 84' ' ' HIS . . . 80.91 -3.33 76.36 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.523 178.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 87' ' ' VAL . 66.4 t0 -65.49 141.06 58.61 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.921 0.36 . . . . 0.0 111.068 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.506 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 14.6 p -112.72 128.83 69.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 120.944 0.402 . . . . 0.0 110.993 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.416 ' CG2' ' CG2' ' A' ' 69' ' ' THR . 65.0 mt -104.37 130.3 55.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.726 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 88.2 m -120.15 123.13 42.57 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.139 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.58 ' CG2' ' H ' ' A' ' 91' ' ' ILE . 16.7 mm -79.85 -145.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.58 ' H ' ' CG2' ' A' ' 90' ' ' ILE . 90.2 mt -63.11 -44.09 99.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 C-N-CA 119.711 -0.796 . . . . 0.0 111.292 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -145.47 8.64 1.18 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 119.751 -0.779 . . . . 0.0 113.046 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.553 HH12 ' H ' ' A' ' 40' ' ' GLN . 99.4 mtt180 -121.62 151.06 40.83 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.88 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.9 m -112.58 144.45 42.04 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.58 ' CE2' ' OG1' ' A' ' 9' ' ' THR . 32.9 m-85 -133.08 145.72 51.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.532 178.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 71.0 mtp180 -116.66 136.91 52.58 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.715 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.508 ' C ' ' CD1' ' A' ' 97' ' ' TYR . 0.6 OUTLIER -106.88 100.62 10.11 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.666 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -117.93 129.64 55.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.487 0.661 . . . . 0.0 111.115 -178.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.631 ' H ' ' NE2' ' A' ' 84' ' ' HIS . 57.7 t-20 -117.39 95.36 4.93 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.947 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 . . . . . 0 C--N 1.329 -0.3 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.032 -179.64 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.3 mtt . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 4.3 m0 -98.18 164.34 17.44 Favored Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -59.63 145.94 96.7 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 121.919 1.746 . . . . 0.0 111.626 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.6 m -118.72 95.03 4.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.161 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.562 ' NH1' ' O ' ' A' ' 54' ' ' HIS . 90.4 mtm180 -132.67 137.93 47.13 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -148.68 153.1 37.79 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.596 -0.441 . . . . 0.0 111.403 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 68.6 mt -112.5 132.25 55.18 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 t -110.66 132.02 60.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 98.9 m -102.27 115.49 30.67 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.168 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.538 ' CD1' ' NE ' ' A' ' 96' ' ' ARG . 84.2 mt -79.08 133.48 29.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.933 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -59.67 140.47 56.4 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -59.99 -43.38 95.2 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.925 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.0 p -100.58 -3.11 31.2 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.681 -0.408 . . . . 0.0 112.1 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -131.35 -140.89 4.68 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 119.977 -1.106 . . . . 0.0 112.046 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.441 ' O ' ' C ' ' A' ' 16' ' ' ASP . 34.2 m -133.99 160.05 42.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 114.945 -0.627 . . . . 0.0 111.133 -178.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.598 ' OD1' ' NH1' ' A' ' 96' ' ' ARG . 65.7 m-20 36.63 -148.27 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.025 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 138.09 -160.09 25.29 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -58.8 143.47 99.09 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 123.279 2.652 . . . . 0.0 112.094 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.421 ' CD2' ' N ' ' A' ' 19' ' ' HIS . 5.4 m170 -93.68 170.08 9.84 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.612 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -140.97 104.56 6.19 Favored Pre-proline 0 N--CA 1.449 -0.508 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.859 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -72.9 154.18 53.22 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.013 1.809 . . . . 0.0 111.892 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.571 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 2.9 mm? -80.55 76.28 7.4 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.845 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 59.8 m -61.29 -40.45 94.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.733 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.2 mt -113.19 153.59 28.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.537 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 55.1 p -61.48 -24.47 66.6 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.981 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.427 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 17.4 p -120.07 122.82 41.93 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.643 -179.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.5 m -97.5 129.96 44.62 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.356 178.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.412 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 61.5 tp -118.44 134.22 55.24 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.241 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -104.92 145.5 30.32 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.848 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 143.73 164.76 10.52 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.755 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.41 ' O ' ' C ' ' A' ' 32' ' ' GLY . 82.2 mtp180 -63.37 -42.84 98.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.264 -0.468 . . . . 0.0 110.249 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 31' ' ' ARG . . . -37.48 139.89 0.43 Allowed Glycine 0 CA--C 1.52 0.373 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.444 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 18.8 tt -64.02 -37.05 78.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.444 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 11.1 pt-20 -57.64 -13.45 3.96 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.764 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 41.5 m -76.03 126.07 30.31 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.666 0.269 . . . . 0.0 111.301 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.427 ' OD2' ' O ' ' A' ' 26' ' ' THR . 87.2 m-20 -63.82 -39.12 93.48 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 179.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mm -105.04 76.78 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 178.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -65.86 134.36 52.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.702 -178.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 98.0 mt -124.71 130.02 73.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.493 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -98.71 81.8 2.72 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.251 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.7 mt -156.53 115.02 2.07 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.928 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -50.22 -34.77 40.96 Favored 'Trans proline' 0 N--CA 1.504 2.093 0 C-N-CA 122.254 1.97 . . . . 0.0 114.014 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.1 m -66.41 -28.1 42.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -178.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 94.6 t -78.59 143.71 12.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.867 0.365 . . . . 0.0 110.491 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.654 ' H ' ' HD1' ' A' ' 48' ' ' HIS . 6.8 m -84.19 166.53 17.49 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.993 -178.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.04 -38.04 89.6 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.094 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.512 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 96.5 mt-30 -128.35 59.95 1.5 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 177.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.654 ' HD1' ' H ' ' A' ' 45' ' ' SER . 10.4 t60 -60.81 -49.43 77.5 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.005 -0.998 . . . . 0.0 112.33 -177.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.46 ' SG ' ' N ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -150.23 152.71 35.0 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.106 0.479 . . . . 0.0 110.197 -179.674 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.536 ' O ' ' N ' ' A' ' 61' ' ' HIS . 72.8 tttt -136.34 124.66 23.28 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.974 -179.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 98.4 mt -107.93 108.81 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.745 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -83.76 140.83 31.83 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 50.9 mm -109.94 132.73 57.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.516 0.674 . . . . 0.0 112.046 -177.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.562 ' O ' ' NH1' ' A' ' 5' ' ' ARG . 44.2 m-70 -111.34 178.16 4.42 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.303 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.546 ' OE1' ' N ' ' A' ' 55' ' ' GLU . 55.9 mp0 -35.82 -49.28 0.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.863 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -146.53 25.13 1.22 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.876 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -141.01 147.48 38.76 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.94 -179.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.35 129.93 55.51 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.426 HD11 HG22 ' A' ' 59' ' ' ILE . 41.2 mm -119.67 124.29 72.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.549 -177.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.8 tt -80.21 145.45 32.25 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.827 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.536 ' N ' ' O ' ' A' ' 50' ' ' LYS . 45.7 m-70 -139.63 79.04 1.7 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.076 -0.966 . . . . 0.0 109.14 179.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.565 ' ND2' ' H ' ' A' ' 69' ' ' THR . 25.5 t-20 -69.32 141.85 54.18 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.729 -178.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.512 ' CD1' ' O ' ' A' ' 47' ' ' GLN . 24.6 m-85 -113.54 -37.47 4.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.659 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 55.9 m -62.37 135.51 57.48 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.377 0.608 . . . . 0.0 112.507 -176.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.5 m -103.23 -50.34 3.5 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.487 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 36.2 p -65.94 -41.63 91.07 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.008 0.432 . . . . 0.0 110.454 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -126.7 80.09 70.85 Favored Pre-proline 0 C--O 1.234 0.264 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -76.27 146.63 28.49 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.391 2.061 . . . . 0.0 112.548 -178.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.565 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 75.0 m -61.44 167.11 3.51 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.23 178.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -134.6 148.35 50.41 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -177.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.41 ' O ' ' N ' ' A' ' 74' ' ' SER . 41.4 t -127.23 127.71 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.259 178.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.621 ' ND2' ' OD1' ' A' ' 86' ' ' ASP . 84.6 m-20 49.41 29.01 2.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.8 0.334 . . . . 0.0 110.684 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.2 12.15 81.23 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 71' ' ' VAL . 39.2 t -107.55 129.47 54.97 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 99.2 t -66.51 145.63 13.74 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.265 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.3 mt -104.47 100.06 9.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.63 -178.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -70.16 -33.53 71.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.924 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -154.72 174.64 3.69 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.337 -179.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.33 133.74 49.11 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.535 1.49 . . . . 0.0 109.967 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.7 m -135.51 160.54 39.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 120.325 -0.55 . . . . 0.0 111.329 -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -80.16 142.19 34.99 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.576 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 73.5 mt -108.47 143.54 37.29 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.955 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -105.95 164.54 11.88 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.736 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 35.3 t60 -65.68 135.38 54.91 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.723 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.93 -2.05 88.5 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.621 ' OD1' ' ND2' ' A' ' 72' ' ' ASN . 27.5 t70 -64.72 148.96 50.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.95 0.405 . . . . 0.0 110.437 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.8 t -118.16 130.65 72.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.24 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 68.2 mt -108.52 132.99 54.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 91.4 m -129.9 122.56 28.86 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -178.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.727 ' CG2' ' H ' ' A' ' 91' ' ' ILE . 94.9 mt -86.39 -153.72 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.239 177.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.727 ' H ' ' CG2' ' A' ' 90' ' ' ILE . 86.3 mt -62.86 -44.2 99.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 119.449 1.022 . . . . 0.0 112.36 -178.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 91' ' ' ILE . 88.2 m-20 -143.86 17.99 1.8 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 121.031 -0.268 . . . . 0.0 111.139 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 35.7 mmm-85 -130.24 145.03 51.7 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.708 -179.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.6 m -125.92 139.77 53.18 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 121.287 0.565 . . . . 0.0 111.973 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -123.78 150.68 44.16 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.779 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.598 ' NH1' ' OD1' ' A' ' 16' ' ' ASP . 73.3 mtt180 -116.01 134.68 54.7 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.488 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -116.72 104.75 11.67 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.82 132.68 53.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.202 0.525 . . . . 0.0 112.351 -178.168 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.736 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 64.9 t-20 -115.12 104.34 11.77 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.224 178.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 121.099 0.476 . . . . 0.0 111.665 -178.81 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtm . . . . . 0 N--CA 1.492 1.659 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.614 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -99.79 -43.22 0.22 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.868 0.366 . . . . 0.0 110.993 -179.429 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 2' ' ' TRP . 32.3 Cg_exo -57.98 143.38 96.28 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 123.024 2.483 . . . . 0.0 112.751 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 82.7 p -91.02 -153.58 0.32 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.831 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.52 ' NH1' ' CB ' ' A' ' 99' ' ' ASN . 95.7 mtt-85 -67.09 137.98 56.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.627 -179.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.9 ptt-85 -155.31 154.81 32.65 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.926 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 91.5 mt -109.24 131.89 54.64 Favored 'General case' 0 N--CA 1.461 0.119 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 77.7 t -114.63 131.19 67.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.446 ' OG1' ' CE2' ' A' ' 95' ' ' PHE . 99.8 m -101.57 121.83 42.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.142 0.496 . . . . 0.0 111.73 -179.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 87.4 mt -78.87 132.0 33.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.832 179.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -63.48 -76.24 0.07 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.392 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -176.88 -26.49 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.352 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.8 m -76.32 -4.27 41.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.883 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.5 31.44 24.72 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 120.372 -0.918 . . . . 0.0 110.998 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.3 m -129.64 162.99 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 121.38 0.61 . . . . 0.0 111.397 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -67.21 138.79 57.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.524 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.91 -155.08 8.28 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -60.37 147.62 93.29 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.166 1.911 . . . . 0.0 110.806 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 5.6 m170 -103.08 167.9 9.53 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.809 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -137.54 109.41 8.7 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.95 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.85 152.34 46.81 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 121.872 1.715 . . . . 0.0 111.685 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 86.9 mt -86.69 82.02 8.02 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.561 -0.455 . . . . 0.0 111.106 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.1 m -62.64 -40.59 97.51 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.906 0.384 . . . . 0.0 110.914 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.0 mp -107.44 145.92 32.38 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.621 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 89.6 p -55.65 -24.15 32.06 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.895 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.462 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 64.3 p -111.64 128.88 56.19 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.058 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -104.09 116.04 31.51 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.424 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 6.7 tt -116.48 144.72 43.97 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.288 0.566 . . . . 0.0 112.031 -178.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -107.51 149.81 27.55 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.076 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.422 ' CA ' ' SG ' ' A' ' 35' ' ' CYS . . . 140.45 164.5 9.93 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.146 -1.026 . . . . 0.0 112.942 178.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 66.2 mtp85 -66.04 -37.84 86.88 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.165 -0.517 . . . . 0.0 110.81 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -47.2 147.16 3.62 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.4 tt -64.22 -29.71 48.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -58.12 -21.66 47.47 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.391 178.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.511 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 56.4 m -69.15 118.15 11.69 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.462 ' OD2' ' O ' ' A' ' 26' ' ' THR . 60.7 m-20 -63.55 -36.71 84.69 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 177.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.588 ' CG2' ' CE2' ' A' ' 95' ' ' PHE . 2.5 mm -106.42 78.42 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 114.611 -1.177 . . . . 0.0 108.454 178.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -64.6 128.79 37.27 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.928 -178.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.7 mt -120.55 123.98 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.218 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -88.61 80.62 7.27 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.851 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.4 tp -154.94 113.3 2.34 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.266 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -53.36 -32.48 61.93 Favored 'Trans proline' 0 N--CA 1.498 1.783 0 C-N-CA 121.79 1.66 . . . . 0.0 112.711 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.6 m -62.81 -43.66 98.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.276 -0.42 . . . . 0.0 112.055 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.478 ' CG1' ' N ' ' A' ' 45' ' ' SER . 97.6 t -68.46 165.57 2.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.478 ' N ' ' CG1' ' A' ' 44' ' ' VAL . 3.2 t -101.97 158.89 15.82 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.805 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.511 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 53.0 mtmt -62.08 -38.5 89.05 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -121.43 64.03 0.89 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 178.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.45 ' CD2' HG23 ' A' ' 90' ' ' ILE . 22.5 t60 -68.75 -51.54 40.19 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -176.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.409 ' HB3' ' ND2' ' A' ' 62' ' ' ASN . 28.6 p -171.2 170.2 6.15 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -178.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -153.72 157.16 39.09 Favored 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.762 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 56.9 mt -116.79 111.39 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.082 178.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.469 ' N ' ' O ' ' A' ' 59' ' ' ILE . 96.3 mt-10 -86.14 151.05 23.98 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.746 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.447 ' O ' ' CG2' ' A' ' 53' ' ' ILE . 5.2 tp -107.81 128.9 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 CA-C-O 121.421 0.629 . . . . 0.0 110.502 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.407 ' O ' ' C ' ' A' ' 55' ' ' GLU . 21.1 m-70 -104.06 -178.29 3.62 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.401 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 54' ' ' HIS . 98.1 mt-10 -39.47 -51.05 2.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.057 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.426 ' C ' ' NH2' ' A' ' 5' ' ' ARG . 35.0 tt0 -146.22 33.85 0.99 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.899 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.442 ' OE2' ' CG ' ' A' ' 81' ' ' ARG . 77.1 tt0 -155.43 154.55 32.09 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 120.394 -0.523 . . . . 0.0 112.081 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.469 ' H ' ' HH ' ' A' ' 97' ' ' TYR . . . -106.34 137.83 43.59 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 177.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.469 ' O ' ' N ' ' A' ' 52' ' ' GLU . 25.4 mm -129.2 138.26 54.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.546 -178.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.423 ' CD2' ' OD1' ' A' ' 62' ' ' ASN . 6.7 tt -99.45 140.0 34.27 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -130.76 79.63 1.9 Allowed 'General case' 0 C--N 1.342 0.255 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.038 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.669 HD22 ' CB ' ' A' ' 69' ' ' THR . 0.8 OUTLIER -60.4 134.96 57.57 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.739 -1.119 . . . . 0.0 112.392 -179.124 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -101.85 -34.16 9.51 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.348 178.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.3 p -65.48 151.63 45.91 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.488 -177.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 m -123.24 -55.02 1.78 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.677 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.1 m -64.18 -47.75 78.61 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.577 ' OD1' ' N ' ' A' ' 67' ' ' ASN . 0.1 OUTLIER -115.14 78.01 5.52 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.754 179.003 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -73.55 147.34 40.58 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 121.355 1.37 . . . . 0.0 112.505 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.669 ' CB ' HD22 ' A' ' 62' ' ' ASN . 22.1 m -67.27 165.76 15.61 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -129.17 153.04 48.1 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 119.991 -0.684 . . . . 0.0 112.674 -177.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.7 t -126.45 130.79 71.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.999 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 45.51 29.88 0.68 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.593 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 88.31 0.88 82.11 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 121.234 -0.508 . . . . 0.0 112.221 179.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.8 m -100.5 157.61 16.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.347 0.573 . . . . 0.0 110.981 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.2 t -84.11 150.9 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.693 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 95.9 mt -114.71 89.7 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.065 -178.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -65.64 -41.77 92.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.065 0.459 . . . . 0.0 110.883 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -141.35 174.9 3.41 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.434 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.37 140.16 73.49 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 C-N-CA 121.72 1.613 . . . . 0.0 110.971 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.9 m -138.54 158.53 31.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.251 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.442 ' CG ' ' OE2' ' A' ' 57' ' ' GLU . 40.6 ttm180 -76.29 137.85 40.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.18 -0.463 . . . . 0.0 109.8 178.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.1 mt -103.44 127.02 50.9 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 119.716 -0.794 . . . . 0.0 112.662 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.585 ' N ' ' OD2' ' A' ' 86' ' ' ASP . 87.7 tttt -86.8 152.9 22.09 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.671 177.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.818 ' HD1' ' H ' ' A' ' 99' ' ' ASN . 76.1 t60 -64.82 133.18 51.42 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.821 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.03 4.87 64.54 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.585 ' OD2' ' N ' ' A' ' 83' ' ' LYS . 84.5 m-20 -68.59 153.64 43.39 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.221 0.534 . . . . 0.0 111.685 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.0 t -117.54 133.02 65.63 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.64 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.7 mm -110.44 133.38 56.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.015 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.9 m -129.83 132.38 46.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.341 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.599 ' CG2' ' H ' ' A' ' 91' ' ' ILE . 7.8 mt -107.74 -143.18 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.599 ' H ' ' CG2' ' A' ' 90' ' ' ILE . 34.4 mm -62.64 -46.02 97.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 91' ' ' ILE . 74.6 m-20 -150.5 16.01 0.8 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 120.814 -0.354 . . . . 0.0 111.304 -178.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 48.6 mmm-85 -131.9 150.27 52.2 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.891 0.377 . . . . 0.0 110.542 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.5 m -128.05 145.83 50.87 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.422 0.63 . . . . 0.0 111.899 -179.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.588 ' CE2' ' CG2' ' A' ' 37' ' ' ILE . 69.9 m-85 -133.84 149.13 51.36 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.801 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -113.53 142.82 45.49 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.331 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.469 ' HH ' ' H ' ' A' ' 58' ' ' ALA . 1.4 t80 -115.41 109.17 17.48 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.731 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.6 mp0 -122.87 132.02 54.0 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.363 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.818 ' H ' ' HD1' ' A' ' 84' ' ' HIS . 27.7 p30 -126.2 143.31 51.19 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.079 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.382 179.825 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.6 mtm . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 3.4 t-105 -154.93 77.45 5.07 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.551 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -61.81 147.92 94.2 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 123.261 2.641 . . . . 0.0 112.186 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.2 p -102.8 10.38 38.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.684 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.419 HH12 HG23 ' A' ' 53' ' ' ILE . 99.8 mtt180 -125.22 145.27 50.06 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.499 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -144.96 144.76 31.22 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.576 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.8 tp -117.85 132.19 56.46 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.0 t -125.65 135.59 63.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.073 0.463 . . . . 0.0 110.986 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.2 m -98.11 113.58 25.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.561 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.1 mt -76.5 129.65 37.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.951 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -84.04 159.35 21.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.281 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -59.49 -32.74 70.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.837 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.4 p -60.11 -20.54 58.77 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.509 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.74 32.6 10.98 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.598 178.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.6 m -130.68 161.23 40.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 117.029 0.414 . . . . 0.0 110.687 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -65.42 142.51 58.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.555 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.33 -157.81 8.73 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -59.79 147.99 90.04 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.933 2.422 . . . . 0.0 111.69 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 6.7 m80 -110.41 164.45 12.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.825 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -133.98 92.78 21.43 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.813 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.49 143.14 99.77 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 121.924 1.749 . . . . 0.0 110.123 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -79.0 83.23 5.11 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.757 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.5 p -89.42 -11.49 42.99 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.974 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.447 ' N ' ' CD2' ' A' ' 24' ' ' LEU . 4.1 mm? -110.26 150.38 28.79 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.352 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 91.9 p -61.55 -35.33 77.46 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.565 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 41.8 p -132.08 138.41 48.13 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.182 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.473 ' O ' ' N ' ' A' ' 51' ' ' ILE . 0.1 OUTLIER -97.5 126.76 42.97 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.837 179.904 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.41 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 55.9 tp -117.4 133.43 55.98 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.279 0.561 . . . . 0.0 110.636 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -107.08 148.28 28.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.705 -178.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 154.55 166.26 14.91 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 119.661 -1.257 . . . . 0.0 112.364 178.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.633 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 85.6 mtm-85 -66.89 -37.63 84.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.131 0.491 . . . . 0.0 110.573 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.408 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -63.46 149.61 50.03 Favored Glycine 0 CA--C 1.521 0.448 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.117 -178.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.453 ' C ' ' H ' ' A' ' 35' ' ' CYS . 18.2 tt -66.6 -32.33 57.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -49.12 -14.36 0.08 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.601 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.453 ' H ' ' C ' ' A' ' 33' ' ' ILE . 3.0 m -89.36 134.16 34.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.774 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.41 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 92.5 m-20 -62.35 -36.04 80.99 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.5 mm -106.63 88.94 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -73.19 126.87 31.05 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.935 -178.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.416 HD12 HG23 ' A' ' 39' ' ' ILE . 96.7 mt -117.29 122.87 70.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.875 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -95.6 81.96 3.58 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.089 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -155.12 114.57 2.33 Favored Pre-proline 0 CA--C 1.536 0.422 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.017 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -52.93 -32.15 56.0 Favored 'Trans proline' 0 N--CA 1.499 1.827 0 C-N-CA 121.84 1.693 . . . . 0.0 112.813 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.4 m -64.04 -39.15 84.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.633 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 94.0 t -66.2 164.59 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.441 ' H ' ' HD1' ' A' ' 48' ' ' HIS . 1.2 m -94.34 165.67 12.46 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.927 -179.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -61.81 -38.65 88.91 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.693 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -132.59 65.78 1.57 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 178.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.441 ' HD1' ' H ' ' A' ' 45' ' ' SER . 16.7 t60 -60.21 -54.89 40.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.28 -1.327 . . . . 0.0 112.62 -176.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -153.66 163.86 39.26 Favored 'General case' 0 CA--C 1.51 -0.565 0 C-N-CA 120.121 -0.632 . . . . 0.0 111.095 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.612 ' O ' ' N ' ' A' ' 61' ' ' HIS . 82.5 tttt -141.83 132.06 24.92 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.088 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.473 ' N ' ' O ' ' A' ' 27' ' ' CYS . 78.6 mt -107.41 110.18 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.072 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.46 ' N ' ' O ' ' A' ' 59' ' ' ILE . 96.1 mt-10 -86.12 142.58 28.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.453 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.419 HG23 HH12 ' A' ' 5' ' ' ARG . 42.5 mm -109.38 130.34 62.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.506 0.669 . . . . 0.0 111.16 -179.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -113.55 169.22 9.12 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.846 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -39.4 -40.92 0.88 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -178.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -139.66 7.98 2.34 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 119.76 -0.776 . . . . 0.0 112.667 -178.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -145.18 151.54 38.59 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 119.975 -0.69 . . . . 0.0 112.772 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.451 ' CB ' ' CZ ' ' A' ' 97' ' ' TYR . . . -103.45 141.23 36.33 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 177.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.46 ' O ' ' N ' ' A' ' 52' ' ' GLU . 20.7 mm -130.26 130.85 65.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.779 -177.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 53.9 tp -77.91 147.74 34.9 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.374 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.631 ' O ' ' CE1' ' A' ' 63' ' ' PHE . 3.7 m-70 -140.33 78.39 1.65 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.639 ' ND2' ' H ' ' A' ' 69' ' ' THR . 12.7 t-20 -76.43 132.51 39.7 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.46 -178.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.631 ' CE1' ' O ' ' A' ' 61' ' ' HIS . 4.2 m-85 -114.69 -19.4 11.09 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.009 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.501 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 10.6 t -63.98 132.44 50.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.129 0.49 . . . . 0.0 111.648 -177.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.6 p -98.85 -61.02 1.42 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.019 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.0 m -63.5 -46.22 87.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.451 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.501 ' O ' ' OG ' ' A' ' 64' ' ' SER . 11.5 m-20 -110.71 78.45 1.55 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.292 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -70.11 150.68 66.4 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 121.851 1.701 . . . . 0.0 113.098 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.639 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 32.9 m -68.08 166.3 16.3 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.565 ' O ' ' N ' ' A' ' 89' ' ' THR . 86.5 mt-30 -137.69 128.62 27.25 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.538 -0.465 . . . . 0.0 112.146 -178.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.51 ' O ' ' OG ' ' A' ' 74' ' ' SER . 42.9 t -124.73 132.18 71.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.611 179.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 50.98 29.32 4.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.016 0.436 . . . . 0.0 110.373 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.38 21.66 61.96 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.535 178.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.51 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 11.6 p -126.95 128.92 47.17 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.622 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.0 m -69.57 139.97 19.47 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-O 121.386 0.612 . . . . 0.0 111.119 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.518 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 96.7 mt -120.26 118.76 57.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.091 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -97.16 -12.39 23.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.678 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.518 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.6 OUTLIER -142.09 172.67 5.57 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.767 -179.279 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -60.26 142.54 98.43 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 122.471 2.114 . . . . 0.0 112.61 -179.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 31.1 m -139.71 161.79 26.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.14 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 76.9 ttt-85 -82.27 138.29 34.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.772 178.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 77.1 mt -101.33 145.65 28.61 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.029 0.442 . . . . 0.0 111.095 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -115.32 156.86 24.7 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.796 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 80.2 t60 -63.86 129.18 39.03 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 120.029 -0.668 . . . . 0.0 110.181 -178.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 92.53 -5.55 77.31 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -178.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 87' ' ' VAL . 59.7 t0 -65.6 137.56 57.44 Favored 'General case' 0 C--N 1.334 -0.102 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.517 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 43.1 t -112.34 130.28 66.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.167 0.508 . . . . 0.0 111.02 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 72.1 mt -102.36 132.48 48.31 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.565 ' N ' ' O ' ' A' ' 70' ' ' GLN . 87.9 m -128.03 131.5 49.16 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.537 0.684 . . . . 0.0 112.387 -178.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.709 ' CG2' ' H ' ' A' ' 91' ' ' ILE . 89.3 mt -102.86 -159.64 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 114.629 -1.168 . . . . 0.0 108.106 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.709 ' H ' ' CG2' ' A' ' 90' ' ' ILE . 95.9 mt -62.65 -44.92 99.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 118.763 0.711 . . . . 0.0 112.575 -177.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.479 ' OD1' ' O ' ' A' ' 91' ' ' ILE . 93.4 m-20 -136.63 9.21 3.11 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.016 -0.673 . . . . 0.0 112.787 -178.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 72.6 mmt-85 -133.46 150.97 51.73 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.914 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.1 m -128.62 147.48 50.73 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.525 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -128.51 145.53 51.09 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.778 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 73.9 mtp85 -109.85 125.27 52.59 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.323 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.553 ' HH ' HD22 ' A' ' 99' ' ' ASN . 11.7 t80 -105.71 97.14 7.01 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -122.22 128.41 51.13 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.21 0.528 . . . . 0.0 112.198 -178.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.796 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 87.8 m-20 -100.44 140.19 35.05 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.408 178.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 . . . . . 0 C--N 1.327 -0.387 0 CA-C-O 121.07 0.462 . . . . 0.0 111.017 -179.705 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.4 mtp . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -80.67 170.29 16.21 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.83 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -56.77 142.36 92.06 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 121.93 1.753 . . . . 0.0 112.427 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 89.6 m -129.75 127.91 41.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.128 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.0 mtm-85 -120.38 127.89 52.72 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.426 ' O ' ' OE1' ' A' ' 98' ' ' GLU . 86.4 mtm180 -131.35 145.98 52.08 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 120.992 0.425 . . . . 0.0 110.849 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.7 tp -110.88 132.28 54.34 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.154 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 50.9 t -118.2 132.43 68.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.301 -179.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.559 ' OG1' ' CE2' ' A' ' 95' ' ' PHE . 92.3 m -108.72 121.72 45.64 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.709 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 89.8 mt -77.71 129.75 37.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.727 178.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -105.74 -147.79 0.4 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.778 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -70.83 151.27 44.96 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.559 ' O ' ' N ' ' A' ' 15' ' ' VAL . 3.0 m 61.71 145.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -178.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.42 50.16 0.07 OUTLIER Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.559 ' N ' ' O ' ' A' ' 13' ' ' SER . 36.0 m -121.2 155.89 24.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.036 0.446 . . . . 0.0 110.711 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -66.31 141.48 57.98 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.927 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -109.39 -162.75 19.78 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.24 153.55 40.72 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.766 2.31 . . . . 0.0 111.788 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.441 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 6.9 m170 -102.56 166.67 10.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.162 0.506 . . . . 0.0 111.433 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -135.0 96.24 14.58 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.431 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.32 148.21 87.45 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 122.573 2.182 . . . . 0.0 110.943 178.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.574 ' N ' ' CD2' ' A' ' 22' ' ' LEU . 2.8 mm? -89.36 76.91 7.47 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.986 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.4 p -71.15 -31.37 67.62 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.354 178.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.1 mt -114.43 140.31 48.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.737 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.0 p -66.91 -15.36 63.61 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.703 0.287 . . . . 0.0 111.493 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.5 p -117.77 113.33 21.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.613 0.244 . . . . 0.0 110.921 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.1 m -96.83 127.67 43.04 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.465 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 67.8 tp -114.78 142.05 47.05 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.151 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.673 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 65.2 m-85 -112.25 141.52 45.86 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.543 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.577 ' O ' ' N ' ' A' ' 39' ' ' ILE . . . 160.9 -177.62 37.21 Favored Glycine 0 C--O 1.228 -0.275 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.44 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 35.3 ptt-85 -103.82 -3.32 25.05 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.062 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -86.25 162.07 34.78 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.2 tp -65.11 -32.12 56.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.174 0.511 . . . . 0.0 109.954 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -57.01 -21.73 33.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.307 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 2.7 m -82.73 127.71 33.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.345 0.593 . . . . 0.0 112.548 -178.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -62.8 -39.34 93.94 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 177.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.2 mm -105.06 85.36 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 178.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -72.26 137.96 47.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.432 -177.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.577 ' N ' ' O ' ' A' ' 30' ' ' GLY . 95.2 mt -129.31 118.86 47.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.781 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -77.74 81.26 4.18 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.327 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 53.0 mt -154.14 106.73 2.44 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.522 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.43 -33.48 67.23 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 122.235 1.957 . . . . 0.0 111.94 178.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.1 m -66.44 -25.26 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.447 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.44 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 86.7 t -87.45 137.78 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.668 ' H ' ' HD1' ' A' ' 48' ' ' HIS . 3.7 m -80.69 155.78 26.61 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.916 0.389 . . . . 0.0 112.016 -178.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.449 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 61.7 mttp -58.0 -38.27 75.82 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -114.7 48.48 1.13 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.668 ' HD1' ' H ' ' A' ' 45' ' ' SER . 14.7 t60 -57.86 -50.01 74.76 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.734 -178.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.673 ' SG ' ' CD1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -152.66 159.44 43.19 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.491 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.627 ' O ' ' N ' ' A' ' 61' ' ' HIS . 68.4 tttt -139.22 135.79 34.31 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.904 -179.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.3 mm -110.01 103.88 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.874 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -83.97 128.55 34.63 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 49.7 mm -96.08 131.87 41.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.63 0.729 . . . . 0.0 111.281 -178.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.504 ' O ' ' C ' ' A' ' 55' ' ' GLU . 47.6 m-70 -119.55 178.92 4.38 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.725 -178.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.504 ' C ' ' O ' ' A' ' 54' ' ' HIS . 96.5 mt-10 -23.36 -65.87 0.04 OUTLIER 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.444 -179.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -140.51 15.03 2.36 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.271 -0.571 . . . . 0.0 111.749 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.574 ' OE1' ' NE ' ' A' ' 81' ' ' ARG . 19.9 pt-20 -134.2 146.96 50.63 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.01 -0.676 . . . . 0.0 111.052 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -99.24 135.81 40.1 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 36.7 mm -119.56 125.84 74.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.179 0.514 . . . . 0.0 111.915 -178.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.9 tp -77.49 142.03 39.33 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.394 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.627 ' N ' ' O ' ' A' ' 50' ' ' LYS . 41.1 m-70 -137.11 81.3 1.86 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-O 121.554 0.692 . . . . 0.0 110.659 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.695 ' ND2' ' H ' ' A' ' 69' ' ' THR . 24.7 t-20 -74.25 128.35 35.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.631 -1.168 . . . . 0.0 112.758 -179.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -102.38 -38.83 7.43 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.262 178.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 41.7 t -53.79 138.16 36.37 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.157 -178.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.0 t -107.28 -53.75 2.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.326 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.433 ' OG1' ' OD1' ' A' ' 67' ' ' ASN . 21.2 p -60.04 -48.23 82.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.497 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.494 ' OD1' ' N ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -120.21 84.45 34.19 Favored Pre-proline 0 N--CA 1.463 0.203 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.692 179.385 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -74.82 146.03 32.93 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.038 1.825 . . . . 0.0 113.392 -178.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.695 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 23.4 m -61.87 154.32 26.42 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.651 178.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' A' ' 89' ' ' THR . 86.1 mt-30 -122.84 148.3 45.56 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.072 0.463 . . . . 0.0 112.028 -177.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.539 ' O ' ' N ' ' A' ' 73' ' ' GLY . 7.9 p -132.99 135.95 56.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.169 178.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 44.78 17.13 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.358 -0.537 . . . . 0.0 109.689 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 71' ' ' VAL . . . 99.86 -15.79 59.16 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.09 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.539 ' N ' ' O ' ' A' ' 71' ' ' VAL . 14.4 m -83.19 140.55 32.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 117.253 0.526 . . . . 0.0 110.575 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.2 t -70.7 143.97 14.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.155 0.502 . . . . 0.0 110.798 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.453 HD13 HG23 ' A' ' 76' ' ' ILE . 41.3 mm -102.5 91.55 2.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.465 -179.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -70.91 -39.17 72.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.581 178.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -141.55 174.21 4.05 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.299 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.51 140.36 89.28 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 121.911 1.741 . . . . 0.0 111.304 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 32.8 m -136.57 163.64 32.84 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.683 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.574 ' NE ' ' OE1' ' A' ' 57' ' ' GLU . 72.7 ttt180 -89.68 135.51 33.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.923 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.434 HD12 ' N ' ' A' ' 82' ' ' LEU . 5.5 mp -105.89 131.86 52.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.19 0.519 . . . . 0.0 110.632 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.452 ' HG2' ' N ' ' A' ' 84' ' ' HIS . 88.8 tttt -88.13 162.81 16.53 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.897 ' HD1' ' H ' ' A' ' 99' ' ' ASN . 73.1 t60 -61.15 129.25 40.39 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.31 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.09 -1.0 62.58 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.672 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.598 ' OD1' ' N ' ' A' ' 87' ' ' VAL . 64.4 t0 -68.58 145.54 53.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.677 0.275 . . . . 0.0 111.736 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.598 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 87.4 t -119.63 133.17 67.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-O 121.223 0.535 . . . . 0.0 111.16 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 71.2 mt -108.02 139.9 28.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.254 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.419 ' O ' ' N ' ' A' ' 70' ' ' GLN . 66.1 m -132.88 135.12 45.41 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.89 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.767 ' CG2' ' H ' ' A' ' 91' ' ' ILE . 58.5 mt -102.17 -147.57 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.767 ' H ' ' CG2' ' A' ' 90' ' ' ILE . 96.1 mt -62.91 -43.47 98.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 118.627 0.649 . . . . 0.0 111.228 -178.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -146.37 20.1 1.36 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -132.87 153.54 51.23 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.27 -0.572 . . . . 0.0 111.211 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.9 m -126.12 138.59 53.69 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.077 0.465 . . . . 0.0 111.266 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.559 ' CE2' ' OG1' ' A' ' 9' ' ' THR . 53.7 m-85 -128.06 138.84 52.72 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.974 178.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -109.92 133.17 53.46 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.985 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.423 ' HH ' ' HA ' ' A' ' 57' ' ' GLU . 10.3 t80 -113.73 118.71 35.06 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.461 ' CD ' ' O ' ' A' ' 98' ' ' GLU . 2.1 pm0 -143.2 133.01 23.93 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 120.072 -0.651 . . . . 0.0 110.433 -178.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.897 ' H ' ' HD1' ' A' ' 84' ' ' HIS . 63.6 t-20 -96.62 110.77 23.12 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.56 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 . . . . . 0 C--O 1.234 0.271 0 CA-C-O 120.938 0.399 . . . . 0.0 110.082 179.977 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.6 mmm . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.586 ' CD1' ' N ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -131.24 84.8 55.83 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.466 -179.939 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -58.03 142.0 96.54 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.756 2.304 . . . . 0.0 112.438 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 82.3 p -120.25 23.68 10.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.261 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.677 ' NH2' ' ND2' ' A' ' 99' ' ' ASN . 95.4 mtt-85 -78.48 137.83 38.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.086 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -140.92 146.16 37.04 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.72 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.1 tp -114.26 131.68 56.41 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.4 t -120.16 136.75 56.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.091 -178.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.415 ' OG1' ' CE2' ' A' ' 95' ' ' PHE . 54.7 m -105.99 126.07 51.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.589 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.406 ' CG2' ' O ' ' A' ' 12' ' ' ARG . 86.9 mt -86.36 107.39 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.221 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -65.27 -44.5 87.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.374 179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.539 ' O ' ' C ' ' A' ' 13' ' ' SER . 84.6 mtt85 -130.03 149.77 51.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.418 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.539 ' C ' ' O ' ' A' ' 12' ' ' ARG . 2.0 t 10.51 -96.67 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.877 0.735 . . . . 0.0 112.194 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.527 ' N ' ' OG ' ' A' ' 13' ' ' SER . . . -113.1 5.73 25.39 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.995 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.9 t -73.9 140.39 17.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.108 0.48 . . . . 0.0 110.834 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -65.22 137.15 57.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.101 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -124.2 -157.89 9.92 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.32 147.15 92.32 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.646 2.23 . . . . 0.0 112.064 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.439 ' CD2' ' N ' ' A' ' 19' ' ' HIS . 10.0 m-70 -107.55 166.12 10.91 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.777 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.559 ' CZ ' ' O ' ' A' ' 36' ' ' ASP . 19.0 t80 -142.46 109.71 5.75 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.893 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.78 146.94 38.91 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 121.762 1.641 . . . . 0.0 111.032 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.0 mt -94.7 107.78 19.78 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.111 -0.636 . . . . 0.0 111.079 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.0 m -111.1 -17.82 13.15 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.509 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.502 ' HG ' ' H ' ' A' ' 26' ' ' THR . 51.1 tp -115.9 136.39 53.09 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.937 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 92.4 p -56.87 -34.14 67.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.175 -179.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.502 ' H ' ' HG ' ' A' ' 24' ' ' LEU . 49.0 p -110.43 119.56 39.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.983 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -102.89 122.77 45.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.869 178.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.426 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 49.1 tp -112.98 141.82 46.38 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.432 0.634 . . . . 0.0 112.16 -178.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -107.66 145.04 33.89 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.736 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.48 166.83 16.15 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 119.453 -1.356 . . . . 0.0 112.666 179.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -66.43 -36.3 82.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.881 -0.659 . . . . 0.0 110.9 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.542 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -63.23 148.64 50.31 Favored Glycine 0 CA--C 1.52 0.372 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.762 -179.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.53 ' C ' ' H ' ' A' ' 35' ' ' CYS . 19.1 tt -65.52 -38.84 83.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.155 0.503 . . . . 0.0 110.152 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.401 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 16.2 pt-20 -47.77 -11.08 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.683 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.542 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 3.0 m -88.65 135.57 33.43 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.955 0.407 . . . . 0.0 111.453 -179.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.559 ' O ' ' CZ ' ' A' ' 20' ' ' PHE . 55.6 m-20 -62.61 -37.78 87.6 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.5 mm -109.44 94.21 2.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -72.53 137.63 46.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.978 0.418 . . . . 0.0 110.29 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.437 HD12 HG22 ' A' ' 39' ' ' ILE . 96.5 mt -127.1 124.49 64.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.79 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -96.94 80.88 3.03 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.848 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.7 mt -156.92 114.17 1.98 Allowed Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.053 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -51.89 -28.66 32.12 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 121.862 1.708 . . . . 0.0 112.397 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.437 ' O ' ' CD1' ' A' ' 91' ' ' ILE . 34.2 m -68.78 -21.94 26.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.495 -179.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 96.3 t -85.87 149.23 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.463 ' HG ' ' CA ' ' A' ' 48' ' ' HIS . 6.8 p -88.23 172.07 9.73 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 120.255 -0.578 . . . . 0.0 112.174 -178.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.42 -40.45 96.58 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -130.5 70.63 1.45 Allowed 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.463 ' CA ' ' HG ' ' A' ' 45' ' ' SER . 21.4 t60 -62.27 -50.11 73.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.73 -1.123 . . . . 0.0 113.183 -177.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.639 ' SG ' ' N ' ' A' ' 50' ' ' LYS . 0.5 OUTLIER -167.65 162.35 14.04 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.323 -178.739 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.639 ' N ' ' SG ' ' A' ' 49' ' ' CYS . 12.5 ptpt -142.54 151.15 41.31 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 119.179 -1.008 . . . . 0.0 112.621 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.7 mt -108.81 110.69 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.165 177.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 59' ' ' ILE . 85.4 tt0 -90.48 148.7 22.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.015 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -105.78 134.57 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 CA-C-O 121.124 0.488 . . . . 0.0 111.691 -178.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.479 ' O ' ' C ' ' A' ' 55' ' ' GLU . 23.4 m-70 -119.85 174.53 6.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.178 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.479 ' C ' ' O ' ' A' ' 54' ' ' HIS . 95.8 mt-10 -24.05 -58.07 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.593 -178.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.589 ' O ' ' NH2' ' A' ' 5' ' ' ARG . 97.8 mt-30 -141.25 7.9 2.0 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.981 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.514 ' OE1' ' NE ' ' A' ' 81' ' ' ARG . 22.0 pt-20 -134.88 161.51 35.02 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.713 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -105.05 147.93 27.32 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.649 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.504 ' O ' ' N ' ' A' ' 52' ' ' GLU . 28.0 mm -130.09 135.21 61.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -179.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.2 tt -98.58 139.33 34.46 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -129.28 79.21 1.9 Allowed 'General case' 0 C--N 1.341 0.219 0 CA-C-O 121.338 0.59 . . . . 0.0 110.325 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.723 ' ND2' ' H ' ' A' ' 69' ' ' THR . 27.1 t-20 -62.01 134.04 56.11 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.765 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -106.15 -39.5 5.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.182 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.9 t -54.54 140.0 36.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.058 0.456 . . . . 0.0 111.213 -178.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.0 m -107.3 -54.65 2.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.812 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.4 m -62.05 -45.61 92.8 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.378 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -123.35 81.19 52.92 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.502 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.31 151.09 37.73 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.301 2.0 . . . . 0.0 113.294 -178.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.723 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 90.6 m -64.89 159.96 21.57 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 177.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -128.02 147.02 50.49 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.08 -0.648 . . . . 0.0 112.282 -178.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.402 ' O ' ' N ' ' A' ' 74' ' ' SER . 22.8 t -125.11 129.06 73.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.293 179.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 49.11 28.2 2.03 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.372 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.91 -5.11 80.69 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 71' ' ' VAL . 17.5 m -88.56 139.42 30.49 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 81.6 t -73.52 141.94 15.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.506 0.669 . . . . 0.0 110.702 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 87.8 mt -103.22 84.84 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.752 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -63.45 -40.36 96.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.372 0.606 . . . . 0.0 109.663 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.51 174.72 3.93 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.555 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.42 137.66 78.08 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 121.663 1.575 . . . . 0.0 110.6 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.4 m -133.21 161.61 41.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.915 -178.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.514 ' NE ' ' OE1' ' A' ' 57' ' ' GLU . 76.2 ttt180 -80.84 139.97 35.67 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.524 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 92.6 mt -107.59 143.91 35.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.333 0.587 . . . . 0.0 111.055 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.52 ' N ' ' OD2' ' A' ' 86' ' ' ASP . 98.6 mttt -118.18 153.1 34.4 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.605 178.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.75 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 36.9 t60 -61.89 131.8 50.95 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.644 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.15 -5.2 57.54 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.52 ' OD2' ' N ' ' A' ' 83' ' ' LYS . 99.0 m-20 -71.75 149.59 45.23 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.608 0.242 . . . . 0.0 110.85 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 70.0 t -116.57 132.92 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.533 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 76.0 mt -107.61 132.88 54.03 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-O 120.916 0.389 . . . . 0.0 110.333 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.1 m -129.82 132.84 46.63 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.792 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.756 ' CG2' ' H ' ' A' ' 91' ' ' ILE . 66.9 mt -98.37 -152.23 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.756 ' H ' ' CG2' ' A' ' 90' ' ' ILE . 95.6 mt -63.72 -44.45 98.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 118.453 0.57 . . . . 0.0 112.382 -178.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 91' ' ' ILE . 97.9 m-20 -141.48 17.62 2.21 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -132.43 154.12 50.16 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.781 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.2 p -124.27 141.38 52.12 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.139 0.495 . . . . 0.0 111.246 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.415 ' CE2' ' OG1' ' A' ' 9' ' ' THR . 76.3 m-85 -132.97 147.67 52.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.697 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 69.6 mtp85 -118.2 140.42 49.82 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.444 -179.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.498 ' C ' ' CD1' ' A' ' 97' ' ' TYR . 0.8 OUTLIER -113.85 107.31 15.54 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.4 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.428 ' HA ' ' HD1' ' A' ' 84' ' ' HIS . 98.1 mt-10 -114.31 120.32 39.98 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 120.837 0.351 . . . . 0.0 111.575 -178.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.75 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 45.8 t30 -113.95 96.75 5.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.239 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.304 -179.645 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.2 mtp . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.659 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 4.1 m95 -96.41 -34.73 0.27 Allowed Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.685 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.659 ' CD ' ' N ' ' A' ' 2' ' ' TRP . 36.3 Cg_endo -83.48 -0.66 9.9 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.472 2.115 . . . . 0.0 112.393 -178.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.5 t -78.34 160.07 28.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.271 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.698 ' HE ' ' ND2' ' A' ' 99' ' ' ASN . 83.2 mtt85 -73.97 137.12 43.33 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -143.56 146.5 33.38 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 120.32 -0.552 . . . . 0.0 112.038 -179.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 91.4 mt -110.72 128.37 55.7 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.738 178.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.5 t -112.56 133.88 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.619 ' OG1' ' CE2' ' A' ' 95' ' ' PHE . 8.6 m -102.44 116.42 32.59 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.185 -0.606 . . . . 0.0 111.834 -179.114 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.403 HD13 ' NE ' ' A' ' 96' ' ' ARG . 96.8 mt -75.77 133.12 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-O 121.007 0.432 . . . . 0.0 110.276 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.529 ' O ' ' O ' ' A' ' 14' ' ' GLY . 14.7 mmmt -99.48 152.64 19.78 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.347 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -66.65 130.57 43.62 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 61.95 21.28 12.19 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -177.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.529 ' O ' ' O ' ' A' ' 11' ' ' LYS . . . -160.19 109.65 0.41 Allowed Glycine 0 CA--C 1.518 0.228 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.429 ' O ' ' CB ' ' A' ' 16' ' ' ASP . 22.5 m -99.84 131.2 47.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.433 0.635 . . . . 0.0 111.531 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.429 ' CB ' ' O ' ' A' ' 15' ' ' VAL . 3.9 t0 80.02 51.59 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.778 179.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.69 -147.54 1.88 Allowed Glycine 0 CA--C 1.53 0.989 0 N-CA-C 110.471 -1.051 . . . . 0.0 110.471 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -59.54 147.07 93.22 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.604 2.203 . . . . 0.0 111.169 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -98.78 -177.24 3.59 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.564 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -150.31 91.76 4.12 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.694 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -57.61 143.61 94.45 Favored 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 122.51 2.14 . . . . 0.0 111.188 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.553 ' CD2' ' SG ' ' A' ' 27' ' ' CYS . 97.8 mt -90.98 76.12 6.26 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 119.901 -0.719 . . . . 0.0 111.074 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.9 p -67.59 -30.69 70.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.916 179.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.4 mt -108.67 144.06 36.92 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.451 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 97.2 p -63.83 -30.29 71.39 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.015 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 81.4 p -109.05 127.36 54.05 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.185 0.517 . . . . 0.0 111.754 -178.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.553 ' SG ' ' CD2' ' A' ' 22' ' ' LEU . 1.2 m -107.93 126.01 52.18 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.103 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.437 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 66.6 tp -115.57 134.14 55.35 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.212 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.533 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 13.9 m-85 -102.52 146.56 27.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.761 -179.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.417 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . 144.57 152.3 5.61 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.246 -0.978 . . . . 0.0 112.502 178.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 75.5 ttt-85 -64.56 -41.43 96.32 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.683 -0.759 . . . . 0.0 111.46 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.403 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -46.88 153.3 1.15 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 18.8 tt -63.64 -31.26 52.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -60.93 -20.27 61.92 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.542 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 2.0 m -74.22 124.65 26.79 Favored 'General case' 0 C--O 1.233 0.209 0 O-C-N 121.961 -0.462 . . . . 0.0 111.95 -179.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.437 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 55.9 m-20 -63.01 -38.6 91.85 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.2 mm -102.4 85.44 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 177.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -66.51 134.57 52.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.79 -177.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 93.9 mt -124.16 108.28 20.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -75.99 81.13 2.86 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 118.973 -1.091 . . . . 0.0 109.97 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 mt -155.27 107.64 2.24 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.323 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -51.46 -36.2 58.03 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.226 1.951 . . . . 0.0 112.488 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 18.1 m -64.4 -22.67 31.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.884 -178.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 76.7 t -86.14 146.03 6.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.359 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.643 ' H ' ' HD1' ' A' ' 48' ' ' HIS . 7.9 m -82.73 159.41 22.57 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.169 -0.612 . . . . 0.0 111.998 -178.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.542 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 98.8 mttt -61.92 -39.49 92.2 Favored 'General case' 0 C--N 1.334 -0.069 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.582 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -118.36 51.51 1.08 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.643 ' HD1' ' H ' ' A' ' 45' ' ' SER . 13.7 t60 -59.29 -50.46 73.91 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.085 -0.962 . . . . 0.0 112.205 -177.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.533 ' SG ' ' CD1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -151.13 161.22 43.13 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.721 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.589 ' O ' ' N ' ' A' ' 61' ' ' HIS . 47.0 tttm -144.7 131.13 19.77 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.485 -179.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 95.8 mt -107.0 109.58 28.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.556 178.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -91.84 130.81 37.54 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.433 ' O ' ' CG2' ' A' ' 53' ' ' ILE . 0.8 OUTLIER -90.2 129.3 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.024 -179.333 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.502 ' O ' ' C ' ' A' ' 55' ' ' GLU . 32.5 m-70 -112.13 -179.37 3.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.716 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.502 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.9 mm-40 -23.82 -63.46 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 O-C-N 123.648 0.593 . . . . 0.0 111.803 -178.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.44 ' O ' ' ND2' ' A' ' 99' ' ' ASN . 90.9 mt-30 -140.32 13.74 2.39 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.967 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.522 ' N ' ' OE1' ' A' ' 57' ' ' GLU . 56.0 mp0 -139.59 148.97 43.25 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 119.891 -0.723 . . . . 0.0 111.882 -179.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -94.15 141.89 28.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.527 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.0 mm -124.06 127.31 73.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 120.967 0.413 . . . . 0.0 111.428 -178.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.7 tp -76.91 144.39 38.94 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.934 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.599 ' O ' ' CE1' ' A' ' 63' ' ' PHE . 15.5 m-70 -136.2 77.62 1.67 Allowed 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.645 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.697 ' ND2' ' H ' ' A' ' 69' ' ' THR . 26.9 t-20 -70.7 132.62 45.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.933 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.599 ' CE1' ' O ' ' A' ' 61' ' ' HIS . 17.2 m-85 -108.02 -34.81 6.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.899 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.2 m -57.69 137.23 56.68 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.294 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.0 p -105.12 -52.91 2.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.515 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.0 m -62.04 -48.09 81.83 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.829 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.52 ' OD1' ' N ' ' A' ' 67' ' ' ASN . 0.1 OUTLIER -117.13 81.03 12.37 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.822 179.103 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -73.03 146.65 41.87 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 121.578 1.519 . . . . 0.0 112.171 -179.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.697 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 62.4 m -64.64 160.83 18.91 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -131.65 150.81 52.02 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.127 -0.629 . . . . 0.0 112.206 -177.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.457 ' O ' ' N ' ' A' ' 74' ' ' SER . 19.8 t -133.45 131.81 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.032 178.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 48.0 29.05 1.6 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.189 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.42 16.42 78.08 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 71' ' ' VAL . 33.5 t -108.23 130.43 55.16 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 65.3 t -70.67 137.12 24.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 CA-C-O 121.68 0.752 . . . . 0.0 110.773 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 95.6 mt -114.78 102.1 13.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.131 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -76.78 -41.73 43.51 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.349 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -130.01 174.35 4.71 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.721 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -53.95 136.91 68.06 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 C-N-CA 122.463 2.109 . . . . 0.0 111.552 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.4 m -135.64 159.54 39.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.327 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 60.8 ttm-85 -79.52 139.95 37.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.308 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 93.3 mt -114.81 143.09 45.65 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 121.27 0.557 . . . . 0.0 111.696 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.424 ' O ' ' CG ' ' A' ' 86' ' ' ASP . 99.1 mttt -106.93 152.37 24.03 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.203 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.702 ' HD1' ' H ' ' A' ' 99' ' ' ASN . 35.8 t60 -59.66 132.7 54.79 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.526 -0.47 . . . . 0.0 109.975 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.71 -2.9 62.59 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 -178.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.424 ' CG ' ' O ' ' A' ' 83' ' ' LYS . 15.7 m-20 -75.07 143.96 43.2 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.2 t -118.46 134.86 60.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-O 120.785 0.326 . . . . 0.0 111.229 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.464 ' CG2' ' CG2' ' A' ' 69' ' ' THR . 62.9 mt -104.89 135.82 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 116.264 -0.425 . . . . 0.0 109.977 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.538 ' HG1' ' HG ' ' A' ' 94' ' ' SER . 89.3 m -126.26 125.85 43.05 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.119 0.485 . . . . 0.0 111.295 179.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.73 ' CG2' ' H ' ' A' ' 91' ' ' ILE . 93.7 mt -94.68 -146.04 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 178.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.73 ' H ' ' CG2' ' A' ' 90' ' ' ILE . 96.9 mt -62.74 -45.24 99.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 119.434 1.016 . . . . 0.0 112.581 -178.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.7 p30 -143.56 -0.61 1.07 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -179.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -122.42 148.7 44.79 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.924 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.538 ' HG ' ' HG1' ' A' ' 89' ' ' THR . 68.9 m -121.69 153.39 38.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.461 -179.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.619 ' CE2' ' OG1' ' A' ' 9' ' ' THR . 48.0 m-85 -126.69 147.25 49.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.833 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.403 ' NE ' HD13 ' A' ' 10' ' ' ILE . 84.2 mtt180 -104.84 122.35 45.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.204 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.425 ' C ' ' CD1' ' A' ' 97' ' ' TYR . 0.8 OUTLIER -104.78 99.35 8.99 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.611 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.426 ' HA ' ' HD1' ' A' ' 84' ' ' HIS . 95.8 mt-10 -110.86 115.55 29.71 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.966 -178.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.702 ' H ' ' HD1' ' A' ' 84' ' ' HIS . 61.3 t-20 -106.46 94.01 4.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.807 178.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.492 ' O ' ' O ' ' A' ' 3' ' ' PRO . 99.0 mt-10 . . . . . 0 C--N 1.321 -0.634 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.028 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.5 mtm . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.644 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 3.4 p90 -154.91 37.01 0.08 OUTLIER Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.02 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.644 ' CD ' ' N ' ' A' ' 2' ' ' TRP . 60.6 Cg_endo -69.63 150.09 68.57 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.325 2.016 . . . . 0.0 112.331 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.87 -175.31 0.16 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.219 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -101.61 148.78 24.82 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.637 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.41 HH22 ' CA ' ' A' ' 2' ' ' TRP . 90.7 mtm-85 -137.63 155.68 48.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.407 0.622 . . . . 0.0 112.375 -178.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 93.6 mt -110.11 137.32 48.03 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 177.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.4 ' O ' ' N ' ' A' ' 96' ' ' ARG . 53.0 t -121.78 132.33 71.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.258 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 59.5 m -108.65 120.3 42.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.284 -178.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 71.5 mt -77.77 130.97 35.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.994 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -62.99 -40.49 97.91 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.126 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -148.52 -93.57 0.08 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.09 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.5 p -149.44 126.95 11.56 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.008 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.96 12.4 75.14 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.4 m -125.78 129.11 72.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.94 0.4 . . . . 0.0 110.915 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -68.96 140.04 55.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.634 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -122.1 -169.28 13.49 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.776 -0.929 . . . . 0.0 110.776 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -71.74 152.08 58.33 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.559 2.173 . . . . 0.0 112.049 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 19.0 m170 -96.51 169.78 9.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.219 0.533 . . . . 0.0 110.638 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.459 ' CZ ' ' O ' ' A' ' 36' ' ' ASP . 73.1 t80 -137.7 96.85 10.46 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.36 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.3 144.93 69.41 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.072 1.848 . . . . 0.0 110.813 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.0 tp -110.8 121.7 45.99 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.989 0.424 . . . . 0.0 111.872 -178.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.0 m -123.91 -38.71 2.46 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.647 178.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.511 ' N ' ' CD2' ' A' ' 24' ' ' LEU . 3.7 mm? -78.22 139.45 38.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.414 179.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 86.0 p -69.83 -15.52 63.12 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.445 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.9 p -120.7 123.29 42.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.851 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -106.68 123.47 48.18 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 59.9 tp -116.05 143.22 45.75 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.055 0.455 . . . . 0.0 111.145 -178.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -113.39 140.65 47.88 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.72 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 146.77 172.66 17.27 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.801 178.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.402 ' NH1' ' HA ' ' A' ' 42' ' ' PRO . 82.4 mtp180 -65.11 -35.52 81.39 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.041 -0.58 . . . . 0.0 110.934 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.563 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -43.9 140.22 3.46 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 tt -66.43 -32.65 59.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.84 0.352 . . . . 0.0 110.86 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -64.82 -17.33 64.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.545 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.563 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 7.8 m -64.31 126.76 28.82 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 120.862 0.363 . . . . 0.0 110.966 -179.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.459 ' O ' ' CZ ' ' A' ' 20' ' ' PHE . 55.3 m-20 -64.07 -39.35 93.88 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.467 ' CG2' ' CE2' ' A' ' 95' ' ' PHE . 5.2 mm -107.12 79.9 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -67.13 127.31 32.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.054 -0.975 . . . . 0.0 112.266 -177.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.7 mt -121.62 130.33 74.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.333 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.499 ' N ' ' CD ' ' A' ' 40' ' ' GLN . 0.0 OUTLIER -101.79 83.18 2.36 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.13 -179.765 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.0 mt -153.88 114.87 2.58 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.667 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.402 ' HA ' ' NH1' ' A' ' 31' ' ' ARG . 51.4 Cg_exo -51.82 -35.05 57.64 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.618 1.545 . . . . 0.0 112.08 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.9 m -64.02 -31.64 54.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.492 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 76.0 t -81.03 155.72 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.569 ' H ' ' HD1' ' A' ' 48' ' ' HIS . 13.0 m -100.16 158.19 16.03 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 120.037 -0.665 . . . . 0.0 112.166 -178.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -59.96 -37.78 80.59 Favored 'General case' 0 C--O 1.23 0.068 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -115.84 50.14 1.05 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.503 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.569 ' HD1' ' H ' ' A' ' 45' ' ' SER . 13.7 t60 -61.9 -51.39 68.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.026 -177.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.435 ' SG ' ' CD1' ' A' ' 60' ' ' LEU . 0.5 OUTLIER -155.62 159.51 39.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.752 -179.138 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.599 ' O ' ' N ' ' A' ' 61' ' ' HIS . 72.9 tttt -140.1 130.34 25.16 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -178.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.7 mt -103.77 113.66 41.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -100.79 125.07 47.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.798 0.332 . . . . 0.0 110.229 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.5 tp -88.71 135.63 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-O 121.377 0.608 . . . . 0.0 111.74 -178.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.452 ' O ' ' C ' ' A' ' 55' ' ' GLU . 6.2 m-70 -112.14 -178.52 3.44 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.454 179.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 54' ' ' HIS . 30.2 tp10 -35.09 -51.84 0.55 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 121.131 -0.228 . . . . 0.0 111.085 -178.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -146.66 24.8 1.21 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 121.095 -0.242 . . . . 0.0 111.364 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.406 ' HG2' ' N ' ' A' ' 58' ' ' ALA . 83.2 tt0 -140.71 156.19 46.27 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.735 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.521 ' O ' ' O ' ' A' ' 82' ' ' LEU . . . -108.85 136.49 48.33 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.238 178.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 49.0 mm -125.43 130.6 72.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.002 -178.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.435 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 46.9 tp -85.51 144.18 28.09 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.821 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.599 ' N ' ' O ' ' A' ' 50' ' ' LYS . 32.4 m-70 -136.13 79.7 1.78 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.403 0.621 . . . . 0.0 110.505 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.651 ' ND2' ' H ' ' A' ' 69' ' ' THR . 24.5 t-20 -75.07 130.16 38.82 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.97 -1.014 . . . . 0.0 112.412 -179.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.486 ' CE1' ' O ' ' A' ' 61' ' ' HIS . 13.0 m-85 -107.28 -35.19 6.88 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.934 179.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.492 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 19.2 t -58.67 140.37 54.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.239 -177.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.5 t -110.54 -54.52 2.58 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.0 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 81.4 p -67.64 -36.41 80.72 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.492 ' O ' ' OG ' ' A' ' 64' ' ' SER . 0.6 OUTLIER -120.57 76.55 26.96 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.498 178.879 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -74.55 148.48 37.55 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 121.878 1.719 . . . . 0.0 113.317 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.651 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 53.5 m -71.88 160.7 32.11 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.552 ' N ' ' O ' ' A' ' 89' ' ' THR . 85.9 mt-30 -126.66 143.8 51.11 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.87 -177.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.459 ' O ' ' N ' ' A' ' 74' ' ' SER . 19.2 t -125.53 133.1 70.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.875 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.443 ' ND2' ' OD1' ' A' ' 86' ' ' ASP . 75.6 m-20 44.38 28.0 0.27 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.903 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.55 21.37 58.3 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 121.051 -0.595 . . . . 0.0 111.9 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.459 ' N ' ' O ' ' A' ' 71' ' ' VAL . 28.5 t -121.18 142.01 50.29 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.8 t -72.96 147.99 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 121.531 0.682 . . . . 0.0 111.772 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 92.7 mt -114.3 114.01 45.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.603 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -96.28 -9.1 31.07 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.555 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -168.58 171.87 3.39 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.802 -178.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -53.99 139.07 70.69 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.602 1.535 . . . . 0.0 111.438 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.5 m -138.83 160.31 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 C-N-CA 120.466 -0.493 . . . . 0.0 110.746 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -68.5 131.98 46.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.778 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.521 ' O ' ' O ' ' A' ' 58' ' ' ALA . 23.2 tp -114.32 121.21 42.93 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.107 0.48 . . . . 0.0 109.929 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -105.49 179.15 4.35 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.108 -178.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.603 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 13.7 t60 -77.62 140.45 39.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.275 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 91.28 -6.22 81.02 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.918 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.603 ' OD1' ' N ' ' A' ' 87' ' ' VAL . 59.1 t0 -79.87 154.89 28.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.998 0.428 . . . . 0.0 111.08 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.603 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 10.1 p -119.82 135.68 59.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.65 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 89.5 mt -108.38 132.28 56.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.164 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.552 ' O ' ' N ' ' A' ' 70' ' ' GLN . 2.0 m -123.91 129.34 50.82 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.849 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.748 ' CG2' ' H ' ' A' ' 91' ' ' ILE . 94.8 mt -100.36 -152.39 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.748 ' H ' ' CG2' ' A' ' 90' ' ' ILE . 94.5 mt -63.2 -44.54 99.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 119.105 0.866 . . . . 0.0 112.793 -178.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.482 ' OD1' ' O ' ' A' ' 91' ' ' ILE . 97.8 m-20 -139.1 1.93 2.07 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 119.833 -0.747 . . . . 0.0 112.737 -179.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -125.85 158.22 35.61 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.301 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.9 t -128.18 142.95 51.03 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.606 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.467 ' CE2' ' CG2' ' A' ' 37' ' ' ILE . 60.4 m-85 -128.5 143.65 51.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.431 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.4 ' N ' ' O ' ' A' ' 8' ' ' VAL . 81.1 mtp180 -120.41 141.01 50.51 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.294 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -114.93 110.8 20.19 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.432 ' HA ' ' HD1' ' A' ' 84' ' ' HIS . 94.0 mt-10 -116.93 125.25 51.16 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.989 -178.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.603 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 32.7 t-20 -121.96 88.77 3.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.366 178.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.493 ' OE2' ' NE2' ' A' ' 84' ' ' HIS . 71.1 mm-40 . . . . . 0 C--N 1.326 -0.413 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.801 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.451 ' O ' ' C ' ' A' ' 2' ' ' TRP . 75.6 mtm . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.451 ' C ' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -28.75 94.01 0.06 OUTLIER Pre-proline 0 CA--C 1.535 0.365 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.848 -179.776 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.41 ' N ' ' O ' ' A' ' 1' ' ' MET . 39.2 Cg_exo -60.32 145.96 97.55 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.436 2.091 . . . . 0.0 111.643 178.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 62.9 p -117.82 7.03 12.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.043 0.449 . . . . 0.0 111.219 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.6 mtm-85 -80.03 139.15 37.07 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.243 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -145.3 139.61 27.2 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.989 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.1 tp -109.66 131.43 55.07 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 79.9 t -120.15 132.39 69.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.443 ' OG1' ' CD2' ' A' ' 95' ' ' PHE . 96.9 m -109.41 120.25 41.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.154 0.502 . . . . 0.0 111.743 -178.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 68.2 mt -81.01 133.1 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.505 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -64.19 -41.57 97.03 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.48 178.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -146.91 -93.68 0.09 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.411 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.6 p -150.5 125.27 9.75 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.928 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.4 27.01 62.3 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.2 p -133.33 149.63 31.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.959 0.409 . . . . 0.0 110.623 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.45 ' O ' ' OD1' ' A' ' 16' ' ' ASP . 45.7 p-10 -96.88 112.32 24.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.634 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -99.04 -174.94 31.82 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -66.96 147.66 80.63 Favored 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.603 2.202 . . . . 0.0 111.809 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -93.46 162.95 13.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.216 -179.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.587 ' CZ ' ' O ' ' A' ' 36' ' ' ASP . 18.6 t80 -135.69 100.78 10.98 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.097 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -72.28 151.09 54.07 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.576 1.517 . . . . 0.0 110.859 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 76.2 mt -81.37 83.08 7.01 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.44 -178.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.6 t -65.4 -40.39 93.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.547 178.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.2 mt -115.7 151.5 34.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.845 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.6 p -63.97 -26.4 68.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.9 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.6 p -110.75 118.07 35.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.427 -179.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.7 m -101.87 131.21 48.36 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.223 179.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 49.9 tp -121.2 141.66 50.65 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.048 0.451 . . . . 0.0 111.009 -179.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 10.8 m-85 -113.77 143.08 45.24 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.327 -179.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 146.18 171.94 16.06 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 120.068 -1.063 . . . . 0.0 112.795 177.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -63.82 -40.0 95.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.903 -0.649 . . . . 0.0 111.89 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.412 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -49.73 141.06 14.54 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.9 tt -67.08 -32.65 58.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.813 0.339 . . . . 0.0 110.541 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -57.11 -18.01 13.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.531 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.412 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 3.9 m -73.76 129.53 38.12 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.947 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.587 ' O ' ' CZ ' ' A' ' 20' ' ' PHE . 92.5 m-20 -62.01 -37.69 85.84 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.503 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.7 mm -107.58 78.32 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -68.76 134.5 49.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.318 -178.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 98.4 mt -123.11 128.05 74.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.174 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.5 tp60 -96.33 82.1 3.38 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.334 -0.546 . . . . 0.0 110.777 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -156.31 124.11 2.81 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -62.37 -25.57 76.39 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 121.74 1.626 . . . . 0.0 112.724 -178.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.483 ' O ' ' CD1' ' A' ' 91' ' ' ILE . 30.8 m -66.62 -31.23 52.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.425 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.0 t -80.08 157.01 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 120.928 0.394 . . . . 0.0 111.246 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.469 ' H ' ' HD1' ' A' ' 48' ' ' HIS . 3.2 m -91.84 165.57 13.19 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.536 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.407 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 98.9 mttt -63.48 -37.07 85.88 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.264 0.554 . . . . 0.0 109.817 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -129.72 60.54 1.58 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 178.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.469 ' HD1' ' H ' ' A' ' 45' ' ' SER . 13.4 t60 -60.99 -51.43 69.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.277 -176.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -149.58 159.32 44.42 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.501 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.55 ' O ' ' N ' ' A' ' 61' ' ' HIS . 69.5 tttt -139.21 127.51 22.73 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.937 -178.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.1 mt -104.24 112.63 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.452 ' O ' ' N ' ' A' ' 59' ' ' ILE . 81.5 tt0 -94.93 136.21 35.52 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.021 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.45 ' O ' ' CG2' ' A' ' 53' ' ' ILE . 4.5 tp -89.23 128.89 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-O 121.096 0.474 . . . . 0.0 110.589 -179.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.521 ' O ' ' C ' ' A' ' 55' ' ' GLU . 3.5 m-70 -112.18 -176.35 2.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.742 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.521 ' C ' ' O ' ' A' ' 54' ' ' HIS . 38.0 tt0 -23.63 -62.2 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 O-C-N 123.664 0.603 . . . . 0.0 111.252 -178.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.536 ' O ' ' ND2' ' A' ' 99' ' ' ASN . 81.1 mt-30 -146.64 20.16 1.32 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.057 178.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -138.64 152.43 48.09 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.502 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.46 ' H ' ' HH ' ' A' ' 97' ' ' TYR . . . -93.28 142.56 27.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.624 179.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.452 ' N ' ' O ' ' A' ' 52' ' ' GLU . 30.8 mm -126.61 126.14 68.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 120.997 0.427 . . . . 0.0 111.378 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 46.4 tp -76.28 145.54 39.57 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.823 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.55 ' N ' ' O ' ' A' ' 50' ' ' LYS . 55.4 m-70 -142.14 79.03 1.65 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.957 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.761 ' ND2' ' H ' ' A' ' 69' ' ' THR . 24.1 t-20 -69.99 138.14 51.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.689 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -107.9 -36.24 6.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.222 178.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.5 m -57.8 138.77 55.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.826 -178.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.9 p -106.07 -56.87 2.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.27 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.505 ' HG1' ' N ' ' A' ' 67' ' ' ASN . 70.2 p -61.97 -42.92 99.67 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.608 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.588 ' OD1' ' N ' ' A' ' 67' ' ' ASN . 0.1 OUTLIER -120.97 79.81 33.54 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.63 -179.875 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.78 151.64 63.4 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.091 1.861 . . . . 0.0 113.226 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.761 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 18.4 m -69.49 165.47 20.89 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.12 -0.946 . . . . 0.0 108.585 178.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -128.74 141.23 51.39 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.448 -0.501 . . . . 0.0 112.18 -177.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 41.3 t -126.21 128.65 71.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.164 178.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 49.48 25.71 1.45 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.151 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 93.75 -13.91 66.44 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.8 m -83.85 143.39 29.95 Favored 'General case' 0 C--N 1.331 -0.211 0 O-C-N 122.693 -0.298 . . . . 0.0 110.834 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.2 t -76.14 144.5 11.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.184 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 45.3 mm -103.92 105.06 17.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.672 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -89.01 -33.08 17.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.913 178.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.62 172.69 5.44 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.133 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.9 137.62 68.56 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 121.544 1.496 . . . . 0.0 111.153 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.7 m -134.08 160.24 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 C-N-CA 120.619 -0.433 . . . . 0.0 110.973 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -86.65 140.15 30.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.536 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 66.9 mt -106.37 143.88 33.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.133 0.492 . . . . 0.0 111.417 -179.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -110.31 150.9 28.08 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.662 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 16.3 t60 -59.85 131.05 49.69 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.28 -179.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 98.7 -9.75 62.32 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.626 ' OD1' ' N ' ' A' ' 87' ' ' VAL . 67.5 t0 -68.48 147.02 52.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.723 0.297 . . . . 0.0 110.329 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.626 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 46.0 t -117.0 132.03 67.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.495 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 60.0 mt -104.81 135.25 43.58 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.9 m -131.16 131.18 43.88 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.954 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.649 ' CG2' ' H ' ' A' ' 91' ' ' ILE . 12.8 mm -86.45 -145.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.649 ' H ' ' CG2' ' A' ' 90' ' ' ILE . 96.7 mt -63.16 -43.37 98.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.363 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.507 ' OD1' ' O ' ' A' ' 92' ' ' ASP . 55.7 t0 -149.58 14.13 0.85 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.685 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 63.0 ttm-85 -121.29 130.04 53.44 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.903 0.382 . . . . 0.0 111.739 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 64.1 m -99.5 141.97 31.59 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.546 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.443 ' CD2' ' OG1' ' A' ' 9' ' ' THR . 73.0 m-85 -128.2 143.83 51.07 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.498 178.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -111.85 135.53 52.34 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.803 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.46 ' HH ' ' H ' ' A' ' 58' ' ' ALA . 0.9 OUTLIER -119.71 107.32 13.07 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.646 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.403 ' HA ' ' HD1' ' A' ' 84' ' ' HIS . 93.9 mt-10 -116.45 125.07 51.46 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.333 -178.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.662 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 58.7 t-20 -123.69 91.59 3.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.997 178.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 . . . . . 0 C--N 1.325 -0.483 0 CA-C-O 121.046 0.45 . . . . 0.0 111.18 -179.568 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.5 mmm . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -156.12 66.73 4.46 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.869 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -69.23 147.16 65.66 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.298 1.999 . . . . 0.0 113.085 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 52.5 p -115.16 10.76 16.15 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.202 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.56 ' NH1' ' CG1' ' A' ' 53' ' ' ILE . 88.7 mtm180 -120.4 131.57 54.87 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.532 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -142.78 154.69 44.46 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.979 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 96.8 mt -111.71 133.97 53.59 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.436 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.2 t -119.69 135.51 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 120.809 0.337 . . . . 0.0 110.675 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.444 ' OG1' ' CE2' ' A' ' 95' ' ' PHE . 24.1 m -101.57 116.86 33.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.534 -179.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.4 mt -78.97 129.56 37.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.914 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -86.77 -172.26 3.92 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -62.0 -43.49 98.72 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.557 ' C ' ' H ' ' A' ' 15' ' ' VAL . 34.8 m -76.31 154.62 34.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.251 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.81 1.96 1.51 Allowed Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.557 ' H ' ' C ' ' A' ' 13' ' ' SER . 12.1 t -83.63 133.8 28.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.151 0.5 . . . . 0.0 110.895 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -68.07 140.64 56.28 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.306 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -103.17 -162.32 25.53 Favored Glycine 0 CA--C 1.532 1.138 0 N-CA-C 110.706 -0.957 . . . . 0.0 110.706 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.4 148.18 91.43 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 123.768 2.979 . . . . 0.0 112.575 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.406 ' CD2' ' N ' ' A' ' 19' ' ' HIS . 3.1 m170 -100.39 161.0 13.89 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.174 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.532 ' CZ ' ' O ' ' A' ' 36' ' ' ASP . 83.2 t80 -130.96 109.77 15.51 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.13 -179.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -75.09 151.2 38.81 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 C-N-CA 121.674 1.582 . . . . 0.0 110.925 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 87.7 mt -75.55 85.52 2.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.23 0.538 . . . . 0.0 111.497 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.6 m -61.75 -42.18 98.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.316 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 97.0 mt -121.37 154.3 36.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.627 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.0 p -59.78 -30.24 68.75 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.731 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 66.0 p -106.5 119.05 38.25 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.117 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.521 ' O ' ' N ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -99.35 119.72 38.41 Favored 'General case' 0 C--O 1.221 -0.404 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.347 179.635 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.43 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 42.2 tp -112.07 138.51 48.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.106 0.479 . . . . 0.0 111.012 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -105.44 147.33 28.39 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.466 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 138.83 163.34 9.49 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 119.754 -1.213 . . . . 0.0 112.998 177.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.405 HH11 ' HA ' ' A' ' 42' ' ' PRO . 80.2 mtp180 -62.7 -36.65 83.62 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.742 -0.729 . . . . 0.0 110.526 179.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -45.62 143.97 3.49 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 109.939 -1.265 . . . . 0.0 109.939 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.4 tt -65.99 -37.8 80.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.779 0.323 . . . . 0.0 110.449 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -55.08 -21.89 14.31 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.406 -0.517 . . . . 0.0 110.389 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 38.9 m -65.38 120.72 13.33 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.802 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.532 ' O ' ' CZ ' ' A' ' 20' ' ' PHE . 59.7 m-20 -61.7 -36.79 81.92 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.432 ' CG2' ' CE2' ' A' ' 95' ' ' PHE . 1.2 mm -106.6 76.18 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.263 179.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 67.4 ttt-85 -65.45 124.74 23.08 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.845 -178.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.41 HD11 HG22 ' A' ' 39' ' ' ILE . 92.3 mt -114.4 124.17 70.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.636 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -91.16 81.24 5.56 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.64 -179.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.3 tp -155.86 118.01 2.3 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.839 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.405 ' HA ' HH11 ' A' ' 31' ' ' ARG . 71.3 Cg_exo -50.08 -36.96 46.8 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 122.017 1.811 . . . . 0.0 113.674 179.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.6 m -64.07 -36.71 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 69.0 t -69.95 141.5 17.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.757 ' HG ' ' N ' ' A' ' 46' ' ' LYS . 4.8 t -83.84 161.73 20.81 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.109 -179.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.757 ' N ' ' HG ' ' A' ' 45' ' ' SER . 98.8 mttt -64.0 -40.01 95.4 Favored 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -119.01 54.3 0.97 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 178.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.526 ' HD1' ' H ' ' A' ' 45' ' ' SER . 15.0 t60 -58.92 -48.04 82.87 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.054 -177.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.8 p -170.82 163.52 7.79 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.467 -179.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.3 ptpt -145.48 145.53 31.11 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 119.055 -1.058 . . . . 0.0 112.321 179.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.521 ' N ' ' O ' ' A' ' 27' ' ' CYS . 96.7 mt -104.82 111.79 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.046 178.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.616 ' N ' ' O ' ' A' ' 59' ' ' ILE . 79.3 tt0 -89.55 148.02 23.62 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.56 ' CG1' ' NH1' ' A' ' 5' ' ' ARG . 3.7 tp -112.31 138.75 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-O 121.106 0.479 . . . . 0.0 111.979 -178.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.422 ' O ' ' C ' ' A' ' 55' ' ' GLU . 22.8 m-70 -115.93 -178.71 3.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.26 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 54' ' ' HIS . 94.1 mt-10 -37.54 -51.88 1.17 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.922 -178.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -145.96 30.4 1.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.644 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -144.17 155.18 43.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.17 0.51 . . . . 0.0 111.554 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -114.05 131.01 56.53 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.936 178.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.616 ' O ' ' N ' ' A' ' 52' ' ' GLU . 1.9 mp -124.55 144.29 34.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.317 0.58 . . . . 0.0 111.421 -178.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 50.2 tp -105.83 144.92 31.89 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.858 -177.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.42 ' ND1' ' HB3' ' A' ' 79' ' ' PRO . 94.6 m-70 -133.3 78.54 1.79 Allowed 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.529 0.681 . . . . 0.0 109.912 179.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.695 ' ND2' ' H ' ' A' ' 69' ' ' THR . 26.2 t-20 -64.94 136.57 56.98 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.569 -1.196 . . . . 0.0 111.278 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -112.33 -33.48 6.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.723 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 40.7 t -58.05 136.14 57.11 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.964 0.411 . . . . 0.0 111.802 -177.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.3 p -109.25 -48.15 3.3 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.732 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.1 p -64.45 -33.89 76.92 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.438 0.637 . . . . 0.0 109.707 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -138.65 79.84 27.76 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.122 179.358 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.21 149.16 51.15 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.582 1.521 . . . . 0.0 112.463 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.695 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 27.9 m -63.83 154.65 32.92 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -125.52 151.8 45.87 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.868 -177.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.404 ' C ' ' N ' ' A' ' 73' ' ' GLY . 9.0 p -136.22 136.57 49.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.169 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 51.69 17.95 0.66 Allowed 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.219 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.404 ' N ' ' C ' ' A' ' 71' ' ' VAL . . . 94.47 -9.2 71.76 Favored Glycine 0 CA--C 1.525 0.691 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.548 178.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 91.3 p -84.61 177.38 8.09 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.4 t -108.05 138.54 34.08 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 CA-C-O 121.418 0.628 . . . . 0.0 109.911 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 80.1 mt -105.08 84.19 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.939 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -66.87 -37.51 84.57 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.983 0.42 . . . . 0.0 110.815 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.462 ' CD ' ' N ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -132.51 174.57 4.55 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.561 -179.614 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.42 ' HB3' ' ND1' ' A' ' 61' ' ' HIS . 41.0 Cg_exo -58.26 138.52 86.32 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 121.781 1.654 . . . . 0.0 111.253 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 26.9 m -140.5 161.64 24.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.031 0.444 . . . . 0.0 110.996 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -98.68 135.35 40.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.356 178.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.648 ' N ' ' CD2' ' A' ' 82' ' ' LEU . 0.1 OUTLIER -111.06 141.0 45.14 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.9 -179.508 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.631 ' N ' ' OD2' ' A' ' 86' ' ' ASP . 74.8 mmtt -87.94 159.11 18.47 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.534 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 29.7 t60 -55.29 141.3 36.24 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.966 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.01 3.78 82.56 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.455 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.631 ' OD2' ' N ' ' A' ' 83' ' ' LYS . 95.6 m-20 -76.72 153.11 35.36 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.015 0.436 . . . . 0.0 111.396 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.7 p -119.97 131.34 72.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.376 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 87.4 mt -108.22 133.81 52.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.543 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 95.1 m -126.28 129.61 49.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.176 0.512 . . . . 0.0 112.346 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.763 ' CG2' ' H ' ' A' ' 91' ' ' ILE . 94.4 mt -97.58 -153.51 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.098 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.763 ' H ' ' CG2' ' A' ' 90' ' ' ILE . 92.2 mt -62.98 -44.91 99.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 118.861 0.755 . . . . 0.0 111.494 -179.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 91' ' ' ILE . 95.6 m-20 -141.88 6.45 1.8 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -123.49 156.61 35.28 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.239 -179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.1 p -136.88 150.96 48.56 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.11 -0.636 . . . . 0.0 112.258 -179.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.444 ' CE2' ' OG1' ' A' ' 9' ' ' THR . 65.3 m-85 -139.34 149.86 44.68 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.509 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -117.51 142.78 46.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.066 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.487 ' CD1' ' C ' ' A' ' 97' ' ' TYR . 1.1 t80 -112.14 104.03 12.23 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.35 -0.386 . . . . 0.0 109.963 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.5 ' HA ' ' HD1' ' A' ' 84' ' ' HIS . 4.1 tt0 -113.04 126.46 55.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.893 -178.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.534 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 61.2 t-20 -124.17 85.92 2.49 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.146 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 C--N 1.331 -0.227 0 CA-C-O 120.845 0.355 . . . . 0.0 110.901 -179.958 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.457 ' O ' ' C ' ' A' ' 2' ' ' TRP . 98.8 mtp . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.457 ' C ' ' O ' ' A' ' 1' ' ' MET . 6.6 m0 35.78 62.09 2.67 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.335 -179.587 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -73.95 153.35 47.3 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 C-N-CA 123.08 2.52 . . . . 0.0 112.587 -179.472 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 96.9 m -114.69 130.45 56.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.138 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.582 HH22 ' C ' ' A' ' 56' ' ' GLN . 99.5 mtt180 -126.1 144.03 50.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.126 -179.609 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -144.41 146.07 32.29 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.901 -179.608 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -90.86 139.68 30.52 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.503 ' O ' ' N ' ' A' ' 96' ' ' ARG . 48.4 t -121.74 132.82 69.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.1 0.476 . . . . 0.0 110.908 -179.233 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 57.9 m -114.26 126.74 55.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.239 -179.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.41 ' CG2' ' O ' ' A' ' 12' ' ' ARG . 92.7 mt -80.84 115.12 22.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.439 -179.406 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -67.6 -46.06 73.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.694 179.383 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.41 ' O ' ' CG2' ' A' ' 10' ' ' ILE . 86.6 mtm180 -135.4 150.48 49.91 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.742 178.801 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 91.0 p -56.74 124.4 18.3 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.464 -0.494 . . . . 0.0 109.864 179.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.53 7.21 60.55 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 -179.642 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.0 t -128.13 152.71 36.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.692 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.519 ' O ' ' O ' ' A' ' 17' ' ' GLY . 46.4 p-10 -97.19 8.05 45.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.161 0.505 . . . . 0.0 111.006 -179.483 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.519 ' O ' ' O ' ' A' ' 16' ' ' ASP . . . 29.75 -155.94 0.0 OUTLIER Glycine 0 CA--C 1.534 1.274 0 CA-C-N 115.267 -0.878 . . . . 0.0 112.292 179.187 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -78.73 161.85 27.34 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 123.199 2.599 . . . . 0.0 113.103 -179.211 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 4.1 m170 -112.4 156.25 22.82 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.754 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.604 ' CE1' ' O ' ' A' ' 21' ' ' PRO . 51.1 t80 -119.97 126.4 26.89 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.451 -179.605 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.604 ' O ' ' CE1' ' A' ' 20' ' ' PHE . 97.0 Cg_endo -75.69 146.47 30.3 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 121.988 1.792 . . . . 0.0 111.694 179.69 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.406 ' CD2' ' SG ' ' A' ' 27' ' ' CYS . 96.2 mt -91.35 83.01 5.41 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.596 -0.441 . . . . 0.0 110.508 179.676 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.9 m -60.87 -41.72 96.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.142 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.2 mt -119.11 150.85 39.32 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.388 179.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.3 p -58.51 -40.69 83.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.035 0.445 . . . . 0.0 110.412 -179.781 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.447 ' H ' ' HG1' ' A' ' 26' ' ' THR . 5.5 p -85.69 115.0 23.1 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.571 -179.904 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.406 ' SG ' ' CD2' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -95.75 130.93 42.52 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 119.798 -0.761 . . . . 0.0 110.294 179.262 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 58.7 tp -118.84 137.04 53.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.036 -179.211 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -109.14 142.28 40.14 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.923 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.85 155.99 7.69 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 119.589 -1.291 . . . . 0.0 112.661 179.309 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 76.4 ttt-85 -66.85 -40.2 87.82 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.534 -0.833 . . . . 0.0 111.416 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -57.22 157.15 13.19 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.649 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.9 tt -66.51 -33.09 61.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.938 0.399 . . . . 0.0 111.215 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -52.58 -18.75 1.89 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.39 -178.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 0.8 OUTLIER -84.23 130.35 34.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.077 0.465 . . . . 0.0 111.62 -179.389 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.404 ' O ' ' CZ ' ' A' ' 20' ' ' PHE . 92.6 m-20 -62.53 -39.59 94.07 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.347 178.929 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.8 mm -102.75 80.2 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -65.56 130.12 42.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.926 -177.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 89.4 mt -115.81 124.6 72.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.163 -179.611 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -88.31 79.99 7.63 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 119.572 -0.851 . . . . 0.0 111.432 -179.443 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.577 ' CD1' ' HE ' ' A' ' 93' ' ' ARG . 4.2 mt -157.26 112.24 1.89 Allowed Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.281 178.412 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -51.8 -32.68 47.29 Favored 'Trans proline' 0 N--CA 1.5 1.874 0 C-N-CA 121.983 1.789 . . . . 0.0 113.13 -179.45 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.5 m -64.68 -29.83 48.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.076 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 98.4 t -72.09 146.85 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 120.848 0.356 . . . . 0.0 110.475 -179.768 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.45 ' H ' ' HD1' ' A' ' 48' ' ' HIS . 41.6 t -85.65 164.56 17.62 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.24 -179.669 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.494 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 68.2 mttm -62.8 -38.54 91.1 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.158 0.504 . . . . 0.0 109.85 179.566 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.413 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 89.2 mt-30 -124.52 58.55 1.21 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.453 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.45 ' HD1' ' H ' ' A' ' 45' ' ' SER . 13.9 t60 -61.59 -51.71 67.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.393 -0.822 . . . . 0.0 112.17 -177.351 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -148.52 158.09 43.89 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.47 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.575 ' O ' ' N ' ' A' ' 61' ' ' HIS . 72.0 tttt -140.57 129.83 23.71 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.348 -178.24 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 89.0 mt -100.12 99.28 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 176.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.566 ' N ' ' O ' ' A' ' 59' ' ' ILE . 83.6 tt0 -81.65 120.73 25.46 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.798 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 78.5 mt -101.29 122.25 53.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.297 0.57 . . . . 0.0 111.168 -178.57 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.666 ' HD1' ' N ' ' A' ' 55' ' ' GLU . 6.1 p80 -110.87 -166.93 1.12 Allowed 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.672 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.666 ' N ' ' HD1' ' A' ' 54' ' ' HIS . 95.3 mt-10 -22.91 -60.99 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.505 -0.77 . . . . 0.0 113.006 -177.663 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.582 ' C ' HH22 ' A' ' 5' ' ' ARG . 27.5 mt-30 -145.56 26.29 1.29 Allowed 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -178.14 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.415 ' HG3' ' N ' ' A' ' 58' ' ' ALA . 43.3 tp10 -153.94 152.79 30.99 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 118.994 -1.082 . . . . 0.0 112.511 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.415 ' N ' ' HG3' ' A' ' 57' ' ' GLU . . . -93.17 134.76 35.02 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.915 178.837 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.566 ' O ' ' N ' ' A' ' 52' ' ' GLU . 31.6 mm -125.98 126.92 70.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.346 -178.847 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.8 tp -74.05 145.44 44.48 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.668 -179.602 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.575 ' N ' ' O ' ' A' ' 50' ' ' LYS . 12.9 m-70 -141.35 78.81 1.66 Allowed 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.104 179.453 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.704 ' ND2' ' H ' ' A' ' 69' ' ' THR . 26.3 t-20 -68.56 134.73 50.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.103 -179.338 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.502 ' CE1' ' O ' ' A' ' 61' ' ' HIS . 23.4 m-85 -107.08 -36.58 6.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.383 179.114 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.9 m -63.02 137.93 58.41 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.948 -178.475 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.452 ' H ' ' HG ' ' A' ' 65' ' ' SER . 2.6 p -104.83 -53.88 2.6 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.377 179.287 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.2 p -62.29 -47.11 85.77 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.961 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.574 ' OD1' ' N ' ' A' ' 67' ' ' ASN . 0.2 OUTLIER -114.46 78.96 5.08 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.669 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -72.67 151.13 51.77 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.035 1.823 . . . . 0.0 112.84 -178.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.704 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 19.9 m -71.54 157.97 37.07 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.481 -0.782 . . . . 0.0 108.983 179.244 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -123.61 141.79 51.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.89 0.376 . . . . 0.0 111.503 -178.026 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.8 t -128.9 129.25 68.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.868 179.339 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 51.14 30.63 5.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.869 179.569 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.4 22.55 60.24 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.075 178.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.2 t -128.73 140.7 51.61 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.567 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.8 t -69.34 149.51 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-O 121.359 0.599 . . . . 0.0 111.596 -178.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 36.6 mm -108.05 92.49 2.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.413 -179.328 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -67.51 -39.72 85.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.051 0.453 . . . . 0.0 110.343 179.171 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -146.24 174.75 3.16 Favored Pre-proline 0 N--CA 1.463 0.188 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.533 -179.569 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.06 137.72 69.85 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 121.78 1.653 . . . . 0.0 111.304 -179.379 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 29.4 m -135.45 160.9 39.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.848 -179.385 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -82.91 136.88 34.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.638 179.648 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 75.0 mt -102.57 139.47 38.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.324 0.583 . . . . 0.0 111.539 -179.533 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.549 ' N ' ' OD2' ' A' ' 86' ' ' ASP . 88.0 tttt -106.7 155.13 19.99 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.159 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.767 ' ND1' ' H ' ' A' ' 99' ' ' ASN . 32.2 t60 -62.47 138.58 58.49 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.559 -178.754 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.17 4.0 78.39 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 121.137 -0.554 . . . . 0.0 111.94 179.6 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.549 ' OD2' ' N ' ' A' ' 83' ' ' LYS . 98.0 m-20 -75.66 155.13 36.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.961 0.38 . . . . 0.0 110.778 179.85 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.1 p -118.04 128.52 75.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 179.322 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.612 ' O ' ' N ' ' A' ' 95' ' ' PHE . 13.4 mt -110.29 133.71 54.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.556 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 25.4 m -131.07 131.51 44.28 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.833 -179.118 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.621 ' CG2' ' H ' ' A' ' 91' ' ' ILE . 6.3 mm -83.74 -145.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.472 -0.785 . . . . 0.0 108.993 178.72 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.621 ' H ' ' CG2' ' A' ' 90' ' ' ILE . 83.2 mt -63.22 -44.13 99.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -179.817 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.507 ' OD1' ' O ' ' A' ' 91' ' ' ILE . 99.8 m-20 -142.77 10.16 1.79 Allowed 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -179.226 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.577 ' HE ' ' CD1' ' A' ' 41' ' ' LEU . 93.7 mtt-85 -125.91 146.0 50.03 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.858 -179.343 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.2 m -102.06 137.36 40.44 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.095 179.759 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.612 ' N ' ' O ' ' A' ' 88' ' ' ILE . 24.0 m-85 -128.67 146.54 50.85 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.931 179.338 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.503 ' N ' ' O ' ' A' ' 8' ' ' VAL . 71.7 mtp85 -127.47 142.99 51.26 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.074 0.464 . . . . 0.0 111.685 -179.07 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.553 ' C ' ' CD1' ' A' ' 97' ' ' TYR . 0.1 OUTLIER -111.98 115.63 29.26 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.963 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -119.79 117.18 27.51 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.43 -177.63 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.767 ' H ' ' ND1' ' A' ' 84' ' ' HIS . 53.9 t-20 -98.46 111.82 24.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.178 179.418 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 . . . . . 0 N--CA 1.463 0.198 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.685 179.487 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.9 ttp . . . . . 0 N--CA 1.488 1.471 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -92.43 162.92 28.46 Favored Pre-proline 0 C--N 1.331 -0.231 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.439 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.23 147.77 60.59 Favored 'Trans proline' 0 C--N 1.302 -1.882 0 C-N-CA 122.734 2.29 . . . . 0.0 112.345 -179.439 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 44.5 p -114.21 18.79 16.82 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.95 -179.591 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.57 ' NH2' ' O ' ' A' ' 55' ' ' GLU . 84.4 mtt85 -107.06 135.59 48.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.899 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -130.39 136.28 48.9 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.301 -179.68 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.7 tp -118.73 132.22 56.15 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.013 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.551 ' O ' ' N ' ' A' ' 96' ' ' ARG . 53.4 t -130.33 150.94 35.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.823 -178.047 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.447 ' CG2' ' O ' ' A' ' 15' ' ' VAL . 30.0 m -86.78 161.18 18.52 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.521 179.336 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.595 ' O ' ' N ' ' A' ' 15' ' ' VAL . 7.6 mt -110.36 136.1 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -179.207 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.577 ' O ' ' N ' ' A' ' 13' ' ' SER . 7.7 mttp -80.75 -167.69 1.48 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.309 179.605 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 59.3 ttm-85 50.23 -82.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -179.177 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.577 ' N ' ' O ' ' A' ' 11' ' ' LYS . 16.7 m -60.16 -40.74 90.98 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 179.064 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.493 ' C ' ' O ' ' A' ' 10' ' ' ILE . . . -129.29 -135.78 3.99 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 178.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.595 ' N ' ' O ' ' A' ' 10' ' ' ILE . 22.0 m -134.58 93.06 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.01 0.433 . . . . 0.0 111.706 178.925 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.65 ' CG ' ' H ' ' A' ' 17' ' ' GLY . 54.8 t0 -69.98 -168.86 0.23 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 177.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.65 ' H ' ' CG ' ' A' ' 16' ' ' ASP . . . 113.65 -82.77 0.31 Allowed Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 179.417 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -73.64 152.6 48.26 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.819 2.346 . . . . 0.0 112.79 -179.52 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 7.7 m80 -118.06 162.56 17.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.321 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.488 ' CZ ' ' O ' ' A' ' 36' ' ' ASP . 26.5 t80 -128.21 91.98 42.83 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.347 179.379 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -60.38 146.22 97.1 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.226 1.951 . . . . 0.0 110.591 178.258 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 22' ' ' LEU . 6.7 mp -98.77 114.26 26.72 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.438 -179.209 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.4 p -110.42 -2.4 16.61 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.449 179.806 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.2 mt -125.15 151.59 45.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.61 -179.523 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 80.2 p -79.2 -3.95 48.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.016 0.436 . . . . 0.0 110.335 179.65 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.3 p -133.34 115.07 14.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.54 179.817 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.9 m -101.27 129.36 47.22 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.474 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.7 tp -122.12 137.27 54.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.263 0.554 . . . . 0.0 112.029 -177.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 8.3 m-85 -105.23 144.07 32.52 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.611 179.531 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 158.35 166.38 17.43 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 119.177 -1.487 . . . . 0.0 113.357 179.184 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.627 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 88.2 mtm-85 -67.25 -37.67 83.89 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 114.94 -0.63 . . . . 0.0 110.856 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.56 147.6 48.72 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.032 -178.345 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.437 ' C ' ' N ' ' A' ' 35' ' ' CYS . 20.0 tt -63.56 -36.82 77.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.23 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -45.38 -23.21 0.18 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.782 179.895 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.437 ' N ' ' C ' ' A' ' 33' ' ' ILE . 58.7 m -74.49 131.75 41.29 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.655 179.494 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.488 ' O ' ' CZ ' ' A' ' 20' ' ' PHE . 39.0 t0 -62.04 -37.03 83.4 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.63 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.1 mm -108.1 88.23 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.547 178.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 75.5 ttt-85 -72.8 134.52 44.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.697 -178.222 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 98.6 mt -124.69 126.83 72.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.212 178.891 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -94.17 80.76 4.03 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.455 179.937 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -156.65 115.94 2.08 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.922 179.287 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -52.77 -33.57 60.92 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 121.9 1.733 . . . . 0.0 112.672 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 19.2 m -63.01 -36.75 77.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.97 -179.172 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.627 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 59.3 t -71.91 135.76 27.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.1 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.613 ' H ' ' HD1' ' A' ' 48' ' ' HIS . 3.9 m -74.36 170.03 16.47 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -178.472 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.41 -37.3 86.75 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.108 179.377 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.408 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 97.8 mt-30 -133.57 59.32 1.74 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.613 ' HD1' ' H ' ' A' ' 45' ' ' SER . 12.5 t60 -58.49 -50.39 73.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.492 -1.231 . . . . 0.0 112.852 -176.651 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.475 ' SG ' ' N ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -150.26 156.51 41.7 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.088 -179.404 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.566 ' O ' ' N ' ' A' ' 61' ' ' HIS . 74.4 tttt -138.97 126.24 21.47 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.26 -179.414 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.4 mt -103.44 106.22 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.529 ' N ' ' O ' ' A' ' 59' ' ' ILE . 85.4 tt0 -79.71 123.28 27.53 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.365 -179.466 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.7 mp -92.94 124.86 45.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.327 -179.801 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.415 ' N ' ' O ' ' A' ' 57' ' ' GLU . 45.4 m-70 -105.88 174.27 5.96 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.354 179.342 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.57 ' O ' ' NH2' ' A' ' 5' ' ' ARG . 95.6 mt-10 -41.16 -42.72 2.11 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -178.609 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -144.06 22.49 1.73 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.275 -0.57 . . . . 0.0 112.227 -179.412 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.415 ' O ' ' N ' ' A' ' 54' ' ' HIS . 31.0 tp10 -151.09 152.21 33.09 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 119.887 -0.725 . . . . 0.0 111.654 -179.655 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.452 ' H ' ' HH ' ' A' ' 97' ' ' TYR . . . -113.9 134.14 55.0 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.713 179.068 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.529 ' O ' ' N ' ' A' ' 52' ' ' GLU . 1.8 mp -124.33 129.19 74.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 112.883 0.698 . . . . 0.0 112.883 -177.711 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 49.1 tp -76.52 144.87 39.48 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.916 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.566 ' N ' ' O ' ' A' ' 50' ' ' LYS . 19.3 m-70 -140.62 79.04 1.68 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.122 179.422 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.729 ' ND2' ' H ' ' A' ' 69' ' ' THR . 24.9 t-20 -71.71 131.58 43.34 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.553 -179.168 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.498 ' CE1' ' O ' ' A' ' 61' ' ' HIS . 15.7 m-85 -105.16 -34.03 8.07 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.461 179.045 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.544 ' HG ' HD22 ' A' ' 62' ' ' ASN . 16.7 p -57.35 133.82 55.47 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.687 -178.406 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.0 p -102.3 -52.38 3.14 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.094 179.263 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.7 m -62.67 -46.73 86.82 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.368 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -121.46 83.76 41.09 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.227 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.47 148.4 54.17 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.576 1.517 . . . . 0.0 112.268 -178.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.729 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 41.3 m -63.35 156.2 26.54 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.973 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.487 ' O ' ' N ' ' A' ' 89' ' ' THR . 86.1 mt-30 -124.56 141.77 51.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.228 0.537 . . . . 0.0 112.374 -177.871 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.505 ' O ' ' N ' ' A' ' 74' ' ' SER . 42.8 t -126.6 133.02 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.342 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 46.1 30.58 0.98 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.075 178.921 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 78.05 18.55 76.51 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.734 -0.947 . . . . 0.0 110.734 179.886 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 71' ' ' VAL . 47.3 t -117.01 137.78 52.01 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.843 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 91.0 t -69.7 149.88 10.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.312 0.577 . . . . 0.0 111.009 -179.568 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.9 mm -108.78 90.14 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.845 -179.549 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -65.23 -41.04 94.77 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.52 179.128 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.49 173.04 4.55 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.673 -179.497 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -53.56 136.72 64.96 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 121.613 1.542 . . . . 0.0 110.304 179.679 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.2 m -137.76 160.31 33.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.413 -178.72 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -78.77 137.08 37.57 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.893 179.197 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 87.2 mt -103.6 134.3 47.17 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.28 -178.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.595 ' N ' ' OD2' ' A' ' 86' ' ' ASP . 99.5 mttt -92.74 152.87 19.25 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.719 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.698 ' HD1' ' H ' ' A' ' 99' ' ' ASN . 46.1 t60 -60.39 131.03 49.5 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.121 -179.528 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.09 6.16 63.41 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 -179.468 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.595 ' OD2' ' N ' ' A' ' 83' ' ' LYS . 86.6 m-20 -74.0 156.52 37.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.977 0.417 . . . . 0.0 111.174 179.728 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 51.1 t -117.73 132.71 66.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.481 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.457 ' O ' ' OG ' ' A' ' 94' ' ' SER . 5.3 mm -100.83 130.99 49.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.666 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.487 ' N ' ' O ' ' A' ' 70' ' ' GLN . 89.1 m -132.01 126.86 34.95 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.62 179.823 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.745 ' CG2' ' H ' ' A' ' 91' ' ' ILE . 75.6 mt -101.71 -152.44 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.083 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.745 ' H ' ' CG2' ' A' ' 90' ' ' ILE . 91.6 mt -62.82 -43.63 98.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 118.644 0.656 . . . . 0.0 112.132 -178.699 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.475 ' OD1' ' O ' ' A' ' 91' ' ' ILE . 96.6 m-20 -141.07 -1.52 1.37 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 119.932 -0.707 . . . . 0.0 112.82 -179.503 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -123.74 146.35 48.36 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.171 -179.319 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 88' ' ' ILE . 8.7 t -131.13 149.99 52.35 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.088 0.47 . . . . 0.0 112.083 -178.988 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -128.92 150.36 50.4 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.608 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.551 ' N ' ' O ' ' A' ' 8' ' ' VAL . 47.0 mtp180 -105.29 134.08 48.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.969 179.489 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.531 ' C ' ' CD1' ' A' ' 97' ' ' TYR . 0.8 OUTLIER -113.13 109.17 18.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.969 0.414 . . . . 0.0 110.627 -179.705 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.8 mp0 -129.18 122.12 29.12 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.816 -179.667 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.698 ' H ' ' HD1' ' A' ' 84' ' ' HIS . 57.7 t-20 -94.89 112.55 24.26 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.151 179.14 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 . . . . . 0 C--N 1.328 -0.354 0 CA-C-O 121.035 0.445 . . . . 0.0 111.166 -179.464 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.0 mtp . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.141 0.496 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' TRP . . . . . 0.485 ' CD1' ' N ' ' A' ' 2' ' ' TRP . 8.8 p-90 -156.52 57.6 1.46 Allowed Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.797 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.41 145.2 82.42 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.544 2.163 . . . . 0.0 112.363 -179.396 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 95.2 m -131.36 133.02 44.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.191 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -80.37 132.24 35.74 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.498 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.506 ' NH2' ' CG ' ' A' ' 19' ' ' HIS . 8.8 ptm180 -143.71 146.17 32.98 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.326 -0.549 . . . . 0.0 111.275 -179.292 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 96.0 mt -110.14 131.58 54.93 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.584 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 43.0 t -116.59 133.15 64.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.805 -179.63 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.54 ' OG1' ' CE2' ' A' ' 95' ' ' PHE . 23.4 m -105.23 122.7 46.48 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.725 -179.319 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.486 ' CG2' ' O ' ' A' ' 12' ' ' ARG . 95.2 mt -77.65 115.38 19.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.32 -179.543 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -64.26 -41.06 97.12 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.486 ' O ' ' CG2' ' A' ' 10' ' ' ILE . 78.1 ttt180 -143.77 146.7 33.31 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.365 179.144 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.413 ' H ' ' HG ' ' A' ' 13' ' ' SER . 2.1 m -61.04 134.77 57.42 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.28 -179.077 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.15 -16.72 60.61 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.333 179.144 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.3 m -132.08 139.84 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 117.372 0.586 . . . . 0.0 111.796 -179.221 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.581 ' OD1' ' NH1' ' A' ' 96' ' ' ARG . 87.0 m-20 -74.33 139.55 44.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.18 179.46 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -110.69 -164.25 18.76 Favored Glycine 0 CA--C 1.533 1.177 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.805 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.02 150.03 80.96 Favored 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 123.139 2.56 . . . . 0.0 112.159 179.324 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.506 ' CG ' ' NH2' ' A' ' 6' ' ' ARG . 6.6 m170 -96.8 173.77 7.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.141 0.496 . . . . 0.0 111.58 -178.92 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -142.21 93.08 7.34 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.01 -179.006 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -58.08 148.1 79.33 Favored 'Trans proline' 0 N--CA 1.501 1.963 0 C-N-CA 122.8 2.333 . . . . 0.0 111.683 179.544 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.2 mt -107.59 120.51 42.4 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.837 -178.576 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.7 p -112.55 -20.42 11.74 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.521 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.2 mp -112.17 134.84 53.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.143 179.725 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 53.3 p -65.15 -16.01 63.03 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.177 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 10.1 p -116.03 109.06 17.02 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.842 179.912 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -101.9 130.99 48.52 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.684 -0.407 . . . . 0.0 110.524 179.546 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.452 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 0.8 OUTLIER -122.01 148.06 45.29 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.035 0.445 . . . . 0.0 111.762 -179.156 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.461 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 10.3 m-85 -111.86 144.78 40.61 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.524 -178.451 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 143.65 169.32 12.66 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 120.243 -0.98 . . . . 0.0 112.28 178.364 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -64.56 -36.05 82.98 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.341 -0.429 . . . . 0.0 112.0 -179.622 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.425 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -48.87 147.25 5.59 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.446 -0.883 . . . . 0.0 111.355 -178.464 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.496 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -66.78 -39.98 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.636 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.496 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 22.1 pt-20 -56.07 -12.91 1.65 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.645 -179.479 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 17.4 m -74.82 124.17 26.35 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.987 -179.761 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.452 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 88.8 m-20 -62.22 -38.95 91.14 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.583 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.475 ' CG2' ' CE2' ' A' ' 95' ' ' PHE . 4.0 mm -108.24 79.95 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.728 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -68.61 131.89 45.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.909 -178.265 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.6 mt -122.54 124.36 70.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.813 179.447 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -92.95 80.43 4.6 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.098 179.896 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -156.27 126.15 3.27 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.007 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -63.98 -24.31 67.29 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.467 1.445 . . . . 0.0 113.064 -178.029 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.8 m -70.24 -32.82 52.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.541 -0.463 . . . . 0.0 111.439 -179.692 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 98.5 t -73.82 138.99 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.66 ' H ' ' HD1' ' A' ' 48' ' ' HIS . 25.9 t -77.69 164.36 25.35 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.406 -0.517 . . . . 0.0 110.574 -179.309 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.42 -38.82 85.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.202 -179.393 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -127.51 59.97 1.43 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.437 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.66 ' HD1' ' H ' ' A' ' 45' ' ' SER . 12.1 t60 -58.77 -52.97 63.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.329 -1.305 . . . . 0.0 112.643 -176.991 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.461 ' SG ' ' CD1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -148.99 160.9 42.88 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.393 -179.459 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.574 ' O ' ' N ' ' A' ' 61' ' ' HIS . 77.6 tttt -145.16 125.66 14.05 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.956 -178.842 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.0 mt -99.34 98.52 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.509 178.539 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.596 ' N ' ' O ' ' A' ' 59' ' ' ILE . 85.4 tt0 -78.43 114.28 17.19 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 75.3 mt -103.26 122.21 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.346 -178.275 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.646 ' CE1' ' H ' ' A' ' 57' ' ' GLU . 9.8 p80 -110.83 158.7 18.4 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.575 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -37.66 -22.83 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -178.105 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.533 ' N ' ' O ' ' A' ' 54' ' ' HIS . 87.4 mt-30 -107.21 -37.55 6.24 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -177.423 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.646 ' H ' ' CE1' ' A' ' 54' ' ' HIS . 63.6 tt0 -157.33 165.67 35.17 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 118.122 -1.431 . . . . 0.0 113.272 -177.128 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.415 ' HB3' ' CZ ' ' A' ' 97' ' ' TYR . . . -89.53 130.78 35.8 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.477 178.223 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.596 ' O ' ' N ' ' A' ' 52' ' ' GLU . 40.8 mm -124.7 127.51 72.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.813 -178.057 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.421 ' HG ' ' N ' ' A' ' 61' ' ' HIS . 48.8 tp -78.56 149.1 33.11 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.912 0.386 . . . . 0.0 111.796 -179.34 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.574 ' N ' ' O ' ' A' ' 50' ' ' LYS . 13.8 m-70 -143.32 78.92 1.62 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.478 179.251 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.646 ' ND2' ' H ' ' A' ' 69' ' ' THR . 26.9 t-20 -71.38 137.92 48.76 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.431 -179.633 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.517 ' CE1' ' O ' ' A' ' 61' ' ' HIS . 14.9 m-85 -111.49 -34.69 6.02 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.698 178.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.2 m -59.69 140.64 56.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.956 -178.102 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.3 t -105.11 -60.66 1.58 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.697 -179.818 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.8 m -61.31 -48.83 79.55 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.805 -179.751 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.403 ' OD1' ' N ' ' A' ' 67' ' ' ASN . 0.1 OUTLIER -114.81 79.4 5.82 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.189 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.87 151.93 36.24 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.257 1.971 . . . . 0.0 112.051 -178.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.646 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 99.4 m -61.05 165.76 4.02 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 178.131 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -136.42 148.03 47.57 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.264 -0.575 . . . . 0.0 111.511 -177.799 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.482 ' O ' ' N ' ' A' ' 74' ' ' SER . 42.0 t -127.34 131.22 70.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.016 179.016 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 48.63 30.19 2.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.631 179.512 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.14 -3.8 86.61 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.4 -0.905 . . . . 0.0 111.005 -179.73 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.482 ' N ' ' O ' ' A' ' 71' ' ' VAL . 61.9 p -82.74 174.03 11.35 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.492 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.2 t -112.84 139.94 35.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.571 0.701 . . . . 0.0 109.928 179.137 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 68.2 mt -107.52 110.12 30.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.425 -178.244 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -97.71 -4.09 37.88 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.083 179.927 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -169.01 171.51 3.37 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.01 -179.583 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.4 138.06 79.05 Favored 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 122.134 1.889 . . . . 0.0 111.231 179.012 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.0 m -138.51 160.14 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-O 121.225 0.536 . . . . 0.0 112.019 -179.64 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -80.19 133.28 36.02 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.748 178.797 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 97.4 mt -104.73 138.04 41.62 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.952 -179.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -102.08 157.59 16.77 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.062 179.025 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . 0.802 ' HD1' ' H ' ' A' ' 99' ' ' ASN . 58.0 t60 -62.44 133.31 54.83 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.647 -179.114 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 94.5 -9.1 71.74 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.211 179.427 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -65.41 147.35 53.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 117.093 0.447 . . . . 0.0 110.524 -179.866 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 45.1 t -114.39 131.7 65.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.333 -179.245 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.414 ' CG2' ' CG2' ' A' ' 69' ' ' THR . 57.7 mt -105.22 134.8 45.68 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 179.824 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 90.0 m -125.39 123.3 39.02 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.007 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.715 ' CG2' ' H ' ' A' ' 91' ' ' ILE . 80.2 mt -93.64 -154.58 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 177.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.715 ' H ' ' CG2' ' A' ' 90' ' ' ILE . 93.9 mt -63.13 -43.44 98.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 119.167 0.894 . . . . 0.0 112.355 -178.385 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -135.7 -1.96 2.45 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -178.551 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -123.26 160.32 26.86 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.805 -179.348 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.7 m -127.55 145.35 50.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.04 179.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.54 ' CE2' ' OG1' ' A' ' 9' ' ' THR . 56.5 m-85 -130.49 151.03 51.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.236 -179.91 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.581 ' NH1' ' OD1' ' A' ' 16' ' ' ASP . 79.7 mtp180 -121.2 136.39 54.98 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.148 -179.257 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.457 ' C ' ' CD1' ' A' ' 97' ' ' TYR . 0.7 OUTLIER -111.72 111.55 22.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.03 0.443 . . . . 0.0 109.957 -179.971 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -117.18 122.76 44.96 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.238 -178.842 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.802 ' H ' ' HD1' ' A' ' 84' ' ' HIS . 55.3 t30 -115.21 100.15 7.93 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.484 179.1 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 . . . . . 0 C--N 1.327 -0.381 0 CA-C-O 121.1 0.476 . . . . 0.0 111.002 -179.164 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.2 mtp . . . . . 0 N--CA 1.496 1.828 0 N-CA-C 108.554 -0.906 . . . . 8.13 108.554 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.738 ' CD1' ' N ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -119.46 77.68 19.44 Favored Pre-proline 0 N--CA 1.446 -0.642 0 CA-C-N 115.225 -0.898 . . . . 6.71 110.768 -178.828 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -62.86 -24.5 74.35 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.742 1.628 . . . . 5.23 109.18 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 37.62 93.22 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 113.761 -1.563 . . . . 2.61 112.359 178.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.584 ' NH2' ' O ' ' A' ' 55' ' ' GLU . 87.0 mtt180 -105.48 99.57 9.17 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 105.592 -2.003 . . . . 2.15 105.592 176.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -99.12 145.05 27.57 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 113.812 1.041 . . . . 2.93 113.812 -175.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.541 HD12 HD21 ' A' ' 22' ' ' LEU . 48.3 mt -110.96 106.1 15.1 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 107.502 -1.296 . . . . 1.4 107.502 175.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 76.1 t -96.22 130.11 45.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.795 -0.446 . . . . 0.52 109.795 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.422 ' OG1' ' CE2' ' A' ' 95' ' ' PHE . 89.9 m -101.51 113.05 25.82 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.673 -0.694 . . . . 0.68 109.93 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 92.5 mt -66.92 120.68 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 108.171 -1.048 . . . . 0.87 108.171 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -58.41 -59.43 5.37 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.157 0.503 . . . . 2.98 109.958 -178.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 12' ' ' ARG . 6.9 ttp180 -143.74 179.85 6.9 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.333 -0.849 . . . . 5.52 109.039 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.403 ' H ' ' HG2' ' A' ' 12' ' ' ARG . 0.4 OUTLIER -66.23 101.36 0.71 Allowed 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 112.11 0.411 . . . . 3.85 112.11 -178.689 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 128.51 -25.56 4.76 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 120.125 -1.036 . . . . 2.73 115.267 177.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.67 156.34 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 118.938 1.369 . . . . 2.93 113.683 -177.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -80.27 141.75 35.23 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 114.486 -1.233 . . . . 2.09 109.987 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -111.14 -165.4 18.52 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.729 -0.948 . . . . 0.85 110.729 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.45 144.97 99.26 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.821 2.347 . . . . 1.11 111.688 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -90.67 166.92 12.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.261 -0.427 . . . . 1.11 110.736 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.503 ' CZ ' ' O ' ' A' ' 36' ' ' ASP . 63.2 t80 -138.02 91.86 12.91 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.45 111.443 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.39 143.99 99.5 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 122.47 2.113 . . . . 0.89 111.443 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.541 HD21 HD12 ' A' ' 7' ' ' LEU . 83.0 mt -93.46 111.94 23.72 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.165 -0.614 . . . . 1.33 111.232 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.4 m -101.33 -22.82 14.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.817 -0.629 . . . . 1.32 109.341 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 89.4 mt -113.42 144.84 42.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.393 -0.822 . . . . 1.63 110.475 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.0 p -67.04 -16.8 64.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.004 -0.544 . . . . 0.57 110.784 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.5 p -118.28 122.58 43.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.473 -0.33 . . . . 0.52 111.352 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.419 ' SG ' ' CD2' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -105.29 127.59 53.03 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.136 -0.484 . . . . 1.08 110.515 179.306 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.457 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 53.0 tp -118.78 141.47 48.6 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.153 -0.476 . . . . 0.67 110.993 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.545 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 14.7 m-85 -111.03 144.65 39.81 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.804 -0.634 . . . . 0.38 111.199 -178.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.473 ' HA3' ' O ' ' A' ' 46' ' ' LYS . . . 144.03 168.89 12.62 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.169 -1.015 . . . . 0.34 113.142 178.049 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -64.16 -40.53 96.32 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.681 -0.759 . . . . 3.04 111.386 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -48.45 139.08 12.23 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.117 -0.793 . . . . 0.47 111.117 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.6 tt -64.78 -26.48 40.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.206 0.527 . . . . 1.23 109.72 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.1 -16.68 54.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.506 -0.77 . . . . 1.68 110.579 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 15.9 m -78.66 130.72 36.18 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.82 0.343 . . . . 0.42 110.761 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.503 ' O ' ' CZ ' ' A' ' 20' ' ' PHE . 25.7 m-20 -62.58 -36.56 83.07 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 109.061 -0.718 . . . . 1.4 109.061 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.463 ' CG2' ' CE2' ' A' ' 95' ' ' PHE . 3.3 mm -106.34 83.49 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.146 -0.934 . . . . 0.48 109.029 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -66.4 130.11 42.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.016 -0.993 . . . . 2.4 111.412 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 97.3 mt -125.28 127.54 72.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.968 -0.56 . . . . 0.36 110.513 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -97.5 81.17 2.93 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.364 -0.534 . . . . 2.71 110.972 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -156.36 116.3 2.14 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.733 -0.667 . . . . 1.36 109.574 178.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -50.96 -36.78 54.69 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 122.559 2.173 . . . . 0.72 113.225 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.45 ' HB ' HD13 ' A' ' 91' ' ' ILE . 26.9 m -62.89 -39.54 85.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.832 -0.347 . . . . 0.4 111.565 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.1 t -68.57 140.91 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 110.158 -0.312 . . . . 0.43 110.158 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.8 m -82.37 163.95 21.37 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.271 0.471 . . . . 1.22 112.271 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.473 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 98.7 mttt -62.56 -40.8 98.01 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.374 0.607 . . . . 2.09 109.965 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -124.14 56.49 1.25 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.802 -1.184 . . . . 1.55 107.802 178.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.726 ' NE2' HG23 ' A' ' 90' ' ' ILE . 16.9 t60 -60.31 -51.3 70.11 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.576 -1.193 . . . . 0.27 112.256 -177.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.545 ' SG ' ' CD1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -149.55 160.32 43.58 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.597 -0.441 . . . . 1.2 110.887 -179.245 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.608 ' O ' ' N ' ' A' ' 61' ' ' HIS . 70.0 tttt -143.37 131.83 22.26 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.969 -0.559 . . . . 1.39 112.063 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.41 HD11 ' CD1' ' A' ' 88' ' ' ILE . 90.8 mt -105.65 112.89 40.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.893 -0.594 . . . . 0.87 109.609 178.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.423 ' N ' ' O ' ' A' ' 59' ' ' ILE . 81.3 tt0 -95.15 115.1 26.99 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.592 -0.521 . . . . 1.47 109.592 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -78.88 132.67 31.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.593 -0.731 . . . . 1.34 111.683 -178.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.476 ' N ' ' O ' ' A' ' 57' ' ' GLU . 13.2 m-70 -114.05 173.91 6.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.368 -0.833 . . . . 1.96 110.247 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.584 ' O ' ' NH2' ' A' ' 5' ' ' ARG . 80.3 mm-40 -37.75 -42.3 0.57 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.514 -0.766 . . . . 2.29 111.176 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.464 ' HA ' ' NH2' ' A' ' 5' ' ' ARG . 99.3 mt-30 -145.97 13.27 1.29 Allowed 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.757 -0.377 . . . . 2.62 111.886 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.476 ' O ' ' N ' ' A' ' 54' ' ' HIS . 80.3 mm-40 -140.86 151.07 44.03 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 119.918 -0.713 . . . . 2.33 112.866 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.599 ' HB3' ' CE2' ' A' ' 97' ' ' TYR . . . -106.45 128.68 54.25 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 108.027 -1.101 . . . . 0.36 108.027 177.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.423 ' O ' ' N ' ' A' ' 52' ' ' GLU . 41.6 mm -118.4 126.31 74.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.568 -0.453 . . . . 0.66 111.951 -177.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.649 ' CD2' HD13 ' A' ' 76' ' ' ILE . 4.6 tp -78.73 145.73 34.31 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.996 -0.547 . . . . 0.86 110.887 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.608 ' N ' ' O ' ' A' ' 50' ' ' LYS . 33.7 m-70 -137.74 78.64 1.7 Allowed 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.35 0.595 . . . . 0.44 109.577 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -71.46 133.33 45.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.097 -0.956 . . . . 1.15 112.195 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.534 ' CE1' ' O ' ' A' ' 61' ' ' HIS . 14.5 m-85 -108.87 -29.6 8.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.504 -0.771 . . . . 0.39 110.732 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.6 t -64.92 136.82 57.28 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.203 -0.453 . . . . 1.37 111.749 -178.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.9 p -104.08 -54.69 2.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.918 -0.583 . . . . 1.4 110.96 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.29 -46.89 86.74 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.86 0.362 . . . . 1.24 110.532 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.565 ' OD1' ' N ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -118.29 80.59 16.07 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.36 -0.607 . . . . 1.16 109.36 179.298 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -73.5 149.93 45.13 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.463 2.109 . . . . 0.31 112.902 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.465 ' C ' HD12 ' A' ' 76' ' ' ILE . 92.6 m -65.76 162.59 18.39 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.073 -1.084 . . . . 0.29 108.073 178.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.453 ' N ' HG22 ' A' ' 69' ' ' THR . 98.3 mt-30 -130.24 147.19 51.94 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.428 -0.509 . . . . 0.81 112.151 -177.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.972 HG23 HD11 ' A' ' 76' ' ' ILE . 41.9 t -128.8 131.77 68.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.541 -0.754 . . . . 0.91 110.453 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 46.52 29.67 0.95 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.062 -0.517 . . . . 1.18 110.71 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.56 20.16 69.51 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.457 -0.657 . . . . 0.62 111.457 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 71' ' ' VAL . 29.3 t -118.22 130.96 56.38 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.091 -0.337 . . . . 1.36 110.091 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 49.4 t -66.38 143.93 15.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.425 0.631 . . . . 0.79 110.734 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.972 HD11 HG23 ' A' ' 71' ' ' VAL . 70.4 mt -107.59 110.06 30.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 114.871 -1.059 . . . . 0.91 111.361 -178.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -76.51 -43.24 40.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.037 0.446 . . . . 1.9 110.675 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.419 ' O ' HG13 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -142.63 175.29 3.01 Favored Pre-proline 0 C--N 1.332 -0.16 0 CA-C-N 115.618 -0.719 . . . . 1.83 109.489 -179.354 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -51.98 137.89 52.71 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 121.861 1.707 . . . . 0.29 110.99 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.419 HG13 ' O ' ' A' ' 78' ' ' GLU . 17.7 m -134.71 162.78 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 121.293 0.568 . . . . 0.34 112.102 -178.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 6.4 ttt180 -84.98 141.72 30.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.393 -0.821 . . . . 2.49 110.345 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 13.0 mt -112.64 148.02 35.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.367 0.603 . . . . 1.09 112.428 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -107.46 158.98 16.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.978 -1.01 . . . . 2.78 108.789 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 28.2 t60 -64.52 130.11 42.44 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.343 -0.543 . . . . 0.66 110.378 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 94.02 0.19 66.22 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.403 -0.679 . . . . 0.39 111.403 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -67.73 147.01 53.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.743 0.306 . . . . 1.85 110.591 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.4 t -111.97 130.1 66.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.159 -0.473 . . . . 1.22 110.711 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.41 ' CD1' HD11 ' A' ' 51' ' ' ILE . 68.5 mt -108.59 132.46 56.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.245 -0.65 . . . . 0.56 109.245 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.411 ' O ' ' N ' ' A' ' 70' ' ' GLN . 56.0 m -129.23 130.49 46.34 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.114 0.483 . . . . 0.4 111.379 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 1.041 HG22 ' H ' ' A' ' 91' ' ' ILE . 89.9 mt -97.56 -146.55 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 108.292 -1.003 . . . . 0.83 108.292 178.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 1.041 ' H ' HG22 ' A' ' 90' ' ' ILE . 89.5 mt -64.93 -44.16 96.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 118.63 0.65 . . . . 0.57 112.433 -178.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.528 ' OD1' ' O ' ' A' ' 91' ' ' ILE . 82.1 m-20 -142.65 10.17 1.81 Allowed 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.738 0.644 . . . . 1.94 112.738 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 17.3 mtp180 -129.11 158.2 39.61 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.208 -0.597 . . . . 1.93 110.816 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 69.3 m -129.06 145.05 51.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.787 -0.642 . . . . 1.31 111.514 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.463 ' CE2' ' CG2' ' A' ' 37' ' ' ILE . 57.3 m-85 -129.27 146.95 51.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.354 -0.839 . . . . 0.35 109.856 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 78.2 mtp180 -115.8 136.23 53.25 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.21 -0.45 . . . . 2.09 109.877 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.599 ' CE2' ' HB3' ' A' ' 58' ' ' ALA . 0.4 OUTLIER -110.21 106.36 15.76 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.483 -0.562 . . . . 0.48 109.483 179.53 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -117.24 123.83 47.57 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.912 -0.585 . . . . 1.91 112.507 -178.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 63.0 t-20 -110.42 102.15 10.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.296 -0.865 . . . . 1.59 109.487 178.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 . . . . . 0 C--N 1.327 -0.384 0 CA-C-O 121.034 0.445 . . . . 2.71 111.196 -179.384 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.1 mtp . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -154.93 70.49 5.77 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.957 0.408 . . . . 0.0 110.549 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.85 142.9 99.48 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.749 2.3 . . . . 0.0 112.239 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.4 t -145.69 161.22 40.37 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.294 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.532 HH11 HD11 ' A' ' 53' ' ' ILE . 99.5 mtt180 -68.27 138.53 55.58 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -137.34 149.83 47.3 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.051 -0.66 . . . . 0.0 111.365 -178.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 97' ' ' TYR . 67.9 mt -113.31 130.25 56.31 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.033 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.417 HG13 ' CD2' ' A' ' 19' ' ' HIS . 2.6 t -113.7 133.49 59.5 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.357 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.844 HG21 HH21 ' A' ' 93' ' ' ARG . 82.0 m -98.35 109.57 22.31 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.705 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 1.064 HD11 ' HE ' ' A' ' 96' ' ' ARG . 96.4 mt -70.32 128.27 33.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -120.16 152.66 37.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.169 0.509 . . . . 0.0 111.424 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 96.6 mtt-85 50.05 25.72 1.8 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.146 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 35.19 36.28 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.345 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -138.54 -100.82 0.52 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.1 t -72.77 141.25 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-O 120.877 0.37 . . . . 0.0 110.055 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -63.74 138.49 58.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.041 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -101.17 -163.87 27.59 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.49 146.52 94.8 Favored 'Trans proline' 0 C--N 1.302 -1.897 0 C-N-CA 123.282 2.655 . . . . 0.0 111.968 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.417 ' CD2' HG13 ' A' ' 8' ' ' VAL . 7.5 m170 -96.69 174.36 6.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.002 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -134.13 120.65 15.16 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.562 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -73.99 151.89 45.47 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 122.123 1.882 . . . . 0.0 112.487 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.522 ' CD1' ' SG ' ' A' ' 27' ' ' CYS . 47.5 tp -109.48 122.09 46.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.37 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.1 p -130.4 -43.0 1.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.008 0.432 . . . . 0.0 110.458 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.609 ' N ' HD22 ' A' ' 24' ' ' LEU . 3.9 mm? -80.14 140.74 36.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.395 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 77.5 p -66.56 -20.35 66.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.283 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.484 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 7.3 p -120.6 115.05 22.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.724 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.522 ' SG ' ' CD1' ' A' ' 22' ' ' LEU . 1.7 m -98.63 123.32 42.76 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.908 0.385 . . . . 0.0 110.105 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.429 HD21 ' HG2' ' A' ' 47' ' ' GLN . 58.9 tp -114.78 140.36 48.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.742 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.532 ' CE1' HD13 ' A' ' 51' ' ' ILE . 6.9 m-85 -110.24 147.65 33.39 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.774 -177.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 138.4 168.94 11.44 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.752 178.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 77.0 mtp85 -63.85 -40.27 96.18 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.149 -0.526 . . . . 0.0 111.568 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.566 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -46.72 148.81 2.49 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.479 HG23 ' N ' ' A' ' 34' ' ' GLU . 20.1 tt -66.4 -39.33 83.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.479 ' N ' HG23 ' A' ' 33' ' ' ILE . 14.1 pt-20 -54.94 -10.14 0.45 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.903 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.566 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 3.5 m -81.09 120.34 24.7 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.484 ' OD2' ' O ' ' A' ' 26' ' ' THR . 98.7 m-20 -62.09 -34.61 76.63 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.426 HG21 ' CE2' ' A' ' 29' ' ' PHE . 3.4 mm -108.42 83.89 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.596 178.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -66.86 130.6 43.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.372 -177.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.685 HG21 HG21 ' A' ' 44' ' ' VAL . 96.9 mt -122.36 127.23 75.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.081 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.686 ' O ' HD12 ' A' ' 41' ' ' LEU . 94.9 mt-30 -97.99 81.51 2.86 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.632 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.686 HD12 ' O ' ' A' ' 40' ' ' GLN . 0.9 OUTLIER -154.91 118.55 2.51 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.953 179.515 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -52.14 -33.63 54.76 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.725 1.617 . . . . 0.0 112.121 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.566 ' CG2' HD23 ' A' ' 41' ' ' LEU . 29.2 m -64.14 -37.61 80.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.809 -179.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.685 HG21 HG21 ' A' ' 39' ' ' ILE . 64.7 t -74.24 142.04 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.153 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.2 m -82.8 166.44 19.01 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.854 0.359 . . . . 0.0 111.54 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -62.13 -39.23 91.87 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.426 0.632 . . . . 0.0 109.364 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.429 ' HG2' HD21 ' A' ' 28' ' ' LEU . 88.2 mt-30 -125.36 58.28 1.29 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.679 ' NE2' HG23 ' A' ' 90' ' ' ILE . 13.2 t60 -59.74 -50.62 73.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.828 -177.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.653 ' SG ' ' N ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -152.96 165.23 36.19 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.151 -179.625 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.653 ' N ' ' SG ' ' A' ' 49' ' ' CYS . 70.4 tttt -141.59 129.8 22.23 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.836 -179.082 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.532 HD13 ' CE1' ' A' ' 29' ' ' PHE . 1.3 mp -103.68 103.56 15.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.422 178.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 59' ' ' ILE . 78.9 tt0 -86.33 135.56 33.48 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.532 HD11 HH11 ' A' ' 5' ' ' ARG . 4.1 tp -91.82 124.76 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.353 -178.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.546 ' CD2' HD13 ' A' ' 59' ' ' ILE . 14.5 m-70 -113.48 144.02 43.54 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.247 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -36.64 -52.52 0.88 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.081 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 64.1 tp60 -79.83 -38.13 33.57 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.401 ' O ' ' N ' ' A' ' 54' ' ' HIS . 93.6 mt-10 -153.26 -171.16 3.83 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.077 0.465 . . . . 0.0 111.675 -179.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.837 ' C ' HD12 ' A' ' 59' ' ' ILE . . . -107.84 144.78 34.55 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.837 HD12 ' C ' ' A' ' 58' ' ' ALA . 2.0 mp -124.74 134.73 66.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -178.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.617 ' HB2' HD11 ' A' ' 82' ' ' LEU . 8.6 tt -82.07 152.29 26.66 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.979 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.544 ' N ' ' O ' ' A' ' 50' ' ' LYS . 23.8 m-70 -144.4 78.72 1.59 Allowed 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 121.372 0.606 . . . . 0.0 110.378 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -70.62 133.24 46.52 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.032 -0.986 . . . . 0.0 112.728 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.471 ' CE2' ' O ' ' A' ' 61' ' ' HIS . 20.3 m-85 -112.28 -14.26 13.36 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.572 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.3 p -74.04 148.97 41.48 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.814 0.34 . . . . 0.0 111.041 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.4 m -115.11 -59.34 2.03 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.069 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.1 p -64.67 -33.42 75.9 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.457 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.462 ' OD1' ' N ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -127.02 82.1 68.71 Favored Pre-proline 0 C--N 1.332 -0.168 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.356 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -74.81 147.43 34.78 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 121.882 1.721 . . . . 0.0 112.678 -178.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.44 HG22 ' N ' ' A' ' 70' ' ' GLN . 59.6 m -67.38 162.58 22.64 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.44 ' N ' HG22 ' A' ' 69' ' ' THR . 84.7 mt-30 -131.83 147.07 52.46 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.079 -0.648 . . . . 0.0 111.706 -178.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.937 HG23 HD11 ' A' ' 76' ' ' ILE . 22.8 t -127.17 131.91 70.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.122 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 49.51 26.0 1.56 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.237 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.4 -7.69 81.04 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.276 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.509 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 24.2 p -84.71 174.29 10.03 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 54.2 t -108.53 139.86 29.34 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-O 121.552 0.691 . . . . 0.0 109.823 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.937 HD11 HG23 ' A' ' 71' ' ' VAL . 73.3 mt -105.5 116.62 49.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.236 -178.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 21.0 p-10 -110.37 2.31 18.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.25 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.407 ' O ' HG13 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -171.32 169.66 3.06 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.274 -179.417 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.47 138.78 81.21 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 121.511 1.474 . . . . 0.0 111.283 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.407 HG13 ' O ' ' A' ' 78' ' ' GLU . 28.3 m -137.74 157.85 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.136 0.493 . . . . 0.0 112.017 -178.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -81.3 135.91 35.74 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.412 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.617 HD11 ' HB2' ' A' ' 60' ' ' LEU . 75.9 mt -109.03 127.6 54.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.164 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.608 ' N ' ' OD2' ' A' ' 86' ' ' ASP . 98.4 mttt -84.67 159.99 20.45 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.42 178.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.717 ' CE1' ' H ' ' A' ' 99' ' ' ASN . 71.0 t60 -64.86 131.15 45.94 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.568 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.0 8.08 76.39 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.369 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.608 ' OD2' ' N ' ' A' ' 83' ' ' LYS . 91.9 m-20 -72.71 164.44 26.53 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 117.007 0.403 . . . . 0.0 110.455 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.2 p -123.78 133.84 68.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-O 121.108 0.48 . . . . 0.0 111.025 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 88.0 mt -107.72 132.88 54.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.853 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.408 ' O ' ' N ' ' A' ' 70' ' ' GLN . 73.7 m -128.78 127.49 42.1 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.262 0.553 . . . . 0.0 111.59 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 1.034 HG22 ' H ' ' A' ' 91' ' ' ILE . 78.3 mt -97.79 -150.46 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 1.034 ' H ' HG22 ' A' ' 90' ' ' ILE . 86.9 mt -62.71 -44.66 99.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 119.293 0.952 . . . . 0.0 112.987 -178.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -143.47 18.2 1.87 Allowed 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 119.694 -0.802 . . . . 0.0 112.502 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.844 HH21 HG21 ' A' ' 9' ' ' THR . 78.4 mtp180 -136.74 162.31 33.54 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.476 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 57.7 m -132.83 145.72 51.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.774 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -130.8 145.69 52.04 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.852 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 1.064 ' HE ' HD11 ' A' ' 10' ' ' ILE . 89.5 mtt180 -108.56 137.29 46.76 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.302 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.609 ' CZ ' ' HB3' ' A' ' 58' ' ' ALA . 3.2 t80 -117.93 105.73 12.22 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -134.74 140.39 45.9 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 120.397 -0.521 . . . . 0.0 111.362 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.717 ' H ' ' CE1' ' A' ' 84' ' ' HIS . 83.0 m-20 -117.23 124.3 48.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.706 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 C--N 1.33 -0.277 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.115 179.073 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.6 mtp . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.64 ' CD2' ' N ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER 52.17 53.16 12.32 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.305 0.574 . . . . 0.0 111.051 179.885 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 2' ' ' TRP . 44.8 Cg_endo -67.96 -26.6 37.42 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.937 2.425 . . . . 0.0 112.502 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.8 p -132.99 172.51 12.53 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.814 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.666 HH21 ' CG2' ' A' ' 53' ' ' ILE . 86.0 mtm-85 -67.59 147.24 53.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.153 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 63.1 ttm-85 -135.75 142.3 44.95 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.994 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 97' ' ' TYR . 16.4 tp -112.05 132.04 55.06 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.585 HG11 ' HE ' ' A' ' 96' ' ' ARG . 48.6 t -119.22 133.63 65.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.944 0.402 . . . . 0.0 110.885 -178.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.404 ' OG1' ' CE2' ' A' ' 95' ' ' PHE . 98.1 m -104.41 116.44 32.13 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.492 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.624 HG23 ' O ' ' A' ' 15' ' ' VAL . 92.5 mt -79.42 124.41 37.62 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 CA-C-O 121.077 0.465 . . . . 0.0 110.266 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -65.24 -48.84 71.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.881 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.774 ' O ' HG22 ' A' ' 15' ' ' VAL . 36.0 ptt180 -154.55 154.59 33.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.66 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.406 ' O ' HG21 ' A' ' 10' ' ' ILE . 78.7 p 44.39 -127.52 0.99 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.954 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -119.3 67.29 0.39 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.774 HG22 ' O ' ' A' ' 12' ' ' ARG . 33.9 m -129.24 163.62 33.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.831 0.348 . . . . 0.0 110.537 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.427 ' C ' ' OD1' ' A' ' 16' ' ' ASP . 60.9 t0 -81.8 115.54 21.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.241 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -108.01 -152.49 16.88 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -60.89 144.59 99.6 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 122.747 2.298 . . . . 0.0 112.305 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 8.3 m170 -103.18 169.77 8.36 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.962 0.41 . . . . 0.0 110.747 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.596 ' CZ ' ' O ' ' A' ' 36' ' ' ASP . 31.5 t80 -149.69 92.97 4.08 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.367 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -58.3 140.63 95.12 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 121.546 1.497 . . . . 0.0 110.299 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.542 HD13 HG12 ' A' ' 53' ' ' ILE . 94.5 mt -91.48 88.1 6.66 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.947 0.403 . . . . 0.0 111.485 -178.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 70.7 m -90.14 -18.9 24.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.548 178.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.559 HD12 ' OD1' ' A' ' 36' ' ' ASP . 85.7 mt -113.4 139.88 48.53 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.769 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 86.1 p -68.22 -17.86 64.42 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.489 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.448 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 39.6 p -116.61 109.14 16.82 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.993 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.448 ' O ' ' N ' ' A' ' 51' ' ' ILE . 3.4 t -99.59 119.03 37.41 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.147 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.459 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 4.2 tt -116.82 149.86 39.31 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.126 0.489 . . . . 0.0 112.308 -178.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -113.23 138.54 49.84 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.929 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 158.68 167.22 19.15 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 119.432 -1.366 . . . . 0.0 113.155 178.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -65.21 -36.53 84.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.661 -0.769 . . . . 0.0 111.11 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.467 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -59.55 145.21 45.3 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.54 ' C ' ' H ' ' A' ' 35' ' ' CYS . 18.7 tt -66.38 -38.8 82.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.901 0.381 . . . . 0.0 110.13 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.427 ' N ' HG23 ' A' ' 33' ' ' ILE . 22.2 pt-20 -48.0 -11.01 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.967 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.54 ' H ' ' C ' ' A' ' 33' ' ' ILE . 25.4 m -82.4 131.71 35.22 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.051 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.596 ' O ' ' CZ ' ' A' ' 20' ' ' PHE . 56.4 m-20 -62.38 -38.04 88.08 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.9 mm -110.53 87.42 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.704 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -71.43 129.96 40.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.08 -179.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.57 HG21 HG21 ' A' ' 44' ' ' VAL . 96.7 mt -118.3 121.82 68.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.739 179.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.543 ' O ' HD12 ' A' ' 41' ' ' LEU . 86.9 mt-30 -97.19 81.41 3.03 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.559 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.543 HD12 ' O ' ' A' ' 40' ' ' GLN . 1.1 tp -154.83 129.87 5.08 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.065 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -65.27 -21.74 61.4 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 121.745 1.63 . . . . 0.0 112.525 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.53 ' CG2' HD23 ' A' ' 41' ' ' LEU . 33.9 m -71.73 -29.41 34.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.031 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.57 HG21 HG21 ' A' ' 39' ' ' ILE . 95.6 t -85.14 160.64 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 120.924 -0.311 . . . . 0.0 110.203 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.549 ' N ' HG12 ' A' ' 44' ' ' VAL . 7.9 t -98.17 160.89 14.0 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.891 -179.266 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -62.39 -39.77 94.3 Favored 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -122.71 74.69 1.21 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 178.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.742 ' NE2' HG23 ' A' ' 90' ' ' ILE . 24.5 t60 -76.16 -66.92 0.74 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.778 -177.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 21.1 p -155.36 173.06 17.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.423 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -155.84 139.56 16.09 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 119.073 -1.051 . . . . 0.0 112.765 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.555 HD11 ' CD1' ' A' ' 88' ' ' ILE . 88.7 mt -100.02 109.53 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.519 177.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 59' ' ' ILE . 93.8 mt-10 -86.3 120.79 28.03 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.666 ' CG2' HH21 ' A' ' 5' ' ' ARG . 1.5 mp -88.18 125.82 41.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.829 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -110.43 177.3 4.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.202 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -40.19 -45.22 2.0 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.3 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -146.07 21.73 1.4 Allowed 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.631 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.596 ' OE2' ' NH2' ' A' ' 81' ' ' ARG . 90.9 mt-10 -143.26 148.37 36.29 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.517 0.675 . . . . 0.0 112.407 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.469 ' HB1' ' CG2' ' A' ' 51' ' ' ILE . . . -112.44 126.8 55.69 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 177.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.415 ' O ' ' N ' ' A' ' 52' ' ' GLU . 50.3 mm -120.01 130.31 74.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.928 0.394 . . . . 0.0 111.158 -177.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.603 ' HB2' HD11 ' A' ' 82' ' ' LEU . 31.2 tp -90.99 140.28 29.98 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.996 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -135.32 78.4 1.73 Allowed 'General case' 0 C--O 1.231 0.103 0 CA-C-O 121.393 0.616 . . . . 0.0 109.512 178.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.455 ' ND2' ' O ' ' A' ' 64' ' ' SER . 6.6 t30 -62.7 135.93 57.62 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.82 -179.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -105.88 -33.56 7.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.074 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.455 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 16.9 m -66.18 140.72 58.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.492 -177.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.9 p -109.06 -53.5 2.64 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.979 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.0 m -62.99 -45.69 91.22 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.205 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.486 ' OD1' ' N ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -119.62 78.88 21.84 Favored Pre-proline 0 C--N 1.331 -0.23 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.598 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -75.14 147.21 33.11 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.251 1.967 . . . . 0.0 113.7 -178.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.425 ' C ' HD12 ' A' ' 76' ' ' ILE . 85.3 m -63.29 160.8 15.07 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.408 ' N ' HG22 ' A' ' 69' ' ' THR . 82.6 mt-30 -130.1 148.9 52.0 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.755 -177.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.958 HG23 HD11 ' A' ' 76' ' ' ILE . 24.4 t -126.31 127.74 70.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.159 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.411 ' ND2' ' OD1' ' A' ' 86' ' ' ASP . 73.5 m-20 46.68 31.33 1.36 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.225 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 84.04 15.39 69.89 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 121.111 -0.566 . . . . 0.0 111.812 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.2 t -115.41 134.69 54.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.964 0.411 . . . . 0.0 110.63 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 74.8 t -66.77 145.68 13.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.511 0.672 . . . . 0.0 111.007 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.958 HD11 HG23 ' A' ' 71' ' ' VAL . 95.5 mt -110.25 114.1 46.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.205 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -94.87 -27.03 15.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.107 0.48 . . . . 0.0 110.342 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -147.87 171.79 5.92 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.452 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.9 139.46 84.34 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 121.596 1.531 . . . . 0.0 111.169 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 31.5 m -134.7 161.28 40.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.969 0.414 . . . . 0.0 111.35 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.596 ' NH2' ' OE2' ' A' ' 57' ' ' GLU . 72.9 ttt180 -87.82 138.58 31.33 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.737 ' CD2' HD11 ' A' ' 88' ' ' ILE . 5.4 mp -104.08 136.8 43.04 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.042 0.449 . . . . 0.0 111.05 -178.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -96.57 169.97 9.53 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -68.41 131.85 46.02 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 119.949 -0.701 . . . . 0.0 109.995 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.81 18.21 66.11 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.411 ' OD1' ' ND2' ' A' ' 72' ' ' ASN . 28.8 t70 -74.24 149.48 40.78 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.83 0.348 . . . . 0.0 110.771 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 39.6 t -115.6 131.61 67.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.335 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.737 HD11 ' CD2' ' A' ' 82' ' ' LEU . 83.0 mt -118.52 133.88 63.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.977 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 96.5 m -129.83 129.01 43.46 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.774 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 1.039 HG22 ' H ' ' A' ' 91' ' ' ILE . 39.4 mt -94.34 -145.48 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 178.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 1.039 ' H ' HG22 ' A' ' 90' ' ' ILE . 90.2 mt -62.98 -44.55 99.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 118.693 0.678 . . . . 0.0 112.097 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.449 ' OD2' HD21 ' A' ' 41' ' ' LEU . 45.4 p-10 -148.16 17.91 1.08 Allowed 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.246 -0.581 . . . . 0.0 111.624 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.51 ' NE ' HG23 ' A' ' 39' ' ' ILE . 96.6 mtt-85 -123.67 154.46 39.36 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.581 -0.447 . . . . 0.0 110.57 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.5 p -125.24 131.9 53.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.122 0.487 . . . . 0.0 111.475 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.404 ' CE2' ' OG1' ' A' ' 9' ' ' THR . 88.4 m-85 -130.05 145.49 51.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.286 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.585 ' HE ' HG11 ' A' ' 8' ' ' VAL . 20.6 ptt85 -134.54 130.83 37.17 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.476 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.416 ' CE2' ' HB3' ' A' ' 58' ' ' ALA . 2.8 t80 -99.32 127.26 45.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.402 -178.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -142.83 135.85 28.17 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.352 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -119.5 105.45 11.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.107 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.544 ' OE1' ' CD1' ' A' ' 2' ' ' TRP . 98.2 mt-10 . . . . . 0 C--N 1.328 -0.352 0 CA-C-O 120.935 0.398 . . . . 0.0 110.843 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.459 ' O ' ' CG ' ' A' ' 2' ' ' TRP . 98.6 mtp . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.459 ' CG ' ' O ' ' A' ' 1' ' ' MET . 30.5 m95 -167.97 66.47 0.75 Allowed Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -71.09 145.36 49.35 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.79 2.327 . . . . 0.0 112.957 -178.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 65.2 p -120.12 19.66 12.2 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.236 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 -97.74 134.4 40.96 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.637 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -137.43 143.69 41.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.879 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.512 HD12 ' HA ' ' A' ' 97' ' ' TYR . 9.9 tp -109.62 129.87 55.55 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 51.0 t -117.47 139.33 44.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.138 0.494 . . . . 0.0 111.452 -177.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.477 ' OG1' ' CE2' ' A' ' 95' ' ' PHE . 93.7 m -108.65 119.15 38.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.106 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 86.1 mt -81.06 124.74 39.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.854 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.429 ' O ' ' C ' ' A' ' 12' ' ' ARG . 88.1 tttt -75.02 140.48 43.61 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.875 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.429 ' C ' ' O ' ' A' ' 11' ' ' LYS . 80.6 ttt180 37.21 -98.91 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.064 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.406 ' N ' ' O ' ' A' ' 11' ' ' LYS . 13.9 t -163.79 121.88 1.87 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.263 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.72 -18.04 55.6 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.954 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.7 m -122.07 131.15 73.78 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-O 121.262 0.553 . . . . 0.0 111.063 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -68.87 138.2 54.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.243 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -101.52 -163.83 27.25 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -60.33 146.08 97.31 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 C-N-CA 122.959 2.439 . . . . 0.0 112.262 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -95.02 165.86 12.22 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -140.1 89.76 10.93 Favored Pre-proline 0 C--N 1.329 -0.29 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.247 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -57.95 144.73 93.7 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.055 1.837 . . . . 0.0 110.685 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 92.1 mt -93.65 121.64 35.29 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.501 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.494 ' C ' HD12 ' A' ' 24' ' ' LEU . 74.9 p -133.92 -12.97 2.53 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.187 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.501 ' N ' HD12 ' A' ' 24' ' ' LEU . 11.1 mp -104.94 142.17 35.25 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.963 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 57.9 p -65.28 -19.73 66.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.196 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 22.3 p -132.25 129.65 39.9 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.282 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.3 m -103.89 130.56 51.5 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.836 0.35 . . . . 0.0 110.154 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.492 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 44.3 tp -123.83 134.84 53.53 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.314 0.578 . . . . 0.0 111.312 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.451 ' N ' ' CD1' ' A' ' 29' ' ' PHE . 9.0 m-85 -106.41 151.34 25.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.533 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 147.77 159.66 8.52 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 120.052 -1.071 . . . . 0.0 112.805 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -66.91 -40.03 87.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.446 -0.877 . . . . 0.0 111.066 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.452 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -54.86 151.86 14.47 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.2 tt -65.17 -26.81 40.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.873 0.368 . . . . 0.0 111.219 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -59.1 -27.53 65.65 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.503 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 0.5 OUTLIER -69.35 130.99 44.09 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.77 0.319 . . . . 0.0 111.467 -179.345 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.492 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 45.1 m-20 -64.53 -35.51 81.2 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 178.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.0 mm -106.89 80.73 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.221 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -65.84 132.02 47.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.133 0.492 . . . . 0.0 110.729 -178.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 98.1 mt -117.56 125.28 73.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.088 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.53 ' O ' HD22 ' A' ' 41' ' ' LEU . 83.4 mt-30 -90.58 81.72 5.88 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 119.819 -0.752 . . . . 0.0 111.253 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.934 HD12 HG22 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -155.88 110.3 2.14 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.423 178.383 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.582 ' HD2' HD13 ' A' ' 41' ' ' LEU . 71.0 Cg_exo -50.12 -36.56 45.86 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 121.886 1.724 . . . . 0.0 112.933 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.934 HG22 HD12 ' A' ' 41' ' ' LEU . 18.9 m -72.32 9.77 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.189 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.495 HG12 ' N ' ' A' ' 45' ' ' SER . 38.4 t -105.25 161.37 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.495 ' N ' HG12 ' A' ' 44' ' ' VAL . 9.7 t -103.33 153.23 20.66 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.955 -179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.14 -37.69 80.87 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.599 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.508 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 18.6 mp0 -116.3 49.52 1.13 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.712 ' CD2' HG23 ' A' ' 90' ' ' ILE . 10.5 t60 -59.83 -57.25 13.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.019 -177.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.473 ' SG ' ' N ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -141.46 155.45 45.85 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.568 179.618 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.568 ' O ' ' N ' ' A' ' 61' ' ' HIS . 81.5 tttt -141.16 124.25 16.39 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.318 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.617 ' CG2' ' HB1' ' A' ' 58' ' ' ALA . 92.8 mt -106.88 110.99 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.756 179.147 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -84.36 137.26 33.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.848 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.8 mm -107.87 130.82 59.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.3 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.507 ' ND1' ' N ' ' A' ' 55' ' ' GLU . 1.7 p80 -132.52 -167.72 1.94 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.521 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.507 ' N ' ' ND1' ' A' ' 54' ' ' HIS . 94.9 mt-10 -21.09 -68.27 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -176.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -146.17 28.05 1.13 Allowed 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 119.517 -0.873 . . . . 0.0 112.338 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.497 ' OE2' ' O ' ' A' ' 82' ' ' LEU . 79.2 tt0 -154.5 147.86 25.0 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 119.265 -0.974 . . . . 0.0 112.567 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.617 ' HB1' ' CG2' ' A' ' 51' ' ' ILE . . . -92.0 140.75 29.34 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.118 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 29.8 mm -125.98 128.97 72.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.39 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.418 ' HB2' HD11 ' A' ' 82' ' ' LEU . 46.1 tp -77.75 146.1 36.09 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 -178.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.621 ' O ' ' CE1' ' A' ' 63' ' ' PHE . 22.1 m-70 -142.12 78.18 1.61 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.819 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -76.88 139.12 40.14 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.357 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.621 ' CE1' ' O ' ' A' ' 61' ' ' HIS . 5.3 m-85 -109.27 -38.43 5.51 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.925 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.3 t -57.63 136.25 56.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.228 0.537 . . . . 0.0 111.885 -178.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.3 p -100.12 -56.97 2.23 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.911 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.6 p -65.11 -43.14 92.99 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.008 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.614 ' OD1' ' N ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -119.48 79.78 21.62 Favored Pre-proline 0 N--CA 1.463 0.211 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.98 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.436 ' HG2' HG13 ' A' ' 75' ' ' VAL . 83.3 Cg_endo -78.3 151.02 26.03 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 122.65 2.233 . . . . 0.0 113.209 -178.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.6 m -65.95 160.35 23.7 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -124.05 141.72 51.8 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -177.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.493 ' HB ' HD11 ' A' ' 76' ' ' ILE . 54.4 t -128.58 131.73 68.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.498 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 51.57 28.3 4.55 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.33 -2.2 85.47 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.8 m -91.39 154.15 19.38 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.436 HG13 ' HG2' ' A' ' 68' ' ' PRO . 88.2 t -84.21 143.71 11.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.516 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.493 HD11 ' HB ' ' A' ' 71' ' ' VAL . 50.2 mm -102.32 108.52 24.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.729 -179.306 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 41.7 p-10 -101.28 2.62 40.0 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.788 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.463 ' O ' HG13 ' A' ' 80' ' ' VAL . 2.5 pt-20 -179.0 166.21 0.96 Allowed Pre-proline 0 C--N 1.33 -0.26 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.13 137.65 70.34 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.658 1.572 . . . . 0.0 111.427 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 78' ' ' GLU . 32.2 m -137.7 161.27 33.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.158 0.504 . . . . 0.0 110.983 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.441 ' HE ' ' CD ' ' A' ' 57' ' ' GLU . 72.0 ttt180 -82.26 134.93 35.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.817 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.497 ' O ' ' OE2' ' A' ' 57' ' ' GLU . 11.7 mt -108.04 126.46 52.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.87 0.366 . . . . 0.0 110.991 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.406 ' N ' ' OD2' ' A' ' 86' ' ' ASP . 65.3 mttm -92.58 150.31 20.81 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.637 ' CE1' ' H ' ' A' ' 99' ' ' ASN . 6.2 t60 -57.71 136.13 56.84 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.821 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.24 -3.93 66.88 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.406 ' OD2' ' N ' ' A' ' 83' ' ' LYS . 92.9 m-20 -76.95 152.95 35.07 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.9 t -116.49 132.84 64.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.874 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.616 ' CD1' HD11 ' A' ' 51' ' ' ILE . 59.3 mt -108.38 130.32 61.23 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.565 HG23 ' O ' ' A' ' 93' ' ' ARG . 24.4 m -128.67 129.99 46.58 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.091 -178.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.781 HG22 ' H ' ' A' ' 91' ' ' ILE . 9.7 mm -84.56 -147.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.781 ' H ' HG22 ' A' ' 90' ' ' ILE . 86.4 mt -63.91 -44.45 98.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 37.7 p30 -142.73 14.46 1.94 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 120.061 -0.656 . . . . 0.0 112.52 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.565 ' O ' HG23 ' A' ' 89' ' ' THR . 95.3 mtt180 -125.58 148.14 49.04 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.837 0.351 . . . . 0.0 111.121 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.7 t -112.51 126.97 55.9 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.366 0.603 . . . . 0.0 112.111 -178.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.477 ' CE2' ' OG1' ' A' ' 9' ' ' THR . 39.6 m-85 -117.23 131.72 56.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.01 178.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.425 ' H ' ' HG2' ' A' ' 96' ' ' ARG . 3.4 ptm180 -117.75 126.12 51.87 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.252 0.549 . . . . 0.0 111.234 -178.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.553 ' C ' ' CD1' ' A' ' 97' ' ' TYR . 0.2 OUTLIER -101.35 110.38 22.38 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.223 -179.138 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -121.99 136.56 54.93 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.128 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.637 ' H ' ' CE1' ' A' ' 84' ' ' HIS . 56.4 t-20 -123.35 98.29 5.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.573 178.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.242 -179.563 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.2 ttp . . . . . 0 N--CA 1.494 1.76 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -95.53 132.99 26.42 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.844 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.97 154.88 48.09 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.886 2.391 . . . . 0.0 112.685 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.5 p -101.41 4.72 41.65 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.58 0.705 . . . . 0.0 109.597 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.574 HH22 ' C ' ' A' ' 56' ' ' GLN . 99.7 mtt180 -133.37 135.07 44.48 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.359 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.595 ' NE ' ' OE2' ' A' ' 100' ' ' GLU . 87.8 mtm180 -144.2 151.94 40.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.202 0.525 . . . . 0.0 111.28 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.474 HD12 HD11 ' A' ' 37' ' ' ILE . 84.0 mt -112.21 136.64 51.37 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.563 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 54.1 t -120.82 134.82 63.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 57.5 m -106.15 118.69 37.28 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.172 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 73.3 mt -71.77 128.32 34.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.318 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.605 ' O ' ' N ' ' A' ' 13' ' ' SER . 88.0 tttt -86.69 134.24 33.61 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.851 0.358 . . . . 0.0 111.536 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 33.62 25.04 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.015 178.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.605 ' N ' ' O ' ' A' ' 11' ' ' LYS . 0.9 OUTLIER 58.55 9.36 1.08 Allowed 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.945 179.737 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -93.95 -56.76 1.37 Allowed Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.42 ' CG2' ' N ' ' A' ' 16' ' ' ASP . 2.1 p -133.71 157.77 42.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.496 ' O ' ' OD1' ' A' ' 16' ' ' ASP . 50.2 p-10 -61.82 119.41 8.72 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.049 -0.66 . . . . 0.0 109.612 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.88 -164.55 20.54 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.531 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -59.24 144.59 99.33 Favored 'Trans proline' 0 C--N 1.302 -1.911 0 C-N-CA 123.316 2.677 . . . . 0.0 111.807 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -88.24 172.89 9.12 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.43 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.635 ' CZ ' ' O ' ' A' ' 36' ' ' ASP . 82.9 t80 -143.23 90.58 7.28 Favored Pre-proline 0 N--CA 1.45 -0.456 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.745 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -59.55 143.35 99.7 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.185 1.923 . . . . 0.0 111.038 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.6 mt -92.85 121.18 33.96 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.425 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.8 m -112.71 -15.7 12.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.906 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.437 HD23 ' HA ' ' A' ' 24' ' ' LEU . 88.7 mt -122.15 141.19 51.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.033 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 62.5 p -64.04 -19.39 65.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.757 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.9 p -115.49 119.93 37.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.129 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.1 t -109.76 126.23 53.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.0 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.643 HD21 ' HG2' ' A' ' 47' ' ' GLN . 49.9 tp -114.27 139.48 49.38 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.839 -179.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.453 ' CE2' HG21 ' A' ' 37' ' ' ILE . 9.8 m-85 -109.52 144.75 37.37 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.077 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 144.49 171.12 14.19 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.504 178.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -63.69 -38.16 90.06 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.191 -0.504 . . . . 0.0 110.483 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -45.75 136.58 7.81 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.437 HG23 ' N ' ' A' ' 34' ' ' GLU . 20.5 tt -65.25 -36.91 78.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.094 0.473 . . . . 0.0 109.931 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.437 ' N ' HG23 ' A' ' 33' ' ' ILE . 15.6 pt-20 -57.33 -13.24 3.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.107 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.1 m -74.76 130.55 39.67 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 120.803 0.335 . . . . 0.0 110.481 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.635 ' O ' ' CZ ' ' A' ' 20' ' ' PHE . 56.4 m-20 -61.73 -39.64 92.28 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.539 ' CG2' ' CE2' ' A' ' 95' ' ' PHE . 3.8 mm -107.97 86.56 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.36 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -70.91 134.79 47.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.047 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.828 HG21 HG21 ' A' ' 44' ' ' VAL . 98.2 mt -118.99 128.07 75.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.331 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.658 ' O ' HD12 ' A' ' 41' ' ' LEU . 87.5 mt-30 -99.6 79.04 2.22 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.303 0.573 . . . . 0.0 110.681 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.658 HD12 ' O ' ' A' ' 40' ' ' GLN . 0.9 OUTLIER -157.55 127.69 3.39 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.565 179.126 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -63.39 -27.08 70.92 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.338 1.359 . . . . 0.0 112.772 -179.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.484 ' CG2' HD23 ' A' ' 41' ' ' LEU . 34.5 m -66.49 -31.14 52.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.572 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.828 HG21 HG21 ' A' ' 39' ' ' ILE . 99.4 t -75.19 156.61 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.768 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.505 ' N ' HG12 ' A' ' 44' ' ' VAL . 75.2 m -95.12 170.42 9.41 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.295 -179.05 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -61.54 -42.55 98.99 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.402 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.643 ' HG2' HD21 ' A' ' 28' ' ' LEU . 87.1 mt-30 -130.46 68.17 1.47 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.761 ' CD2' HG23 ' A' ' 90' ' ' ILE . 13.4 t60 -66.02 -49.9 66.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.497 -176.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.529 ' SG ' ' N ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -148.12 158.22 43.94 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.674 -0.411 . . . . 0.0 111.017 -179.427 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.589 ' O ' ' N ' ' A' ' 61' ' ' HIS . 69.1 tttt -140.8 129.51 22.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.266 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.602 HD11 ' CD1' ' A' ' 88' ' ' ILE . 91.4 mt -105.95 113.38 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.992 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 59' ' ' ILE . 84.2 tt0 -89.98 112.81 24.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.045 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.1 mp -82.43 127.39 39.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.381 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.508 ' O ' ' NH1' ' A' ' 5' ' ' ARG . 66.8 m-70 -117.65 144.53 45.12 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.192 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -42.18 -19.09 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.587 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.574 ' C ' HH22 ' A' ' 5' ' ' ARG . 64.5 tp60 -111.83 -37.91 5.0 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.196 -0.602 . . . . 0.0 112.327 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.441 ' N ' HH22 ' A' ' 5' ' ' ARG . 71.0 mm-40 -152.2 -174.04 4.75 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.707 0.765 . . . . 0.0 112.49 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.86 ' C ' HD12 ' A' ' 59' ' ' ILE . . . -116.15 135.81 53.58 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 114.33 -1.304 . . . . 0.0 109.488 178.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.86 HD12 ' C ' ' A' ' 58' ' ' ALA . 1.8 mp -126.22 129.85 72.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.267 0.556 . . . . 0.0 112.462 -178.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.687 ' HB2' HD11 ' A' ' 82' ' ' LEU . 7.0 tt -79.38 145.66 33.26 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.41 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.589 ' N ' ' O ' ' A' ' 50' ' ' LYS . 55.5 m-70 -136.35 79.2 1.75 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.24 0.543 . . . . 0.0 110.044 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.698 HD21 ' CB ' ' A' ' 69' ' ' THR . 0.8 OUTLIER -64.36 138.46 58.44 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.428 -179.253 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -112.93 -27.19 8.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.219 178.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.3 p -67.86 157.61 34.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.858 -178.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.3 p -129.76 -53.94 1.15 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.67 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.8 m -63.82 -48.06 78.32 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.63 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.603 ' OD1' ' N ' ' A' ' 67' ' ' ASN . 0.1 OUTLIER -117.89 80.51 14.57 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.729 179.383 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.59 147.49 40.66 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.159 1.906 . . . . 0.0 113.196 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.773 HG23 HD13 ' A' ' 90' ' ' ILE . 88.0 m -65.8 170.33 5.46 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 177.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.563 ' N ' HG22 ' A' ' 69' ' ' THR . 86.5 mt-30 -135.94 152.62 51.17 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.711 -178.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.984 HG23 HD11 ' A' ' 76' ' ' ILE . 20.1 t -127.69 129.65 70.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.395 178.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 47.85 30.37 1.9 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.986 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.52 1.19 87.86 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.7 p -87.92 173.27 9.02 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 122.688 -0.301 . . . . 0.0 110.801 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.4 t -110.16 136.1 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-O 121.506 0.67 . . . . 0.0 109.645 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.984 HD11 HG23 ' A' ' 71' ' ' VAL . 68.6 mt -104.22 116.49 48.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 114.579 -1.191 . . . . 0.0 111.238 -177.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -98.47 -11.5 22.25 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.954 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.502 ' O ' HG13 ' A' ' 80' ' ' VAL . 2.1 mt-10 -165.49 170.91 5.62 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.43 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.49 138.39 74.19 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.377 1.384 . . . . 0.0 110.625 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 78' ' ' GLU . 35.2 m -138.97 160.98 29.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.466 -0.493 . . . . 0.0 110.77 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -76.32 143.84 40.56 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.362 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.687 HD11 ' HB2' ' A' ' 60' ' ' LEU . 67.0 mt -113.86 131.06 56.4 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.31 0.576 . . . . 0.0 112.011 -178.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.631 ' N ' ' OD2' ' A' ' 86' ' ' ASP . 43.5 tttp -89.72 158.95 17.32 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.339 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.541 ' CE1' ' H ' ' A' ' 99' ' ' ASN . 28.7 t60 -71.46 133.98 46.26 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.938 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.88 -7.49 65.03 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.631 ' OD2' ' N ' ' A' ' 83' ' ' LYS . 97.0 m-20 -64.83 154.6 36.63 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.042 0.449 . . . . 0.0 111.261 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.401 ' O ' HG13 ' A' ' 87' ' ' VAL . 8.4 p -123.04 134.23 66.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.728 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.602 ' CD1' HD11 ' A' ' 51' ' ' ILE . 82.4 mt -109.2 133.42 54.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.175 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 63.5 m -127.44 127.74 44.61 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.332 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.849 HG22 ' H ' ' A' ' 91' ' ' ILE . 21.0 mm -87.83 -147.46 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.849 ' H ' HG22 ' A' ' 90' ' ' ILE . 95.9 mt -64.15 -43.98 97.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.862 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.506 ' OD1' ' O ' ' A' ' 91' ' ' ILE . 91.0 m-20 -147.8 19.92 1.15 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 121.266 -0.174 . . . . 0.0 110.969 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -126.05 145.81 50.17 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.517 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.4 m -120.48 135.73 54.98 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 121.141 0.496 . . . . 0.0 112.199 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.539 ' CE2' ' CG2' ' A' ' 37' ' ' ILE . 57.3 m-85 -129.34 151.9 49.48 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.254 178.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -121.19 143.56 49.06 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.537 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.562 ' CE2' ' HB3' ' A' ' 58' ' ' ALA . 0.4 OUTLIER -115.87 102.91 10.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.623 179.611 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -115.3 128.41 56.09 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.145 0.498 . . . . 0.0 111.979 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.541 ' H ' ' CE1' ' A' ' 84' ' ' HIS . 54.5 t-20 -102.23 104.76 15.34 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.725 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.595 ' OE2' ' NE ' ' A' ' 6' ' ' ARG . 99.1 mt-10 . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.053 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mtt . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.582 ' H ' ' CD ' ' A' ' 3' ' ' PRO . 0.4 OUTLIER -105.23 -44.56 0.15 Allowed Pre-proline 0 N--CA 1.463 0.181 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.379 -179.231 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.582 ' CD ' ' H ' ' A' ' 2' ' ' TRP . 32.6 Cg_exo -58.59 142.39 98.25 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.484 2.122 . . . . 0.0 111.909 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 93.2 m -134.5 132.43 39.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.856 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 92.3 mtm-85 -105.51 132.23 51.93 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.768 0.318 . . . . 0.0 110.32 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -141.13 149.74 41.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.92 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.6 mt -110.44 136.57 49.38 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.375 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 50.3 t -118.95 133.74 64.81 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.432 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.502 ' OG1' ' CE2' ' A' ' 95' ' ' PHE . 22.4 m -101.66 112.56 25.17 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.271 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.883 HD11 ' NE ' ' A' ' 96' ' ' ARG . 98.5 mt -69.83 127.64 32.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.947 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 15' ' ' VAL . 65.3 tttm -89.96 129.78 36.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.182 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.551 ' O ' ' C ' ' A' ' 13' ' ' SER . 84.5 mtp180 34.18 91.26 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.551 ' C ' ' O ' ' A' ' 12' ' ' ARG . 2.0 t -7.11 105.48 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.982 0.801 . . . . 0.0 111.515 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 131.27 -59.64 0.69 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.514 ' O ' ' N ' ' A' ' 11' ' ' LYS . 14.5 t -83.52 139.94 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-O 120.97 0.414 . . . . 0.0 111.056 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -94.87 106.74 18.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.584 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.3 -166.06 14.06 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.039 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -59.42 150.77 73.13 Favored 'Trans proline' 0 C--N 1.3 -1.974 0 C-N-CA 123.964 3.11 . . . . 0.0 113.55 -178.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -89.7 163.39 15.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.969 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.502 ' CE2' ' CD1' ' A' ' 37' ' ' ILE . 81.7 t80 -127.62 94.6 37.33 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.593 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -60.2 147.9 91.75 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 122.005 1.803 . . . . 0.0 111.194 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 91.3 mt -97.23 122.81 40.68 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.405 0.621 . . . . 0.0 111.875 -178.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.2 p -117.35 -31.59 5.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.216 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.0 tp -107.15 134.53 50.12 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.548 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.0 p -61.36 -38.15 85.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.511 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.456 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 12.5 p -92.01 108.66 20.1 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.994 -0.282 . . . . 0.0 110.463 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.534 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 1.1 t -90.43 124.99 35.41 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.445 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 52.7 tp -119.19 139.78 51.28 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.186 0.517 . . . . 0.0 111.735 -178.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.534 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 46.6 m-85 -110.24 145.09 37.94 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.466 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 153.51 171.24 20.5 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 119.474 -1.346 . . . . 0.0 112.81 178.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -69.62 -37.71 76.95 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.682 -0.759 . . . . 0.0 111.716 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.52 150.4 34.47 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 121.318 -0.467 . . . . 0.0 112.746 -178.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.6 tp -64.22 -27.76 43.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -58.94 -24.47 62.52 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.683 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.438 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 75.9 m -72.59 130.67 41.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.85 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.456 ' OD2' ' O ' ' A' ' 26' ' ' THR . 88.1 m-20 -61.97 -36.15 80.62 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.538 ' CG2' ' CE2' ' A' ' 95' ' ' PHE . 9.7 mm -109.5 91.57 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 114.178 -1.374 . . . . 0.0 108.695 179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -71.12 140.93 50.77 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.28 -178.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.616 HG21 HG21 ' A' ' 44' ' ' VAL . 96.5 mt -130.78 124.19 56.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.913 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -97.66 78.38 2.62 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 119.868 -0.733 . . . . 0.0 110.612 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.411 ' HA ' HD23 ' A' ' 41' ' ' LEU . 6.6 mt -155.53 114.83 2.26 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.547 179.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -52.44 -31.55 48.57 Favored 'Trans proline' 0 N--CA 1.506 2.24 0 C-N-CA 122.334 2.023 . . . . 0.0 114.233 -179.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.449 HG21 HG21 ' A' ' 91' ' ' ILE . 16.9 m -64.6 -25.02 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.616 HG21 HG21 ' A' ' 39' ' ' ILE . 39.2 t -81.43 161.49 3.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.49 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.513 ' N ' HG12 ' A' ' 44' ' ' VAL . 59.8 m -105.7 156.29 18.42 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.699 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.438 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 98.9 mttt -60.31 -37.83 81.79 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.103 0.478 . . . . 0.0 110.393 -179.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -114.32 49.46 1.01 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.746 ' CD2' HG23 ' A' ' 90' ' ' ILE . 18.8 t60 -57.8 -54.72 43.66 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.094 -177.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.633 ' SG ' ' N ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -152.75 165.31 35.74 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 120.636 -0.425 . . . . 0.0 111.308 -179.284 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.633 ' N ' ' SG ' ' A' ' 49' ' ' CYS . 67.1 tttt -146.74 130.35 16.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.339 -178.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.624 HD11 HD13 ' A' ' 88' ' ' ILE . 82.7 mt -105.03 103.93 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' A' ' 59' ' ' ILE . 81.5 tt0 -79.87 135.46 36.45 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.4 mm -105.0 133.58 48.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.75 0.786 . . . . 0.0 111.78 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.476 ' O ' ' C ' ' A' ' 55' ' ' GLU . 87.8 m-70 -122.31 -177.97 3.76 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.312 -1.313 . . . . 0.0 109.973 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.476 ' C ' ' O ' ' A' ' 54' ' ' HIS . 80.3 mm-40 -29.21 -61.04 0.14 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.956 -178.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -145.09 27.0 1.31 Allowed 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.687 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -138.75 144.84 39.63 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 119.979 -0.688 . . . . 0.0 112.139 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.597 ' HB3' ' CE2' ' A' ' 97' ' ' TYR . . . -106.09 130.02 54.07 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.542 ' O ' ' N ' ' A' ' 52' ' ' GLU . 34.5 mm -120.11 126.77 75.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.734 0.302 . . . . 0.0 111.07 -178.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.569 ' HB2' HD11 ' A' ' 82' ' ' LEU . 9.8 tt -78.74 149.31 32.72 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.194 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.597 ' N ' ' O ' ' A' ' 50' ' ' LYS . 22.2 m-70 -141.75 80.29 1.72 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.366 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.457 ' ND2' ' O ' ' A' ' 64' ' ' SER . 9.0 t30 -72.86 131.98 42.94 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.852 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.41 ' CE1' ' O ' ' A' ' 61' ' ' HIS . 13.7 m-85 -108.11 -27.53 10.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.969 178.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.504 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 30.3 t -58.71 145.36 40.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.709 -179.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.2 m -115.34 -55.86 2.41 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.047 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.9 p -62.99 -38.95 93.22 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.428 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.53 ' OD1' ' N ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -126.65 83.46 64.93 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.046 179.401 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -74.35 146.29 35.34 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 121.445 1.43 . . . . 0.0 113.35 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.503 HG23 HD13 ' A' ' 90' ' ' ILE . 61.6 m -62.67 160.05 14.93 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 177.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -123.82 150.31 44.68 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.624 0.25 . . . . 0.0 110.946 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.68 ' HB ' HD11 ' A' ' 76' ' ' ILE . 4.9 p -135.91 134.13 50.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.343 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.4 m120 50.68 18.83 0.52 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.079 0.466 . . . . 0.0 110.382 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 89.07 16.18 58.1 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 41.6 t -117.02 137.33 52.3 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.195 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 79.6 t -69.84 141.1 17.59 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 CA-C-O 121.18 0.514 . . . . 0.0 110.759 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.68 HD11 ' HB ' ' A' ' 71' ' ' VAL . 79.5 mt -106.52 118.48 54.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.714 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -96.2 -28.37 14.58 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.373 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -151.39 175.4 2.9 Favored Pre-proline 0 N--CA 1.465 0.314 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -56.04 138.63 83.16 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 121.598 1.532 . . . . 0.0 111.691 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.7 m -141.11 160.13 22.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.856 0.36 . . . . 0.0 110.863 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 69.6 ttp85 -84.38 142.74 29.93 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.569 HD11 ' HB2' ' A' ' 60' ' ' LEU . 5.7 mp -116.34 141.26 48.4 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.407 -178.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -90.87 158.79 16.59 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.559 ' CE1' ' H ' ' A' ' 99' ' ' ASN . 36.2 t60 -60.25 133.46 56.12 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.983 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.18 16.25 65.18 Favored Glycine 0 CA--C 1.533 1.156 0 N-CA-C 111.581 -0.607 . . . . 0.0 111.581 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.441 ' C ' ' OD1' ' A' ' 86' ' ' ASP . 45.2 t0 -82.95 120.69 26.02 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.795 0.331 . . . . 0.0 111.024 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 53.4 t -86.57 132.61 31.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 121.267 0.556 . . . . 0.0 111.445 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.624 HD13 HD11 ' A' ' 51' ' ' ILE . 5.7 mt -117.05 137.13 51.95 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 56.9 m -128.42 133.94 48.68 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.25 0.547 . . . . 0.0 112.25 -177.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.924 HG22 ' H ' ' A' ' 91' ' ' ILE . 12.6 mm -91.67 -144.66 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.924 ' H ' HG22 ' A' ' 90' ' ' ILE . 36.2 mm -62.38 -45.31 99.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.972 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.491 ' OD1' ' O ' ' A' ' 91' ' ' ILE . 78.4 m-20 -147.58 14.19 1.08 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.45 ' HD2' HG23 ' A' ' 39' ' ' ILE . 97.0 mtt-85 -122.22 145.71 47.95 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.747 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.6 m -114.53 124.05 50.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.252 0.549 . . . . 0.0 112.088 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.538 ' CE2' ' CG2' ' A' ' 37' ' ' ILE . 56.8 m-85 -113.28 139.64 48.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.636 178.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.883 ' NE ' HD11 ' A' ' 10' ' ' ILE . 45.4 mtt-85 -107.13 139.08 42.11 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.104 -178.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.597 ' CE2' ' HB3' ' A' ' 58' ' ' ALA . 0.7 OUTLIER -109.39 107.5 17.7 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 178.795 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -119.65 138.36 53.31 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.559 ' H ' ' CE1' ' A' ' 84' ' ' HIS . 52.6 t-20 -116.04 97.8 6.28 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.506 178.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.7 tp10 . . . . . 0 C--N 1.33 -0.264 0 CA-C-O 120.869 0.366 . . . . 0.0 110.732 179.682 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.1 mtt . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.593 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -58.66 -43.76 98.25 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.639 -179.882 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 2' ' ' TRP . 37.3 Cg_exo -59.51 141.91 98.1 Favored 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 122.907 2.405 . . . . 0.0 112.408 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.454 HG22 ' N ' ' A' ' 5' ' ' ARG . 54.3 m -147.93 158.22 43.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.287 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.454 ' N ' HG22 ' A' ' 4' ' ' THR . 34.1 ptt180 -125.26 133.02 52.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.929 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 80.2 mtt85 -143.48 156.44 44.63 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.499 -0.481 . . . . 0.0 110.749 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.534 HD12 HD21 ' A' ' 22' ' ' LEU . 90.1 mt -109.03 136.4 48.61 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.885 -0.784 . . . . 0.0 108.885 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.474 HG22 ' CG ' ' A' ' 19' ' ' HIS . 53.4 t -115.45 128.9 72.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.046 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 87.7 m -110.24 120.04 41.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.1 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.535 HD11 ' CD ' ' A' ' 96' ' ' ARG . 14.2 mm -71.1 125.6 29.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.827 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.34 -46.0 90.65 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.176 0.512 . . . . 0.0 110.349 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.521 ' O ' HG22 ' A' ' 10' ' ' ILE . 49.1 ptt85 -143.58 -139.65 0.11 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.24 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.9 t -117.91 100.77 7.79 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.449 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.04 -20.68 4.0 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.229 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.437 ' O ' HG23 ' A' ' 10' ' ' ILE . 3.1 p -133.96 153.04 35.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.264 -0.574 . . . . 0.0 111.698 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.437 ' C ' ' OD1' ' A' ' 16' ' ' ASP . 57.8 t0 -87.24 121.38 29.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.843 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.24 -167.5 42.6 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -61.81 145.65 97.05 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 123.261 2.641 . . . . 0.0 112.28 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.474 ' CG ' HG22 ' A' ' 8' ' ' VAL . 28.2 m170 -87.87 171.15 10.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.222 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.455 ' CD2' HD13 ' A' ' 37' ' ' ILE . 87.1 t80 -134.44 97.01 14.86 Favored Pre-proline 0 C--N 1.33 -0.273 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.162 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -59.34 147.85 89.17 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 122.149 1.9 . . . . 0.0 110.732 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.538 HD13 ' CD1' ' A' ' 53' ' ' ILE . 97.9 mt -104.0 126.88 51.46 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.99 0.424 . . . . 0.0 111.931 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 92.4 p -112.01 -23.22 10.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.459 178.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 97.8 mt -116.17 144.72 43.81 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.219 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 93.5 p -67.81 -19.18 65.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.562 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.9 p -111.12 114.81 28.34 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.482 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.532 ' SG ' HD22 ' A' ' 22' ' ' LEU . 1.1 m -99.44 131.51 45.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.964 0.411 . . . . 0.0 110.82 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.506 HD21 HE22 ' A' ' 47' ' ' GLN . 62.5 tp -120.91 135.61 55.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.463 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.595 ' CE2' HG21 ' A' ' 37' ' ' ILE . 23.9 m-85 -109.49 146.75 34.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.428 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.99 169.95 18.06 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 120.222 -0.99 . . . . 0.0 112.349 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -66.57 -37.14 84.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.164 -0.518 . . . . 0.0 111.845 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.416 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -57.22 149.01 32.17 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.801 -178.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 13.5 tt -70.37 -32.36 49.99 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -53.42 -15.05 0.9 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.672 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.416 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 2.9 m -81.57 134.35 35.49 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.402 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -61.86 -36.47 81.33 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.595 HG21 ' CE2' ' A' ' 29' ' ' PHE . 3.5 mm -108.54 88.75 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 114.942 -1.026 . . . . 0.0 108.967 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -68.63 134.01 49.31 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.503 -178.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.757 HG21 HG21 ' A' ' 44' ' ' VAL . 97.0 mt -121.99 116.88 50.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.747 178.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.686 ' O ' HD22 ' A' ' 41' ' ' LEU . 61.1 tt0 -93.54 81.01 4.32 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.622 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.686 HD22 ' O ' ' A' ' 40' ' ' GLN . 0.3 OUTLIER -155.13 120.0 2.56 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -179.47 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.631 ' HD2' HD13 ' A' ' 41' ' ' LEU . 26.5 Cg_endo -60.9 -25.48 81.43 Favored 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 121.218 1.279 . . . . 0.0 114.082 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.597 HG22 HD12 ' A' ' 41' ' ' LEU . 23.9 m -68.3 -37.15 77.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.814 -0.354 . . . . 0.0 111.396 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.757 HG21 HG21 ' A' ' 39' ' ' ILE . 88.1 t -67.02 159.89 4.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.666 0.269 . . . . 0.0 110.476 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.535 ' N ' HG12 ' A' ' 44' ' ' VAL . 44.2 m -104.92 163.38 12.57 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.544 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -60.46 -41.63 94.53 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.038 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.506 HE22 HD21 ' A' ' 28' ' ' LEU . 97.0 mm-40 -117.16 58.81 0.77 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.73 ' CD2' HG23 ' A' ' 90' ' ' ILE . 13.1 t60 -65.08 -56.29 13.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.324 -177.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.556 ' SG ' ' CD1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -150.72 157.8 43.38 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.354 -179.347 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.551 ' O ' ' N ' ' A' ' 61' ' ' HIS . 29.4 tttp -140.18 127.15 20.79 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.18 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.653 HD11 ' CD1' ' A' ' 88' ' ' ILE . 95.6 mt -105.8 105.28 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.224 178.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 59' ' ' ILE . 83.3 tt0 -85.37 121.18 27.72 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 178.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.538 ' CD1' HD13 ' A' ' 22' ' ' LEU . 67.4 mt -105.22 132.55 51.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -176.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.43 ' O ' ' C ' ' A' ' 55' ' ' GLU . 50.8 m-70 -100.03 -172.67 2.27 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.042 178.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 54' ' ' HIS . 98.8 mt-10 -37.09 -49.83 0.89 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.693 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -146.21 22.83 1.35 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.574 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -131.24 140.76 49.9 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 120.35 -0.54 . . . . 0.0 112.228 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.562 ' HB3' ' CE2' ' A' ' 97' ' ' TYR . . . -102.04 124.76 48.2 Favored 'General case' 0 CA--C 1.526 0.051 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.09 178.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.512 ' O ' ' N ' ' A' ' 52' ' ' GLU . 41.2 mm -117.98 121.05 66.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.663 -178.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.587 ' HB2' HD11 ' A' ' 82' ' ' LEU . 61.2 tp -77.48 148.39 35.38 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.499 0.666 . . . . 0.0 112.146 -179.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.551 ' N ' ' O ' ' A' ' 50' ' ' LYS . 32.8 m-70 -142.39 77.91 1.6 Allowed 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.704 -1.134 . . . . 0.0 109.214 178.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -75.3 127.42 33.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.124 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -98.67 -34.94 10.35 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.722 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.495 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 44.3 t -58.87 142.52 50.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.482 -177.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.9 m -111.7 -55.47 2.5 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.193 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.7 p -64.28 -42.28 96.49 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.916 0.388 . . . . 0.0 110.362 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.584 ' OD1' ' N ' ' A' ' 67' ' ' ASN . 0.3 OUTLIER -121.05 78.79 33.23 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.964 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.15 152.23 39.81 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.102 1.868 . . . . 0.0 112.507 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.412 HG22 ' N ' ' A' ' 70' ' ' GLN . 17.2 m -68.32 162.91 24.18 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.412 ' N ' HG22 ' A' ' 69' ' ' THR . 86.5 mt-30 -127.42 143.43 51.21 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -177.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.623 HG13 ' OD2' ' A' ' 86' ' ' ASP . 45.8 t -128.95 131.54 68.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.011 179.094 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.58 ' ND2' ' OD1' ' A' ' 86' ' ' ASP . 91.0 m-20 45.6 29.07 0.59 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.206 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 87.15 1.58 84.22 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.3 t -101.95 139.84 37.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.914 0.388 . . . . 0.0 110.533 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.6 t -71.76 150.88 8.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.115 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 40.3 mm -108.62 121.9 62.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.483 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 27.9 p-10 -114.26 7.3 16.45 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.811 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 176.41 169.1 0.4 Allowed Pre-proline 0 CA--C 1.531 0.248 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -56.39 137.04 78.76 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.762 1.641 . . . . 0.0 111.705 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.7 m -139.82 161.04 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.431 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -87.33 133.37 33.71 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.587 HD11 ' HB2' ' A' ' 60' ' ' LEU . 6.1 mp -103.66 126.74 50.99 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.162 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 84' ' ' HIS . 88.7 tttt -82.15 139.5 34.31 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.739 ' CE1' ' H ' ' A' ' 99' ' ' ASN . 41.3 t60 -40.71 132.06 2.27 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.716 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.83 1.49 73.42 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.428 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.623 ' OD2' HG13 ' A' ' 71' ' ' VAL . 23.6 t70 -61.96 148.82 42.51 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.077 0.465 . . . . 0.0 110.617 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.51 HG22 ' HG2' ' A' ' 96' ' ' ARG . 40.8 t -111.36 130.07 65.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.088 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.653 ' CD1' HD11 ' A' ' 51' ' ' ILE . 70.9 mt -114.7 132.42 63.91 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 93.3 m -130.25 120.68 24.83 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.501 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.89 HG22 ' H ' ' A' ' 91' ' ' ILE . 9.9 mm -77.57 -146.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.89 ' H ' HG22 ' A' ' 90' ' ' ILE . 95.5 mt -64.96 -44.8 96.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 120.786 -0.365 . . . . 0.0 111.418 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 21.7 p30 -142.8 13.56 1.9 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.483 ' HD2' HG23 ' A' ' 39' ' ' ILE . 98.6 mtt180 -125.98 147.79 49.43 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 120.531 -0.467 . . . . 0.0 111.021 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.16 118.57 35.7 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 121.315 0.579 . . . . 0.0 112.377 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.466 ' N ' ' O ' ' A' ' 88' ' ' ILE . 51.6 m-85 -111.78 140.0 46.79 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.672 178.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.535 ' CD ' HD11 ' A' ' 10' ' ' ILE . 72.0 mtp85 -122.01 140.88 51.94 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.312 -178.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.562 ' CE2' ' HB3' ' A' ' 58' ' ' ALA . 0.5 OUTLIER -114.66 113.1 23.89 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.251 -179.925 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -142.69 139.14 31.04 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 119.916 -0.713 . . . . 0.0 111.928 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.739 ' H ' ' CE1' ' A' ' 84' ' ' HIS . 94.7 m-20 -112.06 146.02 38.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.169 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 . . . . . 0 C--N 1.329 -0.291 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 179.485 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.56 ' O ' ' CE3' ' A' ' 2' ' ' TRP . 64.7 mtt . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.56 ' CE3' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER 56.79 148.54 0.05 OUTLIER Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.151 179.617 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.01 145.3 61.04 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 123.045 2.497 . . . . 0.0 112.59 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.3 m -129.3 92.8 3.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.736 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.472 ' HE ' ' CG1' ' A' ' 53' ' ' ILE . 92.2 mtm-85 -127.99 145.26 51.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.931 0.396 . . . . 0.0 111.407 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.545 ' NH1' ' CG2' ' A' ' 8' ' ' VAL . 67.9 ttp85 -140.3 132.36 27.89 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.168 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.514 HD12 HD21 ' A' ' 22' ' ' LEU . 31.2 mt -104.51 135.19 46.4 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.545 ' CG2' ' NH1' ' A' ' 6' ' ' ARG . 48.8 t -122.23 134.47 65.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.76 0.314 . . . . 0.0 110.209 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.598 ' OG1' ' CE2' ' A' ' 95' ' ' PHE . 92.3 m -113.31 112.94 24.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.97 0.414 . . . . 0.0 111.649 -178.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.944 HD12 ' H ' ' A' ' 10' ' ' ILE . 2.7 mp -79.59 129.98 36.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.498 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.01 -41.08 99.47 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.973 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -143.93 -87.93 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.638 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.8 t -161.56 129.69 4.25 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.452 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.76 4.78 89.52 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.089 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.586 ' O ' HG23 ' A' ' 10' ' ' ILE . 12.7 m -124.7 130.84 73.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 117.038 0.419 . . . . 0.0 110.562 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -75.59 138.49 41.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.507 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -121.54 -174.16 14.71 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.834 -0.907 . . . . 0.0 110.834 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.14 147.86 88.51 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 123.059 2.506 . . . . 0.0 111.962 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.455 ' CG ' ' NH1' ' A' ' 6' ' ' ARG . 3.9 m-70 -101.17 153.7 19.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.919 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -118.35 90.87 39.65 Favored Pre-proline 0 N--CA 1.454 -0.229 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.571 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.54 144.65 99.37 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.473 2.116 . . . . 0.0 110.953 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.534 ' CD2' ' SG ' ' A' ' 27' ' ' CYS . 96.5 mt -96.38 126.38 41.54 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.481 -0.487 . . . . 0.0 111.276 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.6 m -122.4 -9.93 8.49 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.048 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.9 mt -126.92 148.43 50.04 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.314 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.6 p -70.87 -16.14 62.68 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.129 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 65.1 p -118.65 114.22 22.41 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.488 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.534 ' SG ' ' CD2' ' A' ' 22' ' ' LEU . 0.8 OUTLIER -98.51 131.97 44.32 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.257 178.666 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.461 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 59.8 tp -120.12 135.65 54.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.25 0.548 . . . . 0.0 111.583 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.471 ' CZ ' HD12 ' A' ' 37' ' ' ILE . 11.3 m-85 -103.7 144.66 31.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.989 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 150.4 151.62 5.59 Favored Glycine 0 C--O 1.224 -0.491 0 C-N-CA 120.429 -0.891 . . . . 0.0 110.956 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -70.81 -18.45 62.74 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.731 -178.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.51 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -69.99 153.34 52.03 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.433 HD12 ' HA ' ' A' ' 33' ' ' ILE . 10.7 tp -64.58 -30.28 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -54.57 -20.47 7.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.977 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.51 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 1.7 m -84.49 126.75 33.57 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.269 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.461 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 56.5 m-20 -63.25 -40.11 96.49 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.471 HD12 ' CZ ' ' A' ' 29' ' ' PHE . 0.8 OUTLIER -101.55 84.56 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-N 115.085 -0.961 . . . . 0.0 108.679 177.806 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -67.98 134.76 51.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.609 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 92.2 mt -121.74 126.0 74.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.256 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.586 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 52.6 tt0 -86.97 82.18 7.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.012 0.434 . . . . 0.0 111.753 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.528 HD12 ' O ' ' A' ' 40' ' ' GLN . 1.1 tp -155.2 127.48 3.96 Favored Pre-proline 0 CA--C 1.531 0.235 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.62 -11.42 29.68 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 121.73 1.62 . . . . 0.0 112.741 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.4 m -95.78 3.18 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 120.746 0.308 . . . . 0.0 111.307 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.526 HG22 HG21 ' A' ' 90' ' ' ILE . 16.4 t -100.45 136.76 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.339 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.7 m -77.89 159.7 28.74 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.97 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.485 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 98.4 mttt -62.15 -35.75 79.74 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.075 0.464 . . . . 0.0 109.915 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -124.82 57.09 1.28 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 178.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.683 ' CD2' HG23 ' A' ' 90' ' ' ILE . 17.7 t60 -60.91 -50.67 72.47 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.969 -177.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -152.49 169.52 22.42 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.816 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 61' ' ' HIS . 27.0 tttp -147.54 134.29 20.02 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.401 -0.52 . . . . 0.0 112.359 -178.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.587 HD11 HD12 ' A' ' 88' ' ' ILE . 89.7 mt -105.59 106.6 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 59' ' ' ILE . 86.8 tt0 -87.58 117.01 26.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.626 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.472 ' CG1' ' HE ' ' A' ' 5' ' ' ARG . 1.0 OUTLIER -86.36 129.8 37.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.153 -179.644 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.429 ' O ' ' C ' ' A' ' 55' ' ' GLU . 15.2 m80 -115.15 179.09 4.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.755 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 54' ' ' HIS . 78.3 mm-40 -33.62 -59.63 0.39 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.887 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -139.26 27.92 2.3 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.81 -178.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.7 tp10 -152.6 151.67 30.92 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.429 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.848 ' C ' HD12 ' A' ' 59' ' ' ILE . . . -109.98 135.87 50.15 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.249 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.848 HD12 ' C ' ' A' ' 58' ' ' ALA . 1.9 mp -123.99 133.57 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 120.848 0.356 . . . . 0.0 111.665 -178.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.698 HD12 HD13 ' A' ' 88' ' ' ILE . 6.4 tt -87.32 151.48 23.07 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.033 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.526 ' N ' ' O ' ' A' ' 50' ' ' LYS . 47.9 m-70 -143.03 78.54 1.61 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.76 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -66.65 133.25 49.87 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.514 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -109.81 -29.52 8.27 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.549 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.9 t -65.84 135.72 55.22 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.98 0.419 . . . . 0.0 111.703 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.0 p -101.89 -54.07 2.8 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.742 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 32.8 p -62.39 -44.15 97.14 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.555 ' OD1' ' N ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -121.78 81.47 41.43 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.547 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -74.8 148.87 36.84 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.221 1.948 . . . . 0.0 113.3 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 51.3 m -64.12 158.34 23.11 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -125.08 156.17 38.67 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.249 0.547 . . . . 0.0 111.234 -177.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.73 ' HB ' HD11 ' A' ' 76' ' ' ILE . 9.8 p -135.58 137.75 49.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.231 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 46.14 14.96 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.16 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 71' ' ' VAL . . . 101.74 -12.61 57.92 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.797 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.473 ' N ' ' O ' ' A' ' 71' ' ' VAL . 13.4 p -83.04 170.52 14.76 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 74.0 t -99.77 137.32 27.61 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 CA-C-O 121.426 0.631 . . . . 0.0 110.13 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.73 HD11 ' HB ' ' A' ' 71' ' ' VAL . 69.7 mt -103.62 116.59 47.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.792 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -90.24 -40.77 11.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.994 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.83 172.07 7.16 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.138 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.15 140.77 80.92 Favored 'Trans proline' 0 N--CA 1.501 1.931 0 C-N-CA 122.539 2.159 . . . . 0.0 112.436 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 18.8 m -146.0 157.57 12.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.24 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -83.28 136.27 34.44 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.127 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 82' ' ' LEU . 6.4 mp -110.77 139.42 46.08 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.488 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -89.85 153.31 20.75 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -55.9 132.83 50.69 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.905 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 99.99 -7.97 59.14 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -72.27 143.98 48.56 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.4 m -116.33 133.22 63.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.253 0.549 . . . . 0.0 111.605 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.698 HD13 HD12 ' A' ' 60' ' ' LEU . 53.6 mt -103.02 131.83 50.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.517 HG23 ' O ' ' A' ' 93' ' ' ARG . 69.4 m -128.24 128.87 45.5 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.381 -178.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.909 HG22 ' H ' ' A' ' 91' ' ' ILE . 8.0 mm -80.86 -147.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 177.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.909 ' H ' HG22 ' A' ' 90' ' ' ILE . 91.5 mt -64.75 -44.21 96.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.624 178.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -141.65 20.5 2.18 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -178.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.586 ' NH2' ' O ' ' A' ' 40' ' ' GLN . 96.4 mtt180 -136.0 146.23 46.95 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 120.218 -0.593 . . . . 0.0 111.274 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.411 ' HB2' HD13 ' A' ' 10' ' ' ILE . 1.0 OUTLIER -109.19 135.84 49.65 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 121.178 0.513 . . . . 0.0 112.316 -178.989 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.598 ' CE2' ' OG1' ' A' ' 9' ' ' THR . 16.2 m-85 -123.44 136.25 54.51 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.355 -0.838 . . . . 0.0 108.958 177.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.658 ' CD ' HD11 ' A' ' 10' ' ' ILE . 70.7 mtp85 -110.09 130.05 55.6 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.935 0.398 . . . . 0.0 111.602 -178.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.586 ' CE2' ' HB3' ' A' ' 58' ' ' ALA . 0.4 OUTLIER -103.73 108.2 19.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.36 179.096 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -115.6 126.74 54.58 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.604 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -113.24 95.96 5.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.944 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 . . . . . 0 C--N 1.327 -0.385 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.797 -179.478 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.8 mtm . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -42.56 136.04 2.55 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.268 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.02 149.18 64.85 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.055 1.837 . . . . 0.0 112.301 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 95.7 m -125.62 124.89 42.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.483 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.519 ' HE ' HD11 ' A' ' 53' ' ' ILE . 89.3 mtm-85 -128.92 139.25 52.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.637 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -137.9 150.35 47.01 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.666 -0.413 . . . . 0.0 111.038 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.3 mt -112.71 134.72 54.09 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 54.2 t -120.16 133.44 66.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.963 0.411 . . . . 0.0 110.432 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.454 HG21 HH11 ' A' ' 93' ' ' ARG . 54.2 m -99.04 119.12 37.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.825 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.486 HD11 ' HD2' ' A' ' 96' ' ' ARG . 96.2 mt -71.23 135.09 28.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.408 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -66.35 143.64 57.04 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.436 ' O ' ' C ' ' A' ' 13' ' ' SER . 42.7 ttm180 -45.65 119.14 2.04 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.376 -0.529 . . . . 0.0 110.29 -178.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 12' ' ' ARG . 70.0 m 35.28 35.78 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.005 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 12' ' ' ARG . . . -128.9 -126.86 2.9 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.2 m -120.1 -168.6 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.771 0.32 . . . . 0.0 110.613 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -64.34 137.97 58.18 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.01 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -113.58 -152.88 11.0 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.6 143.52 94.62 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.277 1.984 . . . . 0.0 111.418 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -94.24 173.35 7.69 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.043 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -140.21 108.95 6.87 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.827 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.81 152.7 52.93 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.972 1.781 . . . . 0.0 111.861 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.1 mt -100.17 123.28 44.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.41 0.624 . . . . 0.0 110.807 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.3 m -113.76 -59.1 2.06 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.386 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.0 mt -74.37 150.3 40.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.68 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 81.1 p -66.09 -16.98 64.41 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.091 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.4 p -120.68 144.01 48.42 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.827 -179.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -119.83 123.06 42.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.523 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.458 HD21 ' HG2' ' A' ' 47' ' ' GLN . 53.5 tp -114.03 138.62 50.13 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.301 0.572 . . . . 0.0 111.222 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -108.19 142.59 38.2 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.35 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 157.92 165.43 15.43 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 119.518 -1.325 . . . . 0.0 112.506 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.428 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 91.2 mtm180 -66.24 -38.73 88.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.934 -0.633 . . . . 0.0 111.675 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.96 153.17 42.05 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 121.34 -0.457 . . . . 0.0 112.59 -178.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.437 HD12 ' HD2' ' A' ' 38' ' ' ARG . 10.9 tp -67.15 -31.52 53.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.239 -0.48 . . . . 0.0 110.368 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -56.39 -14.6 3.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.643 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.1 m -84.99 135.05 34.19 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.512 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.442 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 95.3 m-20 -62.77 -34.34 77.03 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.486 ' CG2' ' CE2' ' A' ' 95' ' ' PHE . 3.5 mm -107.82 84.42 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.461 HH12 ' CD ' ' A' ' 40' ' ' GLN . 77.6 ttt-85 -67.99 125.8 27.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.601 -178.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.667 HG21 HG21 ' A' ' 44' ' ' VAL . 82.8 mt -113.6 123.91 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.381 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.664 ' O ' HD22 ' A' ' 41' ' ' LEU . 32.5 mt-30 -94.0 77.83 4.11 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.368 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.734 HD12 HG22 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -157.19 111.71 1.9 Allowed Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.129 179.194 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.427 ' HD2' HD13 ' A' ' 41' ' ' LEU . 66.6 Cg_exo -51.47 -31.45 39.07 Favored 'Trans proline' 0 N--CA 1.503 2.051 0 C-N-CA 122.29 1.993 . . . . 0.0 113.939 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.734 HG22 HD12 ' A' ' 41' ' ' LEU . 23.4 m -62.71 -38.94 82.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.669 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.667 HG21 HG21 ' A' ' 39' ' ' ILE . 86.7 t -62.54 149.32 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.4 m -82.48 172.77 12.65 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.615 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -62.01 -39.84 93.63 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.095 0.474 . . . . 0.0 110.002 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.458 ' HG2' HD21 ' A' ' 28' ' ' LEU . 88.4 mt-30 -134.78 69.75 1.45 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 178.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.722 ' NE2' HG23 ' A' ' 90' ' ' ILE . 16.3 t60 -60.28 -51.51 69.25 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.638 -1.164 . . . . 0.0 112.783 -176.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.608 ' SG ' ' N ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -151.97 167.0 29.79 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.744 -179.419 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.608 ' N ' ' SG ' ' A' ' 49' ' ' CYS . 67.8 tttt -145.88 127.48 15.14 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.934 -178.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 93.1 mt -100.17 109.12 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 120.422 -0.511 . . . . 0.0 109.866 178.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.469 ' N ' ' O ' ' A' ' 59' ' ' ILE . 84.4 tt0 -90.14 129.04 36.47 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.519 HD11 ' HE ' ' A' ' 5' ' ' ARG . 2.3 tp -87.88 122.07 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 CA-C-O 121.336 0.589 . . . . 0.0 111.554 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.461 ' N ' ' O ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -95.03 166.32 11.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.903 179.354 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 58.7 mp0 -40.13 -38.31 0.73 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.233 -0.439 . . . . 0.0 112.061 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -141.19 7.67 2.01 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 120.127 -0.629 . . . . 0.0 112.354 -178.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.461 ' O ' ' N ' ' A' ' 54' ' ' HIS . 78.6 mm-40 -146.62 164.99 30.89 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 120.199 -0.6 . . . . 0.0 111.78 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.468 ' HB3' ' CE2' ' A' ' 97' ' ' TYR . . . -105.35 143.25 33.77 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.469 ' O ' ' N ' ' A' ' 52' ' ' GLU . 32.1 mm -129.95 128.43 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.792 -178.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.43 HD22 HD13 ' A' ' 76' ' ' ILE . 1.4 tp -79.53 149.8 31.34 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.101 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' A' ' 50' ' ' LYS . 29.5 m-70 -142.2 78.15 1.61 Allowed 'General case' 0 C--N 1.34 0.162 0 CA-C-O 121.285 0.564 . . . . 0.0 110.075 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -67.94 137.17 54.98 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.237 -179.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.412 ' CE1' ' O ' ' A' ' 61' ' ' HIS . 35.7 m-85 -112.27 -21.82 11.23 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.141 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.3 m -65.87 145.97 55.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.645 -178.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.1 t -117.1 -49.37 2.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.991 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.4 p -71.98 -38.66 69.67 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.901 0.381 . . . . 0.0 110.425 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.48 ' OD1' ' N ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -121.85 79.06 40.66 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.467 179.223 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.87 146.17 71.0 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 121.587 1.525 . . . . 0.0 112.656 -179.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 44.6 m -62.35 145.33 54.17 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.562 -0.745 . . . . 0.0 108.998 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.474 ' O ' ' N ' ' A' ' 89' ' ' THR . 87.7 mt-30 -112.8 130.42 56.09 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.377 0.608 . . . . 0.0 112.577 -177.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.574 HG13 ' OD1' ' A' ' 86' ' ' ASP . 21.7 t -129.98 133.59 64.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.33 178.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 57.45 14.79 2.39 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.92 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.39 -20.31 50.33 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.556 178.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.1 m -84.22 153.83 23.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.128 0.464 . . . . 0.0 110.674 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -84.5 153.54 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.81 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.489 HD11 ' HB ' ' A' ' 71' ' ' VAL . 96.3 mt -119.71 106.12 18.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.935 -178.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -78.35 -38.86 41.04 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.394 178.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -132.33 173.92 5.31 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.57 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.55 142.8 80.75 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.399 2.066 . . . . 0.0 111.766 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.1 m -138.32 160.24 31.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.701 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 59.0 ttt85 -80.16 141.6 35.54 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 120.943 0.401 . . . . 0.0 110.806 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.411 HD11 ' HB2' ' A' ' 60' ' ' LEU . 85.1 mt -109.82 139.28 45.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.305 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -109.88 159.78 16.94 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.187 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 44.7 t60 -64.82 128.89 37.67 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.131 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.74 -2.82 62.47 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.595 ' OD1' ' N ' ' A' ' 87' ' ' VAL . 59.3 t0 -69.38 143.31 53.72 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.595 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 53.9 t -115.45 134.77 57.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.848 0.356 . . . . 0.0 110.823 -178.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 65.1 mt -108.26 131.17 59.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.474 ' N ' ' O ' ' A' ' 70' ' ' GLN . 87.2 m -129.04 127.19 41.06 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.245 0.545 . . . . 0.0 111.113 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 1.047 HG22 ' H ' ' A' ' 91' ' ' ILE . 86.6 mt -97.18 -155.93 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 1.047 ' H ' HG22 ' A' ' 90' ' ' ILE . 96.3 mt -62.29 -43.98 98.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 118.453 0.569 . . . . 0.0 112.308 -178.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.477 ' OD1' ' O ' ' A' ' 91' ' ' ILE . 88.6 m-20 -139.79 2.57 1.98 Allowed 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 119.73 -0.788 . . . . 0.0 113.098 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.454 HH11 HG21 ' A' ' 9' ' ' THR . 62.4 ttm-85 -128.68 146.89 50.75 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.128 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.6 m -122.88 148.2 45.7 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.429 0.633 . . . . 0.0 112.101 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.486 ' CE2' ' CG2' ' A' ' 37' ' ' ILE . 56.8 m-85 -130.36 149.25 52.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.286 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.486 ' HD2' HD11 ' A' ' 10' ' ' ILE . 79.9 mtp85 -118.01 138.69 52.03 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.427 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.468 ' CE2' ' HB3' ' A' ' 58' ' ' ALA . 0.8 OUTLIER -114.47 105.72 13.43 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.456 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -114.8 118.37 33.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.736 -178.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 63.7 t-20 -101.9 101.72 12.19 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.442 ' OE1' ' N ' ' A' ' 100' ' ' GLU . 52.2 mp0 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.528 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.457 ' O ' ' C ' ' A' ' 2' ' ' TRP . 5.2 ptt? . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.457 ' C ' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -32.33 97.73 0.11 Allowed Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.021 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.32 143.66 97.07 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 122.134 1.889 . . . . 0.0 111.706 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.9 t -147.06 159.9 43.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.578 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.4 mtt85 -126.65 150.46 48.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.352 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -133.63 145.49 50.04 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.807 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.2 mt -106.51 130.69 54.25 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.1 t -112.79 133.2 59.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.5 m -108.69 125.48 51.94 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.449 -178.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 82.9 mt -76.17 130.24 36.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.316 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -61.2 -45.41 94.69 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.31 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.604 ' O ' ' N ' ' A' ' 14' ' ' GLY . 77.4 ttt-85 -173.86 82.39 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.174 179.065 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.548 ' O ' ' OG ' ' A' ' 13' ' ' SER . 0.0 OUTLIER 36.21 24.59 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.033 0.444 . . . . 0.0 110.844 178.703 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.604 ' N ' ' O ' ' A' ' 12' ' ' ARG . . . -106.41 -116.94 4.21 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.473 ' O ' ' C ' ' A' ' 16' ' ' ASP . 26.3 m -115.95 131.46 68.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.87 0.367 . . . . 0.0 110.407 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.473 ' C ' ' O ' ' A' ' 15' ' ' VAL . 53.2 m-20 31.74 -148.3 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.501 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 152.89 -158.45 27.9 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.444 -1.063 . . . . 0.0 110.444 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.09 144.75 99.46 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.436 2.09 . . . . 0.0 111.539 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 52.8 m-70 -111.36 164.87 12.47 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.825 0.345 . . . . 0.0 111.145 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -154.08 110.99 2.48 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.049 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.2 151.7 44.13 Favored 'Trans proline' 0 N--CA 1.489 1.21 0 C-N-CA 121.973 1.782 . . . . 0.0 111.457 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 14.0 tp -88.73 75.12 8.25 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.79 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.4 t -72.52 -37.07 68.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.639 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.484 ' HG ' ' H ' ' A' ' 26' ' ' THR . 41.6 tp -106.56 134.65 49.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.631 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.3 p -56.21 -34.54 66.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.708 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.484 ' H ' ' HG ' ' A' ' 24' ' ' LEU . 64.4 p -102.57 131.0 49.6 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.47 179.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.3 m -113.7 130.05 56.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.002 0.429 . . . . 0.0 110.714 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.488 HD23 ' HA ' ' A' ' 35' ' ' CYS . 55.8 tp -117.26 140.36 49.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.819 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.826 ' CE1' HD13 ' A' ' 51' ' ' ILE . 8.6 m-85 -113.39 145.17 41.55 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.858 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 150.61 171.27 18.68 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 119.624 -1.274 . . . . 0.0 113.141 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 91.7 mtm180 -67.25 -42.05 84.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.54 -0.83 . . . . 0.0 112.878 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.33 154.81 44.42 Favored Glycine 0 CA--C 1.523 0.535 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.53 -178.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.41 ' C ' ' N ' ' A' ' 35' ' ' CYS . 19.8 tt -68.16 -29.83 45.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.193 0.521 . . . . 0.0 109.871 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -49.27 -19.33 0.47 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.715 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.488 ' HA ' HD23 ' A' ' 28' ' ' LEU . 34.9 m -81.5 131.88 35.29 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.599 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.447 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 93.3 m-20 -62.16 -36.78 82.9 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.478 ' CG2' ' CE2' ' A' ' 95' ' ' PHE . 4.8 mm -106.45 89.33 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.735 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -67.77 133.98 50.19 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.812 -178.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.62 HG21 HG21 ' A' ' 44' ' ' VAL . 97.5 mt -120.88 124.74 72.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.852 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 65.5 tp60 -96.99 79.85 2.92 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.231 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.9 mt -156.07 110.93 2.11 Favored Pre-proline 0 CA--C 1.536 0.422 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.691 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -50.66 -34.07 42.1 Favored 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 122.293 1.995 . . . . 0.0 112.729 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.0 m -63.56 -33.81 63.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.185 -178.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.62 HG21 HG21 ' A' ' 39' ' ' ILE . 81.1 t -71.11 158.48 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.506 ' N ' HG12 ' A' ' 44' ' ' VAL . 13.5 m -93.54 162.7 13.86 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.675 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -58.45 -39.69 80.57 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.023 0.44 . . . . 0.0 110.095 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -128.44 63.84 1.43 Allowed 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.727 ' NE2' HG23 ' A' ' 90' ' ' ILE . 15.1 t60 -59.65 -50.01 75.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 113.926 -1.488 . . . . 0.0 112.728 -177.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.668 ' SG ' ' N ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -156.62 164.14 38.52 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.133 -179.42 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.668 ' N ' ' SG ' ' A' ' 49' ' ' CYS . 71.0 tttt -144.3 133.17 22.56 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.454 -179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.826 HD13 ' CE1' ' A' ' 29' ' ' PHE . 1.6 mp -108.62 107.45 22.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.23 0.538 . . . . 0.0 110.137 178.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -90.28 129.17 36.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.405 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.8 tp -94.64 133.71 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 CA-C-O 121.164 0.507 . . . . 0.0 111.317 -178.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.439 ' O ' ' C ' ' A' ' 55' ' ' GLU . 10.8 m80 -112.3 -179.44 3.68 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.272 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 54' ' ' HIS . 95.3 mt-10 -35.87 -53.7 0.74 Allowed 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 120.974 -0.291 . . . . 0.0 111.423 -178.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -145.93 28.95 1.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.199 -0.6 . . . . 0.0 111.303 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -150.34 143.65 25.01 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.996 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.89 ' C ' HD12 ' A' ' 59' ' ' ILE . . . -98.71 141.82 31.04 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.89 HD12 ' C ' ' A' ' 58' ' ' ALA . 2.1 mp -127.05 129.24 71.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.364 -178.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.609 HD23 ' N ' ' A' ' 61' ' ' HIS . 8.2 tt -82.7 151.76 26.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.103 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.609 ' N ' HD23 ' A' ' 60' ' ' LEU . 19.8 m-70 -140.61 77.64 1.61 Allowed 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 121.512 0.672 . . . . 0.0 109.416 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.464 ' N ' HD23 ' A' ' 60' ' ' LEU . 3.4 t30 -70.14 136.16 49.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.687 -1.142 . . . . 0.0 112.039 -179.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.515 ' CE1' ' O ' ' A' ' 61' ' ' HIS . 16.7 m-85 -117.14 -21.45 8.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.77 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.0 m -70.46 141.1 52.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.169 0.509 . . . . 0.0 112.286 -178.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.498 ' OG ' ' N ' ' A' ' 66' ' ' THR . 13.8 p -105.75 -59.0 1.83 Allowed 'General case' 0 CA--C 1.526 0.057 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.744 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.498 ' N ' ' OG ' ' A' ' 65' ' ' SER . 65.6 p -66.08 -34.32 77.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.767 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.551 ' ND2' HD11 ' A' ' 91' ' ' ILE . 74.6 m-20 -122.34 77.85 44.54 Favored Pre-proline 0 C--N 1.33 -0.251 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.092 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -70.16 146.94 59.13 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.039 1.826 . . . . 0.0 113.043 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.456 HG22 ' N ' ' A' ' 70' ' ' GLN . 46.1 m -73.63 163.44 28.0 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.456 ' N ' HG22 ' A' ' 69' ' ' THR . 88.2 mt-30 -128.14 146.5 50.69 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.535 -178.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.759 ' HB ' HD11 ' A' ' 76' ' ' ILE . 7.1 p -134.64 137.89 50.42 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 CA-C-O 121.132 0.492 . . . . 0.0 111.316 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.7 m120 46.13 21.46 0.11 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.301 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.42 ' N ' ' C ' ' A' ' 71' ' ' VAL . . . 89.33 13.46 61.67 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 120.89 -0.672 . . . . 0.0 111.862 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.0 t -115.77 138.3 51.26 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.322 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.9 t -68.44 142.44 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.352 0.596 . . . . 0.0 110.454 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.759 HD11 ' HB ' ' A' ' 71' ' ' VAL . 85.0 mt -108.89 113.52 44.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.308 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -98.85 -12.35 20.88 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.938 0.399 . . . . 0.0 110.799 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -159.77 170.64 8.41 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.836 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -56.01 137.92 80.74 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 121.812 1.674 . . . . 0.0 111.343 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.3 m -143.43 161.68 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.137 0.494 . . . . 0.0 111.775 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 71.4 ttp85 -78.27 145.58 35.34 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.154 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.466 HD11 ' HB2' ' A' ' 60' ' ' LEU . 95.3 mt -118.5 149.05 41.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.608 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -107.86 153.81 22.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.61 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.608 ' CE1' ' H ' ' A' ' 99' ' ' ASN . 69.6 t60 -56.89 131.08 48.51 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.474 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.57 4.27 80.13 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.215 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -67.58 145.96 54.36 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 117.324 0.562 . . . . 0.0 110.704 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.751 HG22 ' HG2' ' A' ' 96' ' ' ARG . 56.1 t -112.89 130.76 66.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.654 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 84.5 mt -109.75 136.38 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.547 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 68.9 m -126.8 125.89 42.46 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.221 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 1.113 HG22 ' H ' ' A' ' 91' ' ' ILE . 92.1 mt -97.22 -148.49 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 1.113 ' H ' HG22 ' A' ' 90' ' ' ILE . 84.8 mt -63.75 -44.75 98.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 119.156 0.889 . . . . 0.0 113.312 -178.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.495 ' OD1' ' O ' ' A' ' 91' ' ' ILE . 90.9 m-20 -143.59 2.91 1.26 Allowed 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.682 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -130.26 154.56 47.46 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.242 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 59.4 m -133.27 150.24 51.92 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.206 -0.598 . . . . 0.0 111.993 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.478 ' CE2' ' CG2' ' A' ' 37' ' ' ILE . 41.2 m-85 -129.13 150.41 50.53 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.806 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.751 ' HG2' HG22 ' A' ' 87' ' ' VAL . 79.7 mtp180 -120.38 138.93 53.48 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.393 -179.036 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.626 ' CE2' ' HB3' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -108.41 115.95 31.07 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.376 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.62 133.94 26.21 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.413 0.625 . . . . 0.0 111.371 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.608 ' H ' ' CE1' ' A' ' 84' ' ' HIS . 46.9 p30 -99.13 174.0 6.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.928 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 . . . . . 0 C--N 1.324 -0.534 0 CA-C-O 121.073 0.463 . . . . 0.0 111.284 -179.384 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.3 mtp . . . . . 0 N--CA 1.493 1.684 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.605 ' CG ' ' O ' ' A' ' 2' ' ' TRP . 1.8 t90 175.16 91.28 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.251 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.978 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -61.14 144.64 99.2 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.968 1.779 . . . . 0.0 111.625 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.5 t -148.23 165.7 30.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.689 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.479 ' NE ' ' OD1' ' A' ' 99' ' ' ASN . 84.1 mtt85 -72.0 142.63 49.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.904 0.383 . . . . 0.0 110.721 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.661 ' NH2' ' CG ' ' A' ' 19' ' ' HIS . 16.9 ptm180 -143.49 151.04 39.82 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.095 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.0 mt -111.33 132.77 54.15 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.1 t -120.76 132.91 69.07 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-O 121.456 0.646 . . . . 0.0 110.313 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.58 ' OG1' ' CE2' ' A' ' 95' ' ' PHE . 91.4 m -106.2 118.6 37.04 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.514 -179.123 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.563 HD11 ' HD2' ' A' ' 96' ' ' ARG . 62.1 mt -85.04 113.0 22.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.1 mttm -65.53 -42.56 91.86 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 120.096 -0.642 . . . . 0.0 109.641 179.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -139.21 136.16 34.71 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.203 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.9 t -57.26 132.86 54.29 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.489 -0.485 . . . . 0.0 109.924 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.22 -21.37 39.86 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.264 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.5 m -126.93 129.98 71.35 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 CA-C-O 121.546 0.689 . . . . 0.0 111.553 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 52.1 p-10 -65.56 147.75 52.88 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.408 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -123.2 -162.49 11.51 Favored Glycine 0 CA--C 1.531 1.031 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.3 150.66 47.43 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 122.634 2.222 . . . . 0.0 111.971 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.661 ' CG ' ' NH2' ' A' ' 6' ' ' ARG . 3.1 m170 -97.04 167.6 10.97 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.085 0.469 . . . . 0.0 111.539 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.527 ' CZ ' ' O ' ' A' ' 36' ' ' ASP . 82.1 t80 -137.94 89.51 14.81 Favored Pre-proline 0 N--CA 1.455 -0.188 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.761 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -58.17 145.28 93.28 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.505 2.137 . . . . 0.0 110.928 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.9 mt -85.22 136.34 33.56 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.234 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.17 -38.81 2.87 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.536 HD12 ' OD1' ' A' ' 36' ' ' ASP . 92.9 mt -107.08 143.08 35.73 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.604 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 74.4 p -61.8 -22.84 65.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.575 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.45 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 4.7 p -114.85 124.85 52.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.202 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.7 m -109.91 137.86 47.1 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.69 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 64.5 tp -120.63 141.12 50.64 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.806 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.42 ' CE2' HG21 ' A' ' 37' ' ' ILE . 23.9 m-85 -111.38 131.11 55.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.785 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 161.68 172.68 29.37 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.048 -1.073 . . . . 0.0 112.382 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.692 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 83.6 mtm-85 -66.02 -34.54 78.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.698 -0.751 . . . . 0.0 110.837 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -51.7 142.22 21.29 Favored Glycine 0 CA--C 1.521 0.468 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.676 -178.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.1 tt -69.08 -38.63 78.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.231 0.538 . . . . 0.0 109.698 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -55.54 -14.7 2.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.02 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 86.3 m -73.16 136.07 44.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.967 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.536 ' OD1' HD12 ' A' ' 24' ' ' LEU . 91.8 m-20 -63.87 -38.55 91.5 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.45 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.447 ' CD1' ' CD2' ' A' ' 20' ' ' PHE . 7.1 mm -111.73 91.22 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-N 114.913 -1.039 . . . . 0.0 109.213 179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 90.7 mtm180 -74.5 136.75 42.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.746 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.773 HG21 HG21 ' A' ' 44' ' ' VAL . 96.3 mt -125.65 120.11 56.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.714 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.624 ' H ' HH12 ' A' ' 93' ' ' ARG . 98.4 mt-30 -93.31 79.67 4.44 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 119.499 -0.88 . . . . 0.0 110.527 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.6 mt -156.71 116.41 2.08 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.818 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -50.9 -34.31 45.17 Favored 'Trans proline' 0 N--CA 1.498 1.794 0 C-N-CA 122.128 1.885 . . . . 0.0 112.942 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.518 ' O ' ' CD1' ' A' ' 91' ' ' ILE . 19.4 m -64.9 -28.92 45.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.694 -0.403 . . . . 0.0 112.073 -178.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.773 HG21 HG21 ' A' ' 39' ' ' ILE . 99.6 t -78.45 166.96 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 C-N-CA 119.801 -0.76 . . . . 0.0 109.14 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.653 ' N ' HG12 ' A' ' 44' ' ' VAL . 7.3 t -111.48 152.1 27.84 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.612 -179.016 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -59.07 -42.33 90.11 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.4 mm100 -111.5 60.11 0.62 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 177.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.741 ' CD2' HG23 ' A' ' 90' ' ' ILE . 17.1 t60 -70.94 -67.97 0.47 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.698 -176.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.407 ' SG ' ' HB2' ' A' ' 29' ' ' PHE . 1.7 p -142.09 162.61 35.04 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.6 ' O ' ' N ' ' A' ' 61' ' ' HIS . 37.0 tttm -141.42 131.07 24.06 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.244 -0.583 . . . . 0.0 112.284 -178.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.638 HD11 ' CD1' ' A' ' 88' ' ' ILE . 95.7 mt -104.18 115.85 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-O 121.525 0.679 . . . . 0.0 110.001 177.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.401 ' HB2' ' NZ ' ' A' ' 50' ' ' LYS . 85.4 tt0 -97.31 137.82 35.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.332 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.411 ' O ' ' CG2' ' A' ' 53' ' ' ILE . 1.4 tp -103.42 130.68 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-O 121.326 0.584 . . . . 0.0 111.036 -178.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.469 ' O ' ' C ' ' A' ' 55' ' ' GLU . 41.1 m-70 -108.6 176.73 5.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.455 179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.469 ' C ' ' O ' ' A' ' 54' ' ' HIS . 52.0 tp10 -35.2 -51.86 0.57 Allowed 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.342 -178.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -145.54 36.3 1.08 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.743 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -152.3 149.33 28.55 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.021 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.538 ' HB3' ' CE2' ' A' ' 97' ' ' TYR . . . -109.39 133.96 52.42 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 42.4 mm -123.69 130.59 73.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.973 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.818 HD22 HD13 ' A' ' 76' ' ' ILE . 0.6 OUTLIER -85.74 138.74 31.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.369 0.604 . . . . 0.0 111.022 -179.846 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.6 ' N ' ' O ' ' A' ' 50' ' ' LYS . 41.5 m-70 -126.12 79.61 1.85 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.011 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 64' ' ' SER . 11.3 t30 -71.3 123.34 22.06 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.816 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -98.66 -29.87 12.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.368 0.604 . . . . 0.0 110.154 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.497 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 20.5 p -61.27 149.2 38.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.607 -178.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.2 t -117.01 -58.43 2.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.823 179.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.3 m -62.47 -48.92 77.51 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.446 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.599 ' OD1' ' N ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -112.83 81.77 4.67 Favored Pre-proline 0 C--N 1.329 -0.3 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.015 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -76.79 147.85 27.92 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 122.252 1.968 . . . . 0.0 112.406 -178.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.444 HG22 HD12 ' A' ' 76' ' ' ILE . 7.0 m -66.26 155.09 38.14 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -125.34 153.24 43.62 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.307 0.575 . . . . 0.0 111.877 -177.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 1.003 HG23 HD11 ' A' ' 76' ' ' ILE . 24.6 t -129.94 126.13 61.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.055 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 48.5 32.19 3.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.728 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.59 4.48 82.95 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.426 ' N ' ' O ' ' A' ' 71' ' ' VAL . 5.9 p -90.66 174.11 7.67 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.621 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.5 t -113.84 140.56 33.7 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 1.003 HD11 HG23 ' A' ' 71' ' ' VAL . 76.1 mt -112.03 90.12 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.242 -177.159 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.508 ' O ' ' OE1' ' A' ' 78' ' ' GLU . 74.1 m-20 -65.73 -44.71 85.16 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.112 0.482 . . . . 0.0 110.535 178.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.508 ' OE1' ' O ' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -132.64 174.11 5.09 Favored Pre-proline 0 CA--C 1.529 0.168 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.66 -179.856 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -55.49 141.16 83.11 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.237 1.958 . . . . 0.0 111.359 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.3 m -139.43 164.37 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.126 0.489 . . . . 0.0 111.885 -178.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -89.21 145.48 25.38 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.995 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.482 HD12 ' N ' ' A' ' 82' ' ' LEU . 5.4 mp -117.91 149.89 40.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.059 0.457 . . . . 0.0 110.764 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -109.08 156.57 19.64 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.615 ' CE1' ' H ' ' A' ' 99' ' ' ASN . 5.0 t-80 -50.6 142.24 11.24 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.261 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.473 ' N ' ' ND1' ' A' ' 84' ' ' HIS . . . 80.91 -3.33 76.36 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.523 178.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.547 ' OD1' HG13 ' A' ' 71' ' ' VAL . 66.4 t0 -65.49 141.06 58.61 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.921 0.36 . . . . 0.0 111.068 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.506 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 14.6 p -112.72 128.83 69.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 120.944 0.402 . . . . 0.0 110.993 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.638 ' CD1' HD11 ' A' ' 51' ' ' ILE . 65.0 mt -104.37 130.3 55.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.726 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 88.2 m -120.15 123.13 42.57 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.139 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.821 HG22 ' H ' ' A' ' 91' ' ' ILE . 16.7 mm -79.85 -145.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.214 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.821 ' H ' HG22 ' A' ' 90' ' ' ILE . 90.2 mt -63.11 -44.09 99.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 C-N-CA 119.711 -0.796 . . . . 0.0 111.292 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -145.47 8.64 1.18 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 119.751 -0.779 . . . . 0.0 113.046 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.624 HH12 ' H ' ' A' ' 40' ' ' GLN . 99.4 mtt180 -121.62 151.06 40.83 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.88 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.9 m -112.58 144.45 42.04 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.58 ' CE2' ' OG1' ' A' ' 9' ' ' THR . 32.9 m-85 -133.08 145.72 51.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.532 178.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.563 ' HD2' HD11 ' A' ' 10' ' ' ILE . 71.0 mtp180 -116.66 136.91 52.58 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.715 -178.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.538 ' CE2' ' HB3' ' A' ' 58' ' ' ALA . 0.6 OUTLIER -106.88 100.62 10.11 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.666 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -117.93 129.64 55.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.487 0.661 . . . . 0.0 111.115 -178.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.705 ' C ' HD21 ' A' ' 99' ' ' ASN . 0.2 OUTLIER -117.39 95.36 4.93 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.947 179.72 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 . . . . . 0 C--N 1.329 -0.3 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.032 -179.64 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.3 mtt . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 4.3 m0 -98.18 164.34 17.44 Favored Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -59.63 145.94 96.7 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 121.919 1.746 . . . . 0.0 111.626 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.6 m -118.72 95.03 4.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.161 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.582 ' NH1' ' O ' ' A' ' 54' ' ' HIS . 90.4 mtm180 -132.67 137.93 47.13 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -148.68 153.1 37.79 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.596 -0.441 . . . . 0.0 111.403 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 68.6 mt -112.5 132.25 55.18 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 t -110.66 132.02 60.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 98.9 m -102.27 115.49 30.67 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.168 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.989 HD11 ' HE ' ' A' ' 96' ' ' ARG . 84.2 mt -79.08 133.48 29.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.933 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -59.67 140.47 56.4 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -59.99 -43.38 95.2 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.925 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.0 p -100.58 -3.11 31.2 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.681 -0.408 . . . . 0.0 112.1 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -131.35 -140.89 4.68 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 119.977 -1.106 . . . . 0.0 112.046 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.441 ' O ' ' C ' ' A' ' 16' ' ' ASP . 34.2 m -133.99 160.05 42.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 114.945 -0.627 . . . . 0.0 111.133 -178.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.598 ' OD1' ' NH1' ' A' ' 96' ' ' ARG . 65.7 m-20 36.63 -148.27 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.025 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 138.09 -160.09 25.29 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -58.8 143.47 99.09 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 123.279 2.652 . . . . 0.0 112.094 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -93.68 170.08 9.84 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.612 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.464 ' CD2' HD13 ' A' ' 37' ' ' ILE . 73.4 t80 -140.97 104.56 6.19 Favored Pre-proline 0 N--CA 1.449 -0.508 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.859 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -72.9 154.18 53.22 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.013 1.809 . . . . 0.0 111.892 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.706 ' N ' HD22 ' A' ' 22' ' ' LEU . 2.9 mm? -80.55 76.28 7.4 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.845 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 59.8 m -61.29 -40.45 94.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.733 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.2 mt -113.19 153.59 28.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.537 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 55.1 p -61.48 -24.47 66.6 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.981 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.427 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 17.4 p -120.07 122.82 41.93 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.643 -179.307 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.5 m -97.5 129.96 44.62 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.356 178.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.447 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 61.5 tp -118.44 134.22 55.24 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.241 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.537 ' CZ ' HD12 ' A' ' 51' ' ' ILE . 10.2 m-85 -104.92 145.5 30.32 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.848 -179.135 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 143.73 164.76 10.52 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.755 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.41 ' O ' ' C ' ' A' ' 32' ' ' GLY . 82.2 mtp180 -63.37 -42.84 98.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.264 -0.468 . . . . 0.0 110.249 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 31' ' ' ARG . . . -37.48 139.89 0.43 Allowed Glycine 0 CA--C 1.52 0.373 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.444 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 18.8 tt -64.02 -37.05 78.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.444 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 11.1 pt-20 -57.64 -13.45 3.96 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.764 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 41.5 m -76.03 126.07 30.31 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.666 0.269 . . . . 0.0 111.301 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.447 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 87.2 m-20 -63.82 -39.12 93.48 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 179.057 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.467 HG21 ' CE2' ' A' ' 29' ' ' PHE . 1.4 mm -105.04 76.78 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -65.86 134.36 52.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.702 -178.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.486 HG23 ' NH1' ' A' ' 93' ' ' ARG . 98.0 mt -124.71 130.02 73.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.493 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -98.71 81.8 2.72 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.251 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.7 mt -156.53 115.02 2.07 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.928 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -50.22 -34.77 40.96 Favored 'Trans proline' 0 N--CA 1.504 2.093 0 C-N-CA 122.254 1.97 . . . . 0.0 114.014 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.1 m -66.41 -28.1 42.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -178.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.411 HG21 HG21 ' A' ' 39' ' ' ILE . 94.6 t -78.59 143.71 12.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.867 0.365 . . . . 0.0 110.491 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.8 m -84.19 166.53 17.49 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.993 -178.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.04 -38.04 89.6 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.094 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.512 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 96.5 mt-30 -128.35 59.95 1.5 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 177.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.688 ' NE2' HG23 ' A' ' 90' ' ' ILE . 10.4 t60 -60.81 -49.43 77.5 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.005 -0.998 . . . . 0.0 112.33 -177.33 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.46 ' SG ' ' N ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -150.23 152.71 35.0 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.106 0.479 . . . . 0.0 110.197 -179.674 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' A' ' 61' ' ' HIS . 72.8 tttt -136.34 124.66 23.28 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.974 -179.116 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.537 HD12 ' CZ ' ' A' ' 29' ' ' PHE . 98.4 mt -107.93 108.81 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.745 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -83.76 140.83 31.83 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 50.9 mm -109.94 132.73 57.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.516 0.674 . . . . 0.0 112.046 -177.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.582 ' O ' ' NH1' ' A' ' 5' ' ' ARG . 44.2 m-70 -111.34 178.16 4.42 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.303 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.535 ' OE1' ' N ' ' A' ' 55' ' ' GLU . 55.9 mp0 -35.82 -49.28 0.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.863 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -146.53 25.13 1.22 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.876 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -141.01 147.48 38.76 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.94 -179.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.546 ' HB3' ' CE2' ' A' ' 97' ' ' TYR . . . -109.35 129.93 55.51 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 41.2 mm -119.67 124.29 72.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.549 -177.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.655 HD23 ' N ' ' A' ' 61' ' ' HIS . 6.8 tt -80.21 145.45 32.25 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.827 -179.138 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.655 ' N ' HD23 ' A' ' 60' ' ' LEU . 45.7 m-70 -139.63 79.04 1.7 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.076 -0.966 . . . . 0.0 109.14 179.049 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.457 ' N ' HD23 ' A' ' 60' ' ' LEU . 8.4 t30 -69.32 141.85 54.18 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.729 -178.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.512 ' CD1' ' O ' ' A' ' 47' ' ' GLN . 24.6 m-85 -113.54 -37.47 4.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.659 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 55.9 m -62.37 135.51 57.48 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.377 0.608 . . . . 0.0 112.507 -176.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.5 m -103.23 -50.34 3.5 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.487 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 36.2 p -65.94 -41.63 91.07 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.008 0.432 . . . . 0.0 110.454 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -126.7 80.09 70.85 Favored Pre-proline 0 C--O 1.234 0.264 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -76.27 146.63 28.49 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.391 2.061 . . . . 0.0 112.548 -178.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.53 HG22 ' N ' ' A' ' 70' ' ' GLN . 75.0 m -61.44 167.11 3.51 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.23 178.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.53 ' N ' HG22 ' A' ' 69' ' ' THR . 84.1 mt-30 -134.6 148.35 50.41 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -177.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.961 HG23 HD11 ' A' ' 76' ' ' ILE . 41.4 t -127.23 127.71 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.259 178.071 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.621 ' ND2' ' OD1' ' A' ' 86' ' ' ASP . 84.6 m-20 49.41 29.01 2.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.8 0.334 . . . . 0.0 110.684 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.2 12.15 81.23 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 71' ' ' VAL . 39.2 t -107.55 129.47 54.97 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 99.2 t -66.51 145.63 13.74 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.265 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.961 HD11 HG23 ' A' ' 71' ' ' VAL . 96.3 mt -104.47 100.06 9.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.63 -178.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -70.16 -33.53 71.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.924 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.599 ' O ' HG13 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -154.72 174.64 3.69 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.337 -179.008 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.33 133.74 49.11 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.535 1.49 . . . . 0.0 109.967 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.599 HG13 ' O ' ' A' ' 78' ' ' GLU . 27.7 m -135.51 160.54 39.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 120.325 -0.55 . . . . 0.0 111.329 -178.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -80.16 142.19 34.99 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.576 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 73.5 mt -108.47 143.54 37.29 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.955 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -105.95 164.54 11.88 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 35.3 t60 -65.68 135.38 54.91 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.723 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.93 -2.05 88.5 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.621 ' OD1' ' ND2' ' A' ' 72' ' ' ASN . 27.5 t70 -64.72 148.96 50.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.95 0.405 . . . . 0.0 110.437 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.8 t -118.16 130.65 72.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.24 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.422 ' CD1' HD11 ' A' ' 51' ' ' ILE . 68.2 mt -108.52 132.99 54.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 91.4 m -129.9 122.56 28.86 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -178.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 1.099 HG22 ' H ' ' A' ' 91' ' ' ILE . 94.9 mt -86.39 -153.72 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.239 177.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 1.099 ' H ' HG22 ' A' ' 90' ' ' ILE . 86.3 mt -62.86 -44.2 99.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 119.449 1.022 . . . . 0.0 112.36 -178.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 91' ' ' ILE . 88.2 m-20 -143.86 17.99 1.8 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 121.031 -0.268 . . . . 0.0 111.139 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.486 ' NH1' HG23 ' A' ' 39' ' ' ILE . 35.7 mmm-85 -130.24 145.03 51.7 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.708 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.6 m -125.92 139.77 53.18 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 121.287 0.565 . . . . 0.0 111.973 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -123.78 150.68 44.16 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.779 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.989 ' HE ' HD11 ' A' ' 10' ' ' ILE . 73.3 mtt180 -116.01 134.68 54.7 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.488 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.546 ' CE2' ' HB3' ' A' ' 58' ' ' ALA . 2.6 t80 -116.72 104.75 11.67 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.82 132.68 53.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.202 0.525 . . . . 0.0 112.351 -178.168 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 64.9 t-20 -115.12 104.34 11.77 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.224 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 121.099 0.476 . . . . 0.0 111.665 -178.81 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtm . . . . . 0 N--CA 1.492 1.659 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.614 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -99.79 -43.22 0.22 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.868 0.366 . . . . 0.0 110.993 -179.429 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 2' ' ' TRP . 32.3 Cg_exo -57.98 143.38 96.28 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 123.024 2.483 . . . . 0.0 112.751 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 82.7 p -91.02 -153.58 0.32 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.831 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.52 ' NH1' ' CB ' ' A' ' 99' ' ' ASN . 95.7 mtt-85 -67.09 137.98 56.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.627 -179.092 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.9 ptt-85 -155.31 154.81 32.65 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.926 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.501 HD12 HD11 ' A' ' 37' ' ' ILE . 91.5 mt -109.24 131.89 54.64 Favored 'General case' 0 N--CA 1.461 0.119 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.021 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 77.7 t -114.63 131.19 67.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 99.8 m -101.57 121.83 42.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.142 0.496 . . . . 0.0 111.73 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.485 HD11 ' HD2' ' A' ' 96' ' ' ARG . 87.4 mt -78.87 132.0 33.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.832 179.032 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -63.48 -76.24 0.07 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.392 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -176.88 -26.49 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.352 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.8 m -76.32 -4.27 41.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.883 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.5 31.44 24.72 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 120.372 -0.918 . . . . 0.0 110.998 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.3 m -129.64 162.99 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 121.38 0.61 . . . . 0.0 111.397 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -67.21 138.79 57.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.524 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.91 -155.08 8.28 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -60.37 147.62 93.29 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.166 1.911 . . . . 0.0 110.806 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 5.6 m170 -103.08 167.9 9.53 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.809 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -137.54 109.41 8.7 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.95 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.85 152.34 46.81 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 121.872 1.715 . . . . 0.0 111.685 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 86.9 mt -86.69 82.02 8.02 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.561 -0.455 . . . . 0.0 111.106 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.1 m -62.64 -40.59 97.51 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.906 0.384 . . . . 0.0 110.914 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.401 HD12 ' N ' ' A' ' 24' ' ' LEU . 8.0 mp -107.44 145.92 32.38 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.621 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 89.6 p -55.65 -24.15 32.06 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.895 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.462 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 64.3 p -111.64 128.88 56.19 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.058 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.419 ' SG ' HG13 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -104.09 116.04 31.51 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.614 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.447 HD11 ' OE1' ' A' ' 47' ' ' GLN . 6.7 tt -116.48 144.72 43.97 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.288 0.566 . . . . 0.0 112.031 -178.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -107.51 149.81 27.55 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.076 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.422 ' CA ' ' SG ' ' A' ' 35' ' ' CYS . . . 140.45 164.5 9.93 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.146 -1.026 . . . . 0.0 112.942 178.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 66.2 mtp85 -66.04 -37.84 86.88 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.165 -0.517 . . . . 0.0 110.81 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -47.2 147.16 3.62 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.4 tt -64.22 -29.71 48.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -58.12 -21.66 47.47 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.391 178.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.511 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 56.4 m -69.15 118.15 11.69 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.462 ' OD2' ' O ' ' A' ' 26' ' ' THR . 60.7 m-20 -63.55 -36.71 84.69 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 177.051 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.588 ' CG2' ' CE2' ' A' ' 95' ' ' PHE . 2.5 mm -106.42 78.42 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 114.611 -1.177 . . . . 0.0 108.454 178.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -64.6 128.79 37.27 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.928 -178.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.7 mt -120.55 123.98 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.218 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -88.61 80.62 7.27 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.851 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.559 HD23 ' CG2' ' A' ' 43' ' ' VAL . 2.4 tp -154.94 113.3 2.34 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.266 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -53.36 -32.48 61.93 Favored 'Trans proline' 0 N--CA 1.498 1.783 0 C-N-CA 121.79 1.66 . . . . 0.0 112.711 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.559 ' CG2' HD23 ' A' ' 41' ' ' LEU . 30.6 m -62.81 -43.66 98.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.276 -0.42 . . . . 0.0 112.055 -178.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.632 HG12 ' N ' ' A' ' 45' ' ' SER . 97.6 t -68.46 165.57 2.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.632 ' N ' HG12 ' A' ' 44' ' ' VAL . 3.2 t -101.97 158.89 15.82 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.805 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.511 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 53.0 mtmt -62.08 -38.5 89.05 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.447 ' OE1' HD11 ' A' ' 28' ' ' LEU . 96.5 mm-40 -121.43 64.03 0.89 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 178.11 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.581 ' CD2' HG23 ' A' ' 90' ' ' ILE . 22.5 t60 -68.75 -51.54 40.19 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -176.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.44 ' HB3' ' ND2' ' A' ' 62' ' ' ASN . 28.6 p -171.2 170.2 6.15 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -178.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.437 ' HZ2' ' HZ ' ' A' ' 63' ' ' PHE . 25.5 pttm -153.72 157.16 39.09 Favored 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.762 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.416 ' N ' ' O ' ' A' ' 27' ' ' CYS . 56.9 mt -116.79 111.39 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.082 178.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.469 ' N ' ' O ' ' A' ' 59' ' ' ILE . 96.3 mt-10 -86.14 151.05 23.98 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.746 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.476 HD11 ' HD3' ' A' ' 5' ' ' ARG . 5.2 tp -107.81 128.9 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 CA-C-O 121.421 0.629 . . . . 0.0 110.502 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.407 ' O ' ' C ' ' A' ' 55' ' ' GLU . 22.0 m80 -104.06 -178.29 3.62 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.401 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 54' ' ' HIS . 98.1 mt-10 -39.47 -51.05 2.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.057 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.426 ' C ' ' NH2' ' A' ' 5' ' ' ARG . 35.0 tt0 -146.22 33.85 0.99 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.899 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.442 ' OE2' ' CG ' ' A' ' 81' ' ' ARG . 77.1 tt0 -155.43 154.55 32.09 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 120.394 -0.523 . . . . 0.0 112.081 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.607 ' HB3' ' CZ ' ' A' ' 97' ' ' TYR . . . -106.34 137.83 43.59 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 177.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.469 ' O ' ' N ' ' A' ' 52' ' ' GLU . 25.4 mm -129.2 138.26 54.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.546 -178.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.607 ' HB2' HD11 ' A' ' 82' ' ' LEU . 6.7 tt -99.45 140.0 34.27 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.216 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -130.76 79.63 1.9 Allowed 'General case' 0 C--N 1.342 0.255 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.038 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.707 HD21 ' CB ' ' A' ' 69' ' ' THR . 0.8 OUTLIER -60.4 134.96 57.57 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.739 -1.119 . . . . 0.0 112.392 -179.124 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.437 ' HZ ' ' HZ2' ' A' ' 50' ' ' LYS . 75.6 m-85 -101.85 -34.16 9.51 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.348 178.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.402 ' OG ' ' HA ' ' A' ' 68' ' ' PRO . 14.3 p -65.48 151.63 45.91 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.488 -177.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 m -123.24 -55.02 1.78 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.677 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.1 m -64.18 -47.75 78.61 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.577 ' OD1' ' N ' ' A' ' 67' ' ' ASN . 0.1 OUTLIER -115.14 78.01 5.52 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.754 179.003 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.402 ' HA ' ' OG ' ' A' ' 64' ' ' SER . 82.6 Cg_endo -73.55 147.34 40.58 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 121.355 1.37 . . . . 0.0 112.505 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.707 ' CB ' HD21 ' A' ' 62' ' ' ASN . 22.1 m -67.27 165.76 15.61 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.407 ' N ' HG22 ' A' ' 69' ' ' THR . 82.2 mt-30 -129.17 153.04 48.1 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 119.991 -0.684 . . . . 0.0 112.674 -177.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 1.001 HG23 HD11 ' A' ' 76' ' ' ILE . 14.7 t -126.45 130.79 71.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.999 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 45.51 29.88 0.68 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.593 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 88.31 0.88 82.11 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 121.234 -0.508 . . . . 0.0 112.221 179.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.8 m -100.5 157.61 16.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.347 0.573 . . . . 0.0 110.981 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.2 t -84.11 150.9 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.693 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 1.001 HD11 HG23 ' A' ' 71' ' ' VAL . 95.9 mt -114.71 89.7 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.065 -178.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -65.64 -41.77 92.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.065 0.459 . . . . 0.0 110.883 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.472 ' O ' HG13 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -141.35 174.9 3.41 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.434 -179.531 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.37 140.16 73.49 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 C-N-CA 121.72 1.613 . . . . 0.0 110.971 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.472 HG13 ' O ' ' A' ' 78' ' ' GLU . 33.9 m -138.54 158.53 31.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.251 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.442 ' CG ' ' OE2' ' A' ' 57' ' ' GLU . 40.6 ttm180 -76.29 137.85 40.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.18 -0.463 . . . . 0.0 109.8 178.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.607 HD11 ' HB2' ' A' ' 60' ' ' LEU . 96.1 mt -103.44 127.02 50.9 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 119.716 -0.794 . . . . 0.0 112.662 -178.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.585 ' N ' ' OD2' ' A' ' 86' ' ' ASP . 87.7 tttt -86.8 152.9 22.09 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.671 177.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.563 ' CE1' ' H ' ' A' ' 99' ' ' ASN . 76.1 t60 -64.82 133.18 51.42 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.821 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.03 4.87 64.54 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.585 ' OD2' ' N ' ' A' ' 83' ' ' LYS . 84.5 m-20 -68.59 153.64 43.39 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.221 0.534 . . . . 0.0 111.685 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.0 t -117.54 133.02 65.63 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.64 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.457 HD13 HG22 ' A' ' 71' ' ' VAL . 5.7 mm -110.44 133.38 56.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.015 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.9 m -129.83 132.38 46.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.341 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.845 HG22 ' H ' ' A' ' 91' ' ' ILE . 7.8 mt -107.74 -143.18 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.845 ' H ' HG22 ' A' ' 90' ' ' ILE . 34.4 mm -62.64 -46.02 97.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 91' ' ' ILE . 74.6 m-20 -150.5 16.01 0.8 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 120.814 -0.354 . . . . 0.0 111.304 -178.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 48.6 mmm-85 -131.9 150.27 52.2 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.891 0.377 . . . . 0.0 110.542 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.5 m -128.05 145.83 50.87 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.422 0.63 . . . . 0.0 111.899 -179.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.588 ' CE2' ' CG2' ' A' ' 37' ' ' ILE . 69.9 m-85 -133.84 149.13 51.36 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.801 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.485 ' HD2' HD11 ' A' ' 10' ' ' ILE . 79.1 mtp180 -113.53 142.82 45.49 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.331 -179.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.607 ' CZ ' ' HB3' ' A' ' 58' ' ' ALA . 1.4 t80 -115.41 109.17 17.48 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.731 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.6 mp0 -122.87 132.02 54.0 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.363 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.563 ' H ' ' CE1' ' A' ' 84' ' ' HIS . 27.7 p30 -126.2 143.31 51.19 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.079 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.382 179.825 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.6 mtm . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 3.4 t-105 -154.93 77.45 5.07 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.551 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -61.81 147.92 94.2 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 123.261 2.641 . . . . 0.0 112.186 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.2 p -102.8 10.38 38.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.684 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.472 ' NH1' HG23 ' A' ' 53' ' ' ILE . 99.8 mtt180 -125.22 145.27 50.06 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.499 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -144.96 144.76 31.22 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.576 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.47 HD12 ' O ' ' A' ' 96' ' ' ARG . 8.8 tp -117.85 132.19 56.46 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.581 HG22 ' ND1' ' A' ' 19' ' ' HIS . 61.0 t -125.65 135.59 63.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.073 0.463 . . . . 0.0 110.986 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.2 m -98.11 113.58 25.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.561 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.55 HD11 ' HD2' ' A' ' 96' ' ' ARG . 97.1 mt -76.5 129.65 37.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.951 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -84.04 159.35 21.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.281 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -59.49 -32.74 70.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.837 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.597 ' OG ' HG22 ' A' ' 15' ' ' VAL . 78.4 p -60.11 -20.54 58.77 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.509 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.74 32.6 10.98 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.598 178.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.597 HG22 ' OG ' ' A' ' 13' ' ' SER . 29.6 m -130.68 161.23 40.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 117.029 0.414 . . . . 0.0 110.687 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -65.42 142.51 58.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.555 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.495 ' O ' ' CE1' ' A' ' 19' ' ' HIS . . . -132.33 -157.81 8.73 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -59.79 147.99 90.04 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.933 2.422 . . . . 0.0 111.69 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.581 ' ND1' HG22 ' A' ' 8' ' ' VAL . 8.7 m-70 -110.41 164.45 12.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.825 -179.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -133.98 92.78 21.43 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.813 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.49 143.14 99.77 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 121.924 1.749 . . . . 0.0 110.123 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.408 ' HA ' HD13 ' A' ' 22' ' ' LEU . 1.2 mm? -79.0 83.23 5.11 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.757 -178.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.588 ' C ' HD22 ' A' ' 24' ' ' LEU . 78.5 p -89.42 -11.49 42.99 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.974 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.588 HD22 ' C ' ' A' ' 23' ' ' SER . 4.1 mm? -110.26 150.38 28.79 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.352 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.403 ' O ' ' HB ' ' A' ' 53' ' ' ILE . 91.9 p -61.55 -35.33 77.46 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.565 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 41.8 p -132.08 138.41 48.13 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.182 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.473 ' O ' ' N ' ' A' ' 51' ' ' ILE . 0.1 OUTLIER -97.5 126.76 42.97 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.837 179.904 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.434 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 55.9 tp -117.4 133.43 55.98 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.279 0.561 . . . . 0.0 110.636 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.527 ' CE2' HG21 ' A' ' 37' ' ' ILE . 31.4 m-85 -107.08 148.28 28.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.705 -178.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 154.55 166.26 14.91 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 119.661 -1.257 . . . . 0.0 112.364 178.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.633 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 85.6 mtm-85 -66.89 -37.63 84.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.131 0.491 . . . . 0.0 110.573 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.46 149.61 50.03 Favored Glycine 0 CA--C 1.521 0.448 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.117 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.433 ' C ' ' N ' ' A' ' 35' ' ' CYS . 18.2 tt -66.6 -32.33 57.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -49.12 -14.36 0.08 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.601 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.433 ' N ' ' C ' ' A' ' 33' ' ' ILE . 3.0 m -89.36 134.16 34.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.774 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.434 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 92.5 m-20 -62.35 -36.04 80.99 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.071 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.527 HG21 ' CE2' ' A' ' 29' ' ' PHE . 4.5 mm -106.63 88.94 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -73.19 126.87 31.05 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.935 -178.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.473 HG21 HG21 ' A' ' 44' ' ' VAL . 96.7 mt -117.29 122.87 70.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.875 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -95.6 81.96 3.58 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.089 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.484 HD13 ' HB2' ' A' ' 92' ' ' ASP . 1.0 OUTLIER -155.12 114.57 2.33 Favored Pre-proline 0 CA--C 1.536 0.422 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.017 179.359 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -52.93 -32.15 56.0 Favored 'Trans proline' 0 N--CA 1.499 1.827 0 C-N-CA 121.84 1.693 . . . . 0.0 112.813 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.4 m -64.04 -39.15 84.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.633 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 94.0 t -66.2 164.59 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.599 ' N ' HG12 ' A' ' 44' ' ' VAL . 1.2 m -94.34 165.67 12.46 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.927 -179.321 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -61.81 -38.65 88.91 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.693 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -132.59 65.78 1.57 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 178.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.709 ' NE2' HG23 ' A' ' 90' ' ' ILE . 16.7 t60 -60.21 -54.89 40.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.28 -1.327 . . . . 0.0 112.62 -176.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.416 ' HB2' HD11 ' A' ' 60' ' ' LEU . 0.8 OUTLIER -153.66 163.86 39.26 Favored 'General case' 0 CA--C 1.51 -0.565 0 C-N-CA 120.121 -0.632 . . . . 0.0 111.095 -179.376 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.612 ' O ' ' N ' ' A' ' 61' ' ' HIS . 82.5 tttt -141.83 132.06 24.92 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.088 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.644 HD11 ' CD1' ' A' ' 88' ' ' ILE . 78.6 mt -107.41 110.18 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.072 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' A' ' 59' ' ' ILE . 96.1 mt-10 -86.12 142.58 28.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.453 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.472 HG23 ' NH1' ' A' ' 5' ' ' ARG . 42.5 mm -109.38 130.34 62.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.506 0.669 . . . . 0.0 111.16 -179.222 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -113.55 169.22 9.12 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.846 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -39.4 -40.92 0.88 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -178.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.441 ' HA ' ' NH2' ' A' ' 5' ' ' ARG . 76.6 mt-30 -139.66 7.98 2.34 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 119.76 -0.776 . . . . 0.0 112.667 -178.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -145.18 151.54 38.59 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 119.975 -0.69 . . . . 0.0 112.772 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.496 ' HB3' ' CZ ' ' A' ' 97' ' ' TYR . . . -103.45 141.23 36.33 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 177.381 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.536 ' O ' ' N ' ' A' ' 52' ' ' GLU . 20.7 mm -130.26 130.85 65.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.779 -177.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.416 HD11 ' HB2' ' A' ' 49' ' ' CYS . 53.9 tp -77.91 147.74 34.9 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.374 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.631 ' O ' ' CE1' ' A' ' 63' ' ' PHE . 3.7 m-70 -140.33 78.39 1.65 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -76.43 132.51 39.7 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.46 -178.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.631 ' CE1' ' O ' ' A' ' 61' ' ' HIS . 4.2 m-85 -114.69 -19.4 11.09 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.009 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.501 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 10.6 t -63.98 132.44 50.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.129 0.49 . . . . 0.0 111.648 -177.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.6 p -98.85 -61.02 1.42 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.019 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.0 m -63.5 -46.22 87.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.451 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.501 ' O ' ' OG ' ' A' ' 64' ' ' SER . 11.5 m-20 -110.71 78.45 1.55 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.292 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -70.11 150.68 66.4 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 121.851 1.701 . . . . 0.0 113.098 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.48 HG22 ' N ' ' A' ' 70' ' ' GLN . 32.9 m -68.08 166.3 16.3 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.565 ' O ' ' N ' ' A' ' 89' ' ' THR . 86.5 mt-30 -137.69 128.62 27.25 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.538 -0.465 . . . . 0.0 112.146 -178.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.614 HG13 ' OD1' ' A' ' 86' ' ' ASP . 42.9 t -124.73 132.18 71.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.611 179.022 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 50.98 29.32 4.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.016 0.436 . . . . 0.0 110.373 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.38 21.66 61.96 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.535 178.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.477 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 11.6 p -126.95 128.92 47.17 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.622 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.446 ' H ' HG22 ' A' ' 75' ' ' VAL . 5.0 m -69.57 139.97 19.47 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-O 121.386 0.612 . . . . 0.0 111.119 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.518 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 96.7 mt -120.26 118.76 57.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.091 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -97.16 -12.39 23.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.678 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.518 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.6 OUTLIER -142.09 172.67 5.57 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.767 -179.279 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -60.26 142.54 98.43 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 122.471 2.114 . . . . 0.0 112.61 -179.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.469 HG21 HD13 ' A' ' 76' ' ' ILE . 31.1 m -139.71 161.79 26.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.14 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 76.9 ttt-85 -82.27 138.29 34.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.772 178.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 77.1 mt -101.33 145.65 28.61 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.029 0.442 . . . . 0.0 111.095 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -115.32 156.86 24.7 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.648 ' CE1' ' H ' ' A' ' 99' ' ' ASN . 80.2 t60 -63.86 129.18 39.03 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 120.029 -0.668 . . . . 0.0 110.181 -178.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 92.53 -5.55 77.31 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -178.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.614 ' OD1' HG13 ' A' ' 71' ' ' VAL . 59.7 t0 -65.6 137.56 57.44 Favored 'General case' 0 C--N 1.334 -0.102 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.517 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 43.1 t -112.34 130.28 66.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.167 0.508 . . . . 0.0 111.02 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.644 ' CD1' HD11 ' A' ' 51' ' ' ILE . 72.1 mt -102.36 132.48 48.31 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.565 ' N ' ' O ' ' A' ' 70' ' ' GLN . 87.9 m -128.03 131.5 49.16 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.537 0.684 . . . . 0.0 112.387 -178.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 1.1 HG22 ' H ' ' A' ' 91' ' ' ILE . 89.3 mt -102.86 -159.64 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 114.629 -1.168 . . . . 0.0 108.106 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 1.1 ' H ' HG22 ' A' ' 90' ' ' ILE . 95.9 mt -62.65 -44.92 99.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 118.763 0.711 . . . . 0.0 112.575 -177.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.484 ' HB2' HD13 ' A' ' 41' ' ' LEU . 93.4 m-20 -136.63 9.21 3.11 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.016 -0.673 . . . . 0.0 112.787 -178.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 72.6 mmt-85 -133.46 150.97 51.73 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.914 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.1 m -128.62 147.48 50.73 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.525 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -128.51 145.53 51.09 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.778 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.55 ' HD2' HD11 ' A' ' 10' ' ' ILE . 73.9 mtp85 -109.85 125.27 52.59 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.323 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.496 ' CZ ' ' HB3' ' A' ' 58' ' ' ALA . 11.7 t80 -105.71 97.14 7.01 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -122.22 128.41 51.13 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.21 0.528 . . . . 0.0 112.198 -178.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.648 ' H ' ' CE1' ' A' ' 84' ' ' HIS . 87.8 m-20 -100.44 140.19 35.05 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.408 178.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 . . . . . 0 C--N 1.327 -0.387 0 CA-C-O 121.07 0.462 . . . . 0.0 111.017 -179.705 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.4 mtp . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -80.67 170.29 16.21 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.83 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -56.77 142.36 92.06 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 121.93 1.753 . . . . 0.0 112.427 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 89.6 m -129.75 127.91 41.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.128 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.512 ' O ' HD23 ' A' ' 22' ' ' LEU . 90.0 mtm-85 -120.38 127.89 52.72 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.426 ' O ' ' OE1' ' A' ' 98' ' ' GLU . 86.4 mtm180 -131.35 145.98 52.08 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 120.992 0.425 . . . . 0.0 110.849 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.513 HD12 ' HA ' ' A' ' 97' ' ' TYR . 8.7 tp -110.88 132.28 54.34 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.154 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.454 HG22 ' ND1' ' A' ' 19' ' ' HIS . 50.9 t -118.2 132.43 68.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.301 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.559 ' OG1' ' CE2' ' A' ' 95' ' ' PHE . 92.3 m -108.72 121.72 45.64 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.709 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.648 HD11 ' HD2' ' A' ' 96' ' ' ARG . 89.8 mt -77.71 129.75 37.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.727 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -105.74 -147.79 0.4 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.778 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -70.83 151.27 44.96 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.559 ' O ' ' N ' ' A' ' 15' ' ' VAL . 3.0 m 61.71 145.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -178.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.42 50.16 0.07 OUTLIER Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.559 ' N ' ' O ' ' A' ' 13' ' ' SER . 36.0 m -121.2 155.89 24.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.036 0.446 . . . . 0.0 110.711 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -66.31 141.48 57.98 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.927 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -109.39 -162.75 19.78 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.24 153.55 40.72 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.766 2.31 . . . . 0.0 111.788 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.454 ' ND1' HG22 ' A' ' 8' ' ' VAL . 6.9 m170 -102.56 166.67 10.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.162 0.506 . . . . 0.0 111.433 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -135.0 96.24 14.58 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.431 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.32 148.21 87.45 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 122.573 2.182 . . . . 0.0 110.943 178.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.676 ' N ' HD22 ' A' ' 22' ' ' LEU . 2.8 mm? -89.36 76.91 7.47 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.986 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.4 p -71.15 -31.37 67.62 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.354 178.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.1 mt -114.43 140.31 48.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.737 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.0 p -66.91 -15.36 63.61 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.703 0.287 . . . . 0.0 111.493 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.5 p -117.77 113.33 21.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.613 0.244 . . . . 0.0 110.921 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.1 m -96.83 127.67 43.04 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.465 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.46 HD23 ' HA ' ' A' ' 35' ' ' CYS . 67.8 tp -114.78 142.05 47.05 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.151 -179.363 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.673 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 65.2 m-85 -112.25 141.52 45.86 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.543 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.577 ' O ' ' N ' ' A' ' 39' ' ' ILE . . . 160.9 -177.62 37.21 Favored Glycine 0 C--O 1.228 -0.275 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.44 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 35.3 ptt-85 -103.82 -3.32 25.05 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.062 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -86.25 162.07 34.78 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.2 tp -65.11 -32.12 56.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.174 0.511 . . . . 0.0 109.954 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -57.01 -21.73 33.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.307 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.46 ' HA ' HD23 ' A' ' 28' ' ' LEU . 2.7 m -82.73 127.71 33.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.345 0.593 . . . . 0.0 112.548 -178.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -62.8 -39.34 93.94 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 177.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.2 mm -105.06 85.36 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 178.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -72.26 137.96 47.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.432 -177.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.577 ' N ' ' O ' ' A' ' 30' ' ' GLY . 95.2 mt -129.31 118.86 47.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.781 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.421 ' HG2' ' H ' ' A' ' 40' ' ' GLN . 1.2 pt20 -77.74 81.26 4.18 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.327 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 41' ' ' LEU . 53.0 mt -154.14 106.73 2.44 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.522 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.43 -33.48 67.23 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 122.235 1.957 . . . . 0.0 111.94 178.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.497 ' HB ' HD13 ' A' ' 91' ' ' ILE . 26.1 m -66.44 -25.26 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.447 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.44 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 86.7 t -87.45 137.78 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.7 m -80.69 155.78 26.61 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.916 0.389 . . . . 0.0 112.016 -178.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -58.0 -38.27 75.82 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -114.7 48.48 1.13 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.687 ' NE2' HG23 ' A' ' 90' ' ' ILE . 14.7 t60 -57.86 -50.01 74.76 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.734 -178.053 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.673 ' SG ' ' CD1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -152.66 159.44 43.19 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.491 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.627 ' O ' ' N ' ' A' ' 61' ' ' HIS . 68.4 tttt -139.22 135.79 34.31 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.904 -179.163 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.53 HD11 HD11 ' A' ' 88' ' ' ILE . 2.3 mm -110.01 103.88 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.874 178.146 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' A' ' 59' ' ' ILE . 78.1 tt0 -83.97 128.55 34.63 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.195 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 49.7 mm -96.08 131.87 41.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.63 0.729 . . . . 0.0 111.281 -178.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.504 ' O ' ' C ' ' A' ' 55' ' ' GLU . 47.6 m-70 -119.55 178.92 4.38 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.725 -178.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.504 ' C ' ' O ' ' A' ' 54' ' ' HIS . 96.5 mt-10 -23.36 -65.87 0.04 OUTLIER 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.444 -179.088 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -140.51 15.03 2.36 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.271 -0.571 . . . . 0.0 111.749 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.574 ' OE1' ' NE ' ' A' ' 81' ' ' ARG . 19.9 pt-20 -134.2 146.96 50.63 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.01 -0.676 . . . . 0.0 111.052 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -99.24 135.81 40.1 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.418 ' O ' ' N ' ' A' ' 52' ' ' GLU . 36.7 mm -119.56 125.84 74.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.179 0.514 . . . . 0.0 111.915 -178.145 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.5 HD11 ' SG ' ' A' ' 49' ' ' CYS . 59.9 tp -77.49 142.03 39.33 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.394 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.627 ' N ' ' O ' ' A' ' 50' ' ' LYS . 41.1 m-70 -137.11 81.3 1.86 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-O 121.554 0.692 . . . . 0.0 110.659 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -74.25 128.35 35.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.631 -1.168 . . . . 0.0 112.758 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -102.38 -38.83 7.43 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.262 178.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.7 t -53.79 138.16 36.37 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.157 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.0 t -107.28 -53.75 2.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.326 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.2 p -60.04 -48.23 82.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.497 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.494 ' OD1' ' N ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -120.21 84.45 34.19 Favored Pre-proline 0 N--CA 1.463 0.203 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.692 179.385 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.504 ' HG2' HG13 ' A' ' 75' ' ' VAL . 95.7 Cg_endo -74.82 146.03 32.93 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.038 1.825 . . . . 0.0 113.392 -178.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.4 m -61.87 154.32 26.42 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.651 178.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' A' ' 89' ' ' THR . 86.1 mt-30 -122.84 148.3 45.56 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.072 0.463 . . . . 0.0 112.028 -177.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.539 ' O ' ' N ' ' A' ' 73' ' ' GLY . 7.9 p -132.99 135.95 56.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.169 178.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 44.78 17.13 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.358 -0.537 . . . . 0.0 109.689 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 71' ' ' VAL . . . 99.86 -15.79 59.16 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.09 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.539 ' N ' ' O ' ' A' ' 71' ' ' VAL . 14.4 m -83.19 140.55 32.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 117.253 0.526 . . . . 0.0 110.575 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.504 HG13 ' HG2' ' A' ' 68' ' ' PRO . 87.2 t -70.7 143.97 14.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.155 0.502 . . . . 0.0 110.798 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.467 HD11 ' CG1' ' A' ' 71' ' ' VAL . 41.3 mm -102.5 91.55 2.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.465 -179.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -70.91 -39.17 72.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.581 178.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -141.55 174.21 4.05 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.299 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.51 140.36 89.28 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 121.911 1.741 . . . . 0.0 111.304 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 32.8 m -136.57 163.64 32.84 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.683 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.574 ' NE ' ' OE1' ' A' ' 57' ' ' GLU . 72.7 ttt180 -89.68 135.51 33.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.923 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.546 HD12 ' N ' ' A' ' 82' ' ' LEU . 5.5 mp -105.89 131.86 52.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.19 0.519 . . . . 0.0 110.632 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.477 ' HG2' ' N ' ' A' ' 84' ' ' HIS . 88.8 tttt -88.13 162.81 16.53 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.477 ' N ' ' HG2' ' A' ' 83' ' ' LYS . 73.1 t60 -61.15 129.25 40.39 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.31 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.09 -1.0 62.58 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.672 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.598 ' OD1' ' N ' ' A' ' 87' ' ' VAL . 64.4 t0 -68.58 145.54 53.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.677 0.275 . . . . 0.0 111.736 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.598 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 87.4 t -119.63 133.17 67.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-O 121.223 0.535 . . . . 0.0 111.16 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.53 HD11 HD11 ' A' ' 51' ' ' ILE . 71.2 mt -108.02 139.9 28.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.254 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.419 ' O ' ' N ' ' A' ' 70' ' ' GLN . 66.1 m -132.88 135.12 45.41 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.89 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 1.117 HG22 ' H ' ' A' ' 91' ' ' ILE . 58.5 mt -102.17 -147.57 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 1.117 ' H ' HG22 ' A' ' 90' ' ' ILE . 96.1 mt -62.91 -43.47 98.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 118.627 0.649 . . . . 0.0 111.228 -178.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -146.37 20.1 1.36 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -132.87 153.54 51.23 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.27 -0.572 . . . . 0.0 111.211 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.9 m -126.12 138.59 53.69 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.077 0.465 . . . . 0.0 111.266 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.559 ' CE2' ' OG1' ' A' ' 9' ' ' THR . 53.7 m-85 -128.06 138.84 52.72 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.974 178.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.648 ' HD2' HD11 ' A' ' 10' ' ' ILE . 82.2 mtp180 -109.92 133.17 53.46 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.985 -179.416 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.513 ' HA ' HD12 ' A' ' 7' ' ' LEU . 10.3 t80 -113.73 118.71 35.06 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.461 ' CD ' ' O ' ' A' ' 98' ' ' GLU . 2.1 pm0 -143.2 133.01 23.93 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 120.072 -0.651 . . . . 0.0 110.433 -178.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 63.6 t-20 -96.62 110.77 23.12 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.56 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 . . . . . 0 C--O 1.234 0.271 0 CA-C-O 120.938 0.399 . . . . 0.0 110.082 179.977 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.6 mmm . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.586 ' CD1' ' N ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -131.24 84.8 55.83 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.466 -179.939 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -58.03 142.0 96.54 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.756 2.304 . . . . 0.0 112.438 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 82.3 p -120.25 23.68 10.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.261 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.589 ' NH2' ' O ' ' A' ' 56' ' ' GLN . 95.4 mtt-85 -78.48 137.83 38.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.086 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -140.92 146.16 37.04 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.72 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.513 HD12 ' HA ' ' A' ' 97' ' ' TYR . 8.1 tp -114.26 131.68 56.41 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.4 t -120.16 136.75 56.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.091 -178.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.7 m -105.99 126.07 51.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.589 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.711 HG21 ' O ' ' A' ' 13' ' ' SER . 86.9 mt -86.36 107.39 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.221 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -65.27 -44.5 87.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.374 179.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.539 ' O ' ' C ' ' A' ' 13' ' ' SER . 84.6 mtt85 -130.03 149.77 51.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.418 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.711 ' O ' HG21 ' A' ' 10' ' ' ILE . 2.0 t 10.51 -96.67 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.877 0.735 . . . . 0.0 112.194 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.527 ' N ' ' OG ' ' A' ' 13' ' ' SER . . . -113.1 5.73 25.39 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.995 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.9 t -73.9 140.39 17.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.108 0.48 . . . . 0.0 110.834 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -65.22 137.15 57.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.101 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -124.2 -157.89 9.92 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.32 147.15 92.32 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.646 2.23 . . . . 0.0 112.064 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.439 ' CD2' ' N ' ' A' ' 19' ' ' HIS . 10.0 m-70 -107.55 166.12 10.91 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.777 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.559 ' CZ ' ' O ' ' A' ' 36' ' ' ASP . 19.0 t80 -142.46 109.71 5.75 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.893 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.78 146.94 38.91 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 121.762 1.641 . . . . 0.0 111.032 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.0 mt -94.7 107.78 19.78 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.111 -0.636 . . . . 0.0 111.079 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.0 m -111.1 -17.82 13.15 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.509 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.565 ' HG ' ' H ' ' A' ' 26' ' ' THR . 51.1 tp -115.9 136.39 53.09 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.937 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 92.4 p -56.87 -34.14 67.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.175 -179.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.565 ' H ' ' HG ' ' A' ' 24' ' ' LEU . 49.0 p -110.43 119.56 39.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.983 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.406 ' HG ' ' HE1' ' A' ' 29' ' ' PHE . 0.8 OUTLIER -102.89 122.77 45.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.869 178.921 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.543 HD21 ' HG2' ' A' ' 47' ' ' GLN . 49.1 tp -112.98 141.82 46.38 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.432 0.634 . . . . 0.0 112.16 -178.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.406 ' HE1' ' HG ' ' A' ' 27' ' ' CYS . 13.4 m-85 -107.66 145.04 33.89 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.736 179.295 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.48 166.83 16.15 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 119.453 -1.356 . . . . 0.0 112.666 179.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -66.43 -36.3 82.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.881 -0.659 . . . . 0.0 110.9 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.542 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -63.23 148.64 50.31 Favored Glycine 0 CA--C 1.52 0.372 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.762 -179.029 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.502 ' O ' ' N ' ' A' ' 35' ' ' CYS . 19.1 tt -65.52 -38.84 83.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.155 0.503 . . . . 0.0 110.152 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.499 ' N ' HG23 ' A' ' 33' ' ' ILE . 16.2 pt-20 -47.77 -11.08 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.683 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.542 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 3.0 m -88.65 135.57 33.43 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.955 0.407 . . . . 0.0 111.453 -179.207 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.559 ' O ' ' CZ ' ' A' ' 20' ' ' PHE . 55.6 m-20 -62.61 -37.78 87.6 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.5 mm -109.44 94.21 2.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -72.53 137.63 46.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.978 0.418 . . . . 0.0 110.29 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.754 HG21 HG21 ' A' ' 44' ' ' VAL . 96.5 mt -127.1 124.49 64.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.79 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -96.94 80.88 3.03 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.848 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.403 HD22 HG22 ' A' ' 43' ' ' VAL . 3.7 mt -156.92 114.17 1.98 Allowed Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.053 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -51.89 -28.66 32.12 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 121.862 1.708 . . . . 0.0 112.397 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.437 ' O ' ' CD1' ' A' ' 91' ' ' ILE . 34.2 m -68.78 -21.94 26.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.495 -179.202 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.754 HG21 HG21 ' A' ' 39' ' ' ILE . 96.3 t -85.87 149.23 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.8 p -88.23 172.07 9.73 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 120.255 -0.578 . . . . 0.0 112.174 -178.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.42 -40.45 96.58 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.543 ' HG2' HD21 ' A' ' 28' ' ' LEU . 99.5 mt-30 -130.5 70.63 1.45 Allowed 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.254 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.747 ' NE2' HG23 ' A' ' 90' ' ' ILE . 21.4 t60 -62.27 -50.11 73.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.73 -1.123 . . . . 0.0 113.183 -177.091 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.639 ' SG ' ' N ' ' A' ' 50' ' ' LYS . 0.5 OUTLIER -167.65 162.35 14.04 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.323 -178.739 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.639 ' N ' ' SG ' ' A' ' 49' ' ' CYS . 12.5 ptpt -142.54 151.15 41.31 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 119.179 -1.008 . . . . 0.0 112.621 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.492 HD11 ' CD1' ' A' ' 88' ' ' ILE . 96.7 mt -108.81 110.69 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.165 177.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 59' ' ' ILE . 85.4 tt0 -90.48 148.7 22.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.015 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -105.78 134.57 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 CA-C-O 121.124 0.488 . . . . 0.0 111.691 -178.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.479 ' O ' ' C ' ' A' ' 55' ' ' GLU . 38.9 m80 -119.85 174.53 6.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.178 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.479 ' C ' ' O ' ' A' ' 54' ' ' HIS . 95.8 mt-10 -24.05 -58.07 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.593 -178.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.589 ' O ' ' NH2' ' A' ' 5' ' ' ARG . 97.8 mt-30 -141.25 7.9 2.0 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.981 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.514 ' OE1' ' NE ' ' A' ' 81' ' ' ARG . 22.0 pt-20 -134.88 161.51 35.02 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.713 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.575 ' HB3' ' CE2' ' A' ' 97' ' ' TYR . . . -105.05 147.93 27.32 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.649 179.386 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.504 ' O ' ' N ' ' A' ' 52' ' ' GLU . 28.0 mm -130.09 135.21 61.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -179.04 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.745 ' HB2' HD11 ' A' ' 82' ' ' LEU . 7.2 tt -98.58 139.33 34.46 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.085 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -129.28 79.21 1.9 Allowed 'General case' 0 C--N 1.341 0.219 0 CA-C-O 121.338 0.59 . . . . 0.0 110.325 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -62.01 134.04 56.11 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.765 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -106.15 -39.5 5.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.182 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.478 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 20.9 t -54.54 140.0 36.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.058 0.456 . . . . 0.0 111.213 -178.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.0 m -107.3 -54.65 2.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.812 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.4 m -62.05 -45.61 92.8 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.378 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.478 ' O ' ' OG ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -123.35 81.19 52.92 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.502 179.409 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.31 151.09 37.73 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.301 2.0 . . . . 0.0 113.294 -178.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 90.6 m -64.89 159.96 21.57 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 177.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -128.02 147.02 50.49 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.08 -0.648 . . . . 0.0 112.282 -178.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.983 HG23 HD11 ' A' ' 76' ' ' ILE . 22.8 t -125.11 129.06 73.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.293 179.02 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 49.11 28.2 2.03 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.372 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.91 -5.11 80.69 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 71' ' ' VAL . 17.5 m -88.56 139.42 30.49 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.479 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 81.6 t -73.52 141.94 15.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.506 0.669 . . . . 0.0 110.702 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.983 HD11 HG23 ' A' ' 71' ' ' VAL . 87.8 mt -103.22 84.84 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.752 -179.177 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -63.45 -40.36 96.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.372 0.606 . . . . 0.0 109.663 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.422 ' O ' HG13 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -138.51 174.72 3.93 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.555 179.559 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.42 137.66 78.08 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 121.663 1.575 . . . . 0.0 110.6 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.422 HG13 ' O ' ' A' ' 78' ' ' GLU . 30.4 m -133.21 161.61 41.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.915 -178.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.514 ' NE ' ' OE1' ' A' ' 57' ' ' GLU . 76.2 ttt180 -80.84 139.97 35.67 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.524 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.745 HD11 ' HB2' ' A' ' 60' ' ' LEU . 92.6 mt -107.59 143.91 35.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.333 0.587 . . . . 0.0 111.055 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.52 ' N ' ' OD2' ' A' ' 86' ' ' ASP . 98.6 mttt -118.18 153.1 34.4 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.605 178.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 36.9 t60 -61.89 131.8 50.95 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.644 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.15 -5.2 57.54 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.52 ' OD2' ' N ' ' A' ' 83' ' ' LYS . 99.0 m-20 -71.75 149.59 45.23 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.608 0.242 . . . . 0.0 110.85 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 70.0 t -116.57 132.92 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.533 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.492 ' CD1' HD11 ' A' ' 51' ' ' ILE . 76.0 mt -107.61 132.88 54.03 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-O 120.916 0.389 . . . . 0.0 110.333 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.1 m -129.82 132.84 46.63 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.792 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 1.035 HG22 ' H ' ' A' ' 91' ' ' ILE . 66.9 mt -98.37 -152.23 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 1.035 ' H ' HG22 ' A' ' 90' ' ' ILE . 95.6 mt -63.72 -44.45 98.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 118.453 0.57 . . . . 0.0 112.382 -178.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 91' ' ' ILE . 97.9 m-20 -141.48 17.62 2.21 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -132.43 154.12 50.16 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.781 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.2 p -124.27 141.38 52.12 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.139 0.495 . . . . 0.0 111.246 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -132.97 147.67 52.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.697 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.528 ' HD2' HD11 ' A' ' 10' ' ' ILE . 69.6 mtp85 -118.2 140.42 49.82 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.444 -179.034 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.575 ' CE2' ' HB3' ' A' ' 58' ' ' ALA . 0.8 OUTLIER -113.85 107.31 15.54 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.4 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -114.31 120.32 39.98 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 120.837 0.351 . . . . 0.0 111.575 -178.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.528 ' CG ' ' NH1' ' A' ' 5' ' ' ARG . 1.0 OUTLIER -113.95 96.75 5.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.239 178.819 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.304 -179.645 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.2 mtp . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.659 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 4.1 m95 -96.41 -34.73 0.27 Allowed Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.685 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.659 ' CD ' ' N ' ' A' ' 2' ' ' TRP . 36.3 Cg_endo -83.48 -0.66 9.9 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.472 2.115 . . . . 0.0 112.393 -178.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.5 t -78.34 160.07 28.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.271 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.726 ' HE ' ' ND2' ' A' ' 99' ' ' ASN . 83.2 mtt85 -73.97 137.12 43.33 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -143.56 146.5 33.38 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 120.32 -0.552 . . . . 0.0 112.038 -179.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.576 ' CD1' HD21 ' A' ' 22' ' ' LEU . 91.4 mt -110.72 128.37 55.7 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.738 178.35 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.5 t -112.56 133.88 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.619 ' OG1' ' CE2' ' A' ' 95' ' ' PHE . 8.6 m -102.44 116.42 32.59 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.185 -0.606 . . . . 0.0 111.834 -179.114 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.557 HD11 ' HE ' ' A' ' 96' ' ' ARG . 96.8 mt -75.77 133.12 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-O 121.007 0.432 . . . . 0.0 110.276 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.529 ' O ' ' O ' ' A' ' 14' ' ' GLY . 14.7 mmmt -99.48 152.64 19.78 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.347 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -66.65 130.57 43.62 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 61.95 21.28 12.19 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -177.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.529 ' O ' ' O ' ' A' ' 11' ' ' LYS . . . -160.19 109.65 0.41 Allowed Glycine 0 CA--C 1.518 0.228 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.47 ' HA ' HG23 ' A' ' 10' ' ' ILE . 22.5 m -99.84 131.2 47.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.433 0.635 . . . . 0.0 111.531 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.429 ' CB ' ' O ' ' A' ' 15' ' ' VAL . 3.9 t0 80.02 51.59 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.778 179.046 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.69 -147.54 1.88 Allowed Glycine 0 CA--C 1.53 0.989 0 N-CA-C 110.471 -1.051 . . . . 0.0 110.471 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -59.54 147.07 93.22 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.604 2.203 . . . . 0.0 111.169 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -98.78 -177.24 3.59 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.564 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -150.31 91.76 4.12 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.694 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -57.61 143.61 94.45 Favored 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 122.51 2.14 . . . . 0.0 111.188 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.576 HD21 ' CD1' ' A' ' 7' ' ' LEU . 97.8 mt -90.98 76.12 6.26 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 119.901 -0.719 . . . . 0.0 111.074 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.9 p -67.59 -30.69 70.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.916 179.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.4 mt -108.67 144.06 36.92 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.451 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 97.2 p -63.83 -30.29 71.39 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.015 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 81.4 p -109.05 127.36 54.05 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.185 0.517 . . . . 0.0 111.754 -178.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.553 ' SG ' ' CD2' ' A' ' 22' ' ' LEU . 1.2 m -107.93 126.01 52.18 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.103 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.492 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 66.6 tp -115.57 134.14 55.35 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.212 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.512 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 13.9 m-85 -102.52 146.56 27.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.761 -179.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.417 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . 144.57 152.3 5.61 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.246 -0.978 . . . . 0.0 112.502 178.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 75.5 ttt-85 -64.56 -41.43 96.32 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.683 -0.759 . . . . 0.0 111.46 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.403 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -46.88 153.3 1.15 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 18.8 tt -63.64 -31.26 52.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -60.93 -20.27 61.92 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.484 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 2.0 m -74.22 124.65 26.79 Favored 'General case' 0 C--O 1.233 0.209 0 O-C-N 121.961 -0.462 . . . . 0.0 111.95 -179.042 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.492 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 55.9 m-20 -63.01 -38.6 91.85 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.319 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.2 mm -102.4 85.44 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 177.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -66.51 134.57 52.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.79 -177.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.516 HG22 ' HB2' ' A' ' 41' ' ' LEU . 93.9 mt -124.16 108.28 20.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -75.99 81.13 2.86 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 118.973 -1.091 . . . . 0.0 109.97 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.516 ' HB2' HG22 ' A' ' 39' ' ' ILE . 2.0 mt -155.27 107.64 2.24 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.323 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -51.46 -36.2 58.03 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.226 1.951 . . . . 0.0 112.488 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.422 ' HB ' HD13 ' A' ' 91' ' ' ILE . 18.1 m -64.4 -22.67 31.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.884 -178.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 76.7 t -86.14 146.03 6.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.359 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.9 m -82.73 159.41 22.57 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.169 -0.612 . . . . 0.0 111.998 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.484 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 98.8 mttt -61.92 -39.49 92.2 Favored 'General case' 0 C--N 1.334 -0.069 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.582 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -118.36 51.51 1.08 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.676 ' NE2' HG23 ' A' ' 90' ' ' ILE . 13.7 t60 -59.29 -50.46 73.91 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.085 -0.962 . . . . 0.0 112.205 -177.077 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.528 ' SG ' HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -151.13 161.22 43.13 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.721 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.589 ' O ' ' N ' ' A' ' 61' ' ' HIS . 47.0 tttm -144.7 131.13 19.77 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.485 -179.248 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.479 ' CG2' ' HB1' ' A' ' 58' ' ' ALA . 95.8 mt -107.0 109.58 28.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.556 178.074 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -91.84 130.81 37.54 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.433 ' O ' ' CG2' ' A' ' 53' ' ' ILE . 0.8 OUTLIER -90.2 129.3 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.024 -179.333 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.502 ' O ' ' C ' ' A' ' 55' ' ' GLU . 47.3 m80 -112.13 -179.37 3.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.716 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.502 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.9 mm-40 -23.82 -63.46 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 O-C-N 123.648 0.593 . . . . 0.0 111.803 -178.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.44 ' O ' ' ND2' ' A' ' 99' ' ' ASN . 90.9 mt-30 -140.32 13.74 2.39 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.967 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.522 ' N ' ' OE1' ' A' ' 57' ' ' GLU . 56.0 mp0 -139.59 148.97 43.25 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 119.891 -0.723 . . . . 0.0 111.882 -179.192 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.504 ' HB3' ' CE2' ' A' ' 97' ' ' TYR . . . -94.15 141.89 28.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.527 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.0 mm -124.06 127.31 73.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 120.967 0.413 . . . . 0.0 111.428 -178.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.572 HD23 HD13 ' A' ' 76' ' ' ILE . 52.7 tp -76.91 144.39 38.94 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.934 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.599 ' O ' ' CE1' ' A' ' 63' ' ' PHE . 15.5 m-70 -136.2 77.62 1.67 Allowed 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.645 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -70.7 132.62 45.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.933 -179.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.599 ' CE1' ' O ' ' A' ' 61' ' ' HIS . 17.2 m-85 -108.02 -34.81 6.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.899 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.2 m -57.69 137.23 56.68 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.294 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.0 p -105.12 -52.91 2.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.515 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.0 m -62.04 -48.09 81.83 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.829 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.52 ' OD1' ' N ' ' A' ' 67' ' ' ASN . 0.1 OUTLIER -117.13 81.03 12.37 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.822 179.103 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -73.03 146.65 41.87 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 121.578 1.519 . . . . 0.0 112.171 -179.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.464 ' CG2' ' CG2' ' A' ' 88' ' ' ILE . 62.4 m -64.64 160.83 18.91 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.01 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.447 ' N ' HG22 ' A' ' 69' ' ' THR . 85.2 mt-30 -131.65 150.81 52.02 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.127 -0.629 . . . . 0.0 112.206 -177.353 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.476 ' CG2' HD11 ' A' ' 76' ' ' ILE . 19.8 t -133.45 131.81 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.032 178.154 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 48.0 29.05 1.6 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.189 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.42 16.42 78.08 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.5 t -108.23 130.43 55.16 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 65.3 t -70.67 137.12 24.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 CA-C-O 121.68 0.752 . . . . 0.0 110.773 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.572 HD13 HD23 ' A' ' 60' ' ' LEU . 95.6 mt -114.78 102.1 13.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.131 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -76.78 -41.73 43.51 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.349 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -130.01 174.35 4.71 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.721 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -53.95 136.91 68.06 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 C-N-CA 122.463 2.109 . . . . 0.0 111.552 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.4 m -135.64 159.54 39.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.327 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 60.8 ttm-85 -79.52 139.95 37.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.308 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.531 HD11 ' HB2' ' A' ' 60' ' ' LEU . 93.3 mt -114.81 143.09 45.65 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 121.27 0.557 . . . . 0.0 111.696 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.424 ' O ' ' CG ' ' A' ' 86' ' ' ASP . 99.1 mttt -106.93 152.37 24.03 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.203 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 35.8 t60 -59.66 132.7 54.79 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.526 -0.47 . . . . 0.0 109.975 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.71 -2.9 62.59 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 -178.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.424 ' CG ' ' O ' ' A' ' 83' ' ' LYS . 15.7 m-20 -75.07 143.96 43.2 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.2 t -118.46 134.86 60.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-O 120.785 0.326 . . . . 0.0 111.229 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.476 ' CD1' HD11 ' A' ' 51' ' ' ILE . 62.9 mt -104.89 135.82 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 116.264 -0.425 . . . . 0.0 109.977 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 89.3 m -126.26 125.85 43.05 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.119 0.485 . . . . 0.0 111.295 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 1.087 HG22 ' H ' ' A' ' 91' ' ' ILE . 93.7 mt -94.68 -146.04 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 178.601 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 1.087 ' H ' HG22 ' A' ' 90' ' ' ILE . 96.9 mt -62.74 -45.24 99.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 119.434 1.016 . . . . 0.0 112.581 -178.247 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.411 ' OD1' HD13 ' A' ' 41' ' ' LEU . 27.7 p30 -143.56 -0.61 1.07 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -122.42 148.7 44.79 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.924 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.9 m -121.69 153.39 38.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.461 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.619 ' CE2' ' OG1' ' A' ' 9' ' ' THR . 48.0 m-85 -126.69 147.25 49.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.833 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.557 ' HE ' HD11 ' A' ' 10' ' ' ILE . 84.2 mtt180 -104.84 122.35 45.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.204 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.504 ' CE2' ' HB3' ' A' ' 58' ' ' ALA . 0.8 OUTLIER -104.78 99.35 8.99 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.611 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -110.86 115.55 29.71 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.966 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.726 ' ND2' ' HE ' ' A' ' 5' ' ' ARG . 61.3 t-20 -106.46 94.01 4.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.807 178.671 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.492 ' O ' ' O ' ' A' ' 3' ' ' PRO . 99.0 mt-10 . . . . . 0 C--N 1.321 -0.634 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.028 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.5 mtm . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.644 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 3.4 p90 -154.91 37.01 0.08 OUTLIER Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.02 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.644 ' CD ' ' N ' ' A' ' 2' ' ' TRP . 60.6 Cg_endo -69.63 150.09 68.57 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.325 2.016 . . . . 0.0 112.331 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.87 -175.31 0.16 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.219 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -101.61 148.78 24.82 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.637 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.421 HH22 ' CA ' ' A' ' 2' ' ' TRP . 90.7 mtm-85 -137.63 155.68 48.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.407 0.622 . . . . 0.0 112.375 -178.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.611 HD23 ' HA ' ' A' ' 97' ' ' TYR . 93.6 mt -110.11 137.32 48.03 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 177.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.5 HG22 ' ND1' ' A' ' 19' ' ' HIS . 53.0 t -121.78 132.33 71.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.258 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 59.5 m -108.65 120.3 42.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.284 -178.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.704 HD11 ' HD2' ' A' ' 96' ' ' ARG . 71.5 mt -77.77 130.97 35.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.994 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -62.99 -40.49 97.91 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.126 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -148.52 -93.57 0.08 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.09 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.5 p -149.44 126.95 11.56 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.008 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.96 12.4 75.14 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.471 ' O ' HG23 ' A' ' 10' ' ' ILE . 6.4 m -125.78 129.11 72.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.94 0.4 . . . . 0.0 110.915 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -68.96 140.04 55.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.634 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -122.1 -169.28 13.49 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.776 -0.929 . . . . 0.0 110.776 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -71.74 152.08 58.33 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.559 2.173 . . . . 0.0 112.049 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.5 ' ND1' HG22 ' A' ' 8' ' ' VAL . 7.8 m-70 -96.51 169.78 9.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.219 0.533 . . . . 0.0 110.638 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.459 ' CZ ' ' O ' ' A' ' 36' ' ' ASP . 73.1 t80 -137.7 96.85 10.46 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.36 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.3 144.93 69.41 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.072 1.848 . . . . 0.0 110.813 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.0 tp -110.8 121.7 45.99 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.989 0.424 . . . . 0.0 111.872 -178.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.0 m -123.91 -38.71 2.46 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.647 178.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.511 ' N ' ' CD2' ' A' ' 24' ' ' LEU . 3.7 mm? -78.22 139.45 38.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.414 179.032 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 86.0 p -69.83 -15.52 63.12 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.445 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.9 p -120.7 123.29 42.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.851 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -106.68 123.47 48.18 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.428 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 59.9 tp -116.05 143.22 45.75 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.055 0.455 . . . . 0.0 111.145 -178.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.669 ' CE2' HG21 ' A' ' 37' ' ' ILE . 15.8 m-85 -113.39 140.65 47.88 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.72 -178.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 146.77 172.66 17.27 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.801 178.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.403 HH11 ' HA ' ' A' ' 42' ' ' PRO . 82.4 mtp180 -65.11 -35.52 81.39 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.041 -0.58 . . . . 0.0 110.934 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.563 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -43.9 140.22 3.46 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 tt -66.43 -32.65 59.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.84 0.352 . . . . 0.0 110.86 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -64.82 -17.33 64.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.545 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.563 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 7.8 m -64.31 126.76 28.82 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 120.862 0.363 . . . . 0.0 110.966 -179.167 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.459 ' O ' ' CZ ' ' A' ' 20' ' ' PHE . 55.3 m-20 -64.07 -39.35 93.88 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.669 HG21 ' CE2' ' A' ' 29' ' ' PHE . 5.2 mm -107.12 79.9 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -67.13 127.31 32.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.054 -0.975 . . . . 0.0 112.266 -177.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.414 HG23 ' HD2' ' A' ' 93' ' ' ARG . 96.7 mt -121.62 130.33 74.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.333 179.209 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.499 ' N ' ' CD ' ' A' ' 40' ' ' GLN . 0.0 OUTLIER -101.79 83.18 2.36 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.13 -179.765 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.0 mt -153.88 114.87 2.58 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.667 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.403 ' HA ' HH11 ' A' ' 31' ' ' ARG . 51.4 Cg_exo -51.82 -35.05 57.64 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.618 1.545 . . . . 0.0 112.08 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.9 m -64.02 -31.64 54.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.492 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.437 HG12 ' N ' ' A' ' 45' ' ' SER . 76.0 t -81.03 155.72 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.437 ' N ' HG12 ' A' ' 44' ' ' VAL . 13.0 m -100.16 158.19 16.03 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 120.037 -0.665 . . . . 0.0 112.166 -178.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -59.96 -37.78 80.59 Favored 'General case' 0 C--O 1.23 0.068 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -115.84 50.14 1.05 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.503 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.722 ' NE2' HG23 ' A' ' 90' ' ' ILE . 13.7 t60 -61.9 -51.39 68.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.026 -177.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.882 ' SG ' HD11 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -155.62 159.51 39.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.752 -179.138 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.599 ' O ' ' N ' ' A' ' 61' ' ' HIS . 72.9 tttt -140.1 130.34 25.16 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -178.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.7 mt -103.77 113.66 41.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 59' ' ' ILE . 82.7 tt0 -100.79 125.07 47.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.798 0.332 . . . . 0.0 110.229 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.5 tp -88.71 135.63 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-O 121.377 0.608 . . . . 0.0 111.74 -178.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.452 ' O ' ' C ' ' A' ' 55' ' ' GLU . 6.2 m-70 -112.14 -178.52 3.44 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.454 179.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 54' ' ' HIS . 30.2 tp10 -35.09 -51.84 0.55 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 121.131 -0.228 . . . . 0.0 111.085 -178.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -146.66 24.8 1.21 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 121.095 -0.242 . . . . 0.0 111.364 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.425 ' HG2' ' N ' ' A' ' 58' ' ' ALA . 83.2 tt0 -140.71 156.19 46.27 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.735 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.555 ' HB3' ' CE2' ' A' ' 97' ' ' TYR . . . -108.85 136.49 48.33 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.238 178.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.42 HD13 ' O ' ' A' ' 58' ' ' ALA . 49.0 mm -125.43 130.6 72.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.002 -178.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.882 HD11 ' SG ' ' A' ' 49' ' ' CYS . 46.9 tp -85.51 144.18 28.09 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.821 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.599 ' N ' ' O ' ' A' ' 50' ' ' LYS . 32.4 m-70 -136.13 79.7 1.78 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.403 0.621 . . . . 0.0 110.505 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -75.07 130.16 38.82 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.97 -1.014 . . . . 0.0 112.412 -179.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.486 ' CE1' ' O ' ' A' ' 61' ' ' HIS . 13.0 m-85 -107.28 -35.19 6.88 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.934 179.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.492 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 19.2 t -58.67 140.37 54.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.239 -177.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.5 t -110.54 -54.52 2.58 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.0 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 81.4 p -67.64 -36.41 80.72 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.492 ' O ' ' OG ' ' A' ' 64' ' ' SER . 0.6 OUTLIER -120.57 76.55 26.96 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.498 178.879 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -74.55 148.48 37.55 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 121.878 1.719 . . . . 0.0 113.317 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.434 ' C ' HD12 ' A' ' 76' ' ' ILE . 53.5 m -71.88 160.7 32.11 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.1 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.552 ' N ' ' O ' ' A' ' 89' ' ' THR . 85.9 mt-30 -126.66 143.8 51.11 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.87 -177.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.913 HG23 HD11 ' A' ' 76' ' ' ILE . 19.2 t -125.53 133.1 70.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.875 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.443 ' ND2' ' OD1' ' A' ' 86' ' ' ASP . 75.6 m-20 44.38 28.0 0.27 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.903 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.55 21.37 58.3 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 121.051 -0.595 . . . . 0.0 111.9 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.459 ' N ' ' O ' ' A' ' 71' ' ' VAL . 28.5 t -121.18 142.01 50.29 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.8 t -72.96 147.99 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 121.531 0.682 . . . . 0.0 111.772 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.913 HD11 HG23 ' A' ' 71' ' ' VAL . 92.7 mt -114.3 114.01 45.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.603 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -96.28 -9.1 31.07 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.555 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -168.58 171.87 3.39 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.802 -178.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -53.99 139.07 70.69 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.602 1.535 . . . . 0.0 111.438 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.5 m -138.83 160.31 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 C-N-CA 120.466 -0.493 . . . . 0.0 110.746 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -68.5 131.98 46.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.778 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.521 ' O ' ' O ' ' A' ' 58' ' ' ALA . 23.2 tp -114.32 121.21 42.93 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.107 0.48 . . . . 0.0 109.929 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -105.49 179.15 4.35 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.108 -178.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.493 ' NE2' ' OE2' ' A' ' 100' ' ' GLU . 13.7 t60 -77.62 140.45 39.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.275 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 91.28 -6.22 81.02 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.918 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.603 ' OD1' ' N ' ' A' ' 87' ' ' VAL . 59.1 t0 -79.87 154.89 28.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.998 0.428 . . . . 0.0 111.08 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.603 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 10.1 p -119.82 135.68 59.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.65 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 89.5 mt -108.38 132.28 56.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.164 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.552 ' O ' ' N ' ' A' ' 70' ' ' GLN . 2.0 m -123.91 129.34 50.82 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.849 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 1.064 HG22 ' H ' ' A' ' 91' ' ' ILE . 94.8 mt -100.36 -152.39 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 1.064 ' H ' HG22 ' A' ' 90' ' ' ILE . 94.5 mt -63.2 -44.54 99.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 119.105 0.866 . . . . 0.0 112.793 -178.076 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.482 ' OD1' ' O ' ' A' ' 91' ' ' ILE . 97.8 m-20 -139.1 1.93 2.07 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 119.833 -0.747 . . . . 0.0 112.737 -179.193 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.414 ' HD2' HG23 ' A' ' 39' ' ' ILE . 97.8 mtt180 -125.85 158.22 35.61 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.301 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.9 t -128.18 142.95 51.03 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.606 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.467 ' CE2' ' CG2' ' A' ' 37' ' ' ILE . 60.4 m-85 -128.5 143.65 51.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.431 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.704 ' HD2' HD11 ' A' ' 10' ' ' ILE . 81.1 mtp180 -120.41 141.01 50.51 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.294 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.611 ' HA ' HD23 ' A' ' 7' ' ' LEU . 1.0 OUTLIER -114.93 110.8 20.19 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.38 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.403 ' HA ' ' ND1' ' A' ' 84' ' ' HIS . 94.0 mt-10 -116.93 125.25 51.16 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.989 -178.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -121.96 88.77 3.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.366 178.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.493 ' OE2' ' NE2' ' A' ' 84' ' ' HIS . 71.1 mm-40 . . . . . 0 C--N 1.326 -0.413 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.801 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.451 ' O ' ' C ' ' A' ' 2' ' ' TRP . 75.6 mtm . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.451 ' C ' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -28.75 94.01 0.06 OUTLIER Pre-proline 0 CA--C 1.535 0.365 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.848 -179.776 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.41 ' N ' ' O ' ' A' ' 1' ' ' MET . 39.2 Cg_exo -60.32 145.96 97.55 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.436 2.091 . . . . 0.0 111.643 178.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 62.9 p -117.82 7.03 12.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.043 0.449 . . . . 0.0 111.219 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.6 mtm-85 -80.03 139.15 37.07 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.243 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -145.3 139.61 27.2 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.989 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.519 HD12 ' HA ' ' A' ' 97' ' ' TYR . 7.1 tp -109.66 131.43 55.07 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 79.9 t -120.15 132.39 69.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 96.9 m -109.41 120.25 41.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.154 0.502 . . . . 0.0 111.743 -178.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.656 HD11 ' HD2' ' A' ' 96' ' ' ARG . 68.2 mt -81.01 133.1 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.505 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -64.19 -41.57 97.03 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.48 178.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -146.91 -93.68 0.09 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.411 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.6 p -150.5 125.27 9.75 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.928 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.4 27.01 62.3 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.2 p -133.33 149.63 31.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.959 0.409 . . . . 0.0 110.623 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.45 ' O ' ' OD1' ' A' ' 16' ' ' ASP . 45.7 p-10 -96.88 112.32 24.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.634 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -99.04 -174.94 31.82 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -66.96 147.66 80.63 Favored 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.603 2.202 . . . . 0.0 111.809 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -93.46 162.95 13.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.216 -179.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.587 ' CZ ' ' O ' ' A' ' 36' ' ' ASP . 18.6 t80 -135.69 100.78 10.98 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.097 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -72.28 151.09 54.07 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.576 1.517 . . . . 0.0 110.859 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.436 HD13 HD13 ' A' ' 53' ' ' ILE . 76.2 mt -81.37 83.08 7.01 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.44 -178.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.6 t -65.4 -40.39 93.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.547 178.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.2 mt -115.7 151.5 34.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.845 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.6 p -63.97 -26.4 68.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.9 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.6 p -110.75 118.07 35.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.427 -179.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.7 m -101.87 131.21 48.36 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.223 179.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.627 HD21 ' HG2' ' A' ' 47' ' ' GLN . 49.9 tp -121.2 141.66 50.65 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.048 0.451 . . . . 0.0 111.009 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.54 ' CE2' HG21 ' A' ' 37' ' ' ILE . 10.8 m-85 -113.77 143.08 45.24 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.327 -179.056 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 146.18 171.94 16.06 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 120.068 -1.063 . . . . 0.0 112.795 177.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -63.82 -40.0 95.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.903 -0.649 . . . . 0.0 111.89 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.412 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -49.73 141.06 14.54 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.34 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.9 tt -67.08 -32.65 58.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.813 0.339 . . . . 0.0 110.541 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -57.11 -18.01 13.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.531 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.412 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 3.9 m -73.76 129.53 38.12 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.947 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.587 ' O ' ' CZ ' ' A' ' 20' ' ' PHE . 92.5 m-20 -62.01 -37.69 85.84 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.503 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.54 HG21 ' CE2' ' A' ' 29' ' ' PHE . 3.7 mm -107.58 78.32 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.216 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -68.76 134.5 49.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.318 -178.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 98.4 mt -123.11 128.05 74.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.174 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.715 ' O ' HD12 ' A' ' 41' ' ' LEU . 55.5 tp60 -96.33 82.1 3.38 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.334 -0.546 . . . . 0.0 110.777 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.715 HD12 ' O ' ' A' ' 40' ' ' GLN . 0.8 OUTLIER -156.31 124.11 2.81 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.976 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -62.37 -25.57 76.39 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 121.74 1.626 . . . . 0.0 112.724 -178.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.483 ' O ' ' CD1' ' A' ' 91' ' ' ILE . 30.8 m -66.62 -31.23 52.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.425 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.513 HG12 ' N ' ' A' ' 45' ' ' SER . 25.0 t -80.08 157.01 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 120.928 0.394 . . . . 0.0 111.246 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.513 ' N ' HG12 ' A' ' 44' ' ' VAL . 3.2 m -91.84 165.57 13.19 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.536 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.403 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 98.9 mttt -63.48 -37.07 85.88 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.264 0.554 . . . . 0.0 109.817 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.627 ' HG2' HD21 ' A' ' 28' ' ' LEU . 87.9 mt-30 -129.72 60.54 1.58 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 178.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.798 ' CD2' HG23 ' A' ' 90' ' ' ILE . 13.4 t60 -60.99 -51.43 69.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.277 -176.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.543 ' SG ' HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -149.58 159.32 44.42 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.501 -179.498 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.55 ' O ' ' N ' ' A' ' 61' ' ' HIS . 69.5 tttt -139.21 127.51 22.73 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.937 -178.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.604 HD11 ' CD1' ' A' ' 88' ' ' ILE . 97.1 mt -104.24 112.63 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.452 ' O ' ' N ' ' A' ' 59' ' ' ILE . 81.5 tt0 -94.93 136.21 35.52 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.021 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.45 ' O ' ' CG2' ' A' ' 53' ' ' ILE . 4.5 tp -89.23 128.89 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-O 121.096 0.474 . . . . 0.0 110.589 -179.417 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.521 ' O ' ' C ' ' A' ' 55' ' ' GLU . 8.9 m80 -112.18 -176.35 2.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.742 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.521 ' C ' ' O ' ' A' ' 54' ' ' HIS . 38.0 tt0 -23.63 -62.2 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 O-C-N 123.664 0.603 . . . . 0.0 111.252 -178.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.536 ' O ' ' ND2' ' A' ' 99' ' ' ASN . 81.1 mt-30 -146.64 20.16 1.32 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.057 178.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -138.64 152.43 48.09 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.502 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.58 ' HB1' ' CG2' ' A' ' 51' ' ' ILE . . . -93.28 142.56 27.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.624 179.048 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.452 ' N ' ' O ' ' A' ' 52' ' ' GLU . 30.8 mm -126.61 126.14 68.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 120.997 0.427 . . . . 0.0 111.378 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.543 HD11 ' SG ' ' A' ' 49' ' ' CYS . 46.4 tp -76.28 145.54 39.57 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.823 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.55 ' N ' ' O ' ' A' ' 50' ' ' LYS . 55.4 m-70 -142.14 79.03 1.65 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.957 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.466 ' ND2' ' O ' ' A' ' 64' ' ' SER . 2.4 t30 -69.99 138.14 51.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.689 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -107.9 -36.24 6.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.222 178.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.466 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 13.5 m -57.8 138.77 55.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.826 -178.115 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.9 p -106.07 -56.87 2.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.27 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.2 p -61.97 -42.92 99.67 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.608 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.588 ' OD1' ' N ' ' A' ' 67' ' ' ASN . 0.1 OUTLIER -120.97 79.81 33.54 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.63 -179.875 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.435 ' HG2' HG13 ' A' ' 75' ' ' VAL . 73.3 Cg_endo -70.78 151.64 63.4 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.091 1.861 . . . . 0.0 113.226 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.441 HG22 ' N ' ' A' ' 70' ' ' GLN . 18.4 m -69.49 165.47 20.89 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.12 -0.946 . . . . 0.0 108.585 178.485 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.441 ' N ' HG22 ' A' ' 69' ' ' THR . 83.7 mt-30 -128.74 141.23 51.39 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.448 -0.501 . . . . 0.0 112.18 -177.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.47 ' HB ' HD11 ' A' ' 76' ' ' ILE . 41.3 t -126.21 128.65 71.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.164 178.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 49.48 25.71 1.45 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.151 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 93.75 -13.91 66.44 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.8 m -83.85 143.39 29.95 Favored 'General case' 0 C--N 1.331 -0.211 0 O-C-N 122.693 -0.298 . . . . 0.0 110.834 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.435 HG13 ' HG2' ' A' ' 68' ' ' PRO . 60.2 t -76.14 144.5 11.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.184 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.489 HD12 HG21 ' A' ' 80' ' ' VAL . 45.3 mm -103.92 105.06 17.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.672 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -89.01 -33.08 17.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.913 178.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.428 ' O ' HG13 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -142.62 172.69 5.44 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.133 179.722 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.9 137.62 68.56 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 121.544 1.496 . . . . 0.0 111.153 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.489 HG21 HD12 ' A' ' 76' ' ' ILE . 35.7 m -134.08 160.24 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 C-N-CA 120.619 -0.433 . . . . 0.0 110.973 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -86.65 140.15 30.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.536 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 66.9 mt -106.37 143.88 33.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.133 0.492 . . . . 0.0 111.417 -179.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -110.31 150.9 28.08 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 16.3 t60 -59.85 131.05 49.69 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.28 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 98.7 -9.75 62.32 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.626 ' OD1' ' N ' ' A' ' 87' ' ' VAL . 67.5 t0 -68.48 147.02 52.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.723 0.297 . . . . 0.0 110.329 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.626 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 46.0 t -117.0 132.03 67.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.495 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.604 ' CD1' HD11 ' A' ' 51' ' ' ILE . 60.0 mt -104.81 135.25 43.58 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.9 m -131.16 131.18 43.88 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.954 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.882 HG22 ' H ' ' A' ' 91' ' ' ILE . 12.8 mm -86.45 -145.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.882 ' H ' HG22 ' A' ' 90' ' ' ILE . 96.7 mt -63.16 -43.37 98.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.363 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.507 ' OD1' ' O ' ' A' ' 92' ' ' ASP . 55.7 t0 -149.58 14.13 0.85 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.685 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 63.0 ttm-85 -121.29 130.04 53.44 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.903 0.382 . . . . 0.0 111.739 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 64.1 m -99.5 141.97 31.59 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.546 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -128.2 143.83 51.07 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.498 178.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.656 ' HD2' HD11 ' A' ' 10' ' ' ILE . 82.7 mtp180 -111.85 135.53 52.34 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.803 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.519 ' HA ' HD12 ' A' ' 7' ' ' LEU . 0.9 OUTLIER -119.71 107.32 13.07 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.646 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -116.45 125.07 51.46 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.333 -178.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.536 ' ND2' ' O ' ' A' ' 56' ' ' GLN . 58.7 t-20 -123.69 91.59 3.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.997 178.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 . . . . . 0 C--N 1.325 -0.483 0 CA-C-O 121.046 0.45 . . . . 0.0 111.18 -179.568 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.5 mmm . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -156.12 66.73 4.46 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.869 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -69.23 147.16 65.66 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.298 1.999 . . . . 0.0 113.085 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 52.5 p -115.16 10.76 16.15 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.202 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.56 ' NH1' ' CG1' ' A' ' 53' ' ' ILE . 88.7 mtm180 -120.4 131.57 54.87 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.532 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -142.78 154.69 44.46 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.979 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 96.8 mt -111.71 133.97 53.59 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.436 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.2 t -119.69 135.51 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 120.809 0.337 . . . . 0.0 110.675 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.444 ' OG1' ' CE2' ' A' ' 95' ' ' PHE . 24.1 m -101.57 116.86 33.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.534 -179.243 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.467 HD11 ' HD2' ' A' ' 96' ' ' ARG . 96.4 mt -78.97 129.56 37.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.914 179.543 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -86.77 -172.26 3.92 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -62.0 -43.49 98.72 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.515 ' C ' ' H ' ' A' ' 15' ' ' VAL . 34.8 m -76.31 154.62 34.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.251 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.81 1.96 1.51 Allowed Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.515 ' H ' ' C ' ' A' ' 13' ' ' SER . 12.1 t -83.63 133.8 28.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.151 0.5 . . . . 0.0 110.895 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -68.07 140.64 56.28 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.306 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -103.17 -162.32 25.53 Favored Glycine 0 CA--C 1.532 1.138 0 N-CA-C 110.706 -0.957 . . . . 0.0 110.706 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.4 148.18 91.43 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 123.768 2.979 . . . . 0.0 112.575 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -100.39 161.0 13.89 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.174 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.532 ' CZ ' ' O ' ' A' ' 36' ' ' ASP . 83.2 t80 -130.96 109.77 15.51 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.13 -179.237 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -75.09 151.2 38.81 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 C-N-CA 121.674 1.582 . . . . 0.0 110.925 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.431 ' HA ' HD23 ' A' ' 22' ' ' LEU . 87.7 mt -75.55 85.52 2.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.23 0.538 . . . . 0.0 111.497 -179.022 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.6 m -61.75 -42.18 98.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.316 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 97.0 mt -121.37 154.3 36.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.627 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.0 p -59.78 -30.24 68.75 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.731 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 66.0 p -106.5 119.05 38.25 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.117 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.521 ' O ' ' N ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -99.35 119.72 38.41 Favored 'General case' 0 C--O 1.221 -0.404 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.347 179.635 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.53 HD21 ' OE1' ' A' ' 47' ' ' GLN . 42.2 tp -112.07 138.51 48.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.106 0.479 . . . . 0.0 111.012 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -105.44 147.33 28.39 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.466 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 138.83 163.34 9.49 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 119.754 -1.213 . . . . 0.0 112.998 177.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.432 HH11 ' HA ' ' A' ' 42' ' ' PRO . 80.2 mtp180 -62.7 -36.65 83.62 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.742 -0.729 . . . . 0.0 110.526 179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -45.62 143.97 3.49 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 109.939 -1.265 . . . . 0.0 109.939 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.4 tt -65.99 -37.8 80.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.779 0.323 . . . . 0.0 110.449 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -55.08 -21.89 14.31 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.406 -0.517 . . . . 0.0 110.389 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 38.9 m -65.38 120.72 13.33 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.802 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.532 ' O ' ' CZ ' ' A' ' 20' ' ' PHE . 59.7 m-20 -61.7 -36.79 81.92 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.444 HD13 ' CD2' ' A' ' 20' ' ' PHE . 1.2 mm -106.6 76.18 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.263 179.14 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 67.4 ttt-85 -65.45 124.74 23.08 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.845 -178.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.471 HG21 HG21 ' A' ' 44' ' ' VAL . 92.3 mt -114.4 124.17 70.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.636 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -91.16 81.24 5.56 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.64 -179.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.699 HD23 ' CG2' ' A' ' 43' ' ' VAL . 2.3 tp -155.86 118.01 2.3 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.839 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.432 ' HA ' HH11 ' A' ' 31' ' ' ARG . 71.3 Cg_exo -50.08 -36.96 46.8 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 122.017 1.811 . . . . 0.0 113.674 179.109 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.699 ' CG2' HD23 ' A' ' 41' ' ' LEU . 27.6 m -64.07 -36.71 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.471 HG21 HG21 ' A' ' 39' ' ' ILE . 69.0 t -69.95 141.5 17.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.8 t -83.84 161.73 20.81 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.109 -179.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -64.0 -40.01 95.4 Favored 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.53 ' OE1' HD21 ' A' ' 28' ' ' LEU . 88.8 mm-40 -119.01 54.3 0.97 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 178.146 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.721 ' NE2' HG23 ' A' ' 90' ' ' ILE . 15.0 t60 -58.92 -48.04 82.87 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.054 -177.23 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.644 ' HB2' HD11 ' A' ' 60' ' ' LEU . 1.8 p -170.82 163.52 7.79 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.467 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.72 ' O ' HD12 ' A' ' 60' ' ' LEU . 13.3 ptpt -145.48 145.53 31.11 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 119.055 -1.058 . . . . 0.0 112.321 179.025 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.521 ' N ' ' O ' ' A' ' 27' ' ' CYS . 96.7 mt -104.82 111.79 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.046 178.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.616 ' N ' ' O ' ' A' ' 59' ' ' ILE . 79.3 tt0 -89.55 148.02 23.62 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.56 ' CG1' ' NH1' ' A' ' 5' ' ' ARG . 3.7 tp -112.31 138.75 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-O 121.106 0.479 . . . . 0.0 111.979 -178.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.422 ' O ' ' C ' ' A' ' 55' ' ' GLU . 25.8 m80 -115.93 -178.71 3.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.26 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 54' ' ' HIS . 94.1 mt-10 -37.54 -51.88 1.17 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.922 -178.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -145.96 30.4 1.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.644 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -144.17 155.18 43.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.17 0.51 . . . . 0.0 111.554 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.847 ' C ' HD12 ' A' ' 59' ' ' ILE . . . -114.05 131.01 56.53 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.936 178.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.847 HD12 ' C ' ' A' ' 58' ' ' ALA . 1.9 mp -124.55 144.29 34.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.317 0.58 . . . . 0.0 111.421 -178.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.72 HD12 ' O ' ' A' ' 50' ' ' LYS . 50.2 tp -105.83 144.92 31.89 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.858 -177.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.437 ' ND1' ' HB3' ' A' ' 79' ' ' PRO . 94.6 m-70 -133.3 78.54 1.79 Allowed 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.529 0.681 . . . . 0.0 109.912 179.118 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -64.94 136.57 56.98 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.569 -1.196 . . . . 0.0 111.278 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -112.33 -33.48 6.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.723 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 40.7 t -58.05 136.14 57.11 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.964 0.411 . . . . 0.0 111.802 -177.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.3 p -109.25 -48.15 3.3 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.732 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.1 p -64.45 -33.89 76.92 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.438 0.637 . . . . 0.0 109.707 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -138.65 79.84 27.76 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.122 179.358 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.21 149.16 51.15 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.582 1.521 . . . . 0.0 112.463 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.9 m -63.83 154.65 32.92 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -125.52 151.8 45.87 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.868 -177.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.704 ' HB ' HD11 ' A' ' 76' ' ' ILE . 9.0 p -136.22 136.57 49.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.169 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 51.69 17.95 0.66 Allowed 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.219 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.404 ' N ' ' C ' ' A' ' 71' ' ' VAL . . . 94.47 -9.2 71.76 Favored Glycine 0 CA--C 1.525 0.691 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.548 178.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 91.3 p -84.61 177.38 8.09 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.4 t -108.05 138.54 34.08 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 CA-C-O 121.418 0.628 . . . . 0.0 109.911 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.704 HD11 ' HB ' ' A' ' 71' ' ' VAL . 80.1 mt -105.08 84.19 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.939 -178.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -66.87 -37.51 84.57 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.983 0.42 . . . . 0.0 110.815 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.462 ' CD ' ' N ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -132.51 174.57 4.55 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.561 -179.614 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.437 ' HB3' ' ND1' ' A' ' 61' ' ' HIS . 41.0 Cg_exo -58.26 138.52 86.32 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 121.781 1.654 . . . . 0.0 111.253 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 26.9 m -140.5 161.64 24.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.031 0.444 . . . . 0.0 110.996 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.472 ' C ' HD23 ' A' ' 82' ' ' LEU . 44.2 ttm180 -98.68 135.35 40.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.356 178.429 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.866 ' N ' HD23 ' A' ' 82' ' ' LEU . 0.1 OUTLIER -111.06 141.0 45.14 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.9 -179.508 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.631 ' N ' ' OD2' ' A' ' 86' ' ' ASP . 74.8 mmtt -87.94 159.11 18.47 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.412 ' ND1' ' HA ' ' A' ' 98' ' ' GLU . 29.7 t60 -55.29 141.3 36.24 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.966 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.01 3.78 82.56 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.455 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.631 ' OD2' ' N ' ' A' ' 83' ' ' LYS . 95.6 m-20 -76.72 153.11 35.36 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.015 0.436 . . . . 0.0 111.396 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.411 HG13 ' O ' ' A' ' 87' ' ' VAL . 7.7 p -119.97 131.34 72.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.376 -178.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 87.4 mt -108.22 133.81 52.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.543 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 95.1 m -126.28 129.61 49.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.176 0.512 . . . . 0.0 112.346 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 1.027 HG22 ' H ' ' A' ' 91' ' ' ILE . 94.4 mt -97.58 -153.51 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.098 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 1.027 ' H ' HG22 ' A' ' 90' ' ' ILE . 92.2 mt -62.98 -44.91 99.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 118.861 0.755 . . . . 0.0 111.494 -179.364 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 91' ' ' ILE . 95.6 m-20 -141.88 6.45 1.8 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -123.49 156.61 35.28 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.239 -179.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.1 p -136.88 150.96 48.56 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.11 -0.636 . . . . 0.0 112.258 -179.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.444 ' CE2' ' OG1' ' A' ' 9' ' ' THR . 65.3 m-85 -139.34 149.86 44.68 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.509 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.467 ' HD2' HD11 ' A' ' 10' ' ' ILE . 81.2 mtp180 -117.51 142.78 46.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.066 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.609 ' CE2' ' HB3' ' A' ' 58' ' ' ALA . 1.1 t80 -112.14 104.03 12.23 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.35 -0.386 . . . . 0.0 109.963 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.412 ' HA ' ' ND1' ' A' ' 84' ' ' HIS . 4.1 tt0 -113.04 126.46 55.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.893 -178.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -124.17 85.92 2.49 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.146 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 C--N 1.331 -0.227 0 CA-C-O 120.845 0.355 . . . . 0.0 110.901 -179.958 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.457 ' O ' ' C ' ' A' ' 2' ' ' TRP . 98.8 mtp . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.457 ' C ' ' O ' ' A' ' 1' ' ' MET . 6.6 m0 35.78 62.09 2.67 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.335 -179.587 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -73.95 153.35 47.3 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 C-N-CA 123.08 2.52 . . . . 0.0 112.587 -179.472 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 96.9 m -114.69 130.45 56.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.138 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.603 HH22 ' C ' ' A' ' 56' ' ' GLN . 99.5 mtt180 -126.1 144.03 50.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.126 -179.609 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -144.41 146.07 32.29 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.901 -179.608 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.634 HD23 HD21 ' A' ' 22' ' ' LEU . 1.9 mm? -90.86 139.68 30.52 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.869 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.503 ' O ' ' N ' ' A' ' 96' ' ' ARG . 48.4 t -121.74 132.82 69.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.1 0.476 . . . . 0.0 110.908 -179.233 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 57.9 m -114.26 126.74 55.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.239 -179.79 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.881 HG23 ' O ' ' A' ' 15' ' ' VAL . 92.7 mt -80.84 115.12 22.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.439 -179.406 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -67.6 -46.06 73.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.694 179.383 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.41 ' O ' ' CG2' ' A' ' 10' ' ' ILE . 86.6 mtm180 -135.4 150.48 49.91 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.742 178.801 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 91.0 p -56.74 124.4 18.3 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.464 -0.494 . . . . 0.0 109.864 179.646 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.53 7.21 60.55 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 -179.642 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.881 ' O ' HG23 ' A' ' 10' ' ' ILE . 9.0 t -128.13 152.71 36.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.692 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.519 ' O ' ' O ' ' A' ' 17' ' ' GLY . 46.4 p-10 -97.19 8.05 45.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.161 0.505 . . . . 0.0 111.006 -179.483 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.584 ' H ' HG12 ' A' ' 15' ' ' VAL . . . 29.75 -155.94 0.0 OUTLIER Glycine 0 CA--C 1.534 1.274 0 CA-C-N 115.267 -0.878 . . . . 0.0 112.292 179.187 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -78.73 161.85 27.34 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 123.199 2.599 . . . . 0.0 113.103 -179.211 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -112.4 156.25 22.82 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.754 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.604 ' CE1' ' O ' ' A' ' 21' ' ' PRO . 51.1 t80 -119.97 126.4 26.89 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.451 -179.605 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.604 ' O ' ' CE1' ' A' ' 20' ' ' PHE . 97.0 Cg_endo -75.69 146.47 30.3 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 121.988 1.792 . . . . 0.0 111.694 179.69 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.634 HD21 HD23 ' A' ' 7' ' ' LEU . 96.2 mt -91.35 83.01 5.41 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.596 -0.441 . . . . 0.0 110.508 179.676 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.9 m -60.87 -41.72 96.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.142 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.2 mt -119.11 150.85 39.32 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.388 179.769 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.57 ' O ' HD12 ' A' ' 53' ' ' ILE . 84.3 p -58.51 -40.69 83.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.035 0.445 . . . . 0.0 110.412 -179.781 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.5 p -85.69 115.0 23.1 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.571 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.406 ' SG ' ' CD2' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -95.75 130.93 42.52 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 119.798 -0.761 . . . . 0.0 110.294 179.262 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.512 HD23 ' HA ' ' A' ' 35' ' ' CYS . 58.7 tp -118.84 137.04 53.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.036 -179.211 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -109.14 142.28 40.14 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.923 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.85 155.99 7.69 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 119.589 -1.291 . . . . 0.0 112.661 179.309 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 76.4 ttt-85 -66.85 -40.2 87.82 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.534 -0.833 . . . . 0.0 111.416 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -57.22 157.15 13.19 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.649 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.9 tt -66.51 -33.09 61.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.938 0.399 . . . . 0.0 111.215 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -52.58 -18.75 1.89 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.39 -178.987 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.512 ' HA ' HD23 ' A' ' 28' ' ' LEU . 0.8 OUTLIER -84.23 130.35 34.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.077 0.465 . . . . 0.0 111.62 -179.389 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.443 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 92.6 m-20 -62.53 -39.59 94.07 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.347 178.929 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.8 mm -102.75 80.2 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.807 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -65.56 130.12 42.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.926 -177.997 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.434 HG21 HG21 ' A' ' 44' ' ' VAL . 89.4 mt -115.81 124.6 72.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.163 -179.611 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -88.31 79.99 7.63 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 119.572 -0.851 . . . . 0.0 111.432 -179.443 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.657 HD12 ' HE ' ' A' ' 93' ' ' ARG . 4.2 mt -157.26 112.24 1.89 Allowed Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.281 178.412 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -51.8 -32.68 47.29 Favored 'Trans proline' 0 N--CA 1.5 1.874 0 C-N-CA 121.983 1.789 . . . . 0.0 113.13 -179.45 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.5 m -64.68 -29.83 48.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.076 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.434 HG21 HG21 ' A' ' 39' ' ' ILE . 98.4 t -72.09 146.85 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 120.848 0.356 . . . . 0.0 110.475 -179.768 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.6 t -85.65 164.56 17.62 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.24 -179.669 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.411 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 68.2 mttm -62.8 -38.54 91.1 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.158 0.504 . . . . 0.0 109.85 179.566 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.413 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 89.2 mt-30 -124.52 58.55 1.21 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.453 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.834 ' CD2' HG23 ' A' ' 90' ' ' ILE . 13.9 t60 -61.59 -51.71 67.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.393 -0.822 . . . . 0.0 112.17 -177.351 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.578 ' SG ' HD12 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -148.52 158.09 43.89 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.47 179.894 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.575 ' O ' ' N ' ' A' ' 61' ' ' HIS . 72.0 tttt -140.57 129.83 23.71 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.348 -178.24 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.685 ' CG2' ' HB1' ' A' ' 58' ' ' ALA . 89.0 mt -100.12 99.28 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 176.9 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.566 ' N ' ' O ' ' A' ' 59' ' ' ILE . 83.6 tt0 -81.65 120.73 25.46 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.798 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.57 HD12 ' O ' ' A' ' 25' ' ' SER . 78.5 mt -101.29 122.25 53.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.297 0.57 . . . . 0.0 111.168 -178.57 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.476 ' O ' ' C ' ' A' ' 55' ' ' GLU . 6.1 p80 -110.87 -166.93 1.12 Allowed 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.672 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.476 ' C ' ' O ' ' A' ' 54' ' ' HIS . 95.3 mt-10 -22.91 -60.99 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.505 -0.77 . . . . 0.0 113.006 -177.663 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.603 ' C ' HH22 ' A' ' 5' ' ' ARG . 95.7 mt-30 -145.56 26.29 1.29 Allowed 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -178.14 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.418 ' HB3' ' NE2' ' A' ' 54' ' ' HIS . 43.3 tp10 -153.94 152.79 30.99 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 118.994 -1.082 . . . . 0.0 112.511 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.685 ' HB1' ' CG2' ' A' ' 51' ' ' ILE . . . -93.17 134.76 35.02 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.915 178.837 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.566 ' O ' ' N ' ' A' ' 52' ' ' GLU . 31.6 mm -125.98 126.92 70.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.346 -178.847 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.8 tp -74.05 145.44 44.48 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.668 -179.602 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.575 ' N ' ' O ' ' A' ' 50' ' ' LYS . 12.9 m-70 -141.35 78.81 1.66 Allowed 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.104 179.453 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' A' ' 64' ' ' SER . 7.4 t30 -68.56 134.73 50.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.103 -179.338 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.502 ' CE1' ' O ' ' A' ' 61' ' ' HIS . 23.4 m-85 -107.08 -36.58 6.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.383 179.114 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.488 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 13.9 m -63.02 137.93 58.41 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.948 -178.475 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.6 p -104.83 -53.88 2.6 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.377 179.287 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.2 p -62.29 -47.11 85.77 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.961 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.574 ' OD1' ' N ' ' A' ' 67' ' ' ASN . 0.2 OUTLIER -114.46 78.96 5.08 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.669 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -72.67 151.13 51.77 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.035 1.823 . . . . 0.0 112.84 -178.95 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.9 m -71.54 157.97 37.07 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.481 -0.782 . . . . 0.0 108.983 179.244 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -123.61 141.79 51.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.89 0.376 . . . . 0.0 111.503 -178.026 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.582 HG12 ' ND2' ' A' ' 72' ' ' ASN . 54.8 t -128.9 129.25 68.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.868 179.339 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.582 ' ND2' HG12 ' A' ' 71' ' ' VAL . 71.1 m-20 51.14 30.63 5.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.869 179.569 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.4 22.55 60.24 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.075 178.918 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.2 t -128.73 140.7 51.61 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.567 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.411 HG12 ' N ' ' A' ' 76' ' ' ILE . 58.8 t -69.34 149.51 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-O 121.359 0.599 . . . . 0.0 111.596 -178.882 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.411 ' N ' HG12 ' A' ' 75' ' ' VAL . 36.6 mm -108.05 92.49 2.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.413 -179.328 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -67.51 -39.72 85.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.051 0.453 . . . . 0.0 110.343 179.171 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.43 ' O ' HG13 ' A' ' 80' ' ' VAL . 0.4 OUTLIER -146.24 174.75 3.16 Favored Pre-proline 0 N--CA 1.463 0.188 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.533 -179.569 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.06 137.72 69.85 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 121.78 1.653 . . . . 0.0 111.304 -179.379 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.43 HG13 ' O ' ' A' ' 78' ' ' GLU . 29.4 m -135.45 160.9 39.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.848 -179.385 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -82.91 136.88 34.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.638 179.648 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 75.0 mt -102.57 139.47 38.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.324 0.583 . . . . 0.0 111.539 -179.533 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.549 ' N ' ' OD2' ' A' ' 86' ' ' ASP . 88.0 tttt -106.7 155.13 19.99 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.159 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' HIS . . . . . 0.739 ' CE1' ' H ' ' A' ' 99' ' ' ASN . 32.2 t60 -62.47 138.58 58.49 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.559 -178.754 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.17 4.0 78.39 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 121.137 -0.554 . . . . 0.0 111.94 179.6 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.549 ' OD2' ' N ' ' A' ' 83' ' ' LYS . 98.0 m-20 -75.66 155.13 36.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.961 0.38 . . . . 0.0 110.778 179.85 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.1 p -118.04 128.52 75.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 179.322 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.612 ' O ' ' N ' ' A' ' 95' ' ' PHE . 13.4 mt -110.29 133.71 54.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.556 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.641 HG23 ' O ' ' A' ' 93' ' ' ARG . 25.4 m -131.07 131.51 44.28 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.833 -179.118 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.867 HG22 ' H ' ' A' ' 91' ' ' ILE . 6.3 mm -83.74 -145.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.472 -0.785 . . . . 0.0 108.993 178.72 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.867 ' H ' HG22 ' A' ' 90' ' ' ILE . 83.2 mt -63.22 -44.13 99.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -179.817 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.507 ' OD1' ' O ' ' A' ' 91' ' ' ILE . 99.8 m-20 -142.77 10.16 1.79 Allowed 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -179.226 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.657 ' HE ' HD12 ' A' ' 41' ' ' LEU . 93.7 mtt-85 -125.91 146.0 50.03 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.858 -179.343 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.2 m -102.06 137.36 40.44 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.095 179.759 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.612 ' N ' ' O ' ' A' ' 88' ' ' ILE . 24.0 m-85 -128.67 146.54 50.85 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.931 179.338 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.726 ' HD2' HD11 ' A' ' 10' ' ' ILE . 71.7 mtp85 -127.47 142.99 51.26 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.074 0.464 . . . . 0.0 111.685 -179.07 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.553 ' C ' ' CD1' ' A' ' 97' ' ' TYR . 0.1 OUTLIER -111.98 115.63 29.26 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.963 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -119.79 117.18 27.51 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.43 -177.63 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.739 ' H ' ' CE1' ' A' ' 84' ' ' HIS . 53.9 t-20 -98.46 111.82 24.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.178 179.418 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 . . . . . 0 N--CA 1.463 0.198 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.685 179.487 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.9 ttp . . . . . 0 N--CA 1.488 1.471 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -92.43 162.92 28.46 Favored Pre-proline 0 C--N 1.331 -0.231 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.439 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.23 147.77 60.59 Favored 'Trans proline' 0 C--N 1.302 -1.882 0 C-N-CA 122.734 2.29 . . . . 0.0 112.345 -179.439 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 44.5 p -114.21 18.79 16.82 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.95 -179.591 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.57 ' NH2' ' O ' ' A' ' 55' ' ' GLU . 84.4 mtt85 -107.06 135.59 48.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.899 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -130.39 136.28 48.9 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.301 -179.68 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.5 HD12 ' O ' ' A' ' 96' ' ' ARG . 8.7 tp -118.73 132.22 56.15 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.013 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.551 ' O ' ' N ' ' A' ' 96' ' ' ARG . 53.4 t -130.33 150.94 35.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.823 -178.047 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.487 HG22 ' N ' ' A' ' 10' ' ' ILE . 30.0 m -86.78 161.18 18.52 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.521 179.336 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.595 ' O ' ' N ' ' A' ' 15' ' ' VAL . 7.6 mt -110.36 136.1 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -179.207 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.595 ' N ' ' HB2' ' A' ' 16' ' ' ASP . 7.7 mttp -80.75 -167.69 1.48 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.309 179.605 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 59.3 ttm-85 50.23 -82.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -179.177 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.577 ' N ' ' O ' ' A' ' 11' ' ' LYS . 16.7 m -60.16 -40.74 90.98 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 179.064 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.493 ' C ' ' O ' ' A' ' 10' ' ' ILE . . . -129.29 -135.78 3.99 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 178.954 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.595 ' N ' ' O ' ' A' ' 10' ' ' ILE . 22.0 m -134.58 93.06 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.01 0.433 . . . . 0.0 111.706 178.925 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.624 ' OD1' ' N ' ' A' ' 17' ' ' GLY . 54.8 t0 -69.98 -168.86 0.23 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 177.954 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.624 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . 113.65 -82.77 0.31 Allowed Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 179.417 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -73.64 152.6 48.26 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.819 2.346 . . . . 0.0 112.79 -179.52 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -118.06 162.56 17.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.321 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.488 ' CZ ' ' O ' ' A' ' 36' ' ' ASP . 26.5 t80 -128.21 91.98 42.83 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.347 179.379 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -60.38 146.22 97.1 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.226 1.951 . . . . 0.0 110.591 178.258 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.473 ' N ' HD12 ' A' ' 22' ' ' LEU . 6.7 mp -98.77 114.26 26.72 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.438 -179.209 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.4 p -110.42 -2.4 16.61 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.449 179.806 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.2 mt -125.15 151.59 45.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.61 -179.523 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 80.2 p -79.2 -3.95 48.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.016 0.436 . . . . 0.0 110.335 179.65 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.3 p -133.34 115.07 14.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.54 179.817 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.9 m -101.27 129.36 47.22 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.474 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.506 HD23 ' HA ' ' A' ' 35' ' ' CYS . 54.7 tp -122.12 137.27 54.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.263 0.554 . . . . 0.0 112.029 -177.973 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 8.3 m-85 -105.23 144.07 32.52 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.611 179.531 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 158.35 166.38 17.43 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 119.177 -1.487 . . . . 0.0 113.357 179.184 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.627 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 88.2 mtm-85 -67.25 -37.67 83.89 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 114.94 -0.63 . . . . 0.0 110.856 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.56 147.6 48.72 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.032 -178.345 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.437 ' C ' ' N ' ' A' ' 35' ' ' CYS . 20.0 tt -63.56 -36.82 77.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.23 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.412 ' N ' HG23 ' A' ' 33' ' ' ILE . 52.8 tp10 -45.38 -23.21 0.18 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.782 179.895 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.506 ' HA ' HD23 ' A' ' 28' ' ' LEU . 58.7 m -74.49 131.75 41.29 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.655 179.494 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.488 ' O ' ' CZ ' ' A' ' 20' ' ' PHE . 39.0 t0 -62.04 -37.03 83.4 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.63 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.1 mm -108.1 88.23 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.547 178.996 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 75.5 ttt-85 -72.8 134.52 44.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.697 -178.222 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.518 HG21 HG21 ' A' ' 44' ' ' VAL . 98.6 mt -124.69 126.83 72.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.212 178.891 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.619 ' O ' HD12 ' A' ' 41' ' ' LEU . 51.0 tt0 -94.17 80.76 4.03 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.455 179.937 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.619 HD12 ' O ' ' A' ' 40' ' ' GLN . 0.8 OUTLIER -156.65 115.94 2.08 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.922 179.287 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -52.77 -33.57 60.92 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 121.9 1.733 . . . . 0.0 112.672 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.563 ' CG2' HD23 ' A' ' 41' ' ' LEU . 19.2 m -63.01 -36.75 77.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.97 -179.172 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.627 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 59.3 t -71.91 135.76 27.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.1 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.9 m -74.36 170.03 16.47 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -178.472 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.41 -37.3 86.75 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.108 179.377 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.408 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 97.8 mt-30 -133.57 59.32 1.74 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.99 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.684 ' NE2' HG23 ' A' ' 90' ' ' ILE . 12.5 t60 -58.49 -50.39 73.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.492 -1.231 . . . . 0.0 112.852 -176.651 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.475 ' SG ' ' N ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -150.26 156.51 41.7 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.088 -179.404 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.566 ' O ' ' N ' ' A' ' 61' ' ' HIS . 74.4 tttt -138.97 126.24 21.47 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.26 -179.414 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.4 mt -103.44 106.22 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.992 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.596 ' N ' ' O ' ' A' ' 59' ' ' ILE . 85.4 tt0 -79.71 123.28 27.53 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.365 -179.466 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.459 ' N ' HD12 ' A' ' 53' ' ' ILE . 1.7 mp -92.94 124.86 45.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.327 -179.801 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.2 m80 -105.88 174.27 5.96 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.354 179.342 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.57 ' O ' ' NH2' ' A' ' 5' ' ' ARG . 95.6 mt-10 -41.16 -42.72 2.11 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -178.609 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.419 ' HA ' HH21 ' A' ' 5' ' ' ARG . 87.1 mt-30 -144.06 22.49 1.73 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.275 -0.57 . . . . 0.0 112.227 -179.412 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.0 tp10 -151.09 152.21 33.09 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 119.887 -0.725 . . . . 0.0 111.654 -179.655 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.839 ' C ' HD12 ' A' ' 59' ' ' ILE . . . -113.9 134.14 55.0 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.713 179.068 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.839 HD12 ' C ' ' A' ' 58' ' ' ALA . 1.8 mp -124.33 129.19 74.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 112.883 0.698 . . . . 0.0 112.883 -177.711 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.584 ' HB2' HD11 ' A' ' 82' ' ' LEU . 49.1 tp -76.52 144.87 39.48 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.916 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.566 ' N ' ' O ' ' A' ' 50' ' ' LYS . 19.3 m-70 -140.62 79.04 1.68 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.122 179.422 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.415 ' OD1' ' OG ' ' A' ' 64' ' ' SER . 10.5 t30 -71.71 131.58 43.34 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.553 -179.168 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.498 ' CE1' ' O ' ' A' ' 61' ' ' HIS . 15.7 m-85 -105.16 -34.03 8.07 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.461 179.045 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.415 ' OG ' ' OD1' ' A' ' 62' ' ' ASN . 16.7 p -57.35 133.82 55.47 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.687 -178.406 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.0 p -102.3 -52.38 3.14 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.094 179.263 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.7 m -62.67 -46.73 86.82 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.368 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -121.46 83.76 41.09 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.227 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.47 148.4 54.17 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.576 1.517 . . . . 0.0 112.268 -178.968 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.3 m -63.35 156.2 26.54 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.973 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.487 ' O ' ' N ' ' A' ' 89' ' ' THR . 86.1 mt-30 -124.56 141.77 51.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.228 0.537 . . . . 0.0 112.374 -177.871 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.505 ' O ' ' N ' ' A' ' 74' ' ' SER . 42.8 t -126.6 133.02 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.342 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 46.1 30.58 0.98 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.075 178.921 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 78.05 18.55 76.51 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.734 -0.947 . . . . 0.0 110.734 179.886 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 71' ' ' VAL . 47.3 t -117.01 137.78 52.01 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.843 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 91.0 t -69.7 149.88 10.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.312 0.577 . . . . 0.0 111.009 -179.568 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.9 mm -108.78 90.14 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.845 -179.549 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -65.23 -41.04 94.77 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.52 179.128 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.551 ' O ' HG13 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -146.49 173.04 4.55 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.673 -179.497 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -53.56 136.72 64.96 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 121.613 1.542 . . . . 0.0 110.304 179.679 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.551 HG13 ' O ' ' A' ' 78' ' ' GLU . 28.2 m -137.76 160.31 33.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.413 -178.72 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -78.77 137.08 37.57 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.893 179.197 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.584 HD11 ' HB2' ' A' ' 60' ' ' LEU . 87.2 mt -103.6 134.3 47.17 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.28 -178.908 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.595 ' N ' ' OD2' ' A' ' 86' ' ' ASP . 99.5 mttt -92.74 152.87 19.25 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.719 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 46.1 t60 -60.39 131.03 49.5 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.121 -179.528 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.09 6.16 63.41 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 -179.468 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.595 ' OD2' ' N ' ' A' ' 83' ' ' LYS . 86.6 m-20 -74.0 156.52 37.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.977 0.417 . . . . 0.0 111.174 179.728 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 51.1 t -117.73 132.71 66.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.481 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.3 mm -100.83 130.99 49.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.666 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.487 ' N ' ' O ' ' A' ' 70' ' ' GLN . 89.1 m -132.01 126.86 34.95 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.62 179.823 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 1.072 HG22 ' H ' ' A' ' 91' ' ' ILE . 75.6 mt -101.71 -152.44 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.083 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 1.072 ' H ' HG22 ' A' ' 90' ' ' ILE . 91.6 mt -62.82 -43.63 98.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 118.644 0.656 . . . . 0.0 112.132 -178.699 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.475 ' OD1' ' O ' ' A' ' 91' ' ' ILE . 96.6 m-20 -141.07 -1.52 1.37 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 119.932 -0.707 . . . . 0.0 112.82 -179.503 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -123.74 146.35 48.36 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.171 -179.319 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.7 t -131.13 149.99 52.35 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.088 0.47 . . . . 0.0 112.083 -178.988 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -128.92 150.36 50.4 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.608 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.551 ' N ' ' O ' ' A' ' 8' ' ' VAL . 47.0 mtp180 -105.29 134.08 48.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.969 179.489 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.531 ' C ' ' CD1' ' A' ' 97' ' ' TYR . 0.8 OUTLIER -113.13 109.17 18.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.969 0.414 . . . . 0.0 110.627 -179.705 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.8 mp0 -129.18 122.12 29.12 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.816 -179.667 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -94.89 112.55 24.26 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.151 179.14 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 . . . . . 0 C--N 1.328 -0.354 0 CA-C-O 121.035 0.445 . . . . 0.0 111.166 -179.464 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.0 mtp . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.141 0.496 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' TRP . . . . . 0.485 ' CD1' ' N ' ' A' ' 2' ' ' TRP . 8.8 p-90 -156.52 57.6 1.46 Allowed Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.797 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.41 145.2 82.42 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.544 2.163 . . . . 0.0 112.363 -179.396 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 95.2 m -131.36 133.02 44.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.191 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.45 ' HE ' HG21 ' A' ' 53' ' ' ILE . 90.2 mtm-85 -80.37 132.24 35.74 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.498 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.506 ' NH2' ' CG ' ' A' ' 19' ' ' HIS . 8.8 ptm180 -143.71 146.17 32.98 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.326 -0.549 . . . . 0.0 111.275 -179.292 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.563 ' HG ' HD11 ' A' ' 22' ' ' LEU . 96.0 mt -110.14 131.58 54.93 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.584 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 43.0 t -116.59 133.15 64.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.805 -179.63 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.54 ' OG1' ' CE2' ' A' ' 95' ' ' PHE . 23.4 m -105.23 122.7 46.48 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.725 -179.319 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.59 HD11 ' HD2' ' A' ' 96' ' ' ARG . 95.2 mt -77.65 115.38 19.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.32 -179.543 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -64.26 -41.06 97.12 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.838 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.486 ' O ' ' CG2' ' A' ' 10' ' ' ILE . 78.1 ttt180 -143.77 146.7 33.31 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.365 179.144 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.1 m -61.04 134.77 57.42 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.28 -179.077 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.15 -16.72 60.61 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.333 179.144 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.54 ' O ' HG23 ' A' ' 10' ' ' ILE . 3.3 m -132.08 139.84 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 117.372 0.586 . . . . 0.0 111.796 -179.221 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.581 ' OD1' ' NH1' ' A' ' 96' ' ' ARG . 87.0 m-20 -74.33 139.55 44.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.18 179.46 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -110.69 -164.25 18.76 Favored Glycine 0 CA--C 1.533 1.177 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.805 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.02 150.03 80.96 Favored 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 123.139 2.56 . . . . 0.0 112.159 179.324 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.506 ' CG ' ' NH2' ' A' ' 6' ' ' ARG . 8.4 m-70 -96.8 173.77 7.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.141 0.496 . . . . 0.0 111.58 -178.92 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -142.21 93.08 7.34 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.01 -179.006 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -58.08 148.1 79.33 Favored 'Trans proline' 0 N--CA 1.501 1.963 0 C-N-CA 122.8 2.333 . . . . 0.0 111.683 179.544 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.665 HD13 ' CD1' ' A' ' 53' ' ' ILE . 97.2 mt -107.59 120.51 42.4 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.837 -178.576 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.475 ' C ' HD12 ' A' ' 24' ' ' LEU . 78.7 p -112.55 -20.42 11.74 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.521 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.499 ' N ' HD12 ' A' ' 24' ' ' LEU . 9.2 mp -112.17 134.84 53.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.143 179.725 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 53.3 p -65.15 -16.01 63.03 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.177 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 10.1 p -116.03 109.06 17.02 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.842 179.912 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -101.9 130.99 48.52 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.684 -0.407 . . . . 0.0 110.524 179.546 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.454 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 0.8 OUTLIER -122.01 148.06 45.29 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.035 0.445 . . . . 0.0 111.762 -179.156 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.503 ' CE2' HG21 ' A' ' 37' ' ' ILE . 10.3 m-85 -111.86 144.78 40.61 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.524 -178.451 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 143.65 169.32 12.66 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 120.243 -0.98 . . . . 0.0 112.28 178.364 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -64.56 -36.05 82.98 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.341 -0.429 . . . . 0.0 112.0 -179.622 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.425 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -48.87 147.25 5.59 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.446 -0.883 . . . . 0.0 111.355 -178.464 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.744 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -66.78 -39.98 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.636 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.496 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 22.1 pt-20 -56.07 -12.91 1.65 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.645 -179.479 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 17.4 m -74.82 124.17 26.35 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.987 -179.761 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.454 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 88.8 m-20 -62.22 -38.95 91.14 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.583 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.503 HG21 ' CE2' ' A' ' 29' ' ' PHE . 4.0 mm -108.24 79.95 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.728 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -68.61 131.89 45.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.909 -178.265 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.61 HG21 HG21 ' A' ' 44' ' ' VAL . 96.6 mt -122.54 124.36 70.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.813 179.447 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.661 ' O ' HD12 ' A' ' 41' ' ' LEU . 29.6 mm100 -92.95 80.43 4.6 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.098 179.896 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.661 HD12 ' O ' ' A' ' 40' ' ' GLN . 0.8 OUTLIER -156.27 126.15 3.27 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.007 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -63.98 -24.31 67.29 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.467 1.445 . . . . 0.0 113.064 -178.029 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.8 m -70.24 -32.82 52.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.541 -0.463 . . . . 0.0 111.439 -179.692 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.61 HG21 HG21 ' A' ' 39' ' ' ILE . 98.5 t -73.82 138.99 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.9 t -77.69 164.36 25.35 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.406 -0.517 . . . . 0.0 110.574 -179.309 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.42 -38.82 85.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.202 -179.393 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -127.51 59.97 1.43 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.437 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.724 ' CD2' HG23 ' A' ' 90' ' ' ILE . 12.1 t60 -58.77 -52.97 63.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.329 -1.305 . . . . 0.0 112.643 -176.991 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.515 ' SG ' HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -148.99 160.9 42.88 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.393 -179.459 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.574 ' O ' ' N ' ' A' ' 61' ' ' HIS . 77.6 tttt -145.16 125.66 14.05 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.956 -178.842 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.0 mt -99.34 98.52 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.509 178.539 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.596 ' N ' ' O ' ' A' ' 59' ' ' ILE . 85.4 tt0 -78.43 114.28 17.19 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.665 ' CD1' HD13 ' A' ' 22' ' ' LEU . 75.3 mt -103.26 122.21 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.346 -178.275 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.633 ' CE1' ' H ' ' A' ' 57' ' ' GLU . 9.8 p80 -110.83 158.7 18.4 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.575 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -37.66 -22.83 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -178.105 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.533 ' N ' ' O ' ' A' ' 54' ' ' HIS . 87.4 mt-30 -107.21 -37.55 6.24 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -177.423 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.633 ' H ' ' CE1' ' A' ' 54' ' ' HIS . 63.6 tt0 -157.33 165.67 35.17 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 118.122 -1.431 . . . . 0.0 113.272 -177.128 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.548 ' HB3' ' CE2' ' A' ' 97' ' ' TYR . . . -89.53 130.78 35.8 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.477 178.223 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.596 ' O ' ' N ' ' A' ' 52' ' ' GLU . 40.8 mm -124.7 127.51 72.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.813 -178.057 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.754 ' CD2' HD13 ' A' ' 76' ' ' ILE . 48.8 tp -78.56 149.1 33.11 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.912 0.386 . . . . 0.0 111.796 -179.34 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.574 ' N ' ' O ' ' A' ' 50' ' ' LYS . 13.8 m-70 -143.32 78.92 1.62 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.478 179.251 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -71.38 137.92 48.76 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.431 -179.633 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.517 ' CE1' ' O ' ' A' ' 61' ' ' HIS . 14.9 m-85 -111.49 -34.69 6.02 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.698 178.983 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.2 m -59.69 140.64 56.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.956 -178.102 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.3 t -105.11 -60.66 1.58 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.697 -179.818 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.8 m -61.31 -48.83 79.55 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.805 -179.751 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.403 ' OD1' ' N ' ' A' ' 67' ' ' ASN . 0.1 OUTLIER -114.81 79.4 5.82 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.189 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.87 151.93 36.24 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.257 1.971 . . . . 0.0 112.051 -178.944 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.469 HG22 ' N ' ' A' ' 70' ' ' GLN . 99.4 m -61.05 165.76 4.02 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 178.131 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.469 ' N ' HG22 ' A' ' 69' ' ' THR . 83.7 mt-30 -136.42 148.03 47.57 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.264 -0.575 . . . . 0.0 111.511 -177.799 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.958 HG23 HD11 ' A' ' 76' ' ' ILE . 42.0 t -127.34 131.22 70.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.016 179.016 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 48.63 30.19 2.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.631 179.512 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.14 -3.8 86.61 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.4 -0.905 . . . . 0.0 111.005 -179.73 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 61.9 p -82.74 174.03 11.35 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.492 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.2 t -112.84 139.94 35.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.571 0.701 . . . . 0.0 109.928 179.137 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.958 HD11 HG23 ' A' ' 71' ' ' VAL . 68.2 mt -107.52 110.12 30.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.425 -178.244 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -97.71 -4.09 37.88 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.083 179.927 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.42 ' O ' HG13 ' A' ' 80' ' ' VAL . 3.6 mt-10 -169.01 171.51 3.37 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.01 -179.583 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.4 138.06 79.05 Favored 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 122.134 1.889 . . . . 0.0 111.231 179.012 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.42 HG13 ' O ' ' A' ' 78' ' ' GLU . 33.0 m -138.51 160.14 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-O 121.225 0.536 . . . . 0.0 112.019 -179.64 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -80.19 133.28 36.02 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.748 178.797 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.524 HD11 ' HB2' ' A' ' 60' ' ' LEU . 97.4 mt -104.73 138.04 41.62 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.952 -179.865 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -102.08 157.59 16.77 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.062 179.025 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 58.0 t60 -62.44 133.31 54.83 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.647 -179.114 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 94.5 -9.1 71.74 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.211 179.427 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -65.41 147.35 53.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 117.093 0.447 . . . . 0.0 110.524 -179.866 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.428 HG22 ' HG2' ' A' ' 96' ' ' ARG . 45.1 t -114.39 131.7 65.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.333 -179.245 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.414 ' CG2' ' CG2' ' A' ' 69' ' ' THR . 57.7 mt -105.22 134.8 45.68 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 179.824 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 90.0 m -125.39 123.3 39.02 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.007 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 1.041 HG22 ' H ' ' A' ' 91' ' ' ILE . 80.2 mt -93.64 -154.58 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 177.989 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 1.041 ' H ' HG22 ' A' ' 90' ' ' ILE . 93.9 mt -63.13 -43.44 98.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 119.167 0.894 . . . . 0.0 112.355 -178.385 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -135.7 -1.96 2.45 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -178.551 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.452 HH21 HG21 ' A' ' 9' ' ' THR . 82.0 mtp180 -123.26 160.32 26.86 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.805 -179.348 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.7 m -127.55 145.35 50.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.04 179.867 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.54 ' CE2' ' OG1' ' A' ' 9' ' ' THR . 56.5 m-85 -130.49 151.03 51.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.236 -179.91 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.59 ' HD2' HD11 ' A' ' 10' ' ' ILE . 79.7 mtp180 -121.2 136.39 54.98 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.148 -179.257 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.548 ' CE2' ' HB3' ' A' ' 58' ' ' ALA . 0.7 OUTLIER -111.72 111.55 22.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.03 0.443 . . . . 0.0 109.957 -179.971 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -117.18 122.76 44.96 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.238 -178.842 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -115.21 100.15 7.93 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.484 179.1 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 . . . . . 0 C--N 1.327 -0.381 0 CA-C-O 121.1 0.476 . . . . 0.0 111.002 -179.164 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.2 mtp . . . . . 0 N--CA 1.496 1.828 0 N-CA-C 108.554 -0.906 . . . . 8.13 108.554 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.738 ' CD1' ' N ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -119.46 77.68 19.44 Favored Pre-proline 0 N--CA 1.446 -0.642 0 CA-C-N 115.225 -0.898 . . . . 6.71 110.768 -178.828 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -62.86 -24.5 74.35 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.742 1.628 . . . . 5.23 109.18 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 37.62 93.22 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 113.761 -1.563 . . . . 2.61 112.359 178.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.584 ' NH2' ' O ' ' A' ' 55' ' ' GLU . 87.0 mtt180 -105.48 99.57 9.17 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 105.592 -2.003 . . . . 2.15 105.592 176.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -99.12 145.05 27.57 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 113.812 1.041 . . . . 2.93 113.812 -175.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.541 HD12 HD21 ' A' ' 22' ' ' LEU . 48.3 mt -110.96 106.1 15.1 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 107.502 -1.296 . . . . 1.4 107.502 175.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 76.1 t -96.22 130.11 45.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.795 -0.446 . . . . 0.52 109.795 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.422 ' OG1' ' CE2' ' A' ' 95' ' ' PHE . 89.9 m -101.51 113.05 25.82 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.673 -0.694 . . . . 0.68 109.93 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 92.5 mt -66.92 120.68 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 108.171 -1.048 . . . . 0.87 108.171 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -58.41 -59.43 5.37 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.157 0.503 . . . . 2.98 109.958 -178.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 12' ' ' ARG . 6.9 ttp180 -143.74 179.85 6.9 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.333 -0.849 . . . . 5.52 109.039 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.403 ' H ' ' HG2' ' A' ' 12' ' ' ARG . 0.4 OUTLIER -66.23 101.36 0.71 Allowed 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 112.11 0.411 . . . . 3.85 112.11 -178.689 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 128.51 -25.56 4.76 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 120.125 -1.036 . . . . 2.73 115.267 177.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.67 156.34 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 118.938 1.369 . . . . 2.93 113.683 -177.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -80.27 141.75 35.23 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 114.486 -1.233 . . . . 2.09 109.987 178.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -111.14 -165.4 18.52 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.729 -0.948 . . . . 0.85 110.729 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.45 144.97 99.26 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.821 2.347 . . . . 1.11 111.688 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.424 ' CD2' ' N ' ' A' ' 19' ' ' HIS . 18.0 m170 -90.67 166.92 12.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.261 -0.427 . . . . 1.11 110.736 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.503 ' CZ ' ' O ' ' A' ' 36' ' ' ASP . 63.2 t80 -138.02 91.86 12.91 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.45 111.443 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.39 143.99 99.5 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 122.47 2.113 . . . . 0.89 111.443 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.541 HD21 HD12 ' A' ' 7' ' ' LEU . 83.0 mt -93.46 111.94 23.72 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.165 -0.614 . . . . 1.33 111.232 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.4 m -101.33 -22.82 14.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.817 -0.629 . . . . 1.32 109.341 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 89.4 mt -113.42 144.84 42.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.393 -0.822 . . . . 1.63 110.475 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.0 p -67.04 -16.8 64.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.004 -0.544 . . . . 0.57 110.784 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.5 p -118.28 122.58 43.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.473 -0.33 . . . . 0.52 111.352 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.419 ' SG ' ' CD2' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -105.29 127.59 53.03 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.136 -0.484 . . . . 1.08 110.515 179.306 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.457 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 53.0 tp -118.78 141.47 48.6 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.153 -0.476 . . . . 0.67 110.993 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.545 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 14.7 m-85 -111.03 144.65 39.81 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.804 -0.634 . . . . 0.38 111.199 -178.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.473 ' HA3' ' O ' ' A' ' 46' ' ' LYS . . . 144.03 168.89 12.62 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.169 -1.015 . . . . 0.34 113.142 178.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -64.16 -40.53 96.32 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.681 -0.759 . . . . 3.04 111.386 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -48.45 139.08 12.23 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.117 -0.793 . . . . 0.47 111.117 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.6 tt -64.78 -26.48 40.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.206 0.527 . . . . 1.23 109.72 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.1 -16.68 54.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.506 -0.77 . . . . 1.68 110.579 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 15.9 m -78.66 130.72 36.18 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.82 0.343 . . . . 0.42 110.761 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.503 ' O ' ' CZ ' ' A' ' 20' ' ' PHE . 25.7 m-20 -62.58 -36.56 83.07 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 109.061 -0.718 . . . . 1.4 109.061 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.463 ' CG2' ' CE2' ' A' ' 95' ' ' PHE . 3.3 mm -106.34 83.49 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.146 -0.934 . . . . 0.48 109.029 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -66.4 130.11 42.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.016 -0.993 . . . . 2.4 111.412 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 97.3 mt -125.28 127.54 72.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.968 -0.56 . . . . 0.36 110.513 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -97.5 81.17 2.93 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.364 -0.534 . . . . 2.71 110.972 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -156.36 116.3 2.14 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.733 -0.667 . . . . 1.36 109.574 178.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -50.96 -36.78 54.69 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 122.559 2.173 . . . . 0.72 113.225 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.45 ' HB ' HD13 ' A' ' 91' ' ' ILE . 26.9 m -62.89 -39.54 85.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.832 -0.347 . . . . 0.4 111.565 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.1 t -68.57 140.91 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 110.158 -0.312 . . . . 0.43 110.158 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.8 m -82.37 163.95 21.37 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.271 0.471 . . . . 1.22 112.271 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.473 ' O ' ' HA3' ' A' ' 30' ' ' GLY . 98.7 mttt -62.56 -40.8 98.01 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.374 0.607 . . . . 2.09 109.965 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -124.14 56.49 1.25 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 107.802 -1.184 . . . . 1.55 107.802 178.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.726 ' NE2' HG23 ' A' ' 90' ' ' ILE . 16.9 t60 -60.31 -51.3 70.11 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.576 -1.193 . . . . 0.27 112.256 -177.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.545 ' SG ' ' CD1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -149.55 160.32 43.58 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.597 -0.441 . . . . 1.2 110.887 -179.245 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.608 ' O ' ' N ' ' A' ' 61' ' ' HIS . 70.0 tttt -143.37 131.83 22.26 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.969 -0.559 . . . . 1.39 112.063 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.41 HD11 ' CD1' ' A' ' 88' ' ' ILE . 90.8 mt -105.65 112.89 40.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.893 -0.594 . . . . 0.87 109.609 178.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.423 ' N ' ' O ' ' A' ' 59' ' ' ILE . 81.3 tt0 -95.15 115.1 26.99 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.592 -0.521 . . . . 1.47 109.592 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -78.88 132.67 31.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.593 -0.731 . . . . 1.34 111.683 -178.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.476 ' N ' ' O ' ' A' ' 57' ' ' GLU . 13.2 m-70 -114.05 173.91 6.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.368 -0.833 . . . . 1.96 110.247 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.584 ' O ' ' NH2' ' A' ' 5' ' ' ARG . 80.3 mm-40 -37.75 -42.3 0.57 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.514 -0.766 . . . . 2.29 111.176 -179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.464 ' HA ' ' NH2' ' A' ' 5' ' ' ARG . 99.3 mt-30 -145.97 13.27 1.29 Allowed 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.757 -0.377 . . . . 2.62 111.886 -179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.476 ' O ' ' N ' ' A' ' 54' ' ' HIS . 80.3 mm-40 -140.86 151.07 44.03 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 119.918 -0.713 . . . . 2.33 112.866 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.599 ' HB3' ' CE2' ' A' ' 97' ' ' TYR . . . -106.45 128.68 54.25 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 108.027 -1.101 . . . . 0.36 108.027 177.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.423 ' O ' ' N ' ' A' ' 52' ' ' GLU . 41.6 mm -118.4 126.31 74.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.568 -0.453 . . . . 0.66 111.951 -177.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.649 ' CD2' HD13 ' A' ' 76' ' ' ILE . 4.6 tp -78.73 145.73 34.31 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.996 -0.547 . . . . 0.86 110.887 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.608 ' N ' ' O ' ' A' ' 50' ' ' LYS . 33.7 m-70 -137.74 78.64 1.7 Allowed 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.35 0.595 . . . . 0.44 109.577 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.769 ' ND2' ' H ' ' A' ' 69' ' ' THR . 25.4 t-20 -71.46 133.33 45.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.097 -0.956 . . . . 1.15 112.195 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.534 ' CE1' ' O ' ' A' ' 61' ' ' HIS . 14.5 m-85 -108.87 -29.6 8.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.504 -0.771 . . . . 0.39 110.732 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.6 t -64.92 136.82 57.28 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.203 -0.453 . . . . 1.37 111.749 -178.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.9 p -104.08 -54.69 2.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.918 -0.583 . . . . 1.4 110.96 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.29 -46.89 86.74 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.86 0.362 . . . . 1.24 110.532 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.565 ' OD1' ' N ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -118.29 80.59 16.07 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.36 -0.607 . . . . 1.16 109.36 179.298 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -73.5 149.93 45.13 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.463 2.109 . . . . 0.31 112.902 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.769 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 92.6 m -65.76 162.59 18.39 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.073 -1.084 . . . . 0.29 108.073 178.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.453 ' N ' HG22 ' A' ' 69' ' ' THR . 98.3 mt-30 -130.24 147.19 51.94 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.428 -0.509 . . . . 0.81 112.151 -177.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.972 HG23 HD11 ' A' ' 76' ' ' ILE . 41.9 t -128.8 131.77 68.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.541 -0.754 . . . . 0.91 110.453 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 46.52 29.67 0.95 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.062 -0.517 . . . . 1.18 110.71 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.56 20.16 69.51 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.457 -0.657 . . . . 0.62 111.457 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 71' ' ' VAL . 29.3 t -118.22 130.96 56.38 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.091 -0.337 . . . . 1.36 110.091 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 49.4 t -66.38 143.93 15.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.425 0.631 . . . . 0.79 110.734 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.972 HD11 HG23 ' A' ' 71' ' ' VAL . 70.4 mt -107.59 110.06 30.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 114.871 -1.059 . . . . 0.91 111.361 -178.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -76.51 -43.24 40.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.037 0.446 . . . . 1.9 110.675 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.419 ' O ' HG13 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -142.63 175.29 3.01 Favored Pre-proline 0 C--N 1.332 -0.16 0 CA-C-N 115.618 -0.719 . . . . 1.83 109.489 -179.354 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -51.98 137.89 52.71 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 121.861 1.707 . . . . 0.29 110.99 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.419 HG13 ' O ' ' A' ' 78' ' ' GLU . 17.7 m -134.71 162.78 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 121.293 0.568 . . . . 0.34 112.102 -178.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 6.4 ttt180 -84.98 141.72 30.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.393 -0.821 . . . . 2.49 110.345 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 13.0 mt -112.64 148.02 35.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.367 0.603 . . . . 1.09 112.428 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -107.46 158.98 16.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.978 -1.01 . . . . 2.78 108.789 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 28.2 t60 -64.52 130.11 42.44 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.343 -0.543 . . . . 0.66 110.378 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 94.02 0.19 66.22 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.403 -0.679 . . . . 0.39 111.403 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -67.73 147.01 53.2 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.743 0.306 . . . . 1.85 110.591 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.4 t -111.97 130.1 66.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.159 -0.473 . . . . 1.22 110.711 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.41 ' CD1' HD11 ' A' ' 51' ' ' ILE . 68.5 mt -108.59 132.46 56.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.245 -0.65 . . . . 0.56 109.245 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.411 ' O ' ' N ' ' A' ' 70' ' ' GLN . 56.0 m -129.23 130.49 46.34 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.114 0.483 . . . . 0.4 111.379 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 1.041 HG22 ' H ' ' A' ' 91' ' ' ILE . 89.9 mt -97.56 -146.55 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 108.292 -1.003 . . . . 0.83 108.292 178.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 1.041 ' H ' HG22 ' A' ' 90' ' ' ILE . 89.5 mt -64.93 -44.16 96.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 118.63 0.65 . . . . 0.57 112.433 -178.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.528 ' OD1' ' O ' ' A' ' 91' ' ' ILE . 82.1 m-20 -142.65 10.17 1.81 Allowed 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.738 0.644 . . . . 1.94 112.738 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 17.3 mtp180 -129.11 158.2 39.61 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.208 -0.597 . . . . 1.93 110.816 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 69.3 m -129.06 145.05 51.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.787 -0.642 . . . . 1.31 111.514 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.463 ' CE2' ' CG2' ' A' ' 37' ' ' ILE . 57.3 m-85 -129.27 146.95 51.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.354 -0.839 . . . . 0.35 109.856 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 78.2 mtp180 -115.8 136.23 53.25 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.21 -0.45 . . . . 2.09 109.877 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.599 ' CE2' ' HB3' ' A' ' 58' ' ' ALA . 0.4 OUTLIER -110.21 106.36 15.76 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.483 -0.562 . . . . 0.48 109.483 179.53 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -117.24 123.83 47.57 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.912 -0.585 . . . . 1.91 112.507 -178.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 63.0 t-20 -110.42 102.15 10.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.296 -0.865 . . . . 1.59 109.487 178.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 . . . . . 0 C--N 1.327 -0.384 0 CA-C-O 121.034 0.445 . . . . 2.71 111.196 -179.384 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.1 mtp . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -154.93 70.49 5.77 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.957 0.408 . . . . 0.0 110.549 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.85 142.9 99.48 Favored 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 122.749 2.3 . . . . 0.0 112.239 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.4 t -145.69 161.22 40.37 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.294 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.532 HH11 HD11 ' A' ' 53' ' ' ILE . 99.5 mtt180 -68.27 138.53 55.58 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -137.34 149.83 47.3 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.051 -0.66 . . . . 0.0 111.365 -178.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 97' ' ' TYR . 67.9 mt -113.31 130.25 56.31 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.033 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.417 HG13 ' CD2' ' A' ' 19' ' ' HIS . 2.6 t -113.7 133.49 59.5 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.357 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.844 HG21 HH21 ' A' ' 93' ' ' ARG . 82.0 m -98.35 109.57 22.31 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.705 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 1.064 HD11 ' HE ' ' A' ' 96' ' ' ARG . 96.4 mt -70.32 128.27 33.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -120.16 152.66 37.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.169 0.509 . . . . 0.0 111.424 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 96.6 mtt-85 50.05 25.72 1.8 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.146 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 35.19 36.28 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.345 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -138.54 -100.82 0.52 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.1 t -72.77 141.25 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-O 120.877 0.37 . . . . 0.0 110.055 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -63.74 138.49 58.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.041 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -101.17 -163.87 27.59 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.49 146.52 94.8 Favored 'Trans proline' 0 C--N 1.302 -1.897 0 C-N-CA 123.282 2.655 . . . . 0.0 111.968 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.417 ' CD2' HG13 ' A' ' 8' ' ' VAL . 7.5 m170 -96.69 174.36 6.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.002 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -134.13 120.65 15.16 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.562 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -73.99 151.89 45.47 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 122.123 1.882 . . . . 0.0 112.487 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.522 ' CD1' ' SG ' ' A' ' 27' ' ' CYS . 47.5 tp -109.48 122.09 46.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.37 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.1 p -130.4 -43.0 1.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.008 0.432 . . . . 0.0 110.458 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.609 ' N ' HD22 ' A' ' 24' ' ' LEU . 3.9 mm? -80.14 140.74 36.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.395 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 77.5 p -66.56 -20.35 66.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.283 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.484 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 7.3 p -120.6 115.05 22.65 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.724 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.522 ' SG ' ' CD1' ' A' ' 22' ' ' LEU . 1.7 m -98.63 123.32 42.76 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.908 0.385 . . . . 0.0 110.105 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.429 HD21 ' HG2' ' A' ' 47' ' ' GLN . 58.9 tp -114.78 140.36 48.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.742 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.532 ' CE1' HD13 ' A' ' 51' ' ' ILE . 6.9 m-85 -110.24 147.65 33.39 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.774 -177.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 138.4 168.94 11.44 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.752 178.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 77.0 mtp85 -63.85 -40.27 96.18 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.149 -0.526 . . . . 0.0 111.568 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.566 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -46.72 148.81 2.49 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.479 HG23 ' N ' ' A' ' 34' ' ' GLU . 20.1 tt -66.4 -39.33 83.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.479 ' N ' HG23 ' A' ' 33' ' ' ILE . 14.1 pt-20 -54.94 -10.14 0.45 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.903 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.566 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 3.5 m -81.09 120.34 24.7 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.484 ' OD2' ' O ' ' A' ' 26' ' ' THR . 98.7 m-20 -62.09 -34.61 76.63 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.426 HG21 ' CE2' ' A' ' 29' ' ' PHE . 3.4 mm -108.42 83.89 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.596 178.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -66.86 130.6 43.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.372 -177.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.685 HG21 HG21 ' A' ' 44' ' ' VAL . 96.9 mt -122.36 127.23 75.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.081 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.686 ' O ' HD12 ' A' ' 41' ' ' LEU . 94.9 mt-30 -97.99 81.51 2.86 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.632 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.686 HD12 ' O ' ' A' ' 40' ' ' GLN . 0.9 OUTLIER -154.91 118.55 2.51 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.953 179.515 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -52.14 -33.63 54.76 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.725 1.617 . . . . 0.0 112.121 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.566 ' CG2' HD23 ' A' ' 41' ' ' LEU . 29.2 m -64.14 -37.61 80.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.809 -179.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.685 HG21 HG21 ' A' ' 39' ' ' ILE . 64.7 t -74.24 142.04 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.153 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.2 m -82.8 166.44 19.01 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.854 0.359 . . . . 0.0 111.54 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -62.13 -39.23 91.87 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.426 0.632 . . . . 0.0 109.364 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.429 ' HG2' HD21 ' A' ' 28' ' ' LEU . 88.2 mt-30 -125.36 58.28 1.29 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.679 ' NE2' HG23 ' A' ' 90' ' ' ILE . 13.2 t60 -59.74 -50.62 73.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.828 -177.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.653 ' SG ' ' N ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -152.96 165.23 36.19 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.392 -0.523 . . . . 0.0 111.151 -179.625 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.653 ' N ' ' SG ' ' A' ' 49' ' ' CYS . 70.4 tttt -141.59 129.8 22.23 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.836 -179.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.532 HD13 ' CE1' ' A' ' 29' ' ' PHE . 1.3 mp -103.68 103.56 15.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.422 178.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 59' ' ' ILE . 78.9 tt0 -86.33 135.56 33.48 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.532 HD11 HH11 ' A' ' 5' ' ' ARG . 4.1 tp -91.82 124.76 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.353 -178.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.546 ' CD2' HD13 ' A' ' 59' ' ' ILE . 14.5 m-70 -113.48 144.02 43.54 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.247 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -36.64 -52.52 0.88 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.081 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 64.1 tp60 -79.83 -38.13 33.57 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.401 ' O ' ' N ' ' A' ' 54' ' ' HIS . 93.6 mt-10 -153.26 -171.16 3.83 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.077 0.465 . . . . 0.0 111.675 -179.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.837 ' C ' HD12 ' A' ' 59' ' ' ILE . . . -107.84 144.78 34.55 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.837 HD12 ' C ' ' A' ' 58' ' ' ALA . 2.0 mp -124.74 134.73 66.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -178.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.617 ' HB2' HD11 ' A' ' 82' ' ' LEU . 8.6 tt -82.07 152.29 26.66 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.979 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.544 ' N ' ' O ' ' A' ' 50' ' ' LYS . 23.8 m-70 -144.4 78.72 1.59 Allowed 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 121.372 0.606 . . . . 0.0 110.378 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.761 ' ND2' ' H ' ' A' ' 69' ' ' THR . 23.7 t-20 -70.62 133.24 46.52 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.032 -0.986 . . . . 0.0 112.728 -179.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.471 ' CE2' ' O ' ' A' ' 61' ' ' HIS . 20.3 m-85 -112.28 -14.26 13.36 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.572 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.437 ' OG ' ' ND2' ' A' ' 62' ' ' ASN . 25.3 p -74.04 148.97 41.48 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.814 0.34 . . . . 0.0 111.041 -178.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.4 m -115.11 -59.34 2.03 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.069 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.1 p -64.67 -33.42 75.9 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.457 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.462 ' OD1' ' N ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -127.02 82.1 68.71 Favored Pre-proline 0 C--N 1.332 -0.168 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.356 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -74.81 147.43 34.78 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 121.882 1.721 . . . . 0.0 112.678 -178.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.761 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 59.6 m -67.38 162.58 22.64 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.44 ' N ' HG22 ' A' ' 69' ' ' THR . 84.7 mt-30 -131.83 147.07 52.46 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.079 -0.648 . . . . 0.0 111.706 -178.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.937 HG23 HD11 ' A' ' 76' ' ' ILE . 22.8 t -127.17 131.91 70.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.122 178.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.409 ' ND2' HG12 ' A' ' 87' ' ' VAL . 9.9 m120 49.51 26.0 1.56 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.237 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.4 -7.69 81.04 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.276 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.509 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 24.2 p -84.71 174.29 10.03 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 54.2 t -108.53 139.86 29.34 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-O 121.552 0.691 . . . . 0.0 109.823 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.937 HD11 HG23 ' A' ' 71' ' ' VAL . 73.3 mt -105.5 116.62 49.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.236 -178.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 21.0 p-10 -110.37 2.31 18.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.25 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.407 ' O ' HG13 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -171.32 169.66 3.06 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.274 -179.417 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.47 138.78 81.21 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 121.511 1.474 . . . . 0.0 111.283 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.407 HG13 ' O ' ' A' ' 78' ' ' GLU . 28.3 m -137.74 157.85 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.136 0.493 . . . . 0.0 112.017 -178.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -81.3 135.91 35.74 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.412 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.617 HD11 ' HB2' ' A' ' 60' ' ' LEU . 75.9 mt -109.03 127.6 54.24 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.164 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.608 ' N ' ' OD2' ' A' ' 86' ' ' ASP . 98.4 mttt -84.67 159.99 20.45 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.42 178.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.717 ' CE1' ' H ' ' A' ' 99' ' ' ASN . 71.0 t60 -64.86 131.15 45.94 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.568 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.0 8.08 76.39 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.369 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.608 ' OD2' ' N ' ' A' ' 83' ' ' LYS . 91.9 m-20 -72.71 164.44 26.53 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 117.007 0.403 . . . . 0.0 110.455 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.409 HG12 ' ND2' ' A' ' 72' ' ' ASN . 3.2 p -123.78 133.84 68.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-O 121.108 0.48 . . . . 0.0 111.025 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 88.0 mt -107.72 132.88 54.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.853 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.408 ' O ' ' N ' ' A' ' 70' ' ' GLN . 73.7 m -128.78 127.49 42.1 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.262 0.553 . . . . 0.0 111.59 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 1.034 HG22 ' H ' ' A' ' 91' ' ' ILE . 78.3 mt -97.79 -150.46 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 1.034 ' H ' HG22 ' A' ' 90' ' ' ILE . 86.9 mt -62.71 -44.66 99.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 119.293 0.952 . . . . 0.0 112.987 -178.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -143.47 18.2 1.87 Allowed 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 119.694 -0.802 . . . . 0.0 112.502 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.844 HH21 HG21 ' A' ' 9' ' ' THR . 78.4 mtp180 -136.74 162.31 33.54 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.476 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 57.7 m -132.83 145.72 51.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.774 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -130.8 145.69 52.04 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.852 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 1.064 ' HE ' HD11 ' A' ' 10' ' ' ILE . 89.5 mtt180 -108.56 137.29 46.76 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.302 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.609 ' CZ ' ' HB3' ' A' ' 58' ' ' ALA . 3.2 t80 -117.93 105.73 12.22 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -134.74 140.39 45.9 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 120.397 -0.521 . . . . 0.0 111.362 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.717 ' H ' ' CE1' ' A' ' 84' ' ' HIS . 83.0 m-20 -117.23 124.3 48.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.706 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 C--N 1.33 -0.277 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.115 179.073 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.6 mtp . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.64 ' CD2' ' N ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER 52.17 53.16 12.32 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.305 0.574 . . . . 0.0 111.051 179.885 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 2' ' ' TRP . 44.8 Cg_endo -67.96 -26.6 37.42 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.937 2.425 . . . . 0.0 112.502 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.8 p -132.99 172.51 12.53 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.814 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.666 HH21 ' CG2' ' A' ' 53' ' ' ILE . 86.0 mtm-85 -67.59 147.24 53.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.153 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 63.1 ttm-85 -135.75 142.3 44.95 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.994 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 97' ' ' TYR . 16.4 tp -112.05 132.04 55.06 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.585 HG11 ' HE ' ' A' ' 96' ' ' ARG . 48.6 t -119.22 133.63 65.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.944 0.402 . . . . 0.0 110.885 -178.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.404 ' OG1' ' CE2' ' A' ' 95' ' ' PHE . 98.1 m -104.41 116.44 32.13 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.492 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.624 HG23 ' O ' ' A' ' 15' ' ' VAL . 92.5 mt -79.42 124.41 37.62 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 CA-C-O 121.077 0.465 . . . . 0.0 110.266 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -65.24 -48.84 71.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.881 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.774 ' O ' HG22 ' A' ' 15' ' ' VAL . 36.0 ptt180 -154.55 154.59 33.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.66 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.406 ' O ' HG21 ' A' ' 10' ' ' ILE . 78.7 p 44.39 -127.52 0.99 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.954 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -119.3 67.29 0.39 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.774 HG22 ' O ' ' A' ' 12' ' ' ARG . 33.9 m -129.24 163.62 33.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.831 0.348 . . . . 0.0 110.537 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.427 ' C ' ' OD1' ' A' ' 16' ' ' ASP . 60.9 t0 -81.8 115.54 21.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.241 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -108.01 -152.49 16.88 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -60.89 144.59 99.6 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 122.747 2.298 . . . . 0.0 112.305 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 8.3 m170 -103.18 169.77 8.36 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.962 0.41 . . . . 0.0 110.747 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.596 ' CZ ' ' O ' ' A' ' 36' ' ' ASP . 31.5 t80 -149.69 92.97 4.08 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.367 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -58.3 140.63 95.12 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 121.546 1.497 . . . . 0.0 110.299 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.542 HD13 HG12 ' A' ' 53' ' ' ILE . 94.5 mt -91.48 88.1 6.66 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.947 0.403 . . . . 0.0 111.485 -178.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 70.7 m -90.14 -18.9 24.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.548 178.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.559 HD12 ' OD1' ' A' ' 36' ' ' ASP . 85.7 mt -113.4 139.88 48.53 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.769 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 86.1 p -68.22 -17.86 64.42 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.489 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.448 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 39.6 p -116.61 109.14 16.82 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.993 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.448 ' O ' ' N ' ' A' ' 51' ' ' ILE . 3.4 t -99.59 119.03 37.41 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.147 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.459 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 4.2 tt -116.82 149.86 39.31 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.126 0.489 . . . . 0.0 112.308 -178.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -113.23 138.54 49.84 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.929 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 158.68 167.22 19.15 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 119.432 -1.366 . . . . 0.0 113.155 178.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -65.21 -36.53 84.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.661 -0.769 . . . . 0.0 111.11 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.467 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -59.55 145.21 45.3 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.54 ' C ' ' H ' ' A' ' 35' ' ' CYS . 18.7 tt -66.38 -38.8 82.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.901 0.381 . . . . 0.0 110.13 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.427 ' N ' HG23 ' A' ' 33' ' ' ILE . 22.2 pt-20 -48.0 -11.01 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.967 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.54 ' H ' ' C ' ' A' ' 33' ' ' ILE . 25.4 m -82.4 131.71 35.22 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.051 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.596 ' O ' ' CZ ' ' A' ' 20' ' ' PHE . 56.4 m-20 -62.38 -38.04 88.08 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.9 mm -110.53 87.42 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.704 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -71.43 129.96 40.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.08 -179.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.57 HG21 HG21 ' A' ' 44' ' ' VAL . 96.7 mt -118.3 121.82 68.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.739 179.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.543 ' O ' HD12 ' A' ' 41' ' ' LEU . 86.9 mt-30 -97.19 81.41 3.03 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.559 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.543 HD12 ' O ' ' A' ' 40' ' ' GLN . 1.1 tp -154.83 129.87 5.08 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.065 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -65.27 -21.74 61.4 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 121.745 1.63 . . . . 0.0 112.525 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.53 ' CG2' HD23 ' A' ' 41' ' ' LEU . 33.9 m -71.73 -29.41 34.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.031 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.57 HG21 HG21 ' A' ' 39' ' ' ILE . 95.6 t -85.14 160.64 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 120.924 -0.311 . . . . 0.0 110.203 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.549 ' N ' HG12 ' A' ' 44' ' ' VAL . 7.9 t -98.17 160.89 14.0 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.891 -179.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -62.39 -39.77 94.3 Favored 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -122.71 74.69 1.21 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 178.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.742 ' NE2' HG23 ' A' ' 90' ' ' ILE . 24.5 t60 -76.16 -66.92 0.74 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.778 -177.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 21.1 p -155.36 173.06 17.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.423 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -155.84 139.56 16.09 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 119.073 -1.051 . . . . 0.0 112.765 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.555 HD11 ' CD1' ' A' ' 88' ' ' ILE . 88.7 mt -100.02 109.53 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.519 177.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 59' ' ' ILE . 93.8 mt-10 -86.3 120.79 28.03 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.666 ' CG2' HH21 ' A' ' 5' ' ' ARG . 1.5 mp -88.18 125.82 41.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.829 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -110.43 177.3 4.73 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.202 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -40.19 -45.22 2.0 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.3 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -146.07 21.73 1.4 Allowed 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.631 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.596 ' OE2' ' NH2' ' A' ' 81' ' ' ARG . 90.9 mt-10 -143.26 148.37 36.29 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.517 0.675 . . . . 0.0 112.407 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.469 ' HB1' ' CG2' ' A' ' 51' ' ' ILE . . . -112.44 126.8 55.69 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 177.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.415 ' O ' ' N ' ' A' ' 52' ' ' GLU . 50.3 mm -120.01 130.31 74.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.928 0.394 . . . . 0.0 111.158 -177.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.603 ' HB2' HD11 ' A' ' 82' ' ' LEU . 31.2 tp -90.99 140.28 29.98 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.996 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -135.32 78.4 1.73 Allowed 'General case' 0 C--O 1.231 0.103 0 CA-C-O 121.393 0.616 . . . . 0.0 109.512 178.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.744 ' ND2' ' H ' ' A' ' 69' ' ' THR . 23.9 t-20 -62.7 135.93 57.62 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.82 -179.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -105.88 -33.56 7.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.074 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.9 m -66.18 140.72 58.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.492 -177.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.9 p -109.06 -53.5 2.64 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.979 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.0 m -62.99 -45.69 91.22 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.205 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.486 ' OD1' ' N ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -119.62 78.88 21.84 Favored Pre-proline 0 C--N 1.331 -0.23 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.598 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -75.14 147.21 33.11 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.251 1.967 . . . . 0.0 113.7 -178.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.744 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 85.3 m -63.29 160.8 15.07 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.408 ' N ' HG22 ' A' ' 69' ' ' THR . 82.6 mt-30 -130.1 148.9 52.0 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.755 -177.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.958 HG23 HD11 ' A' ' 76' ' ' ILE . 24.4 t -126.31 127.74 70.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.159 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.411 ' ND2' ' OD1' ' A' ' 86' ' ' ASP . 73.5 m-20 46.68 31.33 1.36 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.225 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 84.04 15.39 69.89 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 121.111 -0.566 . . . . 0.0 111.812 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.2 t -115.41 134.69 54.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.964 0.411 . . . . 0.0 110.63 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 74.8 t -66.77 145.68 13.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.511 0.672 . . . . 0.0 111.007 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.958 HD11 HG23 ' A' ' 71' ' ' VAL . 95.5 mt -110.25 114.1 46.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.205 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -94.87 -27.03 15.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.107 0.48 . . . . 0.0 110.342 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -147.87 171.79 5.92 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.452 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.9 139.46 84.34 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 121.596 1.531 . . . . 0.0 111.169 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 31.5 m -134.7 161.28 40.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 120.969 0.414 . . . . 0.0 111.35 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.596 ' NH2' ' OE2' ' A' ' 57' ' ' GLU . 72.9 ttt180 -87.82 138.58 31.33 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.737 ' CD2' HD11 ' A' ' 88' ' ' ILE . 5.4 mp -104.08 136.8 43.04 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.042 0.449 . . . . 0.0 111.05 -178.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -96.57 169.97 9.53 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -68.41 131.85 46.02 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 119.949 -0.701 . . . . 0.0 109.995 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.81 18.21 66.11 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.411 ' OD1' ' ND2' ' A' ' 72' ' ' ASN . 28.8 t70 -74.24 149.48 40.78 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.83 0.348 . . . . 0.0 110.771 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 39.6 t -115.6 131.61 67.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.335 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.737 HD11 ' CD2' ' A' ' 82' ' ' LEU . 83.0 mt -118.52 133.88 63.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.977 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 96.5 m -129.83 129.01 43.46 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.774 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 1.039 HG22 ' H ' ' A' ' 91' ' ' ILE . 39.4 mt -94.34 -145.48 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 178.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 1.039 ' H ' HG22 ' A' ' 90' ' ' ILE . 90.2 mt -62.98 -44.55 99.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 118.693 0.678 . . . . 0.0 112.097 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.449 ' OD2' HD21 ' A' ' 41' ' ' LEU . 45.4 p-10 -148.16 17.91 1.08 Allowed 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.246 -0.581 . . . . 0.0 111.624 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.51 ' NE ' HG23 ' A' ' 39' ' ' ILE . 96.6 mtt-85 -123.67 154.46 39.36 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.581 -0.447 . . . . 0.0 110.57 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.5 p -125.24 131.9 53.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.122 0.487 . . . . 0.0 111.475 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.404 ' CE2' ' OG1' ' A' ' 9' ' ' THR . 88.4 m-85 -130.05 145.49 51.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.286 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.585 ' HE ' HG11 ' A' ' 8' ' ' VAL . 20.6 ptt85 -134.54 130.83 37.17 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.476 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.416 ' CE2' ' HB3' ' A' ' 58' ' ' ALA . 2.8 t80 -99.32 127.26 45.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.402 -178.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -142.83 135.85 28.17 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.352 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -119.5 105.45 11.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.107 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.544 ' OE1' ' CD1' ' A' ' 2' ' ' TRP . 98.2 mt-10 . . . . . 0 C--N 1.328 -0.352 0 CA-C-O 120.935 0.398 . . . . 0.0 110.843 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.459 ' O ' ' CG ' ' A' ' 2' ' ' TRP . 98.6 mtp . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.459 ' CG ' ' O ' ' A' ' 1' ' ' MET . 30.5 m95 -167.97 66.47 0.75 Allowed Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -71.09 145.36 49.35 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.79 2.327 . . . . 0.0 112.957 -178.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 65.2 p -120.12 19.66 12.2 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.236 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 -97.74 134.4 40.96 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.637 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -137.43 143.69 41.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.879 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.512 HD12 ' HA ' ' A' ' 97' ' ' TYR . 9.9 tp -109.62 129.87 55.55 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 51.0 t -117.47 139.33 44.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.138 0.494 . . . . 0.0 111.452 -177.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.477 ' OG1' ' CE2' ' A' ' 95' ' ' PHE . 93.7 m -108.65 119.15 38.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.106 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 86.1 mt -81.06 124.74 39.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.854 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.429 ' O ' ' C ' ' A' ' 12' ' ' ARG . 88.1 tttt -75.02 140.48 43.61 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.875 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.429 ' C ' ' O ' ' A' ' 11' ' ' LYS . 80.6 ttt180 37.21 -98.91 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.064 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.406 ' N ' ' O ' ' A' ' 11' ' ' LYS . 13.9 t -163.79 121.88 1.87 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.263 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.72 -18.04 55.6 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.954 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.7 m -122.07 131.15 73.78 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-O 121.262 0.553 . . . . 0.0 111.063 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -68.87 138.2 54.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.243 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -101.52 -163.83 27.25 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -60.33 146.08 97.31 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 C-N-CA 122.959 2.439 . . . . 0.0 112.262 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -95.02 165.86 12.22 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -140.1 89.76 10.93 Favored Pre-proline 0 C--N 1.329 -0.29 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.247 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -57.95 144.73 93.7 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.055 1.837 . . . . 0.0 110.685 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 92.1 mt -93.65 121.64 35.29 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.501 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.494 ' C ' HD12 ' A' ' 24' ' ' LEU . 74.9 p -133.92 -12.97 2.53 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.187 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.501 ' N ' HD12 ' A' ' 24' ' ' LEU . 11.1 mp -104.94 142.17 35.25 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.963 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 57.9 p -65.28 -19.73 66.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.196 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 22.3 p -132.25 129.65 39.9 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.282 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.3 m -103.89 130.56 51.5 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.836 0.35 . . . . 0.0 110.154 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.492 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 44.3 tp -123.83 134.84 53.53 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.314 0.578 . . . . 0.0 111.312 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.451 ' N ' ' CD1' ' A' ' 29' ' ' PHE . 9.0 m-85 -106.41 151.34 25.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.533 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 147.77 159.66 8.52 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 120.052 -1.071 . . . . 0.0 112.805 178.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -66.91 -40.03 87.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.446 -0.877 . . . . 0.0 111.066 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.452 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -54.86 151.86 14.47 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.2 tt -65.17 -26.81 40.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.873 0.368 . . . . 0.0 111.219 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -59.1 -27.53 65.65 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.503 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 0.5 OUTLIER -69.35 130.99 44.09 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.77 0.319 . . . . 0.0 111.467 -179.345 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.492 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 45.1 m-20 -64.53 -35.51 81.2 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 178.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.0 mm -106.89 80.73 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.221 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -65.84 132.02 47.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.133 0.492 . . . . 0.0 110.729 -178.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 98.1 mt -117.56 125.28 73.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.088 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.53 ' O ' HD22 ' A' ' 41' ' ' LEU . 83.4 mt-30 -90.58 81.72 5.88 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 119.819 -0.752 . . . . 0.0 111.253 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.934 HD12 HG22 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -155.88 110.3 2.14 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.423 178.383 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.582 ' HD2' HD13 ' A' ' 41' ' ' LEU . 71.0 Cg_exo -50.12 -36.56 45.86 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 121.886 1.724 . . . . 0.0 112.933 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.934 HG22 HD12 ' A' ' 41' ' ' LEU . 18.9 m -72.32 9.77 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.495 HG12 ' N ' ' A' ' 45' ' ' SER . 38.4 t -105.25 161.37 5.06 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.495 ' N ' HG12 ' A' ' 44' ' ' VAL . 9.7 t -103.33 153.23 20.66 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.955 -179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.14 -37.69 80.87 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.38 -0.528 . . . . 0.0 109.599 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.508 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 18.6 mp0 -116.3 49.52 1.13 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.712 ' CD2' HG23 ' A' ' 90' ' ' ILE . 10.5 t60 -59.83 -57.25 13.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.019 -177.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.473 ' SG ' ' N ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -141.46 155.45 45.85 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.568 179.618 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.568 ' O ' ' N ' ' A' ' 61' ' ' HIS . 81.5 tttt -141.16 124.25 16.39 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.318 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.617 ' CG2' ' HB1' ' A' ' 58' ' ' ALA . 92.8 mt -106.88 110.99 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.756 179.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -84.36 137.26 33.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.848 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.8 mm -107.87 130.82 59.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.3 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.507 ' ND1' ' N ' ' A' ' 55' ' ' GLU . 1.7 p80 -132.52 -167.72 1.94 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.521 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.507 ' N ' ' ND1' ' A' ' 54' ' ' HIS . 94.9 mt-10 -21.09 -68.27 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -176.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -146.17 28.05 1.13 Allowed 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 119.517 -0.873 . . . . 0.0 112.338 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.497 ' OE2' ' O ' ' A' ' 82' ' ' LEU . 79.2 tt0 -154.5 147.86 25.0 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 119.265 -0.974 . . . . 0.0 112.567 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.617 ' HB1' ' CG2' ' A' ' 51' ' ' ILE . . . -92.0 140.75 29.34 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.118 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 29.8 mm -125.98 128.97 72.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 121.119 -0.232 . . . . 0.0 110.39 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.418 ' HB2' HD11 ' A' ' 82' ' ' LEU . 46.1 tp -77.75 146.1 36.09 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 -178.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.621 ' O ' ' CE1' ' A' ' 63' ' ' PHE . 22.1 m-70 -142.12 78.18 1.61 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.819 179.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.721 ' ND2' ' H ' ' A' ' 69' ' ' THR . 23.6 t-20 -76.88 139.12 40.14 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.357 -178.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.621 ' CE1' ' O ' ' A' ' 61' ' ' HIS . 5.3 m-85 -109.27 -38.43 5.51 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.925 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.3 t -57.63 136.25 56.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.228 0.537 . . . . 0.0 111.885 -178.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.3 p -100.12 -56.97 2.23 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.911 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.6 p -65.11 -43.14 92.99 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.008 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.614 ' OD1' ' N ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -119.48 79.78 21.62 Favored Pre-proline 0 N--CA 1.463 0.211 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.436 ' HG2' HG13 ' A' ' 75' ' ' VAL . 83.3 Cg_endo -78.3 151.02 26.03 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 122.65 2.233 . . . . 0.0 113.209 -178.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.721 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 5.6 m -65.95 160.35 23.7 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -124.05 141.72 51.8 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -177.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.493 ' HB ' HD11 ' A' ' 76' ' ' ILE . 54.4 t -128.58 131.73 68.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.498 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.8 m120 51.57 28.3 4.55 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.33 -2.2 85.47 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 3.8 m -91.39 154.15 19.38 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.436 HG13 ' HG2' ' A' ' 68' ' ' PRO . 88.2 t -84.21 143.71 11.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.516 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.493 HD11 ' HB ' ' A' ' 71' ' ' VAL . 50.2 mm -102.32 108.52 24.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.729 -179.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 41.7 p-10 -101.28 2.62 40.0 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.788 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.463 ' O ' HG13 ' A' ' 80' ' ' VAL . 2.5 pt-20 -179.0 166.21 0.96 Allowed Pre-proline 0 C--N 1.33 -0.26 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.13 137.65 70.34 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.658 1.572 . . . . 0.0 111.427 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 78' ' ' GLU . 32.2 m -137.7 161.27 33.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.158 0.504 . . . . 0.0 110.983 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.441 ' HE ' ' CD ' ' A' ' 57' ' ' GLU . 72.0 ttt180 -82.26 134.93 35.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.817 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.497 ' O ' ' OE2' ' A' ' 57' ' ' GLU . 11.7 mt -108.04 126.46 52.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.87 0.366 . . . . 0.0 110.991 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.406 ' N ' ' OD2' ' A' ' 86' ' ' ASP . 65.3 mttm -92.58 150.31 20.81 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.637 ' CE1' ' H ' ' A' ' 99' ' ' ASN . 6.2 t60 -57.71 136.13 56.84 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.821 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.24 -3.93 66.88 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.406 ' OD2' ' N ' ' A' ' 83' ' ' LYS . 92.9 m-20 -76.95 152.95 35.07 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.9 t -116.49 132.84 64.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 120.639 -0.424 . . . . 0.0 110.874 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.616 ' CD1' HD11 ' A' ' 51' ' ' ILE . 59.3 mt -108.38 130.32 61.23 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.565 HG23 ' O ' ' A' ' 93' ' ' ARG . 24.4 m -128.67 129.99 46.58 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.091 -178.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.781 HG22 ' H ' ' A' ' 91' ' ' ILE . 9.7 mm -84.56 -147.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.781 ' H ' HG22 ' A' ' 90' ' ' ILE . 86.4 mt -63.91 -44.45 98.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 37.7 p30 -142.73 14.46 1.94 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 120.061 -0.656 . . . . 0.0 112.52 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.565 ' O ' HG23 ' A' ' 89' ' ' THR . 95.3 mtt180 -125.58 148.14 49.04 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.837 0.351 . . . . 0.0 111.121 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.7 t -112.51 126.97 55.9 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.366 0.603 . . . . 0.0 112.111 -178.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.477 ' CE2' ' OG1' ' A' ' 9' ' ' THR . 39.6 m-85 -117.23 131.72 56.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.01 178.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.425 ' H ' ' HG2' ' A' ' 96' ' ' ARG . 3.4 ptm180 -117.75 126.12 51.87 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.252 0.549 . . . . 0.0 111.234 -178.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.553 ' C ' ' CD1' ' A' ' 97' ' ' TYR . 0.2 OUTLIER -101.35 110.38 22.38 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.223 -179.138 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -121.99 136.56 54.93 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.128 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.637 ' H ' ' CE1' ' A' ' 84' ' ' HIS . 56.4 t-20 -123.35 98.29 5.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.573 178.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.242 -179.563 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.2 ttp . . . . . 0 N--CA 1.494 1.76 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -95.53 132.99 26.42 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.844 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.97 154.88 48.09 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.886 2.391 . . . . 0.0 112.685 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.5 p -101.41 4.72 41.65 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 121.58 0.705 . . . . 0.0 109.597 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.574 HH22 ' C ' ' A' ' 56' ' ' GLN . 99.7 mtt180 -133.37 135.07 44.48 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.359 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.595 ' NE ' ' OE2' ' A' ' 100' ' ' GLU . 87.8 mtm180 -144.2 151.94 40.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.202 0.525 . . . . 0.0 111.28 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.474 HD12 HD11 ' A' ' 37' ' ' ILE . 84.0 mt -112.21 136.64 51.37 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.563 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.454 HG22 ' CD2' ' A' ' 19' ' ' HIS . 54.1 t -120.82 134.82 63.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 57.5 m -106.15 118.69 37.28 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.172 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 73.3 mt -71.77 128.32 34.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.318 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.605 ' O ' ' N ' ' A' ' 13' ' ' SER . 88.0 tttt -86.69 134.24 33.61 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.851 0.358 . . . . 0.0 111.536 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 33.62 25.04 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.015 178.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.605 ' N ' ' O ' ' A' ' 11' ' ' LYS . 0.9 OUTLIER 58.55 9.36 1.08 Allowed 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.945 179.737 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -93.95 -56.76 1.37 Allowed Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.42 ' CG2' ' N ' ' A' ' 16' ' ' ASP . 2.1 p -133.71 157.77 42.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.496 ' O ' ' OD1' ' A' ' 16' ' ' ASP . 50.2 p-10 -61.82 119.41 8.72 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.049 -0.66 . . . . 0.0 109.612 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.88 -164.55 20.54 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.531 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -59.24 144.59 99.33 Favored 'Trans proline' 0 C--N 1.302 -1.911 0 C-N-CA 123.316 2.677 . . . . 0.0 111.807 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.454 ' CD2' HG22 ' A' ' 8' ' ' VAL . 37.5 m170 -88.24 172.89 9.12 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 120.769 -0.372 . . . . 0.0 110.43 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.635 ' CZ ' ' O ' ' A' ' 36' ' ' ASP . 82.9 t80 -143.23 90.58 7.28 Favored Pre-proline 0 N--CA 1.45 -0.456 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.745 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -59.55 143.35 99.7 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.185 1.923 . . . . 0.0 111.038 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.6 mt -92.85 121.18 33.96 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.425 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.8 m -112.71 -15.7 12.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.906 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.437 HD23 ' HA ' ' A' ' 24' ' ' LEU . 88.7 mt -122.15 141.19 51.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.033 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 62.5 p -64.04 -19.39 65.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.757 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.9 p -115.49 119.93 37.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.129 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.1 t -109.76 126.23 53.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.0 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.643 HD21 ' HG2' ' A' ' 47' ' ' GLN . 49.9 tp -114.27 139.48 49.38 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.839 -179.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.453 ' CE2' HG21 ' A' ' 37' ' ' ILE . 9.8 m-85 -109.52 144.75 37.37 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.077 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 144.49 171.12 14.19 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.504 178.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -63.69 -38.16 90.06 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.191 -0.504 . . . . 0.0 110.483 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -45.75 136.58 7.81 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.437 HG23 ' N ' ' A' ' 34' ' ' GLU . 20.5 tt -65.25 -36.91 78.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.094 0.473 . . . . 0.0 109.931 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.437 ' N ' HG23 ' A' ' 33' ' ' ILE . 15.6 pt-20 -57.33 -13.24 3.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.107 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.1 m -74.76 130.55 39.67 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 120.803 0.335 . . . . 0.0 110.481 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.635 ' O ' ' CZ ' ' A' ' 20' ' ' PHE . 56.4 m-20 -61.73 -39.64 92.28 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.539 ' CG2' ' CE2' ' A' ' 95' ' ' PHE . 3.8 mm -107.97 86.56 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.36 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -70.91 134.79 47.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.047 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.828 HG21 HG21 ' A' ' 44' ' ' VAL . 98.2 mt -118.99 128.07 75.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.331 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.658 ' O ' HD12 ' A' ' 41' ' ' LEU . 87.5 mt-30 -99.6 79.04 2.22 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.303 0.573 . . . . 0.0 110.681 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.658 HD12 ' O ' ' A' ' 40' ' ' GLN . 0.9 OUTLIER -157.55 127.69 3.39 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.565 179.126 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -63.39 -27.08 70.92 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.338 1.359 . . . . 0.0 112.772 -179.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.484 ' CG2' HD23 ' A' ' 41' ' ' LEU . 34.5 m -66.49 -31.14 52.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.572 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.828 HG21 HG21 ' A' ' 39' ' ' ILE . 99.4 t -75.19 156.61 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.768 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.505 ' N ' HG12 ' A' ' 44' ' ' VAL . 75.2 m -95.12 170.42 9.41 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.295 -179.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -61.54 -42.55 98.99 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.402 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.643 ' HG2' HD21 ' A' ' 28' ' ' LEU . 87.1 mt-30 -130.46 68.17 1.47 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.761 ' CD2' HG23 ' A' ' 90' ' ' ILE . 13.4 t60 -66.02 -49.9 66.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.497 -176.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.529 ' SG ' ' N ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -148.12 158.22 43.94 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.674 -0.411 . . . . 0.0 111.017 -179.427 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.589 ' O ' ' N ' ' A' ' 61' ' ' HIS . 69.1 tttt -140.8 129.51 22.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.266 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.602 HD11 ' CD1' ' A' ' 88' ' ' ILE . 91.4 mt -105.95 113.38 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.992 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 59' ' ' ILE . 84.2 tt0 -89.98 112.81 24.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.045 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.1 mp -82.43 127.39 39.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.381 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.508 ' O ' ' NH1' ' A' ' 5' ' ' ARG . 66.8 m-70 -117.65 144.53 45.12 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.192 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -42.18 -19.09 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.587 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.574 ' C ' HH22 ' A' ' 5' ' ' ARG . 64.5 tp60 -111.83 -37.91 5.0 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 120.196 -0.602 . . . . 0.0 112.327 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.441 ' N ' HH22 ' A' ' 5' ' ' ARG . 71.0 mm-40 -152.2 -174.04 4.75 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.707 0.765 . . . . 0.0 112.49 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.86 ' C ' HD12 ' A' ' 59' ' ' ILE . . . -116.15 135.81 53.58 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 114.33 -1.304 . . . . 0.0 109.488 178.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.86 HD12 ' C ' ' A' ' 58' ' ' ALA . 1.8 mp -126.22 129.85 72.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.267 0.556 . . . . 0.0 112.462 -178.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.687 ' HB2' HD11 ' A' ' 82' ' ' LEU . 7.0 tt -79.38 145.66 33.26 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.41 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.589 ' N ' ' O ' ' A' ' 50' ' ' LYS . 55.5 m-70 -136.35 79.2 1.75 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.24 0.543 . . . . 0.0 110.044 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.698 HD21 ' CB ' ' A' ' 69' ' ' THR . 0.8 OUTLIER -64.36 138.46 58.44 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.428 -179.253 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -112.93 -27.19 8.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.219 178.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.3 p -67.86 157.61 34.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.858 -178.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.3 p -129.76 -53.94 1.15 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.67 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.8 m -63.82 -48.06 78.32 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.63 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.603 ' OD1' ' N ' ' A' ' 67' ' ' ASN . 0.1 OUTLIER -117.89 80.51 14.57 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.729 179.383 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.59 147.49 40.66 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.159 1.906 . . . . 0.0 113.196 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.773 HG23 HD13 ' A' ' 90' ' ' ILE . 88.0 m -65.8 170.33 5.46 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 177.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.563 ' N ' HG22 ' A' ' 69' ' ' THR . 86.5 mt-30 -135.94 152.62 51.17 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.711 -178.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.984 HG23 HD11 ' A' ' 76' ' ' ILE . 20.1 t -127.69 129.65 70.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.395 178.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 47.85 30.37 1.9 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.986 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.52 1.19 87.86 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.7 p -87.92 173.27 9.02 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 122.688 -0.301 . . . . 0.0 110.801 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.4 t -110.16 136.1 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-O 121.506 0.67 . . . . 0.0 109.645 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.984 HD11 HG23 ' A' ' 71' ' ' VAL . 68.6 mt -104.22 116.49 48.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 114.579 -1.191 . . . . 0.0 111.238 -177.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -98.47 -11.5 22.25 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.954 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.502 ' O ' HG13 ' A' ' 80' ' ' VAL . 2.1 mt-10 -165.49 170.91 5.62 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.43 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.49 138.39 74.19 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.377 1.384 . . . . 0.0 110.625 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 78' ' ' GLU . 35.2 m -138.97 160.98 29.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.466 -0.493 . . . . 0.0 110.77 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -76.32 143.84 40.56 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.362 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.687 HD11 ' HB2' ' A' ' 60' ' ' LEU . 67.0 mt -113.86 131.06 56.4 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.31 0.576 . . . . 0.0 112.011 -178.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.631 ' N ' ' OD2' ' A' ' 86' ' ' ASP . 43.5 tttp -89.72 158.95 17.32 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.339 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.541 ' CE1' ' H ' ' A' ' 99' ' ' ASN . 28.7 t60 -71.46 133.98 46.26 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.938 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.88 -7.49 65.03 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.631 ' OD2' ' N ' ' A' ' 83' ' ' LYS . 97.0 m-20 -64.83 154.6 36.63 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.042 0.449 . . . . 0.0 111.261 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.401 ' O ' HG13 ' A' ' 87' ' ' VAL . 8.4 p -123.04 134.23 66.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.728 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.602 ' CD1' HD11 ' A' ' 51' ' ' ILE . 82.4 mt -109.2 133.42 54.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.175 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 63.5 m -127.44 127.74 44.61 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.332 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.849 HG22 ' H ' ' A' ' 91' ' ' ILE . 21.0 mm -87.83 -147.46 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.849 ' H ' HG22 ' A' ' 90' ' ' ILE . 95.9 mt -64.15 -43.98 97.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.862 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.506 ' OD1' ' O ' ' A' ' 91' ' ' ILE . 91.0 m-20 -147.8 19.92 1.15 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 121.266 -0.174 . . . . 0.0 110.969 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -126.05 145.81 50.17 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.517 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.4 m -120.48 135.73 54.98 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 121.141 0.496 . . . . 0.0 112.199 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.539 ' CE2' ' CG2' ' A' ' 37' ' ' ILE . 57.3 m-85 -129.34 151.9 49.48 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.254 178.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -121.19 143.56 49.06 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.537 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.562 ' CE2' ' HB3' ' A' ' 58' ' ' ALA . 0.4 OUTLIER -115.87 102.91 10.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.623 179.611 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -115.3 128.41 56.09 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.145 0.498 . . . . 0.0 111.979 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.541 ' H ' ' CE1' ' A' ' 84' ' ' HIS . 54.5 t-20 -102.23 104.76 15.34 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.725 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.595 ' OE2' ' NE ' ' A' ' 6' ' ' ARG . 99.1 mt-10 . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.053 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mtt . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.582 ' H ' ' CD ' ' A' ' 3' ' ' PRO . 0.4 OUTLIER -105.23 -44.56 0.15 Allowed Pre-proline 0 N--CA 1.463 0.181 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.379 -179.231 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.582 ' CD ' ' H ' ' A' ' 2' ' ' TRP . 32.6 Cg_exo -58.59 142.39 98.25 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.484 2.122 . . . . 0.0 111.909 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 93.2 m -134.5 132.43 39.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.856 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 92.3 mtm-85 -105.51 132.23 51.93 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.768 0.318 . . . . 0.0 110.32 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -141.13 149.74 41.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.92 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.6 mt -110.44 136.57 49.38 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.375 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.425 HG22 ' CD2' ' A' ' 19' ' ' HIS . 50.3 t -118.95 133.74 64.81 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.432 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.502 ' OG1' ' CE2' ' A' ' 95' ' ' PHE . 22.4 m -101.66 112.56 25.17 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.271 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.883 HD11 ' NE ' ' A' ' 96' ' ' ARG . 98.5 mt -69.83 127.64 32.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.947 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 15' ' ' VAL . 65.3 tttm -89.96 129.78 36.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.182 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.551 ' O ' ' C ' ' A' ' 13' ' ' SER . 84.5 mtp180 34.18 91.26 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.551 ' C ' ' O ' ' A' ' 12' ' ' ARG . 2.0 t -7.11 105.48 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.982 0.801 . . . . 0.0 111.515 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 131.27 -59.64 0.69 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.514 ' O ' ' N ' ' A' ' 11' ' ' LYS . 14.5 t -83.52 139.94 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-O 120.97 0.414 . . . . 0.0 111.056 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -94.87 106.74 18.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.584 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.3 -166.06 14.06 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.039 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -59.42 150.77 73.13 Favored 'Trans proline' 0 C--N 1.3 -1.974 0 C-N-CA 123.964 3.11 . . . . 0.0 113.55 -178.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.425 ' CD2' HG22 ' A' ' 8' ' ' VAL . 12.1 m170 -89.7 163.39 15.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.969 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.502 ' CE2' ' CD1' ' A' ' 37' ' ' ILE . 81.7 t80 -127.62 94.6 37.33 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.593 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -60.2 147.9 91.75 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 122.005 1.803 . . . . 0.0 111.194 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 91.3 mt -97.23 122.81 40.68 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.405 0.621 . . . . 0.0 111.875 -178.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.2 p -117.35 -31.59 5.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.216 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.0 tp -107.15 134.53 50.12 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.548 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.0 p -61.36 -38.15 85.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.511 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.456 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 12.5 p -92.01 108.66 20.1 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.994 -0.282 . . . . 0.0 110.463 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.534 ' SG ' ' CE1' ' A' ' 29' ' ' PHE . 1.1 t -90.43 124.99 35.41 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.691 HD21 HE22 ' A' ' 47' ' ' GLN . 52.7 tp -119.19 139.78 51.28 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.186 0.517 . . . . 0.0 111.735 -178.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.534 ' CE1' ' SG ' ' A' ' 27' ' ' CYS . 46.6 m-85 -110.24 145.09 37.94 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.466 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 153.51 171.24 20.5 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 119.474 -1.346 . . . . 0.0 112.81 178.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -69.62 -37.71 76.95 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.682 -0.759 . . . . 0.0 111.716 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.52 150.4 34.47 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 121.318 -0.467 . . . . 0.0 112.746 -178.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.6 tp -64.22 -27.76 43.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -58.94 -24.47 62.52 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.683 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.438 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 75.9 m -72.59 130.67 41.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.85 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.456 ' OD2' ' O ' ' A' ' 26' ' ' THR . 88.1 m-20 -61.97 -36.15 80.62 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.538 ' CG2' ' CE2' ' A' ' 95' ' ' PHE . 9.7 mm -109.5 91.57 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 114.178 -1.374 . . . . 0.0 108.695 179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -71.12 140.93 50.77 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.28 -178.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.616 HG21 HG21 ' A' ' 44' ' ' VAL . 96.5 mt -130.78 124.19 56.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.913 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -97.66 78.38 2.62 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 119.868 -0.733 . . . . 0.0 110.612 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.411 ' HA ' HD23 ' A' ' 41' ' ' LEU . 6.6 mt -155.53 114.83 2.26 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.547 179.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -52.44 -31.55 48.57 Favored 'Trans proline' 0 N--CA 1.506 2.24 0 C-N-CA 122.334 2.023 . . . . 0.0 114.233 -179.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.449 HG21 HG21 ' A' ' 91' ' ' ILE . 16.9 m -64.6 -25.02 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.616 HG21 HG21 ' A' ' 39' ' ' ILE . 39.2 t -81.43 161.49 3.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.49 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.513 ' N ' HG12 ' A' ' 44' ' ' VAL . 59.8 m -105.7 156.29 18.42 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.699 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.438 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 98.9 mttt -60.31 -37.83 81.79 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.103 0.478 . . . . 0.0 110.393 -179.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.691 HE22 HD21 ' A' ' 28' ' ' LEU . 99.1 mm-40 -114.32 49.46 1.01 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.746 ' CD2' HG23 ' A' ' 90' ' ' ILE . 18.8 t60 -57.8 -54.72 43.66 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.094 -177.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.633 ' SG ' ' N ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -152.75 165.31 35.74 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 120.636 -0.425 . . . . 0.0 111.308 -179.284 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.633 ' N ' ' SG ' ' A' ' 49' ' ' CYS . 67.1 tttt -146.74 130.35 16.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.339 -178.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.624 HD11 HD13 ' A' ' 88' ' ' ILE . 82.7 mt -105.03 103.93 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' A' ' 59' ' ' ILE . 81.5 tt0 -79.87 135.46 36.45 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.4 mm -105.0 133.58 48.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.75 0.786 . . . . 0.0 111.78 -177.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.476 ' O ' ' C ' ' A' ' 55' ' ' GLU . 87.8 m-70 -122.31 -177.97 3.76 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.312 -1.313 . . . . 0.0 109.973 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.476 ' C ' ' O ' ' A' ' 54' ' ' HIS . 80.3 mm-40 -29.21 -61.04 0.14 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.956 -178.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -145.09 27.0 1.31 Allowed 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.687 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -138.75 144.84 39.63 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 119.979 -0.688 . . . . 0.0 112.139 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.597 ' HB3' ' CE2' ' A' ' 97' ' ' TYR . . . -106.09 130.02 54.07 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.542 ' O ' ' N ' ' A' ' 52' ' ' GLU . 34.5 mm -120.11 126.77 75.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.734 0.302 . . . . 0.0 111.07 -178.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.569 ' HB2' HD11 ' A' ' 82' ' ' LEU . 9.8 tt -78.74 149.31 32.72 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.194 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.597 ' N ' ' O ' ' A' ' 50' ' ' LYS . 22.2 m-70 -141.75 80.29 1.72 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.366 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.752 ' ND2' ' H ' ' A' ' 69' ' ' THR . 28.0 t-20 -72.86 131.98 42.94 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.852 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.41 ' CE1' ' O ' ' A' ' 61' ' ' HIS . 13.7 m-85 -108.11 -27.53 10.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.969 178.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.504 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 30.3 t -58.71 145.36 40.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.709 -179.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.2 m -115.34 -55.86 2.41 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.047 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.9 p -62.99 -38.95 93.22 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.428 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.53 ' OD1' ' N ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -126.65 83.46 64.93 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.046 179.401 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -74.35 146.29 35.34 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 121.445 1.43 . . . . 0.0 113.35 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.752 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 61.6 m -62.67 160.05 14.93 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 177.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -123.82 150.31 44.68 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.624 0.25 . . . . 0.0 110.946 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.68 ' HB ' HD11 ' A' ' 76' ' ' ILE . 4.9 p -135.91 134.13 50.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.343 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.538 HD21 ' CG ' ' A' ' 86' ' ' ASP . 74.3 m-20 50.68 18.83 0.52 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.079 0.466 . . . . 0.0 110.382 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 89.07 16.18 58.1 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 41.6 t -117.02 137.33 52.3 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.195 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 79.6 t -69.84 141.1 17.59 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 CA-C-O 121.18 0.514 . . . . 0.0 110.759 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.68 HD11 ' HB ' ' A' ' 71' ' ' VAL . 79.5 mt -106.52 118.48 54.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.714 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -96.2 -28.37 14.58 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.373 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -151.39 175.4 2.9 Favored Pre-proline 0 N--CA 1.465 0.314 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -56.04 138.63 83.16 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 121.598 1.532 . . . . 0.0 111.691 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.7 m -141.11 160.13 22.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.856 0.36 . . . . 0.0 110.863 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 69.6 ttp85 -84.38 142.74 29.93 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.569 HD11 ' HB2' ' A' ' 60' ' ' LEU . 5.7 mp -116.34 141.26 48.4 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.407 -178.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -90.87 158.79 16.59 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.559 ' CE1' ' H ' ' A' ' 99' ' ' ASN . 36.2 t60 -60.25 133.46 56.12 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.983 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.18 16.25 65.18 Favored Glycine 0 CA--C 1.533 1.156 0 N-CA-C 111.581 -0.607 . . . . 0.0 111.581 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.538 ' CG ' HD21 ' A' ' 72' ' ' ASN . 45.2 t0 -82.95 120.69 26.02 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.795 0.331 . . . . 0.0 111.024 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 53.4 t -86.57 132.61 31.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 121.267 0.556 . . . . 0.0 111.445 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.624 HD13 HD11 ' A' ' 51' ' ' ILE . 5.7 mt -117.05 137.13 51.95 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 56.9 m -128.42 133.94 48.68 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.25 0.547 . . . . 0.0 112.25 -177.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.924 HG22 ' H ' ' A' ' 91' ' ' ILE . 12.6 mm -91.67 -144.66 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.924 ' H ' HG22 ' A' ' 90' ' ' ILE . 36.2 mm -62.38 -45.31 99.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.972 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.491 ' OD1' ' O ' ' A' ' 91' ' ' ILE . 78.4 m-20 -147.58 14.19 1.08 Allowed 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.45 ' HD2' HG23 ' A' ' 39' ' ' ILE . 97.0 mtt-85 -122.22 145.71 47.95 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.747 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.6 m -114.53 124.05 50.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.252 0.549 . . . . 0.0 112.088 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.538 ' CE2' ' CG2' ' A' ' 37' ' ' ILE . 56.8 m-85 -113.28 139.64 48.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.636 178.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.883 ' NE ' HD11 ' A' ' 10' ' ' ILE . 45.4 mtt-85 -107.13 139.08 42.11 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.104 -178.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.597 ' CE2' ' HB3' ' A' ' 58' ' ' ALA . 0.7 OUTLIER -109.39 107.5 17.7 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 178.795 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -119.65 138.36 53.31 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.559 ' H ' ' CE1' ' A' ' 84' ' ' HIS . 52.6 t-20 -116.04 97.8 6.28 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.506 178.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 51.7 tp10 . . . . . 0 C--N 1.33 -0.264 0 CA-C-O 120.869 0.366 . . . . 0.0 110.732 179.682 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.1 mtt . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.593 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -58.66 -43.76 98.25 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.639 -179.882 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 2' ' ' TRP . 37.3 Cg_exo -59.51 141.91 98.1 Favored 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 122.907 2.405 . . . . 0.0 112.408 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.454 HG22 ' N ' ' A' ' 5' ' ' ARG . 54.3 m -147.93 158.22 43.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.287 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.454 ' N ' HG22 ' A' ' 4' ' ' THR . 34.1 ptt180 -125.26 133.02 52.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.929 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 80.2 mtt85 -143.48 156.44 44.63 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.499 -0.481 . . . . 0.0 110.749 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.534 HD12 HD21 ' A' ' 22' ' ' LEU . 90.1 mt -109.03 136.4 48.61 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.885 -0.784 . . . . 0.0 108.885 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.474 HG22 ' CG ' ' A' ' 19' ' ' HIS . 53.4 t -115.45 128.9 72.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.046 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 87.7 m -110.24 120.04 41.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.1 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.535 HD11 ' CD ' ' A' ' 96' ' ' ARG . 14.2 mm -71.1 125.6 29.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.827 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.34 -46.0 90.65 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.176 0.512 . . . . 0.0 110.349 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.521 ' O ' HG22 ' A' ' 10' ' ' ILE . 49.1 ptt85 -143.58 -139.65 0.11 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.24 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.9 t -117.91 100.77 7.79 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.449 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.04 -20.68 4.0 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.229 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.437 ' O ' HG23 ' A' ' 10' ' ' ILE . 3.1 p -133.96 153.04 35.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.264 -0.574 . . . . 0.0 111.698 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.437 ' C ' ' OD1' ' A' ' 16' ' ' ASP . 57.8 t0 -87.24 121.38 29.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.843 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.24 -167.5 42.6 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -61.81 145.65 97.05 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 123.261 2.641 . . . . 0.0 112.28 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.474 ' CG ' HG22 ' A' ' 8' ' ' VAL . 28.2 m170 -87.87 171.15 10.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.222 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.455 ' CD2' HD13 ' A' ' 37' ' ' ILE . 87.1 t80 -134.44 97.01 14.86 Favored Pre-proline 0 C--N 1.33 -0.273 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.162 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -59.34 147.85 89.17 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 122.149 1.9 . . . . 0.0 110.732 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.538 HD13 ' CD1' ' A' ' 53' ' ' ILE . 97.9 mt -104.0 126.88 51.46 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.99 0.424 . . . . 0.0 111.931 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 92.4 p -112.01 -23.22 10.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.459 178.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 97.8 mt -116.17 144.72 43.81 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.219 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 93.5 p -67.81 -19.18 65.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.562 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.9 p -111.12 114.81 28.34 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.482 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.532 ' SG ' HD22 ' A' ' 22' ' ' LEU . 1.1 m -99.44 131.51 45.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.964 0.411 . . . . 0.0 110.82 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.506 HD21 HE22 ' A' ' 47' ' ' GLN . 62.5 tp -120.91 135.61 55.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.463 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.595 ' CE2' HG21 ' A' ' 37' ' ' ILE . 23.9 m-85 -109.49 146.75 34.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.428 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.99 169.95 18.06 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 120.222 -0.99 . . . . 0.0 112.349 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -66.57 -37.14 84.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.164 -0.518 . . . . 0.0 111.845 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.416 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -57.22 149.01 32.17 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.801 -178.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 13.5 tt -70.37 -32.36 49.99 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -53.42 -15.05 0.9 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.672 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.416 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 2.9 m -81.57 134.35 35.49 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.402 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -61.86 -36.47 81.33 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.595 HG21 ' CE2' ' A' ' 29' ' ' PHE . 3.5 mm -108.54 88.75 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 114.942 -1.026 . . . . 0.0 108.967 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -68.63 134.01 49.31 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.503 -178.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.757 HG21 HG21 ' A' ' 44' ' ' VAL . 97.0 mt -121.99 116.88 50.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.747 178.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.686 ' O ' HD22 ' A' ' 41' ' ' LEU . 61.1 tt0 -93.54 81.01 4.32 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.622 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.686 HD22 ' O ' ' A' ' 40' ' ' GLN . 0.3 OUTLIER -155.13 120.0 2.56 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -179.47 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.631 ' HD2' HD13 ' A' ' 41' ' ' LEU . 26.5 Cg_endo -60.9 -25.48 81.43 Favored 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 121.218 1.279 . . . . 0.0 114.082 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.597 HG22 HD12 ' A' ' 41' ' ' LEU . 23.9 m -68.3 -37.15 77.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.814 -0.354 . . . . 0.0 111.396 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.757 HG21 HG21 ' A' ' 39' ' ' ILE . 88.1 t -67.02 159.89 4.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.666 0.269 . . . . 0.0 110.476 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.535 ' N ' HG12 ' A' ' 44' ' ' VAL . 44.2 m -104.92 163.38 12.57 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.544 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -60.46 -41.63 94.53 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.038 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.506 HE22 HD21 ' A' ' 28' ' ' LEU . 97.0 mm-40 -117.16 58.81 0.77 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.73 ' CD2' HG23 ' A' ' 90' ' ' ILE . 13.1 t60 -65.08 -56.29 13.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.324 -177.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.556 ' SG ' ' CD1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -150.72 157.8 43.38 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.354 -179.347 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.551 ' O ' ' N ' ' A' ' 61' ' ' HIS . 29.4 tttp -140.18 127.15 20.79 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.18 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.653 HD11 ' CD1' ' A' ' 88' ' ' ILE . 95.6 mt -105.8 105.28 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.224 178.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 59' ' ' ILE . 83.3 tt0 -85.37 121.18 27.72 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 178.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.538 ' CD1' HD13 ' A' ' 22' ' ' LEU . 67.4 mt -105.22 132.55 51.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -176.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.43 ' O ' ' C ' ' A' ' 55' ' ' GLU . 50.8 m-70 -100.03 -172.67 2.27 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.042 178.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 54' ' ' HIS . 98.8 mt-10 -37.09 -49.83 0.89 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.693 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -146.21 22.83 1.35 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.574 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -131.24 140.76 49.9 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 120.35 -0.54 . . . . 0.0 112.228 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.562 ' HB3' ' CE2' ' A' ' 97' ' ' TYR . . . -102.04 124.76 48.2 Favored 'General case' 0 CA--C 1.526 0.051 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.09 178.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.512 ' O ' ' N ' ' A' ' 52' ' ' GLU . 41.2 mm -117.98 121.05 66.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.663 -178.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.587 ' HB2' HD11 ' A' ' 82' ' ' LEU . 61.2 tp -77.48 148.39 35.38 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.499 0.666 . . . . 0.0 112.146 -179.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.551 ' N ' ' O ' ' A' ' 50' ' ' LYS . 32.8 m-70 -142.39 77.91 1.6 Allowed 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.704 -1.134 . . . . 0.0 109.214 178.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.712 ' ND2' ' H ' ' A' ' 69' ' ' THR . 19.1 t-20 -75.3 127.42 33.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.124 -178.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -98.67 -34.94 10.35 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.722 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.495 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 44.3 t -58.87 142.52 50.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.482 -177.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.9 m -111.7 -55.47 2.5 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.193 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.7 p -64.28 -42.28 96.49 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.916 0.388 . . . . 0.0 110.362 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.584 ' OD1' ' N ' ' A' ' 67' ' ' ASN . 0.3 OUTLIER -121.05 78.79 33.23 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.964 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.15 152.23 39.81 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.102 1.868 . . . . 0.0 112.507 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.712 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 17.2 m -68.32 162.91 24.18 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.412 ' N ' HG22 ' A' ' 69' ' ' THR . 86.5 mt-30 -127.42 143.43 51.21 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -177.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.623 HG13 ' OD2' ' A' ' 86' ' ' ASP . 45.8 t -128.95 131.54 68.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.011 179.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.58 ' ND2' ' OD1' ' A' ' 86' ' ' ASP . 91.0 m-20 45.6 29.07 0.59 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.206 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 87.15 1.58 84.22 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.3 t -101.95 139.84 37.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.914 0.388 . . . . 0.0 110.533 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.6 t -71.76 150.88 8.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.115 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 40.3 mm -108.62 121.9 62.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.483 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 27.9 p-10 -114.26 7.3 16.45 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.885 -0.326 . . . . 0.0 110.811 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 176.41 169.1 0.4 Allowed Pre-proline 0 CA--C 1.531 0.248 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -56.39 137.04 78.76 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.762 1.641 . . . . 0.0 111.705 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.7 m -139.82 161.04 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.431 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -87.33 133.37 33.71 Favored 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.587 HD11 ' HB2' ' A' ' 60' ' ' LEU . 6.1 mp -103.66 126.74 50.99 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.162 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 84' ' ' HIS . 88.7 tttt -82.15 139.5 34.31 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.739 ' CE1' ' H ' ' A' ' 99' ' ' ASN . 41.3 t60 -40.71 132.06 2.27 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.716 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.83 1.49 73.42 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.428 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.623 ' OD2' HG13 ' A' ' 71' ' ' VAL . 23.6 t70 -61.96 148.82 42.51 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.077 0.465 . . . . 0.0 110.617 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.51 HG22 ' HG2' ' A' ' 96' ' ' ARG . 40.8 t -111.36 130.07 65.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.088 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.653 ' CD1' HD11 ' A' ' 51' ' ' ILE . 70.9 mt -114.7 132.42 63.91 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 93.3 m -130.25 120.68 24.83 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.501 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.89 HG22 ' H ' ' A' ' 91' ' ' ILE . 9.9 mm -77.57 -146.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.89 ' H ' HG22 ' A' ' 90' ' ' ILE . 95.5 mt -64.96 -44.8 96.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 120.786 -0.365 . . . . 0.0 111.418 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 21.7 p30 -142.8 13.56 1.9 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.483 ' HD2' HG23 ' A' ' 39' ' ' ILE . 98.6 mtt180 -125.98 147.79 49.43 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 120.531 -0.467 . . . . 0.0 111.021 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.16 118.57 35.7 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 121.315 0.579 . . . . 0.0 112.377 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.466 ' N ' ' O ' ' A' ' 88' ' ' ILE . 51.6 m-85 -111.78 140.0 46.79 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.672 178.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.535 ' CD ' HD11 ' A' ' 10' ' ' ILE . 72.0 mtp85 -122.01 140.88 51.94 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.629 -0.428 . . . . 0.0 111.312 -178.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.562 ' CE2' ' HB3' ' A' ' 58' ' ' ALA . 0.5 OUTLIER -114.66 113.1 23.89 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.251 -179.925 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -142.69 139.14 31.04 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 119.916 -0.713 . . . . 0.0 111.928 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.739 ' H ' ' CE1' ' A' ' 84' ' ' HIS . 94.7 m-20 -112.06 146.02 38.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.169 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 . . . . . 0 C--N 1.329 -0.291 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 179.485 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.56 ' O ' ' CE3' ' A' ' 2' ' ' TRP . 64.7 mtt . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.56 ' CE3' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER 56.79 148.54 0.05 OUTLIER Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.151 179.617 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.01 145.3 61.04 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 123.045 2.497 . . . . 0.0 112.59 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.3 m -129.3 92.8 3.43 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.736 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.472 ' HE ' ' CG1' ' A' ' 53' ' ' ILE . 92.2 mtm-85 -127.99 145.26 51.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.931 0.396 . . . . 0.0 111.407 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.545 ' NH1' ' CG2' ' A' ' 8' ' ' VAL . 67.9 ttp85 -140.3 132.36 27.89 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.168 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.514 HD12 HD21 ' A' ' 22' ' ' LEU . 31.2 mt -104.51 135.19 46.4 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.545 ' CG2' ' NH1' ' A' ' 6' ' ' ARG . 48.8 t -122.23 134.47 65.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.76 0.314 . . . . 0.0 110.209 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.598 ' OG1' ' CE2' ' A' ' 95' ' ' PHE . 92.3 m -113.31 112.94 24.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.97 0.414 . . . . 0.0 111.649 -178.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.944 HD12 ' H ' ' A' ' 10' ' ' ILE . 2.7 mp -79.59 129.98 36.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.498 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.01 -41.08 99.47 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.542 -0.463 . . . . 0.0 110.973 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -143.93 -87.93 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.638 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 36.8 t -161.56 129.69 4.25 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.452 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.76 4.78 89.52 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.089 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.586 ' O ' HG23 ' A' ' 10' ' ' ILE . 12.7 m -124.7 130.84 73.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 117.038 0.419 . . . . 0.0 110.562 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -75.59 138.49 41.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.507 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -121.54 -174.16 14.71 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.834 -0.907 . . . . 0.0 110.834 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.14 147.86 88.51 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 123.059 2.506 . . . . 0.0 111.962 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.455 ' CG ' ' NH1' ' A' ' 6' ' ' ARG . 5.3 m170 -101.17 153.7 19.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.919 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -118.35 90.87 39.65 Favored Pre-proline 0 N--CA 1.454 -0.229 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.571 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.54 144.65 99.37 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.473 2.116 . . . . 0.0 110.953 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.534 ' CD2' ' SG ' ' A' ' 27' ' ' CYS . 96.5 mt -96.38 126.38 41.54 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.481 -0.487 . . . . 0.0 111.276 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.6 m -122.4 -9.93 8.49 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.048 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.9 mt -126.92 148.43 50.04 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.314 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.6 p -70.87 -16.14 62.68 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.129 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 65.1 p -118.65 114.22 22.41 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.488 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.534 ' SG ' ' CD2' ' A' ' 22' ' ' LEU . 0.8 OUTLIER -98.51 131.97 44.32 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.257 178.666 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.461 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 59.8 tp -120.12 135.65 54.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.25 0.548 . . . . 0.0 111.583 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.471 ' CZ ' HD12 ' A' ' 37' ' ' ILE . 11.3 m-85 -103.7 144.66 31.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.989 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 150.4 151.62 5.59 Favored Glycine 0 C--O 1.224 -0.491 0 C-N-CA 120.429 -0.891 . . . . 0.0 110.956 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -70.81 -18.45 62.74 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.731 -178.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.51 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -69.99 153.34 52.03 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.433 HD12 ' HA ' ' A' ' 33' ' ' ILE . 10.7 tp -64.58 -30.28 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -54.57 -20.47 7.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.977 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.51 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 1.7 m -84.49 126.75 33.57 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.269 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.461 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 56.5 m-20 -63.25 -40.11 96.49 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.471 HD12 ' CZ ' ' A' ' 29' ' ' PHE . 0.8 OUTLIER -101.55 84.56 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-N 115.085 -0.961 . . . . 0.0 108.679 177.806 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -67.98 134.76 51.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.609 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 92.2 mt -121.74 126.0 74.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.256 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.586 ' O ' ' NH2' ' A' ' 93' ' ' ARG . 52.6 tt0 -86.97 82.18 7.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.012 0.434 . . . . 0.0 111.753 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.528 HD12 ' O ' ' A' ' 40' ' ' GLN . 1.1 tp -155.2 127.48 3.96 Favored Pre-proline 0 CA--C 1.531 0.235 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.62 -11.42 29.68 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 121.73 1.62 . . . . 0.0 112.741 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.4 m -95.78 3.18 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 120.746 0.308 . . . . 0.0 111.307 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.526 HG22 HG21 ' A' ' 90' ' ' ILE . 16.4 t -100.45 136.76 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.339 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.7 m -77.89 159.7 28.74 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.97 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.485 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 98.4 mttt -62.15 -35.75 79.74 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.075 0.464 . . . . 0.0 109.915 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -124.82 57.09 1.28 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 178.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.683 ' CD2' HG23 ' A' ' 90' ' ' ILE . 17.7 t60 -60.91 -50.67 72.47 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.969 -177.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -152.49 169.52 22.42 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.816 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 61' ' ' HIS . 27.0 tttp -147.54 134.29 20.02 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.401 -0.52 . . . . 0.0 112.359 -178.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.587 HD11 HD12 ' A' ' 88' ' ' ILE . 89.7 mt -105.59 106.6 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' A' ' 59' ' ' ILE . 86.8 tt0 -87.58 117.01 26.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.626 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.472 ' CG1' ' HE ' ' A' ' 5' ' ' ARG . 1.0 OUTLIER -86.36 129.8 37.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.153 -179.644 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.479 ' HD2' HD13 ' A' ' 59' ' ' ILE . 34.9 m-70 -115.15 179.09 4.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.755 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 54' ' ' HIS . 78.3 mm-40 -33.62 -59.63 0.39 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.887 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -139.26 27.92 2.3 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.81 -178.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.7 tp10 -152.6 151.67 30.92 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.429 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.848 ' C ' HD12 ' A' ' 59' ' ' ILE . . . -109.98 135.87 50.15 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.249 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.848 HD12 ' C ' ' A' ' 58' ' ' ALA . 1.9 mp -123.99 133.57 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 120.848 0.356 . . . . 0.0 111.665 -178.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.698 HD12 HD13 ' A' ' 88' ' ' ILE . 6.4 tt -87.32 151.48 23.07 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.033 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.526 ' N ' ' O ' ' A' ' 50' ' ' LYS . 47.9 m-70 -143.03 78.54 1.61 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.76 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.752 ' ND2' ' H ' ' A' ' 69' ' ' THR . 18.2 t-20 -66.65 133.25 49.87 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.514 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -109.81 -29.52 8.27 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.549 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.9 t -65.84 135.72 55.22 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.98 0.419 . . . . 0.0 111.703 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.0 p -101.89 -54.07 2.8 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.742 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 32.8 p -62.39 -44.15 97.14 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.555 ' OD1' ' N ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -121.78 81.47 41.43 Favored Pre-proline 0 C--N 1.328 -0.345 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.547 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -74.8 148.87 36.84 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.221 1.948 . . . . 0.0 113.3 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.752 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 51.3 m -64.12 158.34 23.11 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -125.08 156.17 38.67 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.249 0.547 . . . . 0.0 111.234 -177.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.73 ' HB ' HD11 ' A' ' 76' ' ' ILE . 9.8 p -135.58 137.75 49.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.231 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 46.14 14.96 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.16 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 71' ' ' VAL . . . 101.74 -12.61 57.92 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.797 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.473 ' N ' ' O ' ' A' ' 71' ' ' VAL . 13.4 p -83.04 170.52 14.76 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 74.0 t -99.77 137.32 27.61 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 CA-C-O 121.426 0.631 . . . . 0.0 110.13 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.73 HD11 ' HB ' ' A' ' 71' ' ' VAL . 69.7 mt -103.62 116.59 47.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.792 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -90.24 -40.77 11.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.994 179.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.83 172.07 7.16 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.138 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.15 140.77 80.92 Favored 'Trans proline' 0 N--CA 1.501 1.931 0 C-N-CA 122.539 2.159 . . . . 0.0 112.436 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 18.8 m -146.0 157.57 12.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.24 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -83.28 136.27 34.44 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.127 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 82' ' ' LEU . 6.4 mp -110.77 139.42 46.08 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.488 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -89.85 153.31 20.75 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 177.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -55.9 132.83 50.69 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.905 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 99.99 -7.97 59.14 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 111.071 -0.812 . . . . 0.0 111.071 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -72.27 143.98 48.56 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.4 m -116.33 133.22 63.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.253 0.549 . . . . 0.0 111.605 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.698 HD13 HD12 ' A' ' 60' ' ' LEU . 53.6 mt -103.02 131.83 50.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.517 HG23 ' O ' ' A' ' 93' ' ' ARG . 69.4 m -128.24 128.87 45.5 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.381 -178.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.909 HG22 ' H ' ' A' ' 91' ' ' ILE . 8.0 mm -80.86 -147.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 177.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.909 ' H ' HG22 ' A' ' 90' ' ' ILE . 91.5 mt -64.75 -44.21 96.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.624 178.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -141.65 20.5 2.18 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -178.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.586 ' NH2' ' O ' ' A' ' 40' ' ' GLN . 96.4 mtt180 -136.0 146.23 46.95 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 120.218 -0.593 . . . . 0.0 111.274 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.411 ' HB2' HD13 ' A' ' 10' ' ' ILE . 1.0 OUTLIER -109.19 135.84 49.65 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 121.178 0.513 . . . . 0.0 112.316 -178.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.598 ' CE2' ' OG1' ' A' ' 9' ' ' THR . 16.2 m-85 -123.44 136.25 54.51 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.355 -0.838 . . . . 0.0 108.958 177.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.658 ' CD ' HD11 ' A' ' 10' ' ' ILE . 70.7 mtp85 -110.09 130.05 55.6 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.935 0.398 . . . . 0.0 111.602 -178.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.586 ' CE2' ' HB3' ' A' ' 58' ' ' ALA . 0.4 OUTLIER -103.73 108.2 19.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.36 179.096 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -115.6 126.74 54.58 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.604 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -113.24 95.96 5.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.944 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 . . . . . 0 C--N 1.327 -0.385 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.797 -179.478 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.8 mtm . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -42.56 136.04 2.55 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.268 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.02 149.18 64.85 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.055 1.837 . . . . 0.0 112.301 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 95.7 m -125.62 124.89 42.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.483 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.519 ' HE ' HD11 ' A' ' 53' ' ' ILE . 89.3 mtm-85 -128.92 139.25 52.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.637 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -137.9 150.35 47.01 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.666 -0.413 . . . . 0.0 111.038 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.3 mt -112.71 134.72 54.09 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.595 HG22 ' CD2' ' A' ' 19' ' ' HIS . 54.2 t -120.16 133.44 66.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.963 0.411 . . . . 0.0 110.432 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.454 HG21 HH11 ' A' ' 93' ' ' ARG . 54.2 m -99.04 119.12 37.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.825 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.486 HD11 ' HD2' ' A' ' 96' ' ' ARG . 96.2 mt -71.23 135.09 28.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.408 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -66.35 143.64 57.04 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.436 ' O ' ' C ' ' A' ' 13' ' ' SER . 42.7 ttm180 -45.65 119.14 2.04 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.376 -0.529 . . . . 0.0 110.29 -178.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 12' ' ' ARG . 70.0 m 35.28 35.78 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.005 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 12' ' ' ARG . . . -128.9 -126.86 2.9 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.2 m -120.1 -168.6 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.771 0.32 . . . . 0.0 110.613 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -64.34 137.97 58.18 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.01 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -113.58 -152.88 11.0 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.6 143.52 94.62 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.277 1.984 . . . . 0.0 111.418 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.595 ' CD2' HG22 ' A' ' 8' ' ' VAL . 18.7 m170 -94.24 173.35 7.69 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.043 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -140.21 108.95 6.87 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.827 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.81 152.7 52.93 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.972 1.781 . . . . 0.0 111.861 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.1 mt -100.17 123.28 44.21 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.41 0.624 . . . . 0.0 110.807 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.3 m -113.76 -59.1 2.06 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.386 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.0 mt -74.37 150.3 40.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.68 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 81.1 p -66.09 -16.98 64.41 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.091 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.4 p -120.68 144.01 48.42 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.827 -179.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -119.83 123.06 42.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.523 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.458 HD21 ' HG2' ' A' ' 47' ' ' GLN . 53.5 tp -114.03 138.62 50.13 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.301 0.572 . . . . 0.0 111.222 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -108.19 142.59 38.2 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.35 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 157.92 165.43 15.43 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 119.518 -1.325 . . . . 0.0 112.506 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.428 ' NE ' ' O ' ' A' ' 44' ' ' VAL . 91.2 mtm180 -66.24 -38.73 88.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.934 -0.633 . . . . 0.0 111.675 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.96 153.17 42.05 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 121.34 -0.457 . . . . 0.0 112.59 -178.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.437 HD12 ' HD2' ' A' ' 38' ' ' ARG . 10.9 tp -67.15 -31.52 53.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.239 -0.48 . . . . 0.0 110.368 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -56.39 -14.6 3.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.643 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.1 m -84.99 135.05 34.19 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.512 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.442 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 95.3 m-20 -62.77 -34.34 77.03 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.486 ' CG2' ' CE2' ' A' ' 95' ' ' PHE . 3.5 mm -107.82 84.42 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.543 HH12 ' NE2' ' A' ' 40' ' ' GLN . 77.6 ttt-85 -67.99 125.8 27.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.601 -178.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.667 HG21 HG21 ' A' ' 44' ' ' VAL . 82.8 mt -113.6 123.91 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.381 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.664 ' O ' HD22 ' A' ' 41' ' ' LEU . 84.7 mt-30 -94.0 77.83 4.11 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.368 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.734 HD12 HG22 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -157.19 111.71 1.9 Allowed Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.129 179.194 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.427 ' HD2' HD13 ' A' ' 41' ' ' LEU . 66.6 Cg_exo -51.47 -31.45 39.07 Favored 'Trans proline' 0 N--CA 1.503 2.051 0 C-N-CA 122.29 1.993 . . . . 0.0 113.939 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.734 HG22 HD12 ' A' ' 41' ' ' LEU . 23.4 m -62.71 -38.94 82.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.669 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.667 HG21 HG21 ' A' ' 39' ' ' ILE . 86.7 t -62.54 149.32 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.4 m -82.48 172.77 12.65 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.615 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -62.01 -39.84 93.63 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.095 0.474 . . . . 0.0 110.002 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.458 ' HG2' HD21 ' A' ' 28' ' ' LEU . 88.4 mt-30 -134.78 69.75 1.45 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 178.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.722 ' NE2' HG23 ' A' ' 90' ' ' ILE . 16.3 t60 -60.28 -51.51 69.25 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.638 -1.164 . . . . 0.0 112.783 -176.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.608 ' SG ' ' N ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -151.97 167.0 29.79 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.744 -179.419 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.608 ' N ' ' SG ' ' A' ' 49' ' ' CYS . 67.8 tttt -145.88 127.48 15.14 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.934 -178.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 93.1 mt -100.17 109.12 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 120.422 -0.511 . . . . 0.0 109.866 178.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.469 ' N ' ' O ' ' A' ' 59' ' ' ILE . 84.4 tt0 -90.14 129.04 36.47 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.519 HD11 ' HE ' ' A' ' 5' ' ' ARG . 2.3 tp -87.88 122.07 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 CA-C-O 121.336 0.589 . . . . 0.0 111.554 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.461 ' N ' ' O ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -95.03 166.32 11.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.903 179.354 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 58.7 mp0 -40.13 -38.31 0.73 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.233 -0.439 . . . . 0.0 112.061 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -141.19 7.67 2.01 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 120.127 -0.629 . . . . 0.0 112.354 -178.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.461 ' O ' ' N ' ' A' ' 54' ' ' HIS . 78.6 mm-40 -146.62 164.99 30.89 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 120.199 -0.6 . . . . 0.0 111.78 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.468 ' HB3' ' CE2' ' A' ' 97' ' ' TYR . . . -105.35 143.25 33.77 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 178.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.469 ' O ' ' N ' ' A' ' 52' ' ' GLU . 32.1 mm -129.95 128.43 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.792 -178.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.43 HD22 HD13 ' A' ' 76' ' ' ILE . 1.4 tp -79.53 149.8 31.34 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.101 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.507 ' N ' ' O ' ' A' ' 50' ' ' LYS . 29.5 m-70 -142.2 78.15 1.61 Allowed 'General case' 0 C--N 1.34 0.162 0 CA-C-O 121.285 0.564 . . . . 0.0 110.075 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.708 ' ND2' ' H ' ' A' ' 69' ' ' THR . 18.7 t-20 -67.94 137.17 54.98 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.237 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.412 ' CE1' ' O ' ' A' ' 61' ' ' HIS . 35.7 m-85 -112.27 -21.82 11.23 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.141 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.501 ' HB2' HD21 ' A' ' 62' ' ' ASN . 16.3 m -65.87 145.97 55.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.645 -178.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.1 t -117.1 -49.37 2.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.991 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.4 p -71.98 -38.66 69.67 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.901 0.381 . . . . 0.0 110.425 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.48 ' OD1' ' N ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -121.85 79.06 40.66 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.467 179.223 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.87 146.17 71.0 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 121.587 1.525 . . . . 0.0 112.656 -179.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.708 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 44.6 m -62.35 145.33 54.17 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.562 -0.745 . . . . 0.0 108.998 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.474 ' O ' ' N ' ' A' ' 89' ' ' THR . 87.7 mt-30 -112.8 130.42 56.09 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.377 0.608 . . . . 0.0 112.577 -177.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.574 HG13 ' OD1' ' A' ' 86' ' ' ASP . 21.7 t -129.98 133.59 64.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.33 178.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 12.2 m120 57.45 14.79 2.39 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.92 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.39 -20.31 50.33 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.556 178.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.1 m -84.22 153.83 23.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.128 0.464 . . . . 0.0 110.674 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -84.5 153.54 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.81 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.489 HD11 ' HB ' ' A' ' 71' ' ' VAL . 96.3 mt -119.71 106.12 18.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.935 -178.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -78.35 -38.86 41.04 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.394 178.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -132.33 173.92 5.31 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.57 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.55 142.8 80.75 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.399 2.066 . . . . 0.0 111.766 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.1 m -138.32 160.24 31.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.701 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 59.0 ttt85 -80.16 141.6 35.54 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 120.943 0.401 . . . . 0.0 110.806 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.411 HD11 ' HB2' ' A' ' 60' ' ' LEU . 85.1 mt -109.82 139.28 45.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.305 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -109.88 159.78 16.94 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.187 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 44.7 t60 -64.82 128.89 37.67 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.131 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.74 -2.82 62.47 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.595 ' OD1' ' N ' ' A' ' 87' ' ' VAL . 59.3 t0 -69.38 143.31 53.72 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.595 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 53.9 t -115.45 134.77 57.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.848 0.356 . . . . 0.0 110.823 -178.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 65.1 mt -108.26 131.17 59.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.474 ' N ' ' O ' ' A' ' 70' ' ' GLN . 87.2 m -129.04 127.19 41.06 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.245 0.545 . . . . 0.0 111.113 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 1.047 HG22 ' H ' ' A' ' 91' ' ' ILE . 86.6 mt -97.18 -155.93 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 1.047 ' H ' HG22 ' A' ' 90' ' ' ILE . 96.3 mt -62.29 -43.98 98.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 118.453 0.569 . . . . 0.0 112.308 -178.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.477 ' OD1' ' O ' ' A' ' 91' ' ' ILE . 88.6 m-20 -139.79 2.57 1.98 Allowed 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 119.73 -0.788 . . . . 0.0 113.098 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.454 HH11 HG21 ' A' ' 9' ' ' THR . 62.4 ttm-85 -128.68 146.89 50.75 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.128 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.6 m -122.88 148.2 45.7 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.429 0.633 . . . . 0.0 112.101 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.486 ' CE2' ' CG2' ' A' ' 37' ' ' ILE . 56.8 m-85 -130.36 149.25 52.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.286 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.486 ' HD2' HD11 ' A' ' 10' ' ' ILE . 79.9 mtp85 -118.01 138.69 52.03 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.427 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.468 ' CE2' ' HB3' ' A' ' 58' ' ' ALA . 0.8 OUTLIER -114.47 105.72 13.43 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.456 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -114.8 118.37 33.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.736 -178.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 63.7 t-20 -101.9 101.72 12.19 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.442 ' OE1' ' N ' ' A' ' 100' ' ' GLU . 52.2 mp0 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.528 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.457 ' O ' ' C ' ' A' ' 2' ' ' TRP . 5.2 ptt? . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.457 ' C ' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -32.33 97.73 0.11 Allowed Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.021 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.32 143.66 97.07 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 122.134 1.889 . . . . 0.0 111.706 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.9 t -147.06 159.9 43.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.578 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.642 HH21 ' NE2' ' A' ' 56' ' ' GLN . 85.4 mtt85 -126.65 150.46 48.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.352 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -133.63 145.49 50.04 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.807 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.2 mt -106.51 130.69 54.25 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.1 t -112.79 133.2 59.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.5 m -108.69 125.48 51.94 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.449 -178.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 82.9 mt -76.17 130.24 36.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.316 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -61.2 -45.41 94.69 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.31 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.604 ' O ' ' N ' ' A' ' 14' ' ' GLY . 77.4 ttt-85 -173.86 82.39 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.174 179.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.548 ' O ' ' OG ' ' A' ' 13' ' ' SER . 0.0 OUTLIER 36.21 24.59 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.033 0.444 . . . . 0.0 110.844 178.703 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.604 ' N ' ' O ' ' A' ' 12' ' ' ARG . . . -106.41 -116.94 4.21 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.473 ' O ' ' C ' ' A' ' 16' ' ' ASP . 26.3 m -115.95 131.46 68.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.87 0.367 . . . . 0.0 110.407 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.473 ' C ' ' O ' ' A' ' 15' ' ' VAL . 53.2 m-20 31.74 -148.3 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.501 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 152.89 -158.45 27.9 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.444 -1.063 . . . . 0.0 110.444 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.09 144.75 99.46 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.436 2.09 . . . . 0.0 111.539 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -111.36 164.87 12.47 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.825 0.345 . . . . 0.0 111.145 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -154.08 110.99 2.48 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.049 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.2 151.7 44.13 Favored 'Trans proline' 0 N--CA 1.489 1.21 0 C-N-CA 121.973 1.782 . . . . 0.0 111.457 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 14.0 tp -88.73 75.12 8.25 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.79 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.4 t -72.52 -37.07 68.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.639 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.484 ' HG ' ' H ' ' A' ' 26' ' ' THR . 41.6 tp -106.56 134.65 49.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.631 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.3 p -56.21 -34.54 66.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.708 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.484 ' H ' ' HG ' ' A' ' 24' ' ' LEU . 64.4 p -102.57 131.0 49.6 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.47 179.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.3 m -113.7 130.05 56.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.002 0.429 . . . . 0.0 110.714 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.488 HD23 ' HA ' ' A' ' 35' ' ' CYS . 55.8 tp -117.26 140.36 49.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.819 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.826 ' CE1' HD13 ' A' ' 51' ' ' ILE . 8.6 m-85 -113.39 145.17 41.55 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.858 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 150.61 171.27 18.68 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 119.624 -1.274 . . . . 0.0 113.141 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 91.7 mtm180 -67.25 -42.05 84.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.54 -0.83 . . . . 0.0 112.878 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.33 154.81 44.42 Favored Glycine 0 CA--C 1.523 0.535 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.53 -178.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.41 ' C ' ' N ' ' A' ' 35' ' ' CYS . 19.8 tt -68.16 -29.83 45.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.193 0.521 . . . . 0.0 109.871 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -49.27 -19.33 0.47 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.715 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.488 ' HA ' HD23 ' A' ' 28' ' ' LEU . 34.9 m -81.5 131.88 35.29 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.599 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.447 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 93.3 m-20 -62.16 -36.78 82.9 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.478 ' CG2' ' CE2' ' A' ' 95' ' ' PHE . 4.8 mm -106.45 89.33 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.735 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -67.77 133.98 50.19 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.812 -178.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.62 HG21 HG21 ' A' ' 44' ' ' VAL . 97.5 mt -120.88 124.74 72.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.852 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 65.5 tp60 -96.99 79.85 2.92 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.231 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.9 mt -156.07 110.93 2.11 Favored Pre-proline 0 CA--C 1.536 0.422 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.691 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -50.66 -34.07 42.1 Favored 'Trans proline' 0 N--CA 1.498 1.785 0 C-N-CA 122.293 1.995 . . . . 0.0 112.729 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.0 m -63.56 -33.81 63.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.185 -178.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.62 HG21 HG21 ' A' ' 39' ' ' ILE . 81.1 t -71.11 158.48 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.506 ' N ' HG12 ' A' ' 44' ' ' VAL . 13.5 m -93.54 162.7 13.86 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.675 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -58.45 -39.69 80.57 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.023 0.44 . . . . 0.0 110.095 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -128.44 63.84 1.43 Allowed 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.727 ' NE2' HG23 ' A' ' 90' ' ' ILE . 15.1 t60 -59.65 -50.01 75.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 113.926 -1.488 . . . . 0.0 112.728 -177.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.668 ' SG ' ' N ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -156.62 164.14 38.52 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.133 -179.42 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.668 ' N ' ' SG ' ' A' ' 49' ' ' CYS . 71.0 tttt -144.3 133.17 22.56 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.454 -179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.826 HD13 ' CE1' ' A' ' 29' ' ' PHE . 1.6 mp -108.62 107.45 22.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.23 0.538 . . . . 0.0 110.137 178.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -90.28 129.17 36.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.405 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.8 tp -94.64 133.71 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 CA-C-O 121.164 0.507 . . . . 0.0 111.317 -178.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.547 ' HD2' HD13 ' A' ' 59' ' ' ILE . 19.6 m-70 -112.3 -179.44 3.68 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.272 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 54' ' ' HIS . 95.3 mt-10 -35.87 -53.7 0.74 Allowed 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 120.974 -0.291 . . . . 0.0 111.423 -178.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.642 ' NE2' HH21 ' A' ' 5' ' ' ARG . 45.2 tp60 -145.93 28.95 1.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.199 -0.6 . . . . 0.0 111.303 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -150.34 143.65 25.01 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.996 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.89 ' C ' HD12 ' A' ' 59' ' ' ILE . . . -98.71 141.82 31.04 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.89 HD12 ' C ' ' A' ' 58' ' ' ALA . 2.1 mp -127.05 129.24 71.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.364 -178.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.609 HD23 ' N ' ' A' ' 61' ' ' HIS . 8.2 tt -82.7 151.76 26.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.103 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.609 ' N ' HD23 ' A' ' 60' ' ' LEU . 19.8 m-70 -140.61 77.64 1.61 Allowed 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 121.512 0.672 . . . . 0.0 109.416 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.661 ' ND2' ' H ' ' A' ' 69' ' ' THR . 22.4 t-20 -70.14 136.16 49.87 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.687 -1.142 . . . . 0.0 112.039 -179.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.515 ' CE1' ' O ' ' A' ' 61' ' ' HIS . 16.7 m-85 -117.14 -21.45 8.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.77 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.0 m -70.46 141.1 52.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.169 0.509 . . . . 0.0 112.286 -178.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.498 ' OG ' ' N ' ' A' ' 66' ' ' THR . 13.8 p -105.75 -59.0 1.83 Allowed 'General case' 0 CA--C 1.526 0.057 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.744 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.498 ' N ' ' OG ' ' A' ' 65' ' ' SER . 65.6 p -66.08 -34.32 77.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.767 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.551 ' ND2' HD11 ' A' ' 91' ' ' ILE . 74.6 m-20 -122.34 77.85 44.54 Favored Pre-proline 0 C--N 1.33 -0.251 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -70.16 146.94 59.13 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.039 1.826 . . . . 0.0 113.043 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.661 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 46.1 m -73.63 163.44 28.0 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.456 ' N ' HG22 ' A' ' 69' ' ' THR . 88.2 mt-30 -128.14 146.5 50.69 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.535 -178.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.759 ' HB ' HD11 ' A' ' 76' ' ' ILE . 7.1 p -134.64 137.89 50.42 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 CA-C-O 121.132 0.492 . . . . 0.0 111.316 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 46.13 21.46 0.11 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.301 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.42 ' N ' ' C ' ' A' ' 71' ' ' VAL . . . 89.33 13.46 61.67 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 120.89 -0.672 . . . . 0.0 111.862 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.0 t -115.77 138.3 51.26 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.322 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.9 t -68.44 142.44 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.352 0.596 . . . . 0.0 110.454 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.759 HD11 ' HB ' ' A' ' 71' ' ' VAL . 85.0 mt -108.89 113.52 44.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.308 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -98.85 -12.35 20.88 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.938 0.399 . . . . 0.0 110.799 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -159.77 170.64 8.41 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.836 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -56.01 137.92 80.74 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 121.812 1.674 . . . . 0.0 111.343 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 19.3 m -143.43 161.68 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 121.137 0.494 . . . . 0.0 111.775 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 71.4 ttp85 -78.27 145.58 35.34 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.154 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.466 HD11 ' HB2' ' A' ' 60' ' ' LEU . 95.3 mt -118.5 149.05 41.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.608 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -107.86 153.81 22.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.61 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.608 ' CE1' ' H ' ' A' ' 99' ' ' ASN . 69.6 t60 -56.89 131.08 48.51 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.474 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.57 4.27 80.13 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.215 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -67.58 145.96 54.36 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 117.324 0.562 . . . . 0.0 110.704 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.751 HG22 ' HG2' ' A' ' 96' ' ' ARG . 56.1 t -112.89 130.76 66.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.654 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 84.5 mt -109.75 136.38 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.547 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 68.9 m -126.8 125.89 42.46 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.221 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 1.113 HG22 ' H ' ' A' ' 91' ' ' ILE . 92.1 mt -97.22 -148.49 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 1.113 ' H ' HG22 ' A' ' 90' ' ' ILE . 84.8 mt -63.75 -44.75 98.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 119.156 0.889 . . . . 0.0 113.312 -178.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.495 ' OD1' ' O ' ' A' ' 91' ' ' ILE . 90.9 m-20 -143.59 2.91 1.26 Allowed 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 120.212 -0.595 . . . . 0.0 111.682 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -130.26 154.56 47.46 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.242 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 59.4 m -133.27 150.24 51.92 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.206 -0.598 . . . . 0.0 111.993 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.478 ' CE2' ' CG2' ' A' ' 37' ' ' ILE . 41.2 m-85 -129.13 150.41 50.53 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.806 179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.751 ' HG2' HG22 ' A' ' 87' ' ' VAL . 79.7 mtp180 -120.38 138.93 53.48 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.393 -179.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.626 ' CE2' ' HB3' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -108.41 115.95 31.07 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.376 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.62 133.94 26.21 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.413 0.625 . . . . 0.0 111.371 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.608 ' H ' ' CE1' ' A' ' 84' ' ' HIS . 46.9 p30 -99.13 174.0 6.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.928 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 . . . . . 0 C--N 1.324 -0.534 0 CA-C-O 121.073 0.463 . . . . 0.0 111.284 -179.384 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.3 mtp . . . . . 0 N--CA 1.493 1.684 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.605 ' CG ' ' O ' ' A' ' 2' ' ' TRP . 1.8 t90 175.16 91.28 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.251 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.978 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -61.14 144.64 99.2 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.968 1.779 . . . . 0.0 111.625 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.5 t -148.23 165.7 30.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.689 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.62 ' NE ' ' ND2' ' A' ' 99' ' ' ASN . 84.1 mtt85 -72.0 142.63 49.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.904 0.383 . . . . 0.0 110.721 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.661 ' NH2' ' CG ' ' A' ' 19' ' ' HIS . 16.9 ptm180 -143.49 151.04 39.82 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.095 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.0 mt -111.33 132.77 54.15 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.1 t -120.76 132.91 69.07 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-O 121.456 0.646 . . . . 0.0 110.313 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.58 ' OG1' ' CE2' ' A' ' 95' ' ' PHE . 91.4 m -106.2 118.6 37.04 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.514 -179.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.563 HD11 ' HD2' ' A' ' 96' ' ' ARG . 62.1 mt -85.04 113.0 22.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.1 mttm -65.53 -42.56 91.86 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 120.096 -0.642 . . . . 0.0 109.641 179.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -139.21 136.16 34.71 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.203 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.9 t -57.26 132.86 54.29 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.489 -0.485 . . . . 0.0 109.924 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 103.22 -21.37 39.86 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.264 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.5 m -126.93 129.98 71.35 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 CA-C-O 121.546 0.689 . . . . 0.0 111.553 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 52.1 p-10 -65.56 147.75 52.88 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.408 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -123.2 -162.49 11.51 Favored Glycine 0 CA--C 1.531 1.031 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.3 150.66 47.43 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 122.634 2.222 . . . . 0.0 111.971 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.661 ' CG ' ' NH2' ' A' ' 6' ' ' ARG . 3.1 m170 -97.04 167.6 10.97 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.085 0.469 . . . . 0.0 111.539 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.527 ' CZ ' ' O ' ' A' ' 36' ' ' ASP . 82.1 t80 -137.94 89.51 14.81 Favored Pre-proline 0 N--CA 1.455 -0.188 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.761 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -58.17 145.28 93.28 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.505 2.137 . . . . 0.0 110.928 179.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.9 mt -85.22 136.34 33.56 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.234 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.17 -38.81 2.87 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.536 HD12 ' OD1' ' A' ' 36' ' ' ASP . 92.9 mt -107.08 143.08 35.73 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.604 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 74.4 p -61.8 -22.84 65.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.575 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.45 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 4.7 p -114.85 124.85 52.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.202 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.7 m -109.91 137.86 47.1 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.69 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.544 HD21 HE22 ' A' ' 47' ' ' GLN . 64.5 tp -120.63 141.12 50.64 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.806 -179.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.42 ' CE2' HG21 ' A' ' 37' ' ' ILE . 23.9 m-85 -111.38 131.11 55.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.785 -179.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 161.68 172.68 29.37 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.048 -1.073 . . . . 0.0 112.382 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.692 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 83.6 mtm-85 -66.02 -34.54 78.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.698 -0.751 . . . . 0.0 110.837 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -51.7 142.22 21.29 Favored Glycine 0 CA--C 1.521 0.468 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.676 -178.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.1 tt -69.08 -38.63 78.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.231 0.538 . . . . 0.0 109.698 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -55.54 -14.7 2.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.02 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 86.3 m -73.16 136.07 44.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.967 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.536 ' OD1' HD12 ' A' ' 24' ' ' LEU . 91.8 m-20 -63.87 -38.55 91.5 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.447 ' CD1' ' CD2' ' A' ' 20' ' ' PHE . 7.1 mm -111.73 91.22 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-N 114.913 -1.039 . . . . 0.0 109.213 179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 90.7 mtm180 -74.5 136.75 42.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.746 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.773 HG21 HG21 ' A' ' 44' ' ' VAL . 96.3 mt -125.65 120.11 56.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.714 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.624 ' H ' HH12 ' A' ' 93' ' ' ARG . 98.4 mt-30 -93.31 79.67 4.44 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 119.499 -0.88 . . . . 0.0 110.527 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.6 mt -156.71 116.41 2.08 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.818 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -50.9 -34.31 45.17 Favored 'Trans proline' 0 N--CA 1.498 1.794 0 C-N-CA 122.128 1.885 . . . . 0.0 112.942 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.518 ' O ' ' CD1' ' A' ' 91' ' ' ILE . 19.4 m -64.9 -28.92 45.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.694 -0.403 . . . . 0.0 112.073 -178.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.773 HG21 HG21 ' A' ' 39' ' ' ILE . 99.6 t -78.45 166.96 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.482 0 C-N-CA 119.801 -0.76 . . . . 0.0 109.14 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.653 ' N ' HG12 ' A' ' 44' ' ' VAL . 7.3 t -111.48 152.1 27.84 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.612 -179.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -59.07 -42.33 90.11 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.544 HE22 HD21 ' A' ' 28' ' ' LEU . 98.1 mm-40 -111.5 60.11 0.62 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 177.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.741 ' CD2' HG23 ' A' ' 90' ' ' ILE . 17.1 t60 -70.94 -67.97 0.47 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.698 -176.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.407 ' SG ' ' HB2' ' A' ' 29' ' ' PHE . 1.7 p -142.09 162.61 35.04 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.6 ' O ' ' N ' ' A' ' 61' ' ' HIS . 37.0 tttm -141.42 131.07 24.06 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.244 -0.583 . . . . 0.0 112.284 -178.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.638 HD11 ' CD1' ' A' ' 88' ' ' ILE . 95.7 mt -104.18 115.85 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-O 121.525 0.679 . . . . 0.0 110.001 177.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.401 ' HB2' ' NZ ' ' A' ' 50' ' ' LYS . 85.4 tt0 -97.31 137.82 35.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.332 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.411 ' O ' ' CG2' ' A' ' 53' ' ' ILE . 1.4 tp -103.42 130.68 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-O 121.326 0.584 . . . . 0.0 111.036 -178.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.469 ' O ' ' C ' ' A' ' 55' ' ' GLU . 41.1 m-70 -108.6 176.73 5.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.455 179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.469 ' C ' ' O ' ' A' ' 54' ' ' HIS . 52.0 tp10 -35.2 -51.86 0.57 Allowed 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.342 -178.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -145.54 36.3 1.08 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.743 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -152.3 149.33 28.55 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.021 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.538 ' HB3' ' CE2' ' A' ' 97' ' ' TYR . . . -109.39 133.96 52.42 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 42.4 mm -123.69 130.59 73.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.973 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.818 HD22 HD13 ' A' ' 76' ' ' ILE . 0.6 OUTLIER -85.74 138.74 31.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.369 0.604 . . . . 0.0 111.022 -179.846 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.6 ' N ' ' O ' ' A' ' 50' ' ' LYS . 41.5 m-70 -126.12 79.61 1.85 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.011 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.676 ' ND2' ' H ' ' A' ' 69' ' ' THR . 28.5 t-20 -71.3 123.34 22.06 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.816 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -98.66 -29.87 12.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.368 0.604 . . . . 0.0 110.154 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.594 ' OG ' ' ND2' ' A' ' 62' ' ' ASN . 20.5 p -61.27 149.2 38.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.607 -178.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.2 t -117.01 -58.43 2.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.823 179.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.3 m -62.47 -48.92 77.51 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.446 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.599 ' OD1' ' N ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -112.83 81.77 4.67 Favored Pre-proline 0 C--N 1.329 -0.3 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.015 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -76.79 147.85 27.92 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 122.252 1.968 . . . . 0.0 112.406 -178.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.676 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 7.0 m -66.26 155.09 38.14 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -125.34 153.24 43.62 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.307 0.575 . . . . 0.0 111.877 -177.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 1.003 HG23 HD11 ' A' ' 76' ' ' ILE . 24.6 t -129.94 126.13 61.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.055 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 48.5 32.19 3.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.728 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.59 4.48 82.95 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.426 ' N ' ' O ' ' A' ' 71' ' ' VAL . 5.9 p -90.66 174.11 7.67 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.621 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.5 t -113.84 140.56 33.7 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 1.003 HD11 HG23 ' A' ' 71' ' ' VAL . 76.1 mt -112.03 90.12 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.242 -177.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.508 ' O ' ' OE1' ' A' ' 78' ' ' GLU . 74.1 m-20 -65.73 -44.71 85.16 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.112 0.482 . . . . 0.0 110.535 178.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.508 ' OE1' ' O ' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -132.64 174.11 5.09 Favored Pre-proline 0 CA--C 1.529 0.168 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.66 -179.856 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -55.49 141.16 83.11 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.237 1.958 . . . . 0.0 111.359 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.3 m -139.43 164.37 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.126 0.489 . . . . 0.0 111.885 -178.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -89.21 145.48 25.38 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.995 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.482 HD12 ' N ' ' A' ' 82' ' ' LEU . 5.4 mp -117.91 149.89 40.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.059 0.457 . . . . 0.0 110.764 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -109.08 156.57 19.64 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.615 ' CE1' ' H ' ' A' ' 99' ' ' ASN . 5.0 t-80 -50.6 142.24 11.24 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.261 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.473 ' N ' ' ND1' ' A' ' 84' ' ' HIS . . . 80.91 -3.33 76.36 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.523 178.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.547 ' OD1' HG13 ' A' ' 71' ' ' VAL . 66.4 t0 -65.49 141.06 58.61 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.921 0.36 . . . . 0.0 111.068 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.506 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 14.6 p -112.72 128.83 69.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 120.944 0.402 . . . . 0.0 110.993 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.638 ' CD1' HD11 ' A' ' 51' ' ' ILE . 65.0 mt -104.37 130.3 55.38 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.519 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.726 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 88.2 m -120.15 123.13 42.57 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.139 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.821 HG22 ' H ' ' A' ' 91' ' ' ILE . 16.7 mm -79.85 -145.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.821 ' H ' HG22 ' A' ' 90' ' ' ILE . 90.2 mt -63.11 -44.09 99.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 C-N-CA 119.711 -0.796 . . . . 0.0 111.292 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -145.47 8.64 1.18 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 119.751 -0.779 . . . . 0.0 113.046 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.624 HH12 ' H ' ' A' ' 40' ' ' GLN . 99.4 mtt180 -121.62 151.06 40.83 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.88 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.9 m -112.58 144.45 42.04 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.58 ' CE2' ' OG1' ' A' ' 9' ' ' THR . 32.9 m-85 -133.08 145.72 51.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.532 178.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.563 ' HD2' HD11 ' A' ' 10' ' ' ILE . 71.0 mtp180 -116.66 136.91 52.58 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.715 -178.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.538 ' CE2' ' HB3' ' A' ' 58' ' ' ALA . 0.6 OUTLIER -106.88 100.62 10.11 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.666 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -117.93 129.64 55.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.487 0.661 . . . . 0.0 111.115 -178.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.62 ' ND2' ' NE ' ' A' ' 5' ' ' ARG . 57.7 t-20 -117.39 95.36 4.93 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.947 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 . . . . . 0 C--N 1.329 -0.3 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.032 -179.64 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.3 mtt . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 4.3 m0 -98.18 164.34 17.44 Favored Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -59.63 145.94 96.7 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 121.919 1.746 . . . . 0.0 111.626 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.6 m -118.72 95.03 4.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.161 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.582 ' NH1' ' O ' ' A' ' 54' ' ' HIS . 90.4 mtm180 -132.67 137.93 47.13 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -148.68 153.1 37.79 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.596 -0.441 . . . . 0.0 111.403 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 68.6 mt -112.5 132.25 55.18 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 t -110.66 132.02 60.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 98.9 m -102.27 115.49 30.67 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.168 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.989 HD11 ' HE ' ' A' ' 96' ' ' ARG . 84.2 mt -79.08 133.48 29.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.933 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -59.67 140.47 56.4 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -59.99 -43.38 95.2 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.925 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.0 p -100.58 -3.11 31.2 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.681 -0.408 . . . . 0.0 112.1 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -131.35 -140.89 4.68 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 119.977 -1.106 . . . . 0.0 112.046 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.441 ' O ' ' C ' ' A' ' 16' ' ' ASP . 34.2 m -133.99 160.05 42.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 114.945 -0.627 . . . . 0.0 111.133 -178.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.598 ' OD1' ' NH1' ' A' ' 96' ' ' ARG . 65.7 m-20 36.63 -148.27 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.025 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 138.09 -160.09 25.29 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -58.8 143.47 99.09 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 123.279 2.652 . . . . 0.0 112.094 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.421 ' CD2' ' N ' ' A' ' 19' ' ' HIS . 5.4 m170 -93.68 170.08 9.84 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.612 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.464 ' CD2' HD13 ' A' ' 37' ' ' ILE . 73.4 t80 -140.97 104.56 6.19 Favored Pre-proline 0 N--CA 1.449 -0.508 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.859 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -72.9 154.18 53.22 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.013 1.809 . . . . 0.0 111.892 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.706 ' N ' HD22 ' A' ' 22' ' ' LEU . 2.9 mm? -80.55 76.28 7.4 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.845 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 59.8 m -61.29 -40.45 94.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.733 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.2 mt -113.19 153.59 28.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.537 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 55.1 p -61.48 -24.47 66.6 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.981 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.427 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 17.4 p -120.07 122.82 41.93 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.643 -179.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.5 m -97.5 129.96 44.62 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.356 178.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.447 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 61.5 tp -118.44 134.22 55.24 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.241 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.537 ' CZ ' HD12 ' A' ' 51' ' ' ILE . 10.2 m-85 -104.92 145.5 30.32 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.848 -179.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 143.73 164.76 10.52 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.755 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.41 ' O ' ' C ' ' A' ' 32' ' ' GLY . 82.2 mtp180 -63.37 -42.84 98.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.264 -0.468 . . . . 0.0 110.249 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 31' ' ' ARG . . . -37.48 139.89 0.43 Allowed Glycine 0 CA--C 1.52 0.373 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.444 ' CG2' ' N ' ' A' ' 34' ' ' GLU . 18.8 tt -64.02 -37.05 78.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.444 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 11.1 pt-20 -57.64 -13.45 3.96 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.764 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 41.5 m -76.03 126.07 30.31 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.666 0.269 . . . . 0.0 111.301 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.447 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 87.2 m-20 -63.82 -39.12 93.48 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 179.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.467 HG21 ' CE2' ' A' ' 29' ' ' PHE . 1.4 mm -105.04 76.78 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -65.86 134.36 52.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.702 -178.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.486 HG23 ' NH1' ' A' ' 93' ' ' ARG . 98.0 mt -124.71 130.02 73.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.493 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -98.71 81.8 2.72 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.251 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.7 mt -156.53 115.02 2.07 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.928 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -50.22 -34.77 40.96 Favored 'Trans proline' 0 N--CA 1.504 2.093 0 C-N-CA 122.254 1.97 . . . . 0.0 114.014 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.1 m -66.41 -28.1 42.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -178.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.411 HG21 HG21 ' A' ' 39' ' ' ILE . 94.6 t -78.59 143.71 12.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.867 0.365 . . . . 0.0 110.491 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.8 m -84.19 166.53 17.49 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.993 -178.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.04 -38.04 89.6 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.094 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.512 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 96.5 mt-30 -128.35 59.95 1.5 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 177.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.688 ' NE2' HG23 ' A' ' 90' ' ' ILE . 10.4 t60 -60.81 -49.43 77.5 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.005 -0.998 . . . . 0.0 112.33 -177.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.46 ' SG ' ' N ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -150.23 152.71 35.0 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.106 0.479 . . . . 0.0 110.197 -179.674 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' A' ' 61' ' ' HIS . 72.8 tttt -136.34 124.66 23.28 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.974 -179.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.537 HD12 ' CZ ' ' A' ' 29' ' ' PHE . 98.4 mt -107.93 108.81 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.745 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -83.76 140.83 31.83 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 50.9 mm -109.94 132.73 57.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.516 0.674 . . . . 0.0 112.046 -177.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.582 ' O ' ' NH1' ' A' ' 5' ' ' ARG . 44.2 m-70 -111.34 178.16 4.42 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.303 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.535 ' OE1' ' N ' ' A' ' 55' ' ' GLU . 55.9 mp0 -35.82 -49.28 0.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.863 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -146.53 25.13 1.22 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.876 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -141.01 147.48 38.76 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.94 -179.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.546 ' HB3' ' CE2' ' A' ' 97' ' ' TYR . . . -109.35 129.93 55.51 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 41.2 mm -119.67 124.29 72.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.549 -177.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.655 HD23 ' N ' ' A' ' 61' ' ' HIS . 6.8 tt -80.21 145.45 32.25 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.827 -179.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.655 ' N ' HD23 ' A' ' 60' ' ' LEU . 45.7 m-70 -139.63 79.04 1.7 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.076 -0.966 . . . . 0.0 109.14 179.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.6 ' ND2' ' H ' ' A' ' 69' ' ' THR . 25.5 t-20 -69.32 141.85 54.18 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.729 -178.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.512 ' CD1' ' O ' ' A' ' 47' ' ' GLN . 24.6 m-85 -113.54 -37.47 4.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.659 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 55.9 m -62.37 135.51 57.48 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.377 0.608 . . . . 0.0 112.507 -176.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.5 m -103.23 -50.34 3.5 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.487 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 36.2 p -65.94 -41.63 91.07 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.008 0.432 . . . . 0.0 110.454 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -126.7 80.09 70.85 Favored Pre-proline 0 C--O 1.234 0.264 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -76.27 146.63 28.49 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.391 2.061 . . . . 0.0 112.548 -178.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.6 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 75.0 m -61.44 167.11 3.51 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.23 178.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.53 ' N ' HG22 ' A' ' 69' ' ' THR . 84.1 mt-30 -134.6 148.35 50.41 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -177.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.961 HG23 HD11 ' A' ' 76' ' ' ILE . 41.4 t -127.23 127.71 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.259 178.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.621 ' ND2' ' OD1' ' A' ' 86' ' ' ASP . 84.6 m-20 49.41 29.01 2.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.8 0.334 . . . . 0.0 110.684 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.2 12.15 81.23 Favored Glycine 0 CA--C 1.522 0.472 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 71' ' ' VAL . 39.2 t -107.55 129.47 54.97 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 99.2 t -66.51 145.63 13.74 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.265 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.961 HD11 HG23 ' A' ' 71' ' ' VAL . 96.3 mt -104.47 100.06 9.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.63 -178.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -70.16 -33.53 71.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.924 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.599 ' O ' HG13 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -154.72 174.64 3.69 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.337 -179.008 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.33 133.74 49.11 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.535 1.49 . . . . 0.0 109.967 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.599 HG13 ' O ' ' A' ' 78' ' ' GLU . 27.7 m -135.51 160.54 39.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 120.325 -0.55 . . . . 0.0 111.329 -178.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -80.16 142.19 34.99 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.576 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 73.5 mt -108.47 143.54 37.29 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.955 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -105.95 164.54 11.88 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 35.3 t60 -65.68 135.38 54.91 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.723 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.93 -2.05 88.5 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.621 ' OD1' ' ND2' ' A' ' 72' ' ' ASN . 27.5 t70 -64.72 148.96 50.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.95 0.405 . . . . 0.0 110.437 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.8 t -118.16 130.65 72.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.24 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.422 ' CD1' HD11 ' A' ' 51' ' ' ILE . 68.2 mt -108.52 132.99 54.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 91.4 m -129.9 122.56 28.86 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -178.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 1.099 HG22 ' H ' ' A' ' 91' ' ' ILE . 94.9 mt -86.39 -153.72 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.239 177.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 1.099 ' H ' HG22 ' A' ' 90' ' ' ILE . 86.3 mt -62.86 -44.2 99.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 119.449 1.022 . . . . 0.0 112.36 -178.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 91' ' ' ILE . 88.2 m-20 -143.86 17.99 1.8 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 121.031 -0.268 . . . . 0.0 111.139 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.486 ' NH1' HG23 ' A' ' 39' ' ' ILE . 35.7 mmm-85 -130.24 145.03 51.7 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.708 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.6 m -125.92 139.77 53.18 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 121.287 0.565 . . . . 0.0 111.973 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -123.78 150.68 44.16 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.779 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.989 ' HE ' HD11 ' A' ' 10' ' ' ILE . 73.3 mtt180 -116.01 134.68 54.7 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.488 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.546 ' CE2' ' HB3' ' A' ' 58' ' ' ALA . 2.6 t80 -116.72 104.75 11.67 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.82 132.68 53.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.202 0.525 . . . . 0.0 112.351 -178.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 64.9 t-20 -115.12 104.34 11.77 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.224 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 121.099 0.476 . . . . 0.0 111.665 -178.81 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtm . . . . . 0 N--CA 1.492 1.659 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.614 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -99.79 -43.22 0.22 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.868 0.366 . . . . 0.0 110.993 -179.429 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 2' ' ' TRP . 32.3 Cg_exo -57.98 143.38 96.28 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 123.024 2.483 . . . . 0.0 112.751 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 82.7 p -91.02 -153.58 0.32 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.831 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.52 ' NH1' ' CB ' ' A' ' 99' ' ' ASN . 95.7 mtt-85 -67.09 137.98 56.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.627 -179.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.9 ptt-85 -155.31 154.81 32.65 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.926 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.501 HD12 HD11 ' A' ' 37' ' ' ILE . 91.5 mt -109.24 131.89 54.64 Favored 'General case' 0 N--CA 1.461 0.119 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 77.7 t -114.63 131.19 67.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 99.8 m -101.57 121.83 42.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.142 0.496 . . . . 0.0 111.73 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.485 HD11 ' HD2' ' A' ' 96' ' ' ARG . 87.4 mt -78.87 132.0 33.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.832 179.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -63.48 -76.24 0.07 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.392 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -176.88 -26.49 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.352 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.8 m -76.32 -4.27 41.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.883 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.5 31.44 24.72 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 120.372 -0.918 . . . . 0.0 110.998 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.3 m -129.64 162.99 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 121.38 0.61 . . . . 0.0 111.397 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -67.21 138.79 57.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.524 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -129.91 -155.08 8.28 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -60.37 147.62 93.29 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.166 1.911 . . . . 0.0 110.806 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 5.6 m170 -103.08 167.9 9.53 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.809 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -137.54 109.41 8.7 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.95 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.85 152.34 46.81 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 121.872 1.715 . . . . 0.0 111.685 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 86.9 mt -86.69 82.02 8.02 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.561 -0.455 . . . . 0.0 111.106 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.1 m -62.64 -40.59 97.51 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.906 0.384 . . . . 0.0 110.914 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.401 HD12 ' N ' ' A' ' 24' ' ' LEU . 8.0 mp -107.44 145.92 32.38 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.621 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 89.6 p -55.65 -24.15 32.06 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.895 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.462 ' O ' ' OD2' ' A' ' 36' ' ' ASP . 64.3 p -111.64 128.88 56.19 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.058 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.419 ' SG ' HG13 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -104.09 116.04 31.51 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.614 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.447 HD11 ' OE1' ' A' ' 47' ' ' GLN . 6.7 tt -116.48 144.72 43.97 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.288 0.566 . . . . 0.0 112.031 -178.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -107.51 149.81 27.55 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.076 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.422 ' CA ' ' SG ' ' A' ' 35' ' ' CYS . . . 140.45 164.5 9.93 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.146 -1.026 . . . . 0.0 112.942 178.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 66.2 mtp85 -66.04 -37.84 86.88 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 115.165 -0.517 . . . . 0.0 110.81 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -47.2 147.16 3.62 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.4 tt -64.22 -29.71 48.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -58.12 -21.66 47.47 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.391 178.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.511 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 56.4 m -69.15 118.15 11.69 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.462 ' OD2' ' O ' ' A' ' 26' ' ' THR . 60.7 m-20 -63.55 -36.71 84.69 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 177.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.588 ' CG2' ' CE2' ' A' ' 95' ' ' PHE . 2.5 mm -106.42 78.42 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 114.611 -1.177 . . . . 0.0 108.454 178.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -64.6 128.79 37.27 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.928 -178.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.7 mt -120.55 123.98 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.218 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -88.61 80.62 7.27 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.851 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.559 HD23 ' CG2' ' A' ' 43' ' ' VAL . 2.4 tp -154.94 113.3 2.34 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.266 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -53.36 -32.48 61.93 Favored 'Trans proline' 0 N--CA 1.498 1.783 0 C-N-CA 121.79 1.66 . . . . 0.0 112.711 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.559 ' CG2' HD23 ' A' ' 41' ' ' LEU . 30.6 m -62.81 -43.66 98.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.276 -0.42 . . . . 0.0 112.055 -178.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.632 HG12 ' N ' ' A' ' 45' ' ' SER . 97.6 t -68.46 165.57 2.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.632 ' N ' HG12 ' A' ' 44' ' ' VAL . 3.2 t -101.97 158.89 15.82 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.135 -0.626 . . . . 0.0 111.805 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.511 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 53.0 mtmt -62.08 -38.5 89.05 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.447 ' OE1' HD11 ' A' ' 28' ' ' LEU . 96.5 mm-40 -121.43 64.03 0.89 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 178.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.581 ' CD2' HG23 ' A' ' 90' ' ' ILE . 22.5 t60 -68.75 -51.54 40.19 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -176.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.44 ' HB3' ' ND2' ' A' ' 62' ' ' ASN . 28.6 p -171.2 170.2 6.15 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -178.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.437 ' HZ2' ' HZ ' ' A' ' 63' ' ' PHE . 25.5 pttm -153.72 157.16 39.09 Favored 'General case' 0 CA--C 1.508 -0.654 0 C-N-CA 119.087 -1.045 . . . . 0.0 111.762 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.416 ' N ' ' O ' ' A' ' 27' ' ' CYS . 56.9 mt -116.79 111.39 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.082 178.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.469 ' N ' ' O ' ' A' ' 59' ' ' ILE . 96.3 mt-10 -86.14 151.05 23.98 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.746 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.476 HD11 ' HD3' ' A' ' 5' ' ' ARG . 5.2 tp -107.81 128.9 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 CA-C-O 121.421 0.629 . . . . 0.0 110.502 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.407 ' O ' ' C ' ' A' ' 55' ' ' GLU . 21.1 m-70 -104.06 -178.29 3.62 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.401 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 54' ' ' HIS . 98.1 mt-10 -39.47 -51.05 2.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.057 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.426 ' C ' ' NH2' ' A' ' 5' ' ' ARG . 35.0 tt0 -146.22 33.85 0.99 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.899 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.442 ' OE2' ' CG ' ' A' ' 81' ' ' ARG . 77.1 tt0 -155.43 154.55 32.09 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 120.394 -0.523 . . . . 0.0 112.081 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.607 ' HB3' ' CZ ' ' A' ' 97' ' ' TYR . . . -106.34 137.83 43.59 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 177.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.469 ' O ' ' N ' ' A' ' 52' ' ' GLU . 25.4 mm -129.2 138.26 54.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.546 -178.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.607 ' HB2' HD11 ' A' ' 82' ' ' LEU . 6.7 tt -99.45 140.0 34.27 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -130.76 79.63 1.9 Allowed 'General case' 0 C--N 1.342 0.255 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.038 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.707 HD21 ' CB ' ' A' ' 69' ' ' THR . 0.8 OUTLIER -60.4 134.96 57.57 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.739 -1.119 . . . . 0.0 112.392 -179.124 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.437 ' HZ ' ' HZ2' ' A' ' 50' ' ' LYS . 75.6 m-85 -101.85 -34.16 9.51 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.348 178.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.402 ' OG ' ' HA ' ' A' ' 68' ' ' PRO . 14.3 p -65.48 151.63 45.91 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.488 -177.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 m -123.24 -55.02 1.78 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.677 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.1 m -64.18 -47.75 78.61 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.577 ' OD1' ' N ' ' A' ' 67' ' ' ASN . 0.1 OUTLIER -115.14 78.01 5.52 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.754 179.003 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.402 ' HA ' ' OG ' ' A' ' 64' ' ' SER . 82.6 Cg_endo -73.55 147.34 40.58 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 121.355 1.37 . . . . 0.0 112.505 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.707 ' CB ' HD21 ' A' ' 62' ' ' ASN . 22.1 m -67.27 165.76 15.61 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.407 ' N ' HG22 ' A' ' 69' ' ' THR . 82.2 mt-30 -129.17 153.04 48.1 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 119.991 -0.684 . . . . 0.0 112.674 -177.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 1.001 HG23 HD11 ' A' ' 76' ' ' ILE . 14.7 t -126.45 130.79 71.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.999 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 45.51 29.88 0.68 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.593 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 88.31 0.88 82.11 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 121.234 -0.508 . . . . 0.0 112.221 179.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.8 m -100.5 157.61 16.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.347 0.573 . . . . 0.0 110.981 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.2 t -84.11 150.9 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.693 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 1.001 HD11 HG23 ' A' ' 71' ' ' VAL . 95.9 mt -114.71 89.7 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.065 -178.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -65.64 -41.77 92.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.065 0.459 . . . . 0.0 110.883 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.472 ' O ' HG13 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -141.35 174.9 3.41 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.434 -179.531 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.37 140.16 73.49 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 C-N-CA 121.72 1.613 . . . . 0.0 110.971 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.472 HG13 ' O ' ' A' ' 78' ' ' GLU . 33.9 m -138.54 158.53 31.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.251 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.442 ' CG ' ' OE2' ' A' ' 57' ' ' GLU . 40.6 ttm180 -76.29 137.85 40.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.18 -0.463 . . . . 0.0 109.8 178.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.607 HD11 ' HB2' ' A' ' 60' ' ' LEU . 96.1 mt -103.44 127.02 50.9 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 119.716 -0.794 . . . . 0.0 112.662 -178.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.585 ' N ' ' OD2' ' A' ' 86' ' ' ASP . 87.7 tttt -86.8 152.9 22.09 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.671 177.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.563 ' CE1' ' H ' ' A' ' 99' ' ' ASN . 76.1 t60 -64.82 133.18 51.42 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.821 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.03 4.87 64.54 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.585 ' OD2' ' N ' ' A' ' 83' ' ' LYS . 84.5 m-20 -68.59 153.64 43.39 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.221 0.534 . . . . 0.0 111.685 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.0 t -117.54 133.02 65.63 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.64 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.457 HD13 HG22 ' A' ' 71' ' ' VAL . 5.7 mm -110.44 133.38 56.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.015 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.9 m -129.83 132.38 46.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.341 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.845 HG22 ' H ' ' A' ' 91' ' ' ILE . 7.8 mt -107.74 -143.18 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.845 ' H ' HG22 ' A' ' 90' ' ' ILE . 34.4 mm -62.64 -46.02 97.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 91' ' ' ILE . 74.6 m-20 -150.5 16.01 0.8 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 120.814 -0.354 . . . . 0.0 111.304 -178.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 48.6 mmm-85 -131.9 150.27 52.2 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.891 0.377 . . . . 0.0 110.542 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.5 m -128.05 145.83 50.87 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.422 0.63 . . . . 0.0 111.899 -179.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.588 ' CE2' ' CG2' ' A' ' 37' ' ' ILE . 69.9 m-85 -133.84 149.13 51.36 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.801 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.485 ' HD2' HD11 ' A' ' 10' ' ' ILE . 79.1 mtp180 -113.53 142.82 45.49 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.331 -179.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.607 ' CZ ' ' HB3' ' A' ' 58' ' ' ALA . 1.4 t80 -115.41 109.17 17.48 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.731 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.6 mp0 -122.87 132.02 54.0 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.363 -179.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.563 ' H ' ' CE1' ' A' ' 84' ' ' HIS . 27.7 p30 -126.2 143.31 51.19 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.079 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.382 179.825 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.6 mtm . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 3.4 t-105 -154.93 77.45 5.07 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.551 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -61.81 147.92 94.2 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 C-N-CA 123.261 2.641 . . . . 0.0 112.186 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.2 p -102.8 10.38 38.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.684 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.472 ' NH1' HG23 ' A' ' 53' ' ' ILE . 99.8 mtt180 -125.22 145.27 50.06 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.499 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -144.96 144.76 31.22 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.576 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.47 HD12 ' O ' ' A' ' 96' ' ' ARG . 8.8 tp -117.85 132.19 56.46 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.782 HG22 ' CD2' ' A' ' 19' ' ' HIS . 61.0 t -125.65 135.59 63.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.073 0.463 . . . . 0.0 110.986 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.2 m -98.11 113.58 25.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.561 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.55 HD11 ' HD2' ' A' ' 96' ' ' ARG . 97.1 mt -76.5 129.65 37.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.951 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -84.04 159.35 21.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.281 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -59.49 -32.74 70.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.837 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.597 ' OG ' HG22 ' A' ' 15' ' ' VAL . 78.4 p -60.11 -20.54 58.77 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.509 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.74 32.6 10.98 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.598 178.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.597 HG22 ' OG ' ' A' ' 13' ' ' SER . 29.6 m -130.68 161.23 40.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 117.029 0.414 . . . . 0.0 110.687 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -65.42 142.51 58.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.555 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -132.33 -157.81 8.73 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -59.79 147.99 90.04 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.933 2.422 . . . . 0.0 111.69 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.782 ' CD2' HG22 ' A' ' 8' ' ' VAL . 6.7 m80 -110.41 164.45 12.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.825 -179.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -133.98 92.78 21.43 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.813 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.49 143.14 99.77 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 121.924 1.749 . . . . 0.0 110.123 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.408 ' HA ' HD13 ' A' ' 22' ' ' LEU . 1.2 mm? -79.0 83.23 5.11 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.757 -178.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.588 ' C ' HD22 ' A' ' 24' ' ' LEU . 78.5 p -89.42 -11.49 42.99 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.974 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.588 HD22 ' C ' ' A' ' 23' ' ' SER . 4.1 mm? -110.26 150.38 28.79 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.352 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.403 ' O ' ' HB ' ' A' ' 53' ' ' ILE . 91.9 p -61.55 -35.33 77.46 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.565 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 41.8 p -132.08 138.41 48.13 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.182 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.473 ' O ' ' N ' ' A' ' 51' ' ' ILE . 0.1 OUTLIER -97.5 126.76 42.97 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.837 179.904 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.434 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 55.9 tp -117.4 133.43 55.98 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.279 0.561 . . . . 0.0 110.636 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.527 ' CE2' HG21 ' A' ' 37' ' ' ILE . 31.4 m-85 -107.08 148.28 28.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.705 -178.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 154.55 166.26 14.91 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 119.661 -1.257 . . . . 0.0 112.364 178.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.633 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 85.6 mtm-85 -66.89 -37.63 84.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.131 0.491 . . . . 0.0 110.573 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.46 149.61 50.03 Favored Glycine 0 CA--C 1.521 0.448 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.117 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.433 ' C ' ' N ' ' A' ' 35' ' ' CYS . 18.2 tt -66.6 -32.33 57.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -49.12 -14.36 0.08 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.601 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.433 ' N ' ' C ' ' A' ' 33' ' ' ILE . 3.0 m -89.36 134.16 34.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.774 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.434 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 92.5 m-20 -62.35 -36.04 80.99 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.527 HG21 ' CE2' ' A' ' 29' ' ' PHE . 4.5 mm -106.63 88.94 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -73.19 126.87 31.05 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.935 -178.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.473 HG21 HG21 ' A' ' 44' ' ' VAL . 96.7 mt -117.29 122.87 70.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.875 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -95.6 81.96 3.58 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.145 -0.622 . . . . 0.0 111.089 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.484 HD13 ' HB2' ' A' ' 92' ' ' ASP . 1.0 OUTLIER -155.12 114.57 2.33 Favored Pre-proline 0 CA--C 1.536 0.422 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.017 179.359 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -52.93 -32.15 56.0 Favored 'Trans proline' 0 N--CA 1.499 1.827 0 C-N-CA 121.84 1.693 . . . . 0.0 112.813 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.4 m -64.04 -39.15 84.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.633 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 94.0 t -66.2 164.59 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.599 ' N ' HG12 ' A' ' 44' ' ' VAL . 1.2 m -94.34 165.67 12.46 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.927 -179.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -61.81 -38.65 88.91 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.693 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -132.59 65.78 1.57 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 178.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.709 ' NE2' HG23 ' A' ' 90' ' ' ILE . 16.7 t60 -60.21 -54.89 40.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.28 -1.327 . . . . 0.0 112.62 -176.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.416 ' HB2' HD11 ' A' ' 60' ' ' LEU . 0.8 OUTLIER -153.66 163.86 39.26 Favored 'General case' 0 CA--C 1.51 -0.565 0 C-N-CA 120.121 -0.632 . . . . 0.0 111.095 -179.376 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.612 ' O ' ' N ' ' A' ' 61' ' ' HIS . 82.5 tttt -141.83 132.06 24.92 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.088 -179.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.644 HD11 ' CD1' ' A' ' 88' ' ' ILE . 78.6 mt -107.41 110.18 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.072 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' A' ' 59' ' ' ILE . 96.1 mt-10 -86.12 142.58 28.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.453 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.472 HG23 ' NH1' ' A' ' 5' ' ' ARG . 42.5 mm -109.38 130.34 62.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.506 0.669 . . . . 0.0 111.16 -179.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -113.55 169.22 9.12 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.846 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -39.4 -40.92 0.88 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -178.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.441 ' HA ' ' NH2' ' A' ' 5' ' ' ARG . 76.6 mt-30 -139.66 7.98 2.34 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 119.76 -0.776 . . . . 0.0 112.667 -178.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -145.18 151.54 38.59 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 119.975 -0.69 . . . . 0.0 112.772 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.496 ' HB3' ' CZ ' ' A' ' 97' ' ' TYR . . . -103.45 141.23 36.33 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 177.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.536 ' O ' ' N ' ' A' ' 52' ' ' GLU . 20.7 mm -130.26 130.85 65.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.779 -177.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.416 HD11 ' HB2' ' A' ' 49' ' ' CYS . 53.9 tp -77.91 147.74 34.9 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.374 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.631 ' O ' ' CE1' ' A' ' 63' ' ' PHE . 3.7 m-70 -140.33 78.39 1.65 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.692 ' ND2' ' H ' ' A' ' 69' ' ' THR . 12.7 t-20 -76.43 132.51 39.7 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.46 -178.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.631 ' CE1' ' O ' ' A' ' 61' ' ' HIS . 4.2 m-85 -114.69 -19.4 11.09 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.009 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.501 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 10.6 t -63.98 132.44 50.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.129 0.49 . . . . 0.0 111.648 -177.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 52.6 p -98.85 -61.02 1.42 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.019 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.0 m -63.5 -46.22 87.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.451 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.501 ' O ' ' OG ' ' A' ' 64' ' ' SER . 11.5 m-20 -110.71 78.45 1.55 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.292 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -70.11 150.68 66.4 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 121.851 1.701 . . . . 0.0 113.098 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.692 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 32.9 m -68.08 166.3 16.3 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.565 ' O ' ' N ' ' A' ' 89' ' ' THR . 86.5 mt-30 -137.69 128.62 27.25 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.538 -0.465 . . . . 0.0 112.146 -178.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.614 HG13 ' OD1' ' A' ' 86' ' ' ASP . 42.9 t -124.73 132.18 71.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.611 179.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 50.98 29.32 4.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.016 0.436 . . . . 0.0 110.373 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.38 21.66 61.96 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.535 178.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.477 ' OG ' ' O ' ' A' ' 71' ' ' VAL . 11.6 p -126.95 128.92 47.17 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.622 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.446 ' H ' HG22 ' A' ' 75' ' ' VAL . 5.0 m -69.57 139.97 19.47 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-O 121.386 0.612 . . . . 0.0 111.119 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.518 ' CG2' ' O ' ' A' ' 78' ' ' GLU . 96.7 mt -120.26 118.76 57.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.091 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -97.16 -12.39 23.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.678 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.518 ' O ' ' CG2' ' A' ' 76' ' ' ILE . 0.6 OUTLIER -142.09 172.67 5.57 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.767 -179.279 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -60.26 142.54 98.43 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 122.471 2.114 . . . . 0.0 112.61 -179.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.469 HG21 HD13 ' A' ' 76' ' ' ILE . 31.1 m -139.71 161.79 26.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.14 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 76.9 ttt-85 -82.27 138.29 34.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.772 178.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 77.1 mt -101.33 145.65 28.61 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.029 0.442 . . . . 0.0 111.095 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -115.32 156.86 24.7 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.648 ' CE1' ' H ' ' A' ' 99' ' ' ASN . 80.2 t60 -63.86 129.18 39.03 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 120.029 -0.668 . . . . 0.0 110.181 -178.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 92.53 -5.55 77.31 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -178.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.614 ' OD1' HG13 ' A' ' 71' ' ' VAL . 59.7 t0 -65.6 137.56 57.44 Favored 'General case' 0 C--N 1.334 -0.102 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.517 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 43.1 t -112.34 130.28 66.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.167 0.508 . . . . 0.0 111.02 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.644 ' CD1' HD11 ' A' ' 51' ' ' ILE . 72.1 mt -102.36 132.48 48.31 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.565 ' N ' ' O ' ' A' ' 70' ' ' GLN . 87.9 m -128.03 131.5 49.16 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.537 0.684 . . . . 0.0 112.387 -178.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 1.1 HG22 ' H ' ' A' ' 91' ' ' ILE . 89.3 mt -102.86 -159.64 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 114.629 -1.168 . . . . 0.0 108.106 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 1.1 ' H ' HG22 ' A' ' 90' ' ' ILE . 95.9 mt -62.65 -44.92 99.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 118.763 0.711 . . . . 0.0 112.575 -177.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.484 ' HB2' HD13 ' A' ' 41' ' ' LEU . 93.4 m-20 -136.63 9.21 3.11 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 120.016 -0.673 . . . . 0.0 112.787 -178.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 72.6 mmt-85 -133.46 150.97 51.73 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.914 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.1 m -128.62 147.48 50.73 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.525 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -128.51 145.53 51.09 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.778 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.55 ' HD2' HD11 ' A' ' 10' ' ' ILE . 73.9 mtp85 -109.85 125.27 52.59 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.323 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.496 ' CZ ' ' HB3' ' A' ' 58' ' ' ALA . 11.7 t80 -105.71 97.14 7.01 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -122.22 128.41 51.13 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.21 0.528 . . . . 0.0 112.198 -178.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.648 ' H ' ' CE1' ' A' ' 84' ' ' HIS . 87.8 m-20 -100.44 140.19 35.05 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.408 178.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 . . . . . 0 C--N 1.327 -0.387 0 CA-C-O 121.07 0.462 . . . . 0.0 111.017 -179.705 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.4 mtp . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -80.67 170.29 16.21 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.83 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -56.77 142.36 92.06 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 121.93 1.753 . . . . 0.0 112.427 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 89.6 m -129.75 127.91 41.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.128 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.512 ' O ' HD23 ' A' ' 22' ' ' LEU . 90.0 mtm-85 -120.38 127.89 52.72 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.426 ' O ' ' OE1' ' A' ' 98' ' ' GLU . 86.4 mtm180 -131.35 145.98 52.08 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 120.992 0.425 . . . . 0.0 110.849 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.513 HD12 ' HA ' ' A' ' 97' ' ' TYR . 8.7 tp -110.88 132.28 54.34 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.154 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.454 HG22 ' ND1' ' A' ' 19' ' ' HIS . 50.9 t -118.2 132.43 68.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.301 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.559 ' OG1' ' CE2' ' A' ' 95' ' ' PHE . 92.3 m -108.72 121.72 45.64 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.709 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.648 HD11 ' HD2' ' A' ' 96' ' ' ARG . 89.8 mt -77.71 129.75 37.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.727 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -105.74 -147.79 0.4 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.778 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -70.83 151.27 44.96 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.559 ' O ' ' N ' ' A' ' 15' ' ' VAL . 3.0 m 61.71 145.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -178.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.42 50.16 0.07 OUTLIER Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.559 ' N ' ' O ' ' A' ' 13' ' ' SER . 36.0 m -121.2 155.89 24.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.036 0.446 . . . . 0.0 110.711 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -66.31 141.48 57.98 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.927 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -109.39 -162.75 19.78 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.24 153.55 40.72 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.766 2.31 . . . . 0.0 111.788 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.454 ' ND1' HG22 ' A' ' 8' ' ' VAL . 6.9 m170 -102.56 166.67 10.39 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.162 0.506 . . . . 0.0 111.433 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -135.0 96.24 14.58 Favored Pre-proline 0 CA--C 1.537 0.453 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.431 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.32 148.21 87.45 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 122.573 2.182 . . . . 0.0 110.943 178.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.676 ' N ' HD22 ' A' ' 22' ' ' LEU . 2.8 mm? -89.36 76.91 7.47 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.986 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.4 p -71.15 -31.37 67.62 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.354 178.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.1 mt -114.43 140.31 48.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.737 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.0 p -66.91 -15.36 63.61 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.703 0.287 . . . . 0.0 111.493 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.5 p -117.77 113.33 21.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.613 0.244 . . . . 0.0 110.921 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.1 m -96.83 127.67 43.04 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.465 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.46 HD23 ' HA ' ' A' ' 35' ' ' CYS . 67.8 tp -114.78 142.05 47.05 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.151 -179.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.673 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 65.2 m-85 -112.25 141.52 45.86 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.543 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.577 ' O ' ' N ' ' A' ' 39' ' ' ILE . . . 160.9 -177.62 37.21 Favored Glycine 0 C--O 1.228 -0.275 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.44 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 35.3 ptt-85 -103.82 -3.32 25.05 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.062 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -86.25 162.07 34.78 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.2 tp -65.11 -32.12 56.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.174 0.511 . . . . 0.0 109.954 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -57.01 -21.73 33.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.307 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.46 ' HA ' HD23 ' A' ' 28' ' ' LEU . 2.7 m -82.73 127.71 33.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.345 0.593 . . . . 0.0 112.548 -178.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -62.8 -39.34 93.94 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 177.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.2 mm -105.06 85.36 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 178.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -72.26 137.96 47.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.432 -177.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.577 ' N ' ' O ' ' A' ' 30' ' ' GLY . 95.2 mt -129.31 118.86 47.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.781 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.421 ' HG2' ' H ' ' A' ' 40' ' ' GLN . 1.2 pt20 -77.74 81.26 4.18 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.327 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 41' ' ' LEU . 53.0 mt -154.14 106.73 2.44 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.522 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.43 -33.48 67.23 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 122.235 1.957 . . . . 0.0 111.94 178.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.497 ' HB ' HD13 ' A' ' 91' ' ' ILE . 26.1 m -66.44 -25.26 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.447 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.44 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 86.7 t -87.45 137.78 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.7 m -80.69 155.78 26.61 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.916 0.389 . . . . 0.0 112.016 -178.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -58.0 -38.27 75.82 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -114.7 48.48 1.13 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.687 ' NE2' HG23 ' A' ' 90' ' ' ILE . 14.7 t60 -57.86 -50.01 74.76 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.734 -178.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.673 ' SG ' ' CD1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -152.66 159.44 43.19 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.491 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.627 ' O ' ' N ' ' A' ' 61' ' ' HIS . 68.4 tttt -139.22 135.79 34.31 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.904 -179.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.53 HD11 HD11 ' A' ' 88' ' ' ILE . 2.3 mm -110.01 103.88 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.874 178.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' A' ' 59' ' ' ILE . 78.1 tt0 -83.97 128.55 34.63 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 49.7 mm -96.08 131.87 41.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.63 0.729 . . . . 0.0 111.281 -178.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.504 ' O ' ' C ' ' A' ' 55' ' ' GLU . 47.6 m-70 -119.55 178.92 4.38 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.725 -178.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.504 ' C ' ' O ' ' A' ' 54' ' ' HIS . 96.5 mt-10 -23.36 -65.87 0.04 OUTLIER 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.444 -179.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -140.51 15.03 2.36 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.271 -0.571 . . . . 0.0 111.749 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.574 ' OE1' ' NE ' ' A' ' 81' ' ' ARG . 19.9 pt-20 -134.2 146.96 50.63 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.01 -0.676 . . . . 0.0 111.052 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -99.24 135.81 40.1 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.418 ' O ' ' N ' ' A' ' 52' ' ' GLU . 36.7 mm -119.56 125.84 74.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.179 0.514 . . . . 0.0 111.915 -178.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.5 HD11 ' SG ' ' A' ' 49' ' ' CYS . 59.9 tp -77.49 142.03 39.33 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.394 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.627 ' N ' ' O ' ' A' ' 50' ' ' LYS . 41.1 m-70 -137.11 81.3 1.86 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-O 121.554 0.692 . . . . 0.0 110.659 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.75 ' ND2' ' H ' ' A' ' 69' ' ' THR . 24.7 t-20 -74.25 128.35 35.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.631 -1.168 . . . . 0.0 112.758 -179.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -102.38 -38.83 7.43 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.262 178.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.7 t -53.79 138.16 36.37 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.157 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.0 t -107.28 -53.75 2.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.326 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.2 p -60.04 -48.23 82.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.497 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.494 ' OD1' ' N ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -120.21 84.45 34.19 Favored Pre-proline 0 N--CA 1.463 0.203 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.692 179.385 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.504 ' HG2' HG13 ' A' ' 75' ' ' VAL . 95.7 Cg_endo -74.82 146.03 32.93 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.038 1.825 . . . . 0.0 113.392 -178.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.75 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 23.4 m -61.87 154.32 26.42 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.651 178.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' A' ' 89' ' ' THR . 86.1 mt-30 -122.84 148.3 45.56 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.072 0.463 . . . . 0.0 112.028 -177.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.539 ' O ' ' N ' ' A' ' 73' ' ' GLY . 7.9 p -132.99 135.95 56.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.169 178.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 44.78 17.13 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.358 -0.537 . . . . 0.0 109.689 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 71' ' ' VAL . . . 99.86 -15.79 59.16 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.09 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.539 ' N ' ' O ' ' A' ' 71' ' ' VAL . 14.4 m -83.19 140.55 32.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 117.253 0.526 . . . . 0.0 110.575 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.504 HG13 ' HG2' ' A' ' 68' ' ' PRO . 87.2 t -70.7 143.97 14.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.155 0.502 . . . . 0.0 110.798 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.467 HD11 ' CG1' ' A' ' 71' ' ' VAL . 41.3 mm -102.5 91.55 2.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.465 -179.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -70.91 -39.17 72.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.581 178.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -141.55 174.21 4.05 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.299 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.51 140.36 89.28 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 121.911 1.741 . . . . 0.0 111.304 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 32.8 m -136.57 163.64 32.84 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.683 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.574 ' NE ' ' OE1' ' A' ' 57' ' ' GLU . 72.7 ttt180 -89.68 135.51 33.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.923 179.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.546 HD12 ' N ' ' A' ' 82' ' ' LEU . 5.5 mp -105.89 131.86 52.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.19 0.519 . . . . 0.0 110.632 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.477 ' HG2' ' N ' ' A' ' 84' ' ' HIS . 88.8 tttt -88.13 162.81 16.53 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.477 ' N ' ' HG2' ' A' ' 83' ' ' LYS . 73.1 t60 -61.15 129.25 40.39 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 119.511 -0.876 . . . . 0.0 109.31 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.09 -1.0 62.58 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.672 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.598 ' OD1' ' N ' ' A' ' 87' ' ' VAL . 64.4 t0 -68.58 145.54 53.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.677 0.275 . . . . 0.0 111.736 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.598 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 87.4 t -119.63 133.17 67.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-O 121.223 0.535 . . . . 0.0 111.16 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.53 HD11 HD11 ' A' ' 51' ' ' ILE . 71.2 mt -108.02 139.9 28.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.254 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.419 ' O ' ' N ' ' A' ' 70' ' ' GLN . 66.1 m -132.88 135.12 45.41 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.89 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 1.117 HG22 ' H ' ' A' ' 91' ' ' ILE . 58.5 mt -102.17 -147.57 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 1.117 ' H ' HG22 ' A' ' 90' ' ' ILE . 96.1 mt -62.91 -43.47 98.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 118.627 0.649 . . . . 0.0 111.228 -178.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -146.37 20.1 1.36 Allowed 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -179.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -132.87 153.54 51.23 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.27 -0.572 . . . . 0.0 111.211 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.9 m -126.12 138.59 53.69 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.077 0.465 . . . . 0.0 111.266 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.559 ' CE2' ' OG1' ' A' ' 9' ' ' THR . 53.7 m-85 -128.06 138.84 52.72 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.974 178.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.648 ' HD2' HD11 ' A' ' 10' ' ' ILE . 82.2 mtp180 -109.92 133.17 53.46 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.985 -179.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.513 ' HA ' HD12 ' A' ' 7' ' ' LEU . 10.3 t80 -113.73 118.71 35.06 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.461 ' CD ' ' O ' ' A' ' 98' ' ' GLU . 2.1 pm0 -143.2 133.01 23.93 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 120.072 -0.651 . . . . 0.0 110.433 -178.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 63.6 t-20 -96.62 110.77 23.12 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.56 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 . . . . . 0 C--O 1.234 0.271 0 CA-C-O 120.938 0.399 . . . . 0.0 110.082 179.977 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.6 mmm . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.586 ' CD1' ' N ' ' A' ' 2' ' ' TRP . 0.0 OUTLIER -131.24 84.8 55.83 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.466 -179.939 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -58.03 142.0 96.54 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.756 2.304 . . . . 0.0 112.438 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 82.3 p -120.25 23.68 10.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.261 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.677 ' NH2' ' ND2' ' A' ' 99' ' ' ASN . 95.4 mtt-85 -78.48 137.83 38.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.086 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -140.92 146.16 37.04 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.72 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.513 HD12 ' HA ' ' A' ' 97' ' ' TYR . 8.1 tp -114.26 131.68 56.41 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 58.4 t -120.16 136.75 56.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.091 -178.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.7 m -105.99 126.07 51.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.589 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.711 HG21 ' O ' ' A' ' 13' ' ' SER . 86.9 mt -86.36 107.39 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.221 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -65.27 -44.5 87.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.374 179.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.539 ' O ' ' C ' ' A' ' 13' ' ' SER . 84.6 mtt85 -130.03 149.77 51.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.418 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.711 ' O ' HG21 ' A' ' 10' ' ' ILE . 2.0 t 10.51 -96.67 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.877 0.735 . . . . 0.0 112.194 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.527 ' N ' ' OG ' ' A' ' 13' ' ' SER . . . -113.1 5.73 25.39 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.995 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.9 t -73.9 140.39 17.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.108 0.48 . . . . 0.0 110.834 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -65.22 137.15 57.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.101 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -124.2 -157.89 9.92 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.32 147.15 92.32 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.646 2.23 . . . . 0.0 112.064 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.439 ' CD2' ' N ' ' A' ' 19' ' ' HIS . 10.0 m-70 -107.55 166.12 10.91 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.777 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.559 ' CZ ' ' O ' ' A' ' 36' ' ' ASP . 19.0 t80 -142.46 109.71 5.75 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.893 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.78 146.94 38.91 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 121.762 1.641 . . . . 0.0 111.032 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.0 mt -94.7 107.78 19.78 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.111 -0.636 . . . . 0.0 111.079 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.0 m -111.1 -17.82 13.15 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.509 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.565 ' HG ' ' H ' ' A' ' 26' ' ' THR . 51.1 tp -115.9 136.39 53.09 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.937 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 92.4 p -56.87 -34.14 67.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.175 -179.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.565 ' H ' ' HG ' ' A' ' 24' ' ' LEU . 49.0 p -110.43 119.56 39.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.983 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.406 ' HG ' ' HE1' ' A' ' 29' ' ' PHE . 0.8 OUTLIER -102.89 122.77 45.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.869 178.921 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.543 HD21 ' HG2' ' A' ' 47' ' ' GLN . 49.1 tp -112.98 141.82 46.38 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.432 0.634 . . . . 0.0 112.16 -178.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.406 ' HE1' ' HG ' ' A' ' 27' ' ' CYS . 13.4 m-85 -107.66 145.04 33.89 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.736 179.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.48 166.83 16.15 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 119.453 -1.356 . . . . 0.0 112.666 179.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -66.43 -36.3 82.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.881 -0.659 . . . . 0.0 110.9 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.542 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -63.23 148.64 50.31 Favored Glycine 0 CA--C 1.52 0.372 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.762 -179.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.502 ' O ' ' N ' ' A' ' 35' ' ' CYS . 19.1 tt -65.52 -38.84 83.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.155 0.503 . . . . 0.0 110.152 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.499 ' N ' HG23 ' A' ' 33' ' ' ILE . 16.2 pt-20 -47.77 -11.08 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.683 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.542 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 3.0 m -88.65 135.57 33.43 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.955 0.407 . . . . 0.0 111.453 -179.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.559 ' O ' ' CZ ' ' A' ' 20' ' ' PHE . 55.6 m-20 -62.61 -37.78 87.6 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.5 mm -109.44 94.21 2.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -72.53 137.63 46.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.978 0.418 . . . . 0.0 110.29 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.754 HG21 HG21 ' A' ' 44' ' ' VAL . 96.5 mt -127.1 124.49 64.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.79 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -96.94 80.88 3.03 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.848 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.403 HD22 HG22 ' A' ' 43' ' ' VAL . 3.7 mt -156.92 114.17 1.98 Allowed Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.053 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -51.89 -28.66 32.12 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 121.862 1.708 . . . . 0.0 112.397 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.437 ' O ' ' CD1' ' A' ' 91' ' ' ILE . 34.2 m -68.78 -21.94 26.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.495 -179.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.754 HG21 HG21 ' A' ' 39' ' ' ILE . 96.3 t -85.87 149.23 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.8 p -88.23 172.07 9.73 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 120.255 -0.578 . . . . 0.0 112.174 -178.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.42 -40.45 96.58 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.543 ' HG2' HD21 ' A' ' 28' ' ' LEU . 99.5 mt-30 -130.5 70.63 1.45 Allowed 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 178.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.747 ' NE2' HG23 ' A' ' 90' ' ' ILE . 21.4 t60 -62.27 -50.11 73.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.73 -1.123 . . . . 0.0 113.183 -177.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.639 ' SG ' ' N ' ' A' ' 50' ' ' LYS . 0.5 OUTLIER -167.65 162.35 14.04 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.323 -178.739 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.639 ' N ' ' SG ' ' A' ' 49' ' ' CYS . 12.5 ptpt -142.54 151.15 41.31 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 119.179 -1.008 . . . . 0.0 112.621 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.492 HD11 ' CD1' ' A' ' 88' ' ' ILE . 96.7 mt -108.81 110.69 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.165 177.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 59' ' ' ILE . 85.4 tt0 -90.48 148.7 22.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.015 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -105.78 134.57 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 CA-C-O 121.124 0.488 . . . . 0.0 111.691 -178.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.479 ' O ' ' C ' ' A' ' 55' ' ' GLU . 23.4 m-70 -119.85 174.53 6.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.178 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.479 ' C ' ' O ' ' A' ' 54' ' ' HIS . 95.8 mt-10 -24.05 -58.07 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.593 -178.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.589 ' O ' ' NH2' ' A' ' 5' ' ' ARG . 97.8 mt-30 -141.25 7.9 2.0 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.981 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.514 ' OE1' ' NE ' ' A' ' 81' ' ' ARG . 22.0 pt-20 -134.88 161.51 35.02 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.246 -0.582 . . . . 0.0 111.713 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.575 ' HB3' ' CE2' ' A' ' 97' ' ' TYR . . . -105.05 147.93 27.32 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.649 179.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.504 ' O ' ' N ' ' A' ' 52' ' ' GLU . 28.0 mm -130.09 135.21 61.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 -179.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.745 ' HB2' HD11 ' A' ' 82' ' ' LEU . 7.2 tt -98.58 139.33 34.46 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -129.28 79.21 1.9 Allowed 'General case' 0 C--N 1.341 0.219 0 CA-C-O 121.338 0.59 . . . . 0.0 110.325 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.778 ' ND2' ' H ' ' A' ' 69' ' ' THR . 27.1 t-20 -62.01 134.04 56.11 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.765 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -106.15 -39.5 5.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.182 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.478 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 20.9 t -54.54 140.0 36.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.058 0.456 . . . . 0.0 111.213 -178.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.0 m -107.3 -54.65 2.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.812 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.4 m -62.05 -45.61 92.8 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.378 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.478 ' O ' ' OG ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -123.35 81.19 52.92 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.502 179.409 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.31 151.09 37.73 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.301 2.0 . . . . 0.0 113.294 -178.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.778 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 90.6 m -64.89 159.96 21.57 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 177.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -128.02 147.02 50.49 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.08 -0.648 . . . . 0.0 112.282 -178.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.983 HG23 HD11 ' A' ' 76' ' ' ILE . 22.8 t -125.11 129.06 73.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.293 179.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 49.11 28.2 2.03 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.372 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.91 -5.11 80.69 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 71' ' ' VAL . 17.5 m -88.56 139.42 30.49 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 81.6 t -73.52 141.94 15.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.506 0.669 . . . . 0.0 110.702 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.983 HD11 HG23 ' A' ' 71' ' ' VAL . 87.8 mt -103.22 84.84 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.752 -179.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -63.45 -40.36 96.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.372 0.606 . . . . 0.0 109.663 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.422 ' O ' HG13 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -138.51 174.72 3.93 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.555 179.559 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.42 137.66 78.08 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 121.663 1.575 . . . . 0.0 110.6 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.422 HG13 ' O ' ' A' ' 78' ' ' GLU . 30.4 m -133.21 161.61 41.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.915 -178.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.514 ' NE ' ' OE1' ' A' ' 57' ' ' GLU . 76.2 ttt180 -80.84 139.97 35.67 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.524 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.745 HD11 ' HB2' ' A' ' 60' ' ' LEU . 92.6 mt -107.59 143.91 35.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.333 0.587 . . . . 0.0 111.055 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.52 ' N ' ' OD2' ' A' ' 86' ' ' ASP . 98.6 mttt -118.18 153.1 34.4 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.605 178.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 36.9 t60 -61.89 131.8 50.95 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.644 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.15 -5.2 57.54 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.52 ' OD2' ' N ' ' A' ' 83' ' ' LYS . 99.0 m-20 -71.75 149.59 45.23 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.608 0.242 . . . . 0.0 110.85 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 70.0 t -116.57 132.92 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.533 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.492 ' CD1' HD11 ' A' ' 51' ' ' ILE . 76.0 mt -107.61 132.88 54.03 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-O 120.916 0.389 . . . . 0.0 110.333 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.1 m -129.82 132.84 46.63 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.792 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 1.035 HG22 ' H ' ' A' ' 91' ' ' ILE . 66.9 mt -98.37 -152.23 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 1.035 ' H ' HG22 ' A' ' 90' ' ' ILE . 95.6 mt -63.72 -44.45 98.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 118.453 0.57 . . . . 0.0 112.382 -178.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 91' ' ' ILE . 97.9 m-20 -141.48 17.62 2.21 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 94.4 mtt-85 -132.43 154.12 50.16 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.781 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.2 p -124.27 141.38 52.12 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.139 0.495 . . . . 0.0 111.246 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -132.97 147.67 52.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.697 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.528 ' HD2' HD11 ' A' ' 10' ' ' ILE . 69.6 mtp85 -118.2 140.42 49.82 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.444 -179.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.575 ' CE2' ' HB3' ' A' ' 58' ' ' ALA . 0.8 OUTLIER -113.85 107.31 15.54 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.4 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -114.31 120.32 39.98 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 120.837 0.351 . . . . 0.0 111.575 -178.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.677 ' ND2' ' NH2' ' A' ' 5' ' ' ARG . 45.8 t30 -113.95 96.75 5.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.239 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.304 -179.645 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.2 mtp . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.659 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 4.1 m95 -96.41 -34.73 0.27 Allowed Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.685 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.659 ' CD ' ' N ' ' A' ' 2' ' ' TRP . 36.3 Cg_endo -83.48 -0.66 9.9 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.472 2.115 . . . . 0.0 112.393 -178.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.5 t -78.34 160.07 28.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.271 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.726 ' HE ' ' ND2' ' A' ' 99' ' ' ASN . 83.2 mtt85 -73.97 137.12 43.33 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -143.56 146.5 33.38 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 120.32 -0.552 . . . . 0.0 112.038 -179.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.576 ' CD1' HD21 ' A' ' 22' ' ' LEU . 91.4 mt -110.72 128.37 55.7 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.738 178.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.5 t -112.56 133.88 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.619 ' OG1' ' CE2' ' A' ' 95' ' ' PHE . 8.6 m -102.44 116.42 32.59 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.185 -0.606 . . . . 0.0 111.834 -179.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.557 HD11 ' HE ' ' A' ' 96' ' ' ARG . 96.8 mt -75.77 133.12 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-O 121.007 0.432 . . . . 0.0 110.276 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.529 ' O ' ' O ' ' A' ' 14' ' ' GLY . 14.7 mmmt -99.48 152.64 19.78 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.347 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -66.65 130.57 43.62 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 61.95 21.28 12.19 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -177.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.529 ' O ' ' O ' ' A' ' 11' ' ' LYS . . . -160.19 109.65 0.41 Allowed Glycine 0 CA--C 1.518 0.228 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.47 ' HA ' HG23 ' A' ' 10' ' ' ILE . 22.5 m -99.84 131.2 47.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.433 0.635 . . . . 0.0 111.531 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.429 ' CB ' ' O ' ' A' ' 15' ' ' VAL . 3.9 t0 80.02 51.59 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.778 179.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.69 -147.54 1.88 Allowed Glycine 0 CA--C 1.53 0.989 0 N-CA-C 110.471 -1.051 . . . . 0.0 110.471 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -59.54 147.07 93.22 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.604 2.203 . . . . 0.0 111.169 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -98.78 -177.24 3.59 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.564 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -150.31 91.76 4.12 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.694 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -57.61 143.61 94.45 Favored 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 122.51 2.14 . . . . 0.0 111.188 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.576 HD21 ' CD1' ' A' ' 7' ' ' LEU . 97.8 mt -90.98 76.12 6.26 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 119.901 -0.719 . . . . 0.0 111.074 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.9 p -67.59 -30.69 70.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.916 179.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.4 mt -108.67 144.06 36.92 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.451 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 97.2 p -63.83 -30.29 71.39 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.015 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 81.4 p -109.05 127.36 54.05 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.185 0.517 . . . . 0.0 111.754 -178.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.553 ' SG ' ' CD2' ' A' ' 22' ' ' LEU . 1.2 m -107.93 126.01 52.18 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.103 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.492 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 66.6 tp -115.57 134.14 55.35 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.212 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.512 ' CD1' ' SG ' ' A' ' 49' ' ' CYS . 13.9 m-85 -102.52 146.56 27.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.761 -179.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.417 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . 144.57 152.3 5.61 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.246 -0.978 . . . . 0.0 112.502 178.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 75.5 ttt-85 -64.56 -41.43 96.32 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.683 -0.759 . . . . 0.0 111.46 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.403 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -46.88 153.3 1.15 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 18.8 tt -63.64 -31.26 52.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -60.93 -20.27 61.92 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.484 ' SG ' ' O ' ' A' ' 46' ' ' LYS . 2.0 m -74.22 124.65 26.79 Favored 'General case' 0 C--O 1.233 0.209 0 O-C-N 121.961 -0.462 . . . . 0.0 111.95 -179.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.492 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 55.9 m-20 -63.01 -38.6 91.85 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.2 mm -102.4 85.44 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 177.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -66.51 134.57 52.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.79 -177.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.516 HG22 ' HB2' ' A' ' 41' ' ' LEU . 93.9 mt -124.16 108.28 20.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -75.99 81.13 2.86 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 118.973 -1.091 . . . . 0.0 109.97 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.516 ' HB2' HG22 ' A' ' 39' ' ' ILE . 2.0 mt -155.27 107.64 2.24 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.323 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -51.46 -36.2 58.03 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.226 1.951 . . . . 0.0 112.488 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.422 ' HB ' HD13 ' A' ' 91' ' ' ILE . 18.1 m -64.4 -22.67 31.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.884 -178.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 76.7 t -86.14 146.03 6.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.359 178.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.9 m -82.73 159.41 22.57 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.169 -0.612 . . . . 0.0 111.998 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.484 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 98.8 mttt -61.92 -39.49 92.2 Favored 'General case' 0 C--N 1.334 -0.069 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.582 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -118.36 51.51 1.08 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.676 ' NE2' HG23 ' A' ' 90' ' ' ILE . 13.7 t60 -59.29 -50.46 73.91 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.085 -0.962 . . . . 0.0 112.205 -177.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.528 ' SG ' HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -151.13 161.22 43.13 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.721 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.589 ' O ' ' N ' ' A' ' 61' ' ' HIS . 47.0 tttm -144.7 131.13 19.77 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.485 -179.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.479 ' CG2' ' HB1' ' A' ' 58' ' ' ALA . 95.8 mt -107.0 109.58 28.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.556 178.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -91.84 130.81 37.54 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.433 ' O ' ' CG2' ' A' ' 53' ' ' ILE . 0.8 OUTLIER -90.2 129.3 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.024 -179.333 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.502 ' O ' ' C ' ' A' ' 55' ' ' GLU . 32.5 m-70 -112.13 -179.37 3.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.716 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.502 ' C ' ' O ' ' A' ' 54' ' ' HIS . 79.9 mm-40 -23.82 -63.46 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 O-C-N 123.648 0.593 . . . . 0.0 111.803 -178.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.44 ' O ' ' ND2' ' A' ' 99' ' ' ASN . 90.9 mt-30 -140.32 13.74 2.39 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.648 -0.421 . . . . 0.0 111.967 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.522 ' N ' ' OE1' ' A' ' 57' ' ' GLU . 56.0 mp0 -139.59 148.97 43.25 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 119.891 -0.723 . . . . 0.0 111.882 -179.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.504 ' HB3' ' CE2' ' A' ' 97' ' ' TYR . . . -94.15 141.89 28.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.527 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.0 mm -124.06 127.31 73.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 120.967 0.413 . . . . 0.0 111.428 -178.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.572 HD23 HD13 ' A' ' 76' ' ' ILE . 52.7 tp -76.91 144.39 38.94 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.934 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.599 ' O ' ' CE1' ' A' ' 63' ' ' PHE . 15.5 m-70 -136.2 77.62 1.67 Allowed 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.645 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.727 ' ND2' ' H ' ' A' ' 69' ' ' THR . 26.9 t-20 -70.7 132.62 45.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.933 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.599 ' CE1' ' O ' ' A' ' 61' ' ' HIS . 17.2 m-85 -108.02 -34.81 6.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.899 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.2 m -57.69 137.23 56.68 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.294 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.0 p -105.12 -52.91 2.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.515 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.0 m -62.04 -48.09 81.83 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.829 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.52 ' OD1' ' N ' ' A' ' 67' ' ' ASN . 0.1 OUTLIER -117.13 81.03 12.37 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.822 179.103 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -73.03 146.65 41.87 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 121.578 1.519 . . . . 0.0 112.171 -179.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.727 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 62.4 m -64.64 160.83 18.91 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.447 ' N ' HG22 ' A' ' 69' ' ' THR . 85.2 mt-30 -131.65 150.81 52.02 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.127 -0.629 . . . . 0.0 112.206 -177.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.476 ' CG2' HD11 ' A' ' 76' ' ' ILE . 19.8 t -133.45 131.81 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.032 178.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 48.0 29.05 1.6 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.189 179.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.42 16.42 78.08 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.5 t -108.23 130.43 55.16 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 65.3 t -70.67 137.12 24.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 CA-C-O 121.68 0.752 . . . . 0.0 110.773 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.572 HD13 HD23 ' A' ' 60' ' ' LEU . 95.6 mt -114.78 102.1 13.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.131 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -76.78 -41.73 43.51 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.349 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -130.01 174.35 4.71 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.721 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -53.95 136.91 68.06 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 C-N-CA 122.463 2.109 . . . . 0.0 111.552 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.4 m -135.64 159.54 39.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.327 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 60.8 ttm-85 -79.52 139.95 37.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.308 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.531 HD11 ' HB2' ' A' ' 60' ' ' LEU . 93.3 mt -114.81 143.09 45.65 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 121.27 0.557 . . . . 0.0 111.696 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.424 ' O ' ' CG ' ' A' ' 86' ' ' ASP . 99.1 mttt -106.93 152.37 24.03 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.203 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 35.8 t60 -59.66 132.7 54.79 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.526 -0.47 . . . . 0.0 109.975 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.71 -2.9 62.59 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 -178.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.424 ' CG ' ' O ' ' A' ' 83' ' ' LYS . 15.7 m-20 -75.07 143.96 43.2 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.2 t -118.46 134.86 60.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-O 120.785 0.326 . . . . 0.0 111.229 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.476 ' CD1' HD11 ' A' ' 51' ' ' ILE . 62.9 mt -104.89 135.82 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 116.264 -0.425 . . . . 0.0 109.977 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 89.3 m -126.26 125.85 43.05 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.119 0.485 . . . . 0.0 111.295 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 1.087 HG22 ' H ' ' A' ' 91' ' ' ILE . 93.7 mt -94.68 -146.04 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 178.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 1.087 ' H ' HG22 ' A' ' 90' ' ' ILE . 96.9 mt -62.74 -45.24 99.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 119.434 1.016 . . . . 0.0 112.581 -178.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.411 ' OD1' HD13 ' A' ' 41' ' ' LEU . 27.7 p30 -143.56 -0.61 1.07 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -179.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -122.42 148.7 44.79 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.924 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.9 m -121.69 153.39 38.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.461 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.619 ' CE2' ' OG1' ' A' ' 9' ' ' THR . 48.0 m-85 -126.69 147.25 49.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.833 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.557 ' HE ' HD11 ' A' ' 10' ' ' ILE . 84.2 mtt180 -104.84 122.35 45.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.204 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.504 ' CE2' ' HB3' ' A' ' 58' ' ' ALA . 0.8 OUTLIER -104.78 99.35 8.99 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.611 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -110.86 115.55 29.71 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.966 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.726 ' ND2' ' HE ' ' A' ' 5' ' ' ARG . 61.3 t-20 -106.46 94.01 4.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.807 178.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.492 ' O ' ' O ' ' A' ' 3' ' ' PRO . 99.0 mt-10 . . . . . 0 C--N 1.321 -0.634 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.028 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.5 mtm . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.644 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 3.4 p90 -154.91 37.01 0.08 OUTLIER Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.02 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.644 ' CD ' ' N ' ' A' ' 2' ' ' TRP . 60.6 Cg_endo -69.63 150.09 68.57 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.325 2.016 . . . . 0.0 112.331 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 63.87 -175.31 0.16 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.219 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -101.61 148.78 24.82 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.637 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.421 HH22 ' CA ' ' A' ' 2' ' ' TRP . 90.7 mtm-85 -137.63 155.68 48.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.407 0.622 . . . . 0.0 112.375 -178.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.611 HD23 ' HA ' ' A' ' 97' ' ' TYR . 93.6 mt -110.11 137.32 48.03 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 177.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.7 HG22 ' CD2' ' A' ' 19' ' ' HIS . 53.0 t -121.78 132.33 71.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.258 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 59.5 m -108.65 120.3 42.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.284 -178.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.704 HD11 ' HD2' ' A' ' 96' ' ' ARG . 71.5 mt -77.77 130.97 35.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.994 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -62.99 -40.49 97.91 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.126 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -148.52 -93.57 0.08 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.09 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.5 p -149.44 126.95 11.56 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.008 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.96 12.4 75.14 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.471 ' O ' HG23 ' A' ' 10' ' ' ILE . 6.4 m -125.78 129.11 72.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.94 0.4 . . . . 0.0 110.915 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -68.96 140.04 55.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.634 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -122.1 -169.28 13.49 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.776 -0.929 . . . . 0.0 110.776 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -71.74 152.08 58.33 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.559 2.173 . . . . 0.0 112.049 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.7 ' CD2' HG22 ' A' ' 8' ' ' VAL . 19.0 m170 -96.51 169.78 9.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.219 0.533 . . . . 0.0 110.638 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.459 ' CZ ' ' O ' ' A' ' 36' ' ' ASP . 73.1 t80 -137.7 96.85 10.46 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.36 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.3 144.93 69.41 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.072 1.848 . . . . 0.0 110.813 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.0 tp -110.8 121.7 45.99 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.989 0.424 . . . . 0.0 111.872 -178.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.0 m -123.91 -38.71 2.46 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.647 178.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.511 ' N ' ' CD2' ' A' ' 24' ' ' LEU . 3.7 mm? -78.22 139.45 38.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.414 179.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 86.0 p -69.83 -15.52 63.12 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.445 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.9 p -120.7 123.29 42.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.851 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -106.68 123.47 48.18 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.428 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 59.9 tp -116.05 143.22 45.75 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.055 0.455 . . . . 0.0 111.145 -178.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.669 ' CE2' HG21 ' A' ' 37' ' ' ILE . 15.8 m-85 -113.39 140.65 47.88 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.624 -0.717 . . . . 0.0 111.72 -178.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 146.77 172.66 17.27 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.801 178.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.403 HH11 ' HA ' ' A' ' 42' ' ' PRO . 82.4 mtp180 -65.11 -35.52 81.39 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.041 -0.58 . . . . 0.0 110.934 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.563 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -43.9 140.22 3.46 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 tt -66.43 -32.65 59.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.84 0.352 . . . . 0.0 110.86 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -64.82 -17.33 64.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.545 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.563 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 7.8 m -64.31 126.76 28.82 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 120.862 0.363 . . . . 0.0 110.966 -179.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.459 ' O ' ' CZ ' ' A' ' 20' ' ' PHE . 55.3 m-20 -64.07 -39.35 93.88 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.669 HG21 ' CE2' ' A' ' 29' ' ' PHE . 5.2 mm -107.12 79.9 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -67.13 127.31 32.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.054 -0.975 . . . . 0.0 112.266 -177.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.414 HG23 ' HD2' ' A' ' 93' ' ' ARG . 96.7 mt -121.62 130.33 74.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.333 179.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.499 ' N ' ' CD ' ' A' ' 40' ' ' GLN . 0.0 OUTLIER -101.79 83.18 2.36 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.13 -179.765 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.0 mt -153.88 114.87 2.58 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.667 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.403 ' HA ' HH11 ' A' ' 31' ' ' ARG . 51.4 Cg_exo -51.82 -35.05 57.64 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.618 1.545 . . . . 0.0 112.08 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.9 m -64.02 -31.64 54.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.492 -179.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.437 HG12 ' N ' ' A' ' 45' ' ' SER . 76.0 t -81.03 155.72 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.437 ' N ' HG12 ' A' ' 44' ' ' VAL . 13.0 m -100.16 158.19 16.03 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 120.037 -0.665 . . . . 0.0 112.166 -178.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -59.96 -37.78 80.59 Favored 'General case' 0 C--O 1.23 0.068 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -115.84 50.14 1.05 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.503 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.722 ' NE2' HG23 ' A' ' 90' ' ' ILE . 13.7 t60 -61.9 -51.39 68.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.026 -177.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.882 ' SG ' HD11 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -155.62 159.51 39.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.752 -179.138 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.599 ' O ' ' N ' ' A' ' 61' ' ' HIS . 72.9 tttt -140.1 130.34 25.16 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -178.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.7 mt -103.77 113.66 41.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 59' ' ' ILE . 82.7 tt0 -100.79 125.07 47.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.798 0.332 . . . . 0.0 110.229 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.5 tp -88.71 135.63 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-O 121.377 0.608 . . . . 0.0 111.74 -178.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.452 ' O ' ' C ' ' A' ' 55' ' ' GLU . 6.2 m-70 -112.14 -178.52 3.44 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.454 179.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 54' ' ' HIS . 30.2 tp10 -35.09 -51.84 0.55 Allowed 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 121.131 -0.228 . . . . 0.0 111.085 -178.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -146.66 24.8 1.21 Allowed 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 121.095 -0.242 . . . . 0.0 111.364 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.425 ' HG2' ' N ' ' A' ' 58' ' ' ALA . 83.2 tt0 -140.71 156.19 46.27 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.735 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.555 ' HB3' ' CE2' ' A' ' 97' ' ' TYR . . . -108.85 136.49 48.33 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.238 178.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.42 HD13 ' O ' ' A' ' 58' ' ' ALA . 49.0 mm -125.43 130.6 72.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 120.894 -0.322 . . . . 0.0 111.002 -178.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.882 HD11 ' SG ' ' A' ' 49' ' ' CYS . 46.9 tp -85.51 144.18 28.09 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.821 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.599 ' N ' ' O ' ' A' ' 50' ' ' LYS . 32.4 m-70 -136.13 79.7 1.78 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.403 0.621 . . . . 0.0 110.505 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.697 ' ND2' ' H ' ' A' ' 69' ' ' THR . 24.5 t-20 -75.07 130.16 38.82 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.97 -1.014 . . . . 0.0 112.412 -179.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.486 ' CE1' ' O ' ' A' ' 61' ' ' HIS . 13.0 m-85 -107.28 -35.19 6.88 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.934 179.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.492 ' OG ' ' O ' ' A' ' 67' ' ' ASN . 19.2 t -58.67 140.37 54.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.239 -177.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.5 t -110.54 -54.52 2.58 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.0 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 81.4 p -67.64 -36.41 80.72 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.492 ' O ' ' OG ' ' A' ' 64' ' ' SER . 0.6 OUTLIER -120.57 76.55 26.96 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.498 178.879 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -74.55 148.48 37.55 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 121.878 1.719 . . . . 0.0 113.317 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.697 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 53.5 m -71.88 160.7 32.11 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.552 ' N ' ' O ' ' A' ' 89' ' ' THR . 85.9 mt-30 -126.66 143.8 51.11 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.87 -177.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.913 HG23 HD11 ' A' ' 76' ' ' ILE . 19.2 t -125.53 133.1 70.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.875 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.443 ' ND2' ' OD1' ' A' ' 86' ' ' ASP . 75.6 m-20 44.38 28.0 0.27 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.903 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.55 21.37 58.3 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 121.051 -0.595 . . . . 0.0 111.9 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.459 ' N ' ' O ' ' A' ' 71' ' ' VAL . 28.5 t -121.18 142.01 50.29 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.8 t -72.96 147.99 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 121.531 0.682 . . . . 0.0 111.772 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.913 HD11 HG23 ' A' ' 71' ' ' VAL . 92.7 mt -114.3 114.01 45.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.603 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -96.28 -9.1 31.07 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.555 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -168.58 171.87 3.39 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.802 -178.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -53.99 139.07 70.69 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 121.602 1.535 . . . . 0.0 111.438 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.5 m -138.83 160.31 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 C-N-CA 120.466 -0.493 . . . . 0.0 110.746 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -68.5 131.98 46.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.778 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.521 ' O ' ' O ' ' A' ' 58' ' ' ALA . 23.2 tp -114.32 121.21 42.93 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.107 0.48 . . . . 0.0 109.929 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -105.49 179.15 4.35 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.108 -178.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.493 ' NE2' ' OE2' ' A' ' 100' ' ' GLU . 13.7 t60 -77.62 140.45 39.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.275 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 91.28 -6.22 81.02 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.918 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.603 ' OD1' ' N ' ' A' ' 87' ' ' VAL . 59.1 t0 -79.87 154.89 28.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.998 0.428 . . . . 0.0 111.08 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.603 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 10.1 p -119.82 135.68 59.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.65 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 89.5 mt -108.38 132.28 56.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.164 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.552 ' O ' ' N ' ' A' ' 70' ' ' GLN . 2.0 m -123.91 129.34 50.82 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.849 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 1.064 HG22 ' H ' ' A' ' 91' ' ' ILE . 94.8 mt -100.36 -152.39 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 1.064 ' H ' HG22 ' A' ' 90' ' ' ILE . 94.5 mt -63.2 -44.54 99.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 119.105 0.866 . . . . 0.0 112.793 -178.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.482 ' OD1' ' O ' ' A' ' 91' ' ' ILE . 97.8 m-20 -139.1 1.93 2.07 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 119.833 -0.747 . . . . 0.0 112.737 -179.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.414 ' HD2' HG23 ' A' ' 39' ' ' ILE . 97.8 mtt180 -125.85 158.22 35.61 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.301 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 33.9 t -128.18 142.95 51.03 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.606 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.467 ' CE2' ' CG2' ' A' ' 37' ' ' ILE . 60.4 m-85 -128.5 143.65 51.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.431 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.704 ' HD2' HD11 ' A' ' 10' ' ' ILE . 81.1 mtp180 -120.41 141.01 50.51 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.294 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.611 ' HA ' HD23 ' A' ' 7' ' ' LEU . 1.0 OUTLIER -114.93 110.8 20.19 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.38 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.403 ' HA ' ' ND1' ' A' ' 84' ' ' HIS . 94.0 mt-10 -116.93 125.25 51.16 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.989 -178.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -121.96 88.77 3.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.366 178.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.493 ' OE2' ' NE2' ' A' ' 84' ' ' HIS . 71.1 mm-40 . . . . . 0 C--N 1.326 -0.413 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.801 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.451 ' O ' ' C ' ' A' ' 2' ' ' TRP . 75.6 mtm . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.451 ' C ' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -28.75 94.01 0.06 OUTLIER Pre-proline 0 CA--C 1.535 0.365 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.848 -179.776 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.41 ' N ' ' O ' ' A' ' 1' ' ' MET . 39.2 Cg_exo -60.32 145.96 97.55 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.436 2.091 . . . . 0.0 111.643 178.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 62.9 p -117.82 7.03 12.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.043 0.449 . . . . 0.0 111.219 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.6 mtm-85 -80.03 139.15 37.07 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.243 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -145.3 139.61 27.2 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.989 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.519 HD12 ' HA ' ' A' ' 97' ' ' TYR . 7.1 tp -109.66 131.43 55.07 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 79.9 t -120.15 132.39 69.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 96.9 m -109.41 120.25 41.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.154 0.502 . . . . 0.0 111.743 -178.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.656 HD11 ' HD2' ' A' ' 96' ' ' ARG . 68.2 mt -81.01 133.1 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.505 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -64.19 -41.57 97.03 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.48 178.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -146.91 -93.68 0.09 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.411 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.6 p -150.5 125.27 9.75 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.928 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.4 27.01 62.3 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.2 p -133.33 149.63 31.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.959 0.409 . . . . 0.0 110.623 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.45 ' O ' ' OD1' ' A' ' 16' ' ' ASP . 45.7 p-10 -96.88 112.32 24.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.634 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -99.04 -174.94 31.82 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -66.96 147.66 80.63 Favored 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.603 2.202 . . . . 0.0 111.809 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -93.46 162.95 13.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.216 -179.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.587 ' CZ ' ' O ' ' A' ' 36' ' ' ASP . 18.6 t80 -135.69 100.78 10.98 Favored Pre-proline 0 CA--C 1.531 0.245 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.097 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -72.28 151.09 54.07 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.576 1.517 . . . . 0.0 110.859 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.436 HD13 HD13 ' A' ' 53' ' ' ILE . 76.2 mt -81.37 83.08 7.01 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.28 -0.568 . . . . 0.0 111.44 -178.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.6 t -65.4 -40.39 93.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.547 178.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.2 mt -115.7 151.5 34.96 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.845 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.6 p -63.97 -26.4 68.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.9 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.6 p -110.75 118.07 35.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.427 -179.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.7 m -101.87 131.21 48.36 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.223 179.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.627 HD21 ' HG2' ' A' ' 47' ' ' GLN . 49.9 tp -121.2 141.66 50.65 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.048 0.451 . . . . 0.0 111.009 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.54 ' CE2' HG21 ' A' ' 37' ' ' ILE . 10.8 m-85 -113.77 143.08 45.24 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.327 -179.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 146.18 171.94 16.06 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 120.068 -1.063 . . . . 0.0 112.795 177.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -63.82 -40.0 95.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.903 -0.649 . . . . 0.0 111.89 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.412 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -49.73 141.06 14.54 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.9 tt -67.08 -32.65 58.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.813 0.339 . . . . 0.0 110.541 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -57.11 -18.01 13.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.531 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.412 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 3.9 m -73.76 129.53 38.12 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.947 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.587 ' O ' ' CZ ' ' A' ' 20' ' ' PHE . 92.5 m-20 -62.01 -37.69 85.84 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.503 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.54 HG21 ' CE2' ' A' ' 29' ' ' PHE . 3.7 mm -107.58 78.32 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -68.76 134.5 49.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.318 -178.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 98.4 mt -123.11 128.05 74.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.174 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.715 ' O ' HD12 ' A' ' 41' ' ' LEU . 55.5 tp60 -96.33 82.1 3.38 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.334 -0.546 . . . . 0.0 110.777 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.715 HD12 ' O ' ' A' ' 40' ' ' GLN . 0.8 OUTLIER -156.31 124.11 2.81 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.976 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -62.37 -25.57 76.39 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 121.74 1.626 . . . . 0.0 112.724 -178.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.483 ' O ' ' CD1' ' A' ' 91' ' ' ILE . 30.8 m -66.62 -31.23 52.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.425 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.513 HG12 ' N ' ' A' ' 45' ' ' SER . 25.0 t -80.08 157.01 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 120.928 0.394 . . . . 0.0 111.246 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.513 ' N ' HG12 ' A' ' 44' ' ' VAL . 3.2 m -91.84 165.57 13.19 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.536 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.403 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 98.9 mttt -63.48 -37.07 85.88 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.264 0.554 . . . . 0.0 109.817 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.627 ' HG2' HD21 ' A' ' 28' ' ' LEU . 87.9 mt-30 -129.72 60.54 1.58 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 178.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.798 ' CD2' HG23 ' A' ' 90' ' ' ILE . 13.4 t60 -60.99 -51.43 69.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.277 -176.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.543 ' SG ' HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -149.58 159.32 44.42 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.501 -179.498 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.55 ' O ' ' N ' ' A' ' 61' ' ' HIS . 69.5 tttt -139.21 127.51 22.73 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.937 -178.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.604 HD11 ' CD1' ' A' ' 88' ' ' ILE . 97.1 mt -104.24 112.63 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.452 ' O ' ' N ' ' A' ' 59' ' ' ILE . 81.5 tt0 -94.93 136.21 35.52 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.021 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.45 ' O ' ' CG2' ' A' ' 53' ' ' ILE . 4.5 tp -89.23 128.89 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-O 121.096 0.474 . . . . 0.0 110.589 -179.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.521 ' O ' ' C ' ' A' ' 55' ' ' GLU . 3.5 m-70 -112.18 -176.35 2.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.742 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.521 ' C ' ' O ' ' A' ' 54' ' ' HIS . 38.0 tt0 -23.63 -62.2 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 O-C-N 123.664 0.603 . . . . 0.0 111.252 -178.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.536 ' O ' ' ND2' ' A' ' 99' ' ' ASN . 81.1 mt-30 -146.64 20.16 1.32 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.057 178.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -138.64 152.43 48.09 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.502 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.58 ' HB1' ' CG2' ' A' ' 51' ' ' ILE . . . -93.28 142.56 27.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.624 179.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.452 ' N ' ' O ' ' A' ' 52' ' ' GLU . 30.8 mm -126.61 126.14 68.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 120.997 0.427 . . . . 0.0 111.378 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.543 HD11 ' SG ' ' A' ' 49' ' ' CYS . 46.4 tp -76.28 145.54 39.57 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.823 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.55 ' N ' ' O ' ' A' ' 50' ' ' LYS . 55.4 m-70 -142.14 79.03 1.65 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.957 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.827 ' ND2' ' H ' ' A' ' 69' ' ' THR . 24.1 t-20 -69.99 138.14 51.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.689 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -107.9 -36.24 6.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.222 178.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.5 m -57.8 138.77 55.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.826 -178.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.9 p -106.07 -56.87 2.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.27 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.2 p -61.97 -42.92 99.67 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.608 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.588 ' OD1' ' N ' ' A' ' 67' ' ' ASN . 0.1 OUTLIER -120.97 79.81 33.54 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.63 -179.875 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.435 ' HG2' HG13 ' A' ' 75' ' ' VAL . 73.3 Cg_endo -70.78 151.64 63.4 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.091 1.861 . . . . 0.0 113.226 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.827 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 18.4 m -69.49 165.47 20.89 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.12 -0.946 . . . . 0.0 108.585 178.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.441 ' N ' HG22 ' A' ' 69' ' ' THR . 83.7 mt-30 -128.74 141.23 51.39 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.448 -0.501 . . . . 0.0 112.18 -177.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.47 ' HB ' HD11 ' A' ' 76' ' ' ILE . 41.3 t -126.21 128.65 71.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.164 178.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 49.48 25.71 1.45 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.151 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 93.75 -13.91 66.44 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.8 m -83.85 143.39 29.95 Favored 'General case' 0 C--N 1.331 -0.211 0 O-C-N 122.693 -0.298 . . . . 0.0 110.834 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.435 HG13 ' HG2' ' A' ' 68' ' ' PRO . 60.2 t -76.14 144.5 11.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.184 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.489 HD12 HG21 ' A' ' 80' ' ' VAL . 45.3 mm -103.92 105.06 17.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.672 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -89.01 -33.08 17.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.913 178.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.428 ' O ' HG13 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -142.62 172.69 5.44 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.133 179.722 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.9 137.62 68.56 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 121.544 1.496 . . . . 0.0 111.153 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.489 HG21 HD12 ' A' ' 76' ' ' ILE . 35.7 m -134.08 160.24 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 C-N-CA 120.619 -0.433 . . . . 0.0 110.973 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -86.65 140.15 30.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.536 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 66.9 mt -106.37 143.88 33.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.133 0.492 . . . . 0.0 111.417 -179.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -110.31 150.9 28.08 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 16.3 t60 -59.85 131.05 49.69 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.28 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 98.7 -9.75 62.32 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.626 ' OD1' ' N ' ' A' ' 87' ' ' VAL . 67.5 t0 -68.48 147.02 52.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.723 0.297 . . . . 0.0 110.329 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.626 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 46.0 t -117.0 132.03 67.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.495 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.604 ' CD1' HD11 ' A' ' 51' ' ' ILE . 60.0 mt -104.81 135.25 43.58 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 52.9 m -131.16 131.18 43.88 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.954 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.882 HG22 ' H ' ' A' ' 91' ' ' ILE . 12.8 mm -86.45 -145.28 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.882 ' H ' HG22 ' A' ' 90' ' ' ILE . 96.7 mt -63.16 -43.37 98.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.363 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.507 ' OD1' ' O ' ' A' ' 92' ' ' ASP . 55.7 t0 -149.58 14.13 0.85 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.685 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 63.0 ttm-85 -121.29 130.04 53.44 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.903 0.382 . . . . 0.0 111.739 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 64.1 m -99.5 141.97 31.59 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.546 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -128.2 143.83 51.07 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.498 178.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.656 ' HD2' HD11 ' A' ' 10' ' ' ILE . 82.7 mtp180 -111.85 135.53 52.34 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.803 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.519 ' HA ' HD12 ' A' ' 7' ' ' LEU . 0.9 OUTLIER -119.71 107.32 13.07 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.646 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -116.45 125.07 51.46 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.333 -178.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.536 ' ND2' ' O ' ' A' ' 56' ' ' GLN . 58.7 t-20 -123.69 91.59 3.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.997 178.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 . . . . . 0 C--N 1.325 -0.483 0 CA-C-O 121.046 0.45 . . . . 0.0 111.18 -179.568 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.5 mmm . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -156.12 66.73 4.46 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.869 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -69.23 147.16 65.66 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.298 1.999 . . . . 0.0 113.085 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 52.5 p -115.16 10.76 16.15 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.202 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.56 ' NH1' ' CG1' ' A' ' 53' ' ' ILE . 88.7 mtm180 -120.4 131.57 54.87 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.532 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -142.78 154.69 44.46 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.979 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 96.8 mt -111.71 133.97 53.59 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.436 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.421 HG22 ' CD2' ' A' ' 19' ' ' HIS . 55.2 t -119.69 135.51 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 120.809 0.337 . . . . 0.0 110.675 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.444 ' OG1' ' CE2' ' A' ' 95' ' ' PHE . 24.1 m -101.57 116.86 33.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.534 -179.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.467 HD11 ' HD2' ' A' ' 96' ' ' ARG . 96.4 mt -78.97 129.56 37.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.914 179.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -86.77 -172.26 3.92 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -62.0 -43.49 98.72 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.515 ' C ' ' H ' ' A' ' 15' ' ' VAL . 34.8 m -76.31 154.62 34.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.251 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.81 1.96 1.51 Allowed Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.515 ' H ' ' C ' ' A' ' 13' ' ' SER . 12.1 t -83.63 133.8 28.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.151 0.5 . . . . 0.0 110.895 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -68.07 140.64 56.28 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.306 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -103.17 -162.32 25.53 Favored Glycine 0 CA--C 1.532 1.138 0 N-CA-C 110.706 -0.957 . . . . 0.0 110.706 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.4 148.18 91.43 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 123.768 2.979 . . . . 0.0 112.575 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.421 ' CD2' HG22 ' A' ' 8' ' ' VAL . 3.1 m170 -100.39 161.0 13.89 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.174 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.532 ' CZ ' ' O ' ' A' ' 36' ' ' ASP . 83.2 t80 -130.96 109.77 15.51 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.13 -179.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -75.09 151.2 38.81 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 C-N-CA 121.674 1.582 . . . . 0.0 110.925 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.431 ' HA ' HD23 ' A' ' 22' ' ' LEU . 87.7 mt -75.55 85.52 2.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.23 0.538 . . . . 0.0 111.497 -179.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 66.6 m -61.75 -42.18 98.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.316 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 97.0 mt -121.37 154.3 36.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.627 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.0 p -59.78 -30.24 68.75 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.731 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 66.0 p -106.5 119.05 38.25 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.117 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.521 ' O ' ' N ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -99.35 119.72 38.41 Favored 'General case' 0 C--O 1.221 -0.404 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.347 179.635 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.53 HD21 ' OE1' ' A' ' 47' ' ' GLN . 42.2 tp -112.07 138.51 48.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.106 0.479 . . . . 0.0 111.012 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -105.44 147.33 28.39 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.466 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 138.83 163.34 9.49 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 119.754 -1.213 . . . . 0.0 112.998 177.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.432 HH11 ' HA ' ' A' ' 42' ' ' PRO . 80.2 mtp180 -62.7 -36.65 83.62 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.742 -0.729 . . . . 0.0 110.526 179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -45.62 143.97 3.49 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 109.939 -1.265 . . . . 0.0 109.939 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.4 tt -65.99 -37.8 80.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.779 0.323 . . . . 0.0 110.449 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -55.08 -21.89 14.31 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.406 -0.517 . . . . 0.0 110.389 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 38.9 m -65.38 120.72 13.33 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.802 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.532 ' O ' ' CZ ' ' A' ' 20' ' ' PHE . 59.7 m-20 -61.7 -36.79 81.92 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.444 HD13 ' CD2' ' A' ' 20' ' ' PHE . 1.2 mm -106.6 76.18 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.263 179.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 67.4 ttt-85 -65.45 124.74 23.08 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.845 -178.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.471 HG21 HG21 ' A' ' 44' ' ' VAL . 92.3 mt -114.4 124.17 70.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.636 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -91.16 81.24 5.56 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.64 -179.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.699 HD23 ' CG2' ' A' ' 43' ' ' VAL . 2.3 tp -155.86 118.01 2.3 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.839 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.432 ' HA ' HH11 ' A' ' 31' ' ' ARG . 71.3 Cg_exo -50.08 -36.96 46.8 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 122.017 1.811 . . . . 0.0 113.674 179.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.699 ' CG2' HD23 ' A' ' 41' ' ' LEU . 27.6 m -64.07 -36.71 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.471 HG21 HG21 ' A' ' 39' ' ' ILE . 69.0 t -69.95 141.5 17.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.8 t -83.84 161.73 20.81 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.109 -179.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -64.0 -40.01 95.4 Favored 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.53 ' OE1' HD21 ' A' ' 28' ' ' LEU . 88.8 mm-40 -119.01 54.3 0.97 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 178.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.721 ' NE2' HG23 ' A' ' 90' ' ' ILE . 15.0 t60 -58.92 -48.04 82.87 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.054 -177.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.644 ' HB2' HD11 ' A' ' 60' ' ' LEU . 1.8 p -170.82 163.52 7.79 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.467 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.72 ' O ' HD12 ' A' ' 60' ' ' LEU . 13.3 ptpt -145.48 145.53 31.11 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 119.055 -1.058 . . . . 0.0 112.321 179.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.521 ' N ' ' O ' ' A' ' 27' ' ' CYS . 96.7 mt -104.82 111.79 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.046 178.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.616 ' N ' ' O ' ' A' ' 59' ' ' ILE . 79.3 tt0 -89.55 148.02 23.62 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.56 ' CG1' ' NH1' ' A' ' 5' ' ' ARG . 3.7 tp -112.31 138.75 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-O 121.106 0.479 . . . . 0.0 111.979 -178.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.422 ' O ' ' C ' ' A' ' 55' ' ' GLU . 22.8 m-70 -115.93 -178.71 3.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.26 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 54' ' ' HIS . 94.1 mt-10 -37.54 -51.88 1.17 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.922 -178.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -145.96 30.4 1.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.644 179.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -144.17 155.18 43.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.17 0.51 . . . . 0.0 111.554 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.847 ' C ' HD12 ' A' ' 59' ' ' ILE . . . -114.05 131.01 56.53 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.936 178.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.847 HD12 ' C ' ' A' ' 58' ' ' ALA . 1.9 mp -124.55 144.29 34.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.317 0.58 . . . . 0.0 111.421 -178.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.72 HD12 ' O ' ' A' ' 50' ' ' LYS . 50.2 tp -105.83 144.92 31.89 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.858 -177.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.437 ' ND1' ' HB3' ' A' ' 79' ' ' PRO . 94.6 m-70 -133.3 78.54 1.79 Allowed 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.529 0.681 . . . . 0.0 109.912 179.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.738 ' ND2' ' H ' ' A' ' 69' ' ' THR . 26.2 t-20 -64.94 136.57 56.98 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.569 -1.196 . . . . 0.0 111.278 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -112.33 -33.48 6.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.723 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 40.7 t -58.05 136.14 57.11 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.964 0.411 . . . . 0.0 111.802 -177.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.3 p -109.25 -48.15 3.3 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.732 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.1 p -64.45 -33.89 76.92 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.438 0.637 . . . . 0.0 109.707 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -138.65 79.84 27.76 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.122 179.358 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.21 149.16 51.15 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.582 1.521 . . . . 0.0 112.463 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.738 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 27.9 m -63.83 154.65 32.92 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -125.52 151.8 45.87 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.868 -177.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.704 ' HB ' HD11 ' A' ' 76' ' ' ILE . 9.0 p -136.22 136.57 49.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.169 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 51.69 17.95 0.66 Allowed 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.219 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.404 ' N ' ' C ' ' A' ' 71' ' ' VAL . . . 94.47 -9.2 71.76 Favored Glycine 0 CA--C 1.525 0.691 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.548 178.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 91.3 p -84.61 177.38 8.09 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.4 t -108.05 138.54 34.08 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 CA-C-O 121.418 0.628 . . . . 0.0 109.911 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.704 HD11 ' HB ' ' A' ' 71' ' ' VAL . 80.1 mt -105.08 84.19 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.939 -178.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -66.87 -37.51 84.57 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.983 0.42 . . . . 0.0 110.815 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.462 ' CD ' ' N ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -132.51 174.57 4.55 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.561 -179.614 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.437 ' HB3' ' ND1' ' A' ' 61' ' ' HIS . 41.0 Cg_exo -58.26 138.52 86.32 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 121.781 1.654 . . . . 0.0 111.253 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 26.9 m -140.5 161.64 24.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.031 0.444 . . . . 0.0 110.996 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.472 ' C ' HD23 ' A' ' 82' ' ' LEU . 44.2 ttm180 -98.68 135.35 40.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.356 178.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.866 ' N ' HD23 ' A' ' 82' ' ' LEU . 0.1 OUTLIER -111.06 141.0 45.14 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.9 -179.508 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.631 ' N ' ' OD2' ' A' ' 86' ' ' ASP . 74.8 mmtt -87.94 159.11 18.47 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.412 ' ND1' ' HA ' ' A' ' 98' ' ' GLU . 29.7 t60 -55.29 141.3 36.24 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.966 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.01 3.78 82.56 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.455 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.631 ' OD2' ' N ' ' A' ' 83' ' ' LYS . 95.6 m-20 -76.72 153.11 35.36 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.015 0.436 . . . . 0.0 111.396 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.411 HG13 ' O ' ' A' ' 87' ' ' VAL . 7.7 p -119.97 131.34 72.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.376 -178.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 87.4 mt -108.22 133.81 52.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.543 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 95.1 m -126.28 129.61 49.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.176 0.512 . . . . 0.0 112.346 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 1.027 HG22 ' H ' ' A' ' 91' ' ' ILE . 94.4 mt -97.58 -153.51 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 1.027 ' H ' HG22 ' A' ' 90' ' ' ILE . 92.2 mt -62.98 -44.91 99.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 118.861 0.755 . . . . 0.0 111.494 -179.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 91' ' ' ILE . 95.6 m-20 -141.88 6.45 1.8 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -123.49 156.61 35.28 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.239 -179.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.1 p -136.88 150.96 48.56 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.11 -0.636 . . . . 0.0 112.258 -179.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.444 ' CE2' ' OG1' ' A' ' 9' ' ' THR . 65.3 m-85 -139.34 149.86 44.68 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.509 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.467 ' HD2' HD11 ' A' ' 10' ' ' ILE . 81.2 mtp180 -117.51 142.78 46.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.066 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.609 ' CE2' ' HB3' ' A' ' 58' ' ' ALA . 1.1 t80 -112.14 104.03 12.23 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.35 -0.386 . . . . 0.0 109.963 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.412 ' HA ' ' ND1' ' A' ' 84' ' ' HIS . 4.1 tt0 -113.04 126.46 55.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.893 -178.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -124.17 85.92 2.49 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.146 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 C--N 1.331 -0.227 0 CA-C-O 120.845 0.355 . . . . 0.0 110.901 -179.958 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.457 ' O ' ' C ' ' A' ' 2' ' ' TRP . 98.8 mtp . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.457 ' C ' ' O ' ' A' ' 1' ' ' MET . 6.6 m0 35.78 62.09 2.67 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.335 -179.587 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -73.95 153.35 47.3 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 C-N-CA 123.08 2.52 . . . . 0.0 112.587 -179.472 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 96.9 m -114.69 130.45 56.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.138 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.603 HH22 ' C ' ' A' ' 56' ' ' GLN . 99.5 mtt180 -126.1 144.03 50.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.126 -179.609 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -144.41 146.07 32.29 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.901 -179.608 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.634 HD23 HD21 ' A' ' 22' ' ' LEU . 1.9 mm? -90.86 139.68 30.52 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.869 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.503 ' O ' ' N ' ' A' ' 96' ' ' ARG . 48.4 t -121.74 132.82 69.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.1 0.476 . . . . 0.0 110.908 -179.233 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 57.9 m -114.26 126.74 55.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.239 -179.79 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.881 HG23 ' O ' ' A' ' 15' ' ' VAL . 92.7 mt -80.84 115.12 22.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.439 -179.406 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -67.6 -46.06 73.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.694 179.383 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.41 ' O ' ' CG2' ' A' ' 10' ' ' ILE . 86.6 mtm180 -135.4 150.48 49.91 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.742 178.801 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 91.0 p -56.74 124.4 18.3 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.464 -0.494 . . . . 0.0 109.864 179.646 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.53 7.21 60.55 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 -179.642 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.881 ' O ' HG23 ' A' ' 10' ' ' ILE . 9.0 t -128.13 152.71 36.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.692 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.519 ' O ' ' O ' ' A' ' 17' ' ' GLY . 46.4 p-10 -97.19 8.05 45.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.161 0.505 . . . . 0.0 111.006 -179.483 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.584 ' H ' HG12 ' A' ' 15' ' ' VAL . . . 29.75 -155.94 0.0 OUTLIER Glycine 0 CA--C 1.534 1.274 0 CA-C-N 115.267 -0.878 . . . . 0.0 112.292 179.187 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -78.73 161.85 27.34 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 123.199 2.599 . . . . 0.0 113.103 -179.211 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 4.1 m170 -112.4 156.25 22.82 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.754 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.604 ' CE1' ' O ' ' A' ' 21' ' ' PRO . 51.1 t80 -119.97 126.4 26.89 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.451 -179.605 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.604 ' O ' ' CE1' ' A' ' 20' ' ' PHE . 97.0 Cg_endo -75.69 146.47 30.3 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 121.988 1.792 . . . . 0.0 111.694 179.69 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.634 HD21 HD23 ' A' ' 7' ' ' LEU . 96.2 mt -91.35 83.01 5.41 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.596 -0.441 . . . . 0.0 110.508 179.676 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.9 m -60.87 -41.72 96.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.142 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.2 mt -119.11 150.85 39.32 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.388 179.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.57 ' O ' HD12 ' A' ' 53' ' ' ILE . 84.3 p -58.51 -40.69 83.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.035 0.445 . . . . 0.0 110.412 -179.781 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.5 p -85.69 115.0 23.1 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.571 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.406 ' SG ' ' CD2' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -95.75 130.93 42.52 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 119.798 -0.761 . . . . 0.0 110.294 179.262 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.512 HD23 ' HA ' ' A' ' 35' ' ' CYS . 58.7 tp -118.84 137.04 53.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.036 -179.211 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -109.14 142.28 40.14 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.923 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 156.85 155.99 7.69 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 119.589 -1.291 . . . . 0.0 112.661 179.309 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 76.4 ttt-85 -66.85 -40.2 87.82 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.534 -0.833 . . . . 0.0 111.416 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -57.22 157.15 13.19 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.649 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 20.9 tt -66.51 -33.09 61.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.938 0.399 . . . . 0.0 111.215 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -52.58 -18.75 1.89 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.39 -178.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.512 ' HA ' HD23 ' A' ' 28' ' ' LEU . 0.8 OUTLIER -84.23 130.35 34.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.077 0.465 . . . . 0.0 111.62 -179.389 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.443 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 92.6 m-20 -62.53 -39.59 94.07 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.347 178.929 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.8 mm -102.75 80.2 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.807 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -65.56 130.12 42.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.926 -177.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.434 HG21 HG21 ' A' ' 44' ' ' VAL . 89.4 mt -115.81 124.6 72.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.163 -179.611 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -88.31 79.99 7.63 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 119.572 -0.851 . . . . 0.0 111.432 -179.443 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.657 HD12 ' HE ' ' A' ' 93' ' ' ARG . 4.2 mt -157.26 112.24 1.89 Allowed Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.281 178.412 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -51.8 -32.68 47.29 Favored 'Trans proline' 0 N--CA 1.5 1.874 0 C-N-CA 121.983 1.789 . . . . 0.0 113.13 -179.45 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.5 m -64.68 -29.83 48.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.076 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.434 HG21 HG21 ' A' ' 39' ' ' ILE . 98.4 t -72.09 146.85 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 120.848 0.356 . . . . 0.0 110.475 -179.768 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.6 t -85.65 164.56 17.62 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.24 -179.669 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.411 ' O ' ' SG ' ' A' ' 35' ' ' CYS . 68.2 mttm -62.8 -38.54 91.1 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.158 0.504 . . . . 0.0 109.85 179.566 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.413 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 89.2 mt-30 -124.52 58.55 1.21 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.453 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.834 ' CD2' HG23 ' A' ' 90' ' ' ILE . 13.9 t60 -61.59 -51.71 67.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.393 -0.822 . . . . 0.0 112.17 -177.351 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.578 ' SG ' HD12 ' A' ' 90' ' ' ILE . 0.5 OUTLIER -148.52 158.09 43.89 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.47 179.894 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.575 ' O ' ' N ' ' A' ' 61' ' ' HIS . 72.0 tttt -140.57 129.83 23.71 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.348 -178.24 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.685 ' CG2' ' HB1' ' A' ' 58' ' ' ALA . 89.0 mt -100.12 99.28 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 176.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.566 ' N ' ' O ' ' A' ' 59' ' ' ILE . 83.6 tt0 -81.65 120.73 25.46 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.798 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.57 HD12 ' O ' ' A' ' 25' ' ' SER . 78.5 mt -101.29 122.25 53.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.297 0.57 . . . . 0.0 111.168 -178.57 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.476 ' O ' ' C ' ' A' ' 55' ' ' GLU . 6.1 p80 -110.87 -166.93 1.12 Allowed 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.672 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.476 ' C ' ' O ' ' A' ' 54' ' ' HIS . 95.3 mt-10 -22.91 -60.99 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.505 -0.77 . . . . 0.0 113.006 -177.663 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.603 ' C ' HH22 ' A' ' 5' ' ' ARG . 27.5 mt-30 -145.56 26.29 1.29 Allowed 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -178.14 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.418 ' HB3' ' NE2' ' A' ' 54' ' ' HIS . 43.3 tp10 -153.94 152.79 30.99 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 118.994 -1.082 . . . . 0.0 112.511 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.685 ' HB1' ' CG2' ' A' ' 51' ' ' ILE . . . -93.17 134.76 35.02 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.915 178.837 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.566 ' O ' ' N ' ' A' ' 52' ' ' GLU . 31.6 mm -125.98 126.92 70.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.79 -0.364 . . . . 0.0 111.346 -178.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.8 tp -74.05 145.44 44.48 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.668 -179.602 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.575 ' N ' ' O ' ' A' ' 50' ' ' LYS . 12.9 m-70 -141.35 78.81 1.66 Allowed 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.104 179.453 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.742 ' ND2' ' H ' ' A' ' 69' ' ' THR . 26.3 t-20 -68.56 134.73 50.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.103 -179.338 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.502 ' CE1' ' O ' ' A' ' 61' ' ' HIS . 23.4 m-85 -107.08 -36.58 6.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.383 179.114 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.9 m -63.02 137.93 58.41 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.948 -178.475 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.6 p -104.83 -53.88 2.6 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.377 179.287 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.2 p -62.29 -47.11 85.77 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.961 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.574 ' OD1' ' N ' ' A' ' 67' ' ' ASN . 0.2 OUTLIER -114.46 78.96 5.08 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.669 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -72.67 151.13 51.77 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.035 1.823 . . . . 0.0 112.84 -178.95 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.742 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 19.9 m -71.54 157.97 37.07 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.481 -0.782 . . . . 0.0 108.983 179.244 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -123.61 141.79 51.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.89 0.376 . . . . 0.0 111.503 -178.026 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.582 HG12 ' ND2' ' A' ' 72' ' ' ASN . 54.8 t -128.9 129.25 68.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.868 179.339 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.582 ' ND2' HG12 ' A' ' 71' ' ' VAL . 71.1 m-20 51.14 30.63 5.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.869 179.569 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.4 22.55 60.24 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.075 178.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.2 t -128.73 140.7 51.61 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.567 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.411 HG12 ' N ' ' A' ' 76' ' ' ILE . 58.8 t -69.34 149.51 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-O 121.359 0.599 . . . . 0.0 111.596 -178.882 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.411 ' N ' HG12 ' A' ' 75' ' ' VAL . 36.6 mm -108.05 92.49 2.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.413 -179.328 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -67.51 -39.72 85.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.051 0.453 . . . . 0.0 110.343 179.171 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.43 ' O ' HG13 ' A' ' 80' ' ' VAL . 0.4 OUTLIER -146.24 174.75 3.16 Favored Pre-proline 0 N--CA 1.463 0.188 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.533 -179.569 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.06 137.72 69.85 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 121.78 1.653 . . . . 0.0 111.304 -179.379 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.43 HG13 ' O ' ' A' ' 78' ' ' GLU . 29.4 m -135.45 160.9 39.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.848 -179.385 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -82.91 136.88 34.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.638 179.648 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 75.0 mt -102.57 139.47 38.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.324 0.583 . . . . 0.0 111.539 -179.533 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.549 ' N ' ' OD2' ' A' ' 86' ' ' ASP . 88.0 tttt -106.7 155.13 19.99 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.159 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . 0.739 ' CE1' ' H ' ' A' ' 99' ' ' ASN . 32.2 t60 -62.47 138.58 58.49 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.559 -178.754 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.17 4.0 78.39 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 121.137 -0.554 . . . . 0.0 111.94 179.6 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.549 ' OD2' ' N ' ' A' ' 83' ' ' LYS . 98.0 m-20 -75.66 155.13 36.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.961 0.38 . . . . 0.0 110.778 179.85 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.1 p -118.04 128.52 75.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 179.322 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.612 ' O ' ' N ' ' A' ' 95' ' ' PHE . 13.4 mt -110.29 133.71 54.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.556 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.641 HG23 ' O ' ' A' ' 93' ' ' ARG . 25.4 m -131.07 131.51 44.28 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.833 -179.118 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.867 HG22 ' H ' ' A' ' 91' ' ' ILE . 6.3 mm -83.74 -145.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.472 -0.785 . . . . 0.0 108.993 178.72 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.867 ' H ' HG22 ' A' ' 90' ' ' ILE . 83.2 mt -63.22 -44.13 99.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -179.817 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.507 ' OD1' ' O ' ' A' ' 91' ' ' ILE . 99.8 m-20 -142.77 10.16 1.79 Allowed 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -179.226 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.657 ' HE ' HD12 ' A' ' 41' ' ' LEU . 93.7 mtt-85 -125.91 146.0 50.03 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.858 -179.343 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.2 m -102.06 137.36 40.44 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.095 179.759 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.612 ' N ' ' O ' ' A' ' 88' ' ' ILE . 24.0 m-85 -128.67 146.54 50.85 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.931 179.338 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.726 ' HD2' HD11 ' A' ' 10' ' ' ILE . 71.7 mtp85 -127.47 142.99 51.26 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.074 0.464 . . . . 0.0 111.685 -179.07 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.553 ' C ' ' CD1' ' A' ' 97' ' ' TYR . 0.1 OUTLIER -111.98 115.63 29.26 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.963 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -119.79 117.18 27.51 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.43 -177.63 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.739 ' H ' ' CE1' ' A' ' 84' ' ' HIS . 53.9 t-20 -98.46 111.82 24.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.178 179.418 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 . . . . . 0 N--CA 1.463 0.198 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.685 179.487 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.9 ttp . . . . . 0 N--CA 1.488 1.471 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -92.43 162.92 28.46 Favored Pre-proline 0 C--N 1.331 -0.231 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.439 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.23 147.77 60.59 Favored 'Trans proline' 0 C--N 1.302 -1.882 0 C-N-CA 122.734 2.29 . . . . 0.0 112.345 -179.439 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 44.5 p -114.21 18.79 16.82 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.95 -179.591 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.57 ' NH2' ' O ' ' A' ' 55' ' ' GLU . 84.4 mtt85 -107.06 135.59 48.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.899 179.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 94.1 mtt-85 -130.39 136.28 48.9 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.301 -179.68 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.5 HD12 ' O ' ' A' ' 96' ' ' ARG . 8.7 tp -118.73 132.22 56.15 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.013 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.551 ' O ' ' N ' ' A' ' 96' ' ' ARG . 53.4 t -130.33 150.94 35.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.823 -178.047 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.487 HG22 ' N ' ' A' ' 10' ' ' ILE . 30.0 m -86.78 161.18 18.52 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.521 179.336 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.595 ' O ' ' N ' ' A' ' 15' ' ' VAL . 7.6 mt -110.36 136.1 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -179.207 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.595 ' N ' ' HB2' ' A' ' 16' ' ' ASP . 7.7 mttp -80.75 -167.69 1.48 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.309 179.605 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 59.3 ttm-85 50.23 -82.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -179.177 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.577 ' N ' ' O ' ' A' ' 11' ' ' LYS . 16.7 m -60.16 -40.74 90.98 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 179.064 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.493 ' C ' ' O ' ' A' ' 10' ' ' ILE . . . -129.29 -135.78 3.99 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 178.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.595 ' N ' ' O ' ' A' ' 10' ' ' ILE . 22.0 m -134.58 93.06 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.01 0.433 . . . . 0.0 111.706 178.925 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.624 ' OD1' ' N ' ' A' ' 17' ' ' GLY . 54.8 t0 -69.98 -168.86 0.23 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 177.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.624 ' N ' ' OD1' ' A' ' 16' ' ' ASP . . . 113.65 -82.77 0.31 Allowed Glycine 0 CA--C 1.527 0.836 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 179.417 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -73.64 152.6 48.26 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.819 2.346 . . . . 0.0 112.79 -179.52 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.492 ' CD2' HG22 ' A' ' 8' ' ' VAL . 7.7 m80 -118.06 162.56 17.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.321 -179.989 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.488 ' CZ ' ' O ' ' A' ' 36' ' ' ASP . 26.5 t80 -128.21 91.98 42.83 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.347 179.379 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -60.38 146.22 97.1 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.226 1.951 . . . . 0.0 110.591 178.258 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.473 ' N ' HD12 ' A' ' 22' ' ' LEU . 6.7 mp -98.77 114.26 26.72 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.438 -179.209 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.4 p -110.42 -2.4 16.61 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.449 179.806 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.2 mt -125.15 151.59 45.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.61 -179.523 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 80.2 p -79.2 -3.95 48.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.016 0.436 . . . . 0.0 110.335 179.65 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 17.3 p -133.34 115.07 14.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.54 179.817 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.9 m -101.27 129.36 47.22 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.474 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.506 HD23 ' HA ' ' A' ' 35' ' ' CYS . 54.7 tp -122.12 137.27 54.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.263 0.554 . . . . 0.0 112.029 -177.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 8.3 m-85 -105.23 144.07 32.52 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.611 179.531 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 158.35 166.38 17.43 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 119.177 -1.487 . . . . 0.0 113.357 179.184 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.627 ' NH1' ' O ' ' A' ' 44' ' ' VAL . 88.2 mtm-85 -67.25 -37.67 83.89 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 114.94 -0.63 . . . . 0.0 110.856 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.56 147.6 48.72 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.032 -178.345 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.437 ' C ' ' N ' ' A' ' 35' ' ' CYS . 20.0 tt -63.56 -36.82 77.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.23 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.412 ' N ' HG23 ' A' ' 33' ' ' ILE . 52.8 tp10 -45.38 -23.21 0.18 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.782 179.895 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.506 ' HA ' HD23 ' A' ' 28' ' ' LEU . 58.7 m -74.49 131.75 41.29 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.655 179.494 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.488 ' O ' ' CZ ' ' A' ' 20' ' ' PHE . 39.0 t0 -62.04 -37.03 83.4 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.63 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.1 mm -108.1 88.23 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.547 178.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 75.5 ttt-85 -72.8 134.52 44.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.697 -178.222 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.518 HG21 HG21 ' A' ' 44' ' ' VAL . 98.6 mt -124.69 126.83 72.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.212 178.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.619 ' O ' HD12 ' A' ' 41' ' ' LEU . 51.0 tt0 -94.17 80.76 4.03 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.455 179.937 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.619 HD12 ' O ' ' A' ' 40' ' ' GLN . 0.8 OUTLIER -156.65 115.94 2.08 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.922 179.287 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -52.77 -33.57 60.92 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 121.9 1.733 . . . . 0.0 112.672 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.563 ' CG2' HD23 ' A' ' 41' ' ' LEU . 19.2 m -63.01 -36.75 77.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.97 -179.172 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.627 ' O ' ' NH1' ' A' ' 31' ' ' ARG . 59.3 t -71.91 135.76 27.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.1 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.9 m -74.36 170.03 16.47 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -178.472 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.41 -37.3 86.75 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.108 179.377 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.408 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 97.8 mt-30 -133.57 59.32 1.74 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.684 ' NE2' HG23 ' A' ' 90' ' ' ILE . 12.5 t60 -58.49 -50.39 73.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.492 -1.231 . . . . 0.0 112.852 -176.651 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.475 ' SG ' ' N ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -150.26 156.51 41.7 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.088 -179.404 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.566 ' O ' ' N ' ' A' ' 61' ' ' HIS . 74.4 tttt -138.97 126.24 21.47 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.26 -179.414 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.4 mt -103.44 106.22 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.596 ' N ' ' O ' ' A' ' 59' ' ' ILE . 85.4 tt0 -79.71 123.28 27.53 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.365 -179.466 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.459 ' N ' HD12 ' A' ' 53' ' ' ILE . 1.7 mp -92.94 124.86 45.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.327 -179.801 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -105.88 174.27 5.96 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.354 179.342 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.57 ' O ' ' NH2' ' A' ' 5' ' ' ARG . 95.6 mt-10 -41.16 -42.72 2.11 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -178.609 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.419 ' HA ' HH21 ' A' ' 5' ' ' ARG . 87.1 mt-30 -144.06 22.49 1.73 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.275 -0.57 . . . . 0.0 112.227 -179.412 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.0 tp10 -151.09 152.21 33.09 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 119.887 -0.725 . . . . 0.0 111.654 -179.655 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.839 ' C ' HD12 ' A' ' 59' ' ' ILE . . . -113.9 134.14 55.0 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.713 179.068 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.839 HD12 ' C ' ' A' ' 58' ' ' ALA . 1.8 mp -124.33 129.19 74.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 112.883 0.698 . . . . 0.0 112.883 -177.711 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.584 ' HB2' HD11 ' A' ' 82' ' ' LEU . 49.1 tp -76.52 144.87 39.48 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.916 -179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.566 ' N ' ' O ' ' A' ' 50' ' ' LYS . 19.3 m-70 -140.62 79.04 1.68 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.122 179.422 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.762 ' ND2' ' H ' ' A' ' 69' ' ' THR . 24.9 t-20 -71.71 131.58 43.34 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.553 -179.168 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.498 ' CE1' ' O ' ' A' ' 61' ' ' HIS . 15.7 m-85 -105.16 -34.03 8.07 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.461 179.045 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.494 ' OG ' ' ND2' ' A' ' 62' ' ' ASN . 16.7 p -57.35 133.82 55.47 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.687 -178.406 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.0 p -102.3 -52.38 3.14 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.094 179.263 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.7 m -62.67 -46.73 86.82 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.368 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -121.46 83.76 41.09 Favored Pre-proline 0 C--N 1.327 -0.382 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.227 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.47 148.4 54.17 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.576 1.517 . . . . 0.0 112.268 -178.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.762 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 41.3 m -63.35 156.2 26.54 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.487 ' O ' ' N ' ' A' ' 89' ' ' THR . 86.1 mt-30 -124.56 141.77 51.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.228 0.537 . . . . 0.0 112.374 -177.871 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.505 ' O ' ' N ' ' A' ' 74' ' ' SER . 42.8 t -126.6 133.02 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.342 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 46.1 30.58 0.98 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.075 178.921 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 78.05 18.55 76.51 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.734 -0.947 . . . . 0.0 110.734 179.886 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 71' ' ' VAL . 47.3 t -117.01 137.78 52.01 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.843 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 91.0 t -69.7 149.88 10.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.312 0.577 . . . . 0.0 111.009 -179.568 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.9 mm -108.78 90.14 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.845 -179.549 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -65.23 -41.04 94.77 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.52 179.128 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.551 ' O ' HG13 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -146.49 173.04 4.55 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.673 -179.497 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -53.56 136.72 64.96 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 121.613 1.542 . . . . 0.0 110.304 179.679 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.551 HG13 ' O ' ' A' ' 78' ' ' GLU . 28.2 m -137.76 160.31 33.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.413 -178.72 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -78.77 137.08 37.57 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.893 179.197 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.584 HD11 ' HB2' ' A' ' 60' ' ' LEU . 87.2 mt -103.6 134.3 47.17 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.28 -178.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.595 ' N ' ' OD2' ' A' ' 86' ' ' ASP . 99.5 mttt -92.74 152.87 19.25 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.719 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 46.1 t60 -60.39 131.03 49.5 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.121 -179.528 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.09 6.16 63.41 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 -179.468 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.595 ' OD2' ' N ' ' A' ' 83' ' ' LYS . 86.6 m-20 -74.0 156.52 37.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.977 0.417 . . . . 0.0 111.174 179.728 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 51.1 t -117.73 132.71 66.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.481 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.3 mm -100.83 130.99 49.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.666 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.487 ' N ' ' O ' ' A' ' 70' ' ' GLN . 89.1 m -132.01 126.86 34.95 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.266 -0.574 . . . . 0.0 111.62 179.823 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 1.072 HG22 ' H ' ' A' ' 91' ' ' ILE . 75.6 mt -101.71 -152.44 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.083 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 1.072 ' H ' HG22 ' A' ' 90' ' ' ILE . 91.6 mt -62.82 -43.63 98.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 118.644 0.656 . . . . 0.0 112.132 -178.699 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.475 ' OD1' ' O ' ' A' ' 91' ' ' ILE . 96.6 m-20 -141.07 -1.52 1.37 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 119.932 -0.707 . . . . 0.0 112.82 -179.503 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -123.74 146.35 48.36 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.171 -179.319 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.7 t -131.13 149.99 52.35 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.088 0.47 . . . . 0.0 112.083 -178.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -128.92 150.36 50.4 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.608 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.551 ' N ' ' O ' ' A' ' 8' ' ' VAL . 47.0 mtp180 -105.29 134.08 48.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.969 179.489 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.531 ' C ' ' CD1' ' A' ' 97' ' ' TYR . 0.8 OUTLIER -113.13 109.17 18.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.969 0.414 . . . . 0.0 110.627 -179.705 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.8 mp0 -129.18 122.12 29.12 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.816 -179.667 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -94.89 112.55 24.26 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.151 179.14 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 . . . . . 0 C--N 1.328 -0.354 0 CA-C-O 121.035 0.445 . . . . 0.0 111.166 -179.464 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.0 mtp . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.141 0.496 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' TRP . . . . . 0.485 ' CD1' ' N ' ' A' ' 2' ' ' TRP . 8.8 p-90 -156.52 57.6 1.46 Allowed Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.797 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -65.41 145.2 82.42 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.544 2.163 . . . . 0.0 112.363 -179.396 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 95.2 m -131.36 133.02 44.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.191 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.45 ' HE ' HG21 ' A' ' 53' ' ' ILE . 90.2 mtm-85 -80.37 132.24 35.74 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.498 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.506 ' NH2' ' CG ' ' A' ' 19' ' ' HIS . 8.8 ptm180 -143.71 146.17 32.98 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.326 -0.549 . . . . 0.0 111.275 -179.292 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.563 ' HG ' HD11 ' A' ' 22' ' ' LEU . 96.0 mt -110.14 131.58 54.93 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.584 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 43.0 t -116.59 133.15 64.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.805 -179.63 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.54 ' OG1' ' CE2' ' A' ' 95' ' ' PHE . 23.4 m -105.23 122.7 46.48 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.725 -179.319 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.59 HD11 ' HD2' ' A' ' 96' ' ' ARG . 95.2 mt -77.65 115.38 19.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.32 -179.543 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -64.26 -41.06 97.12 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 178.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.486 ' O ' ' CG2' ' A' ' 10' ' ' ILE . 78.1 ttt180 -143.77 146.7 33.31 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.365 179.144 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.1 m -61.04 134.77 57.42 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.28 -179.077 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.15 -16.72 60.61 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.333 179.144 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.54 ' O ' HG23 ' A' ' 10' ' ' ILE . 3.3 m -132.08 139.84 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 117.372 0.586 . . . . 0.0 111.796 -179.221 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.581 ' OD1' ' NH1' ' A' ' 96' ' ' ARG . 87.0 m-20 -74.33 139.55 44.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.18 179.46 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -110.69 -164.25 18.76 Favored Glycine 0 CA--C 1.533 1.177 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.805 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.02 150.03 80.96 Favored 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 123.139 2.56 . . . . 0.0 112.159 179.324 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.506 ' CG ' ' NH2' ' A' ' 6' ' ' ARG . 6.6 m170 -96.8 173.77 7.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.141 0.496 . . . . 0.0 111.58 -178.92 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -142.21 93.08 7.34 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.01 -179.006 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -58.08 148.1 79.33 Favored 'Trans proline' 0 N--CA 1.501 1.963 0 C-N-CA 122.8 2.333 . . . . 0.0 111.683 179.544 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.665 HD13 ' CD1' ' A' ' 53' ' ' ILE . 97.2 mt -107.59 120.51 42.4 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.837 -178.576 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.475 ' C ' HD12 ' A' ' 24' ' ' LEU . 78.7 p -112.55 -20.42 11.74 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.521 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.499 ' N ' HD12 ' A' ' 24' ' ' LEU . 9.2 mp -112.17 134.84 53.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.143 179.725 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 53.3 p -65.15 -16.01 63.03 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.177 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 10.1 p -116.03 109.06 17.02 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.842 179.912 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -101.9 130.99 48.52 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.684 -0.407 . . . . 0.0 110.524 179.546 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.454 ' H ' ' HB2' ' A' ' 36' ' ' ASP . 0.8 OUTLIER -122.01 148.06 45.29 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.035 0.445 . . . . 0.0 111.762 -179.156 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.503 ' CE2' HG21 ' A' ' 37' ' ' ILE . 10.3 m-85 -111.86 144.78 40.61 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.524 -178.451 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 143.65 169.32 12.66 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 120.243 -0.98 . . . . 0.0 112.28 178.364 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 79.3 mtp180 -64.56 -36.05 82.98 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.341 -0.429 . . . . 0.0 112.0 -179.622 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.425 ' O ' ' SG ' ' A' ' 35' ' ' CYS . . . -48.87 147.25 5.59 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.446 -0.883 . . . . 0.0 111.355 -178.464 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.744 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -66.78 -39.98 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.636 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.496 ' N ' ' CG2' ' A' ' 33' ' ' ILE . 22.1 pt-20 -56.07 -12.91 1.65 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.645 -179.479 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' A' ' 32' ' ' GLY . 17.4 m -74.82 124.17 26.35 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.987 -179.761 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.454 ' HB2' ' H ' ' A' ' 28' ' ' LEU . 88.8 m-20 -62.22 -38.95 91.14 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.583 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.503 HG21 ' CE2' ' A' ' 29' ' ' PHE . 4.0 mm -108.24 79.95 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.728 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -68.61 131.89 45.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.909 -178.265 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.61 HG21 HG21 ' A' ' 44' ' ' VAL . 96.6 mt -122.54 124.36 70.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.813 179.447 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.661 ' O ' HD12 ' A' ' 41' ' ' LEU . 99.4 mm-40 -92.95 80.43 4.6 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.098 179.896 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.661 HD12 ' O ' ' A' ' 40' ' ' GLN . 0.8 OUTLIER -156.27 126.15 3.27 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.007 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -63.98 -24.31 67.29 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.467 1.445 . . . . 0.0 113.064 -178.029 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.8 m -70.24 -32.82 52.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.541 -0.463 . . . . 0.0 111.439 -179.692 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.61 HG21 HG21 ' A' ' 39' ' ' ILE . 98.5 t -73.82 138.99 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.9 t -77.69 164.36 25.35 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.406 -0.517 . . . . 0.0 110.574 -179.309 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.42 -38.82 85.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.202 -179.393 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -127.51 59.97 1.43 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.437 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.724 ' CD2' HG23 ' A' ' 90' ' ' ILE . 12.1 t60 -58.77 -52.97 63.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.329 -1.305 . . . . 0.0 112.643 -176.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.515 ' SG ' HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -148.99 160.9 42.88 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.393 -179.459 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.574 ' O ' ' N ' ' A' ' 61' ' ' HIS . 77.6 tttt -145.16 125.66 14.05 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.956 -178.842 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 97.0 mt -99.34 98.52 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.509 178.539 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.596 ' N ' ' O ' ' A' ' 59' ' ' ILE . 85.4 tt0 -78.43 114.28 17.19 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.665 ' CD1' HD13 ' A' ' 22' ' ' LEU . 75.3 mt -103.26 122.21 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.346 -178.275 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.633 ' CE1' ' H ' ' A' ' 57' ' ' GLU . 9.8 p80 -110.83 158.7 18.4 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.575 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -37.66 -22.83 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -178.105 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.533 ' N ' ' O ' ' A' ' 54' ' ' HIS . 87.4 mt-30 -107.21 -37.55 6.24 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -177.423 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.633 ' H ' ' CE1' ' A' ' 54' ' ' HIS . 63.6 tt0 -157.33 165.67 35.17 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 118.122 -1.431 . . . . 0.0 113.272 -177.128 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.548 ' HB3' ' CE2' ' A' ' 97' ' ' TYR . . . -89.53 130.78 35.8 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.477 178.223 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.596 ' O ' ' N ' ' A' ' 52' ' ' GLU . 40.8 mm -124.7 127.51 72.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.813 -178.057 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.754 ' CD2' HD13 ' A' ' 76' ' ' ILE . 48.8 tp -78.56 149.1 33.11 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.912 0.386 . . . . 0.0 111.796 -179.34 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.574 ' N ' ' O ' ' A' ' 50' ' ' LYS . 13.8 m-70 -143.32 78.92 1.62 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.478 179.251 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.697 ' ND2' ' H ' ' A' ' 69' ' ' THR . 26.9 t-20 -71.38 137.92 48.76 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.431 -179.633 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.517 ' CE1' ' O ' ' A' ' 61' ' ' HIS . 14.9 m-85 -111.49 -34.69 6.02 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.698 178.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.2 m -59.69 140.64 56.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.956 -178.102 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.3 t -105.11 -60.66 1.58 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.697 -179.818 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.8 m -61.31 -48.83 79.55 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.805 -179.751 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.403 ' OD1' ' N ' ' A' ' 67' ' ' ASN . 0.1 OUTLIER -114.81 79.4 5.82 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.189 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.87 151.93 36.24 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.257 1.971 . . . . 0.0 112.051 -178.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.697 ' H ' ' ND2' ' A' ' 62' ' ' ASN . 99.4 m -61.05 165.76 4.02 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 178.131 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.469 ' N ' HG22 ' A' ' 69' ' ' THR . 83.7 mt-30 -136.42 148.03 47.57 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.264 -0.575 . . . . 0.0 111.511 -177.799 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.958 HG23 HD11 ' A' ' 76' ' ' ILE . 42.0 t -127.34 131.22 70.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.016 179.016 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 48.63 30.19 2.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.631 179.512 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.14 -3.8 86.61 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 120.4 -0.905 . . . . 0.0 111.005 -179.73 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 61.9 p -82.74 174.03 11.35 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.492 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.2 t -112.84 139.94 35.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.571 0.701 . . . . 0.0 109.928 179.137 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.958 HD11 HG23 ' A' ' 71' ' ' VAL . 68.2 mt -107.52 110.12 30.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.425 -178.244 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -97.71 -4.09 37.88 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.083 179.927 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.42 ' O ' HG13 ' A' ' 80' ' ' VAL . 3.6 mt-10 -169.01 171.51 3.37 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.01 -179.583 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.4 138.06 79.05 Favored 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 122.134 1.889 . . . . 0.0 111.231 179.012 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.42 HG13 ' O ' ' A' ' 78' ' ' GLU . 33.0 m -138.51 160.14 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-O 121.225 0.536 . . . . 0.0 112.019 -179.64 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -80.19 133.28 36.02 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.748 178.797 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.524 HD11 ' HB2' ' A' ' 60' ' ' LEU . 97.4 mt -104.73 138.04 41.62 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.952 -179.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -102.08 157.59 16.77 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.062 179.025 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 58.0 t60 -62.44 133.31 54.83 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.647 -179.114 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 94.5 -9.1 71.74 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.211 179.427 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -65.41 147.35 53.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 117.093 0.447 . . . . 0.0 110.524 -179.866 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.428 HG22 ' HG2' ' A' ' 96' ' ' ARG . 45.1 t -114.39 131.7 65.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.333 -179.245 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.414 ' CG2' ' CG2' ' A' ' 69' ' ' THR . 57.7 mt -105.22 134.8 45.68 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 179.824 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 90.0 m -125.39 123.3 39.02 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.007 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 1.041 HG22 ' H ' ' A' ' 91' ' ' ILE . 80.2 mt -93.64 -154.58 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 177.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 1.041 ' H ' HG22 ' A' ' 90' ' ' ILE . 93.9 mt -63.13 -43.44 98.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 119.167 0.894 . . . . 0.0 112.355 -178.385 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -135.7 -1.96 2.45 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -178.551 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.452 HH21 HG21 ' A' ' 9' ' ' THR . 82.0 mtp180 -123.26 160.32 26.86 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.805 -179.348 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.7 m -127.55 145.35 50.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.04 179.867 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.54 ' CE2' ' OG1' ' A' ' 9' ' ' THR . 56.5 m-85 -130.49 151.03 51.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.236 -179.91 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.59 ' HD2' HD11 ' A' ' 10' ' ' ILE . 79.7 mtp180 -121.2 136.39 54.98 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.148 -179.257 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.548 ' CE2' ' HB3' ' A' ' 58' ' ' ALA . 0.7 OUTLIER -111.72 111.55 22.6 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.03 0.443 . . . . 0.0 109.957 -179.971 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -117.18 122.76 44.96 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.238 -178.842 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -115.21 100.15 7.93 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.484 179.1 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 . . . . . 0 C--N 1.327 -0.381 0 CA-C-O 121.1 0.476 . . . . 0.0 111.002 -179.164 . . . . . . . . 0 0 . 1 stop_ save_